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Summary 
Maintaining an undamaged, stable genome during DNA transcription, replication and 
cell division is a pivotal task for cells and therefore governed by a vast variety of 
surveillance and repair mechanisms. Lesions in genomic DNA are recognized and 
reported by a signaling network termed DNA damage checkpoint. Subsequently, affected 
cells stop their cell cycle and activate DNA repair mechanisms in order to clear the 
genome from DNA lesions and resume the cell cycle with a healthy genome. The 
molecular pathways coordinating and executing the response to DNA damage are 
tailored to the nature of the lesion as well as to the cell cycle stage-specific properties of 
chromosomes. As a consequence, the DNA damage response (DDR) is highly cell cycle-
regulated. We are interested in the molecular mechanisms underlying this regulation.  
Our entry point to these studies was the scaffold protein Dpb11, which acts as a reader of 
cell cycle-regulated PTMs set by the major cell cycle kinase CDK (cyclin-dependent 
kinase). Earlier research has identified two key points of CDK regulation in the DNA 
damage response: DNA damage checkpoint signaling and DNA repair pathway choice. 
Intriguingly, both processes are controlled by DNA end processing via resection. 
Therefore I propose that the cell cycle control of DNA end resection shapes these 
downstream responses.  
Yet, it remained elusive how DNA end resection is ultimately regulated by the cell cycle, 
how chromatin – the resection substrate – plays into this regulation and how the amount 
of end resection, which can be viewed as an indicator of the repair status of the DNA 
lesion, is quantitatively sensed by DNA damage checkpoint proteins and translated in an 
appropriate signaling response. 
 
In this thesis work, we demonstrate that the nucleosome remodeler Fun30 is targeted to 
DSBs in a cell cycle-regulated manner by a CDK-dependent complex with Dpb11. By 
using loss- and gain of function mutants of FUN30, which specifically manipulate 
FUN30 activity at DSBs, we could establish Fun30 and resected chromatin as decisive 
bottleneck to end resection (Bantele et al, eLife (2017)).  
One specific result of DNA end resection is the generation of single-stranded DNA 
(ssDNA), which is recognized and quantified by the DNA damage checkpoint machinery 
Summary 
  
	 10	
in order to signal the presence and severity of a DNA lesion and facilitate its repair. Here, 
we could dissect two distinctly acting checkpoint circuits, both activated by the apical 
checkpoint kinase Mec1. Interestingly, we find that only one of them integrates the 
ssDNA signal generated during resection, while the other was resection-independent. 
Interestingly, we were able to reveal a synergy between two DNA damage sensors – the 9-
1-1 complex and RPA – in counting ssDNA signals, and thus demonstrate a novel role 
for the 9-1-1 complex as quantitative checkpoint signal sensor at DSBs (Bantele et al, in 
revision).  
Notably, both resection and checkpoint signaling share one central regulator, the scaffold 
protein Rad9. Rad9 is an antagonist of Fun30, as it inhibits DNA end resection, but at 
the same time an important checkpoint mediator that recruits the effector kinase Rad53 
to DSBs. Current models distinguish between cell cycle-independent chromatin 
association of Rad9 and a cell cycle-dependent Rad9-Dpb11 interaction, both targeting 
Rad9 to DSBs. We uncovered a novel mode of the Rad9-Dpb11 interaction. This 
interaction mode allows cell cycle-independent Dpb11-Rad9 complex formation and 
suggests a yet unknown function of Rad9 outside of CDK-active cell cycle phases (Di 
Cicco et al, Scientific Reports (2017)). 
Previous studies hypothesized putative removal of Rad9 from DSBs by competition with 
other Dpb11 binders, such as the repair scaffolds Slx4 and Rtt107, which was thought to 
dampen the DNA damage checkpoint. Here, we demonstrate that rather the Dpb11-
Slx4-Rtt107 complex has an active function in DNA repair thus removing DNA lesions, 
which elicit the checkpoint in the first place. In this context, we describe a cell cycle-
dependent multi-protein complex of Dpb11-Slx4-Rtt107 with structure-specific 
endonucleases, which serves to promote the resolution of joined molecules  (for example 
Holliday junctions) in a spatially and temporally controlled manner (Gritenaite et al, 
Genes and Development (2014)).  
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Introduction 
1.1  Maintenance of genome integrity 	
Our entire genetic information is stored in the sequence and epigenetic regulation of 
each cell’s genomic DNA. As such, the genomic DNA is a living organism’s most 
valuable biomolecule and needs to be preserved over many cycles of DNA replication and 
cell division. This presents a major challenge since the DNA is substrate of a number of 
metabolic processes such as transcription, replication and mitosis and is in this context 
being exposed from its protective chromatin packaging (Takata et al., 2013). The 
genome is vulnerable to DNA damage, which can cause mutagenesis, loss of genetic 
information and finally result in genomic instability if not removed timely and with high 
precision. It is well known that elevated mutagenesis rates can be correlated with ageing 
and disease ((Kennedy, Loeb, & Herr, 2012), (Lodato et al., 2018)). The vital 
importance of fast and error-free DNA repair and maintenance of genome stability is 
underscored by the connection between malfunctioning DNA repair systems and a 
prevalence of human diseases, often characterized by predispositions to tumorigenesis or 
premature ageing (progeria). Prominent examples are Werner Syndrome, Bloom 
syndrome (BS), Fanconi anemia (FA), Xeroderma pigmentosum (XP), Ataxia 
talengiectasia (AT), Nijmegen breakage syndrome (NBS), and hereditary ovarian and 
breast cancer (O'Driscoll, 2012). With growing knowledge about the mechanisms of 
DNA repair, ever more syndromes connected to failures in these mechanisms emerge 
(O'Driscoll, 2012).  
It is particularly fascinating that the DNA maintains one feature that distinguishes it 
from all other biomolecules which piece together a cell like proteins, lipids, RNAs and 
sugars. These cellular components can be degraded and rebuilt from scratch in case they 
get damaged. In stark contrast, the DNA as unique blueprint and genetic repository must 
be maintained throughout the entire life of the cell. For this reason, the machineries to 
detect and repair DNA damages are highly conserved, and underlie sophisticated 
networks of regulation. Nonetheless, the whole concept of evolution mandates the 
acquisition of mutations as result of faulty DNA damage repair. DNA damage can 
Introduction 
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therefore be equally seen as threat to a cell’s survival and opportunity to evolve according 
to the cellular consequence that a particular mutation brings along. 
Despite the fact that we know many of the players involved in the DNA damage response 
(DDR), we only begin to understand their regulation on the molecular level. It is 
therefore a great motivation to further study the molecular mechanisms that govern the 
signaling at and repair of DNA damage sites. This thesis focuses on regulatory aspects of 
the DNA damage response, the cell cycle regulation of protein-protein interactions and 
their impact on several central processes within the DDR.  
1.1.1 Occurrence and nature of DNA lesions 
The DNA molecule has two breaking points being affected by damage: The 
phosphodiester backbone and the nucleobases, which connect the two single strands by 
forming hydrogen bonds. Different types of DNA lesions range from single nucleotide or 
nucleobase modifications (abasic sites, deamination, addition of small chemical groups 
like alkylation or oxidation, or addition of larger chemical groups or protein adducts) 
over single-strand breaks (SSBs) up to complete disruption of both strands of the DNA 
double-helix, the so-called DNA double-strand breaks (DSBs) (Fig. 1). Another group of 
damage comprises intra- or inter-strand crosslinks as generated by radiation or certain 
chemotherapeutic chemicals. 
All kinds of DNA lesions – if not properly repaired – can severely affect function and 
structure of the DNA and potentially give rise to mutagenic events like point mutations 
or larger alterations in the DNA sequence. In particular, two-ended DSBs can cause 
dramatic genome rearrangements (translocations) and loss of genetic information by 
fusion of wrong ends or mis-guided recombination (Pfeiffer, 1998). Therefore, DSBs are 
regarded as one of the most deleterious and genotoxic forms of DNA damage. 
The sources of DNA lesions can have different origins and can be sub-grouped in 
external (environmental) and internal (metabolic) sources.  External environmental 
stresses like radiation or exposure to genotoxic chemicals are a common source of DNA 
damage. Particularly ionizing radiation (IR) threatens the genome integrity since it 
generates DNA breaks in a direct manner or by producing free water radicals (Sonntag, 
2006), which react with the DNA molecule causing single-strand breaks often 
accompanied by oxidative damage ((Olive, Durand, & Banáth, 1990), (Ward, 1988)). 
Furthermore, ultraviolet (UV) radiation damages the DNA by inducing the formation of 
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photo-products like cyclobutane-pyrimidine dimers (CPDs) and 6-4 photoproducts, 
which both distort the DNA helix (Pearlman, Holbrook, Pirkle, & Kim, 1985), but also 
by generation of DSBs at sites of clustered oxidative lesions ((Greinert et al., 2012),(R. P. 
Sinha & Häder, 2002)). Besides these external factors, a variety of aberrant metabolic 
processes challenge the integrity of the genomic DNA. Among these are reactive nitrogen 
and oxygen species (ROS) ((Ohshima, Yermilov, Yoshie, & Rubio, 1999), (Cadet & 
Wagner, 2013)) and errors during DNA replication leading to small deletions, insertions 
or mismatched bases (Lindahl, 1993).  
 
 
Fig.1 Overview over different kinds of DNA damage. DNA lesions can be classified in two 
categories: lesions affecting single bases which leave the phosphodiester-backbone of the DNA strand 
intact (blue), and lesions affecting the integrity of one or two DNA strands including the backbone 
(breakage or distortion, red). Single base lesions comprise abasic sites, chemical modification such as 
oxidation or methylation, and larger chemical modifications generating bulky adducts. A second class of 
DNA lesions, by which the conformation and integrity of the DNA helix is affected, comprise DNA 
double-strand breaks (DSBs), DNA single-strand breaks (SSBs), pyrimidine dimers (such as thymine 
dimers), inter- and intra-strand crosslinks (not shown in this figure) and base mismatches. Importantly, 
also single base damages can be converted to SSBs or even single-ended DSBs when clashing with helicases 
during transcription or DNA replication.  
 
DNA lesions that involve damage of just one DNA strand are repaired by mechanisms 
that remove the damage site and fill in the missing nucleotides templated by the non-
damaged DNA strand, for example during nucleotide excision repair (NER), base 
excision repair (BER), mismatch repair (MMR) and interstrand-crosslink repair (ICL). 
Such mechanisms cannot operate at DNA double-strand breaks, at which both DNA 
strands are broken. For the purpose of this thesis, I will focus on the repair of DNA 
double-strand breaks in the following.  
Importantly, some DSBs are developmentally programmed and deliberately introduced 
into the genomic DNA, being required for housekeeping DNA metabolism. In those 
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cases, cells either prevent recognition of the DSB by the DNA damage response 
machinery or utilize it in a targeted manner to trigger recombination events. The latter is 
vital to establish diversity in germ cells during meiosis (Longhese, Bonetti, Guerini, 
Manfrini, & Clerici, 2009) and B- and T-cells by class switch recombination and V(D)J 
recombination of antibody segments (Arya & Bassing, 2017). Yeast cells additionally use 
the specific induction of a DSB to switch the mating type by recombination of mating 
type cassettes (Haber, 2012). In contrast, several other DNA metabolic processes do not 
trigger recombination. One example are DSBs introduced by topoisomerase II (TopII) 
during replication (Vos, Tretter, Schmidt, & Berger, 2011). They serve to release 
topological stress arising before and behind DNA replication forks because of the un- and 
re-winding of the DNA helix. Finally, DNA intermediates arising during recombination 
(joined molecules (JMs), such as Holliday junctions) are cleaved by endonucleases to 
disentangle the repair template and substrate (Dehé & Gaillard, 2017).  
1.1.2 Cell cycle checkpoints 
The genome is permanently scanned for damages by a network of tightly regulated 
damage recognition and repair machineries, which are collectively referred to as the DNA 
damage response (DDR). The general substrate of the DDR network is the genomic 
DNA in the form of chromosomes. During the cell cycle, chromosomes undergo several 
structural rearrangements to allow efficient DNA replication and safe division of the 
resulting sister chromatids in two cells during the anaphase of mitosis. These 
rearrangements include relaxation and condensation of chromatin, DNA and chromatin 
modifications, association of accessory proteins and changes in the copy number of the 
DNA (1n DNA content in G1 versus 2n DNA content after S and in the G2/M phase, 
Fig. 2 A).   
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Fig.2 Genomic DNA rearrangements and DNA damage checkpoint coordination 
within the cel l  cycle.  (a)  The cell cycle starts with a first gap phase (G1), in which the cell 
contains a 1n DNA content with relaxed chromatin and which is used to take up nutrients and 
grow. When the cell is large enough, it starts to re-synthesize its DNA (S phase) in order to 
duplicate the genome precisely once, so that cells end up with a 2n DNA content. A cell that has 
finished DNA replication with a fully duplicated genome transits into the second gap phase (G2), 
which in yeast is negligible and directly moves on to mitosis (M phase). During mitosis, the two 
replicated sister chromatids of each chromosome are separated to the two daughter cells. To do so, 
the chromosomes are highly condensed and display the well known X-shaped chromosome 
structure. Upon completion of anaphase, the cell returns to the gap phase (G1) and relaxes its 1n 
chromatin. (b) The major driver of the cell cycle is the cyclin-dependent kinase (CDK), which 
becomes activated to set off S-phase, stays active until the meta-to anaphase transition (timeframe 
of activity shaded in blue) and finally gets switched off to permit the mitotic exit. (c)  The integrity 
of the genomic DNA and the successful completion of the previous cell cycle stage is surveilled at 
each crucial cell cycle transition by so-called DNA damage checkpoints (red STOP signs).  
 
In order to ensure an optimal reaction to occurring DNA lesions in all cell cycle stages, 
the repair machineries need to be adjusted to these rearrangements. 
In general, this is achieved by two fundamental mechanisms. First, the major cell cycle 
kinase that drives the cell cycle - cyclin-dependent kinase (CDK) - also governs the 
choice of the correct repair mechanism ((Mathiasen & Lisby, 2014), (Langerak & 
Russell, 2011), (Symington & Gautier, 2011); as detailed below in paragraph 1.2.1) (Fig. 
2 B). Second, the DNA integrity is constantly kept on check by cell cycle stage-specific 
DNA damage checkpoints, which are signaling networks that are locally assembled and 
activated at the sites of DNA lesions in order to communicate their presence and severity 
to the cell (B. Zhou & Elledge, 2000). This becomes particularly important when the 
lesions cannot be mended instantly. In such cases, the checkpoints stop the cell cycle 
prior to the transition to the next cell cycle phase and up-regulate DNA repair 
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mechanisms (Fig. 2 C). This provides a window of time for the cell to repair the lesion 
and prevents the inheritance of the damaged DNA to the next generation. In case of too 
severe damage that the cell fails to repair, the checkpoint can trigger cell death.  
It is important to note that the term DNA damage checkpoint summarizes a complex 
network of proteins and signaling pathways, which are diverse in composition and 
regulation throughout the cell cycle. During G1, two distinct checkpoint mechanisms 
clear the cell for the entry into the cell cycle. First, the START checkpoint is assessing 
whether the cell is provided with enough nutrients and large enough to enter a new 
round of the cell cycle. Additionally, a G1 DNA damage checkpoint can get activated 
when DNA damage is present (Gerald, Benjamin, & Kron, 2002). After entry into S-
phase, an intra-S DNA damage checkpoint that is in parts physically connected with the 
moving replication forks detects damages present in the replication template or 
introduced during DNA replication (Branzei & Foiani, 2007). When replication is 
finished and cells enter mitosis, the resulting doubled genome is scanned for DNA 
lesions by the mitotic DNA damage checkpoint. Finally, before cells divide, the spindle 
assembly checkpoint (SAC) controls for correct attachment of the opposing spindle poles 
to the kinetochores of the chromosomes at the metaphase plane prior to physical 
separation of the chromosomes (Joglekar, 2016). This synergy between checkpoints 
controlling proper cell physiology by the START and SAC checkpoints and the DNA 
damage checkpoints controlling for the integrity of the genomic DNA throughout the 
cell cycle ensures safe cell propagation.  
 
The following work will focus on the DNA damage checkpoint and its response to DSBs 
throughout the cell cycle. Both difficult-to-repair lesions persisting too long or a high 
number of lesions present are situations that seriously challenge the repair machineries. 
To carry out the repair in a nonetheless faithful and complete manner, the cell requires a 
time buffer. Providing this time buffer is the major task of the DNA damage checkpoint, 
and it does so by not only pausing the cell cycle, but also enhancing subsequent DNA 
repair (Harrison & Haber, 2006)(Fig. 3). To achieve this, the checkpoint effector kinases 
(yeast Rad53, Chk1 and Dun1) target a plethora of substrates. Outcomes of this 
regulation are cell cycle arrest by stabilization of the anaphase inhibitor Pds1 (securin) 
(Cohen-Fix & Koshland, 1997) and a delay of anaphase progression by regulation of 
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microtubule-associated proteins (Krishnan, Nirantar, Crasta, Cheng, & Surana, 2004).  
Furthermore, the checkpoint kinases activate the transcriptional up- regulation of repair 
genes ((Gasch et al., 2001), (Jelinsky & Samson, 1999)) and enhance the expression of 
ribonucleotide reductase (RNR), an enzyme essential to dNTP production, which 
establishes adequate dNTPs levels for proper DNA replication and repair (Elledge, Zhou, 
Allen, & Navas, 1993). Locally, the upstream checkpoint signaling directly facilitates 
DNA repair by phosphorylating H2A-S129 (then termed γH2A.X or γH2A in 
yeast)((Downs, Lowndes, Nature, 2000, n.d.), (Nakamura, Du, Redon, & Russell, 
2004), (Paull et al., 2000), (Redon et al., 2003)), which constitutes a recruitment 
platform for repair factors such as Rtt107 ((X. Li et al., 2012), (Ohouo, de Oliveira, Liu, 
Ma, & Smolka, 2013)) and cohesin ((Unal et al., 2004), (Ström, Lindroos, Shirahige, & 
Sjögren, 2004)). Once all DNA damage has been removed from the cell, the checkpoint 
arrest is released allowing cells to re-enter the cell cycle. Figure 3 provides an overview 
over the global checkpoint response in yeast. 
 
 
 
Fig.3 Targets of the cel lular DNA damage checkpoint response.  The DNA damage 
checkpoint response establishes genome stability by facilitating DNA repair in three ways. While 
inhibition of cell cycle progression provides a window of time for the cells to act on the DNA lesion, 
repair factors and dNTP levels are up-regulated. Furthermore, the chromatin modification γH2A 
marking the DNA damage site helps to recruit repair factors and sustain checkpoint signaling until the 
DNA lesion is repaired successfully.  
 
The DNA damage checkpoint recognizes specific DNA structures that are generated at 
DNA lesion sites. The first signals being recognized are unprotected DNA ends. They are 
bound by the Ku complex ((Paillard & Strauss, 1991), (Blier, Griffith, Craft, & Hardin, 
1993), (Griffith, Blier, Mimori, & Hardin, 1992), (Walker, Corpina, & Goldberg, 
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2001)) and recognized by the MRX complex ((Lisby, Barlow, Burgess, & Rothstein, 
2004), reviewed in (Schiller, Seifert, Linke-Winnebeck, & Hopfner, 2014)). Both of 
them contribute to the stabilization of the DNA end and facilitate the binding of 
downstream checkpoint and repair factors. The DSB ends can then be further processed 
by various nuclease activities giving rise to two more molecular structures, which 
additionally serve as DNA damage signals. First, the concerted action of an endo- and 
two exonucleases in a process called DNA end resection ((Mimitou & Symington, 2009); 
chapter 1.2.2) generates 3’ single-stranded overhangs by digestion of the 5’ DNA strand. 
Additionally, resection creates a junction of single- to double-stranded DNA (ss-ds-
junction). Two distinct checkpoint sensor proteins independently recognize these 
structures (Kondo, Wakayama, Naiki, Matsumoto, & Sugimoto, 2001; Melo, Cohen, & 
Toczyski, 2001): single-stranded DNA is rapidly covered by a filament of RPA 
(Replication Protein A) molecules, while the ss-ds-junction is a signal to load the hetero-
trimeric ring-shaped 9-1-1 checkpoint clamp complex. Both sensors act as recruitment 
anchors for the checkpoint kinase cascade (see chapter 1.2.3).   
Sensor proteins are by definition the first factors present at a lesion site and fulfill the 
important task of marking position and possibly the amount of DNA damage. These two 
pieces of information are then integrated into the checkpoint signaling cascade and 
processed to the necessary degree of checkpoint activity, meaning a correlating amount of 
activated effector kinase molecules that set off the cellular response to the DNA lesion. 
Since this response stalls the cell proliferation and is energetically cost-intense, cells need 
to prevent unnecessary activation of the checkpoint.  
However, it can be estimated that a single cell accumulates more than 100,000 DNA 
lesions from endogenous and exogenous sources each day (Ciccia & Elledge, 2010; 
Hoeijmakers, 2009; LINDAHL & BARNES, 2000). These numbers sum up to almost 
two new DNA lesions per second per cell. Based on these numbers, it is likely that there 
is a basal level of DNA damage continuously present in the cell. Yet, cells need to 
proliferate while ensuring that the integrity of their genetic information is preserved 
throughout many generations.  
The critical challenge therefore is to find a proper balance between tolerance of a certain 
number of DNA lesions to allow proliferation and activation of the full-blown DNA 
damage response when the threshold of tolerance is exceeded. In other words, cells must 
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evaluate whether it is needed to activate the checkpoint or not. This in turn depends on 
the DNA damage load and the repair efficiency of the present damage.  
It has long been known that DNA damage signaling in general follows quantitative rules. 
In simple terms, one DNA lesions triggers less kinase activity than two or four lesions 
(Zierhut & Diffley, 2008). In addition, the amount of DSB resection plays a central role 
in reaching signaling thresholds, since it generates a very important damage signal, the 
ssDNA. Therefore, resection-proficient cells do activate the checkpoint stronger than 
resection-deficient cells (Bantele et al, in revision, (Balogun, Truman, & Kron, 2013), 
(Clerici, Trovesi, Galbiati, Lucchini, & Longhese, 2013)). Overall this suggests a model 
in which the cells locally assess the damage load, relay this information quantitatively to 
the global checkpoint effectors, and once a signaling threshold is reached, the full DNA 
damage response is triggered. To date, the mechanism underlying the quantitative 
assessment of signaling thresholds on the molecular level remains however elusive.  
 
1.2  The response to DNA double-strand breaks 	
The cellular response to DNA double-strand breaks can be subdivided in three groups of 
reactions: recognition and processing of the lesion site, the communication of the 
presence of the lesion via checkpoint signaling, and the actual repair of the lesion. 
Importantly, these reactions are tightly interconnected and fully interdependent, and 
they involve decision-making at several steps. Particularly, the manner in which lesion 
sites are processed dictates the subsequent repair pathway. Choice of the appropriate 
repair pathway is essential to successful repair and genome integrity, as it strongly 
depends on the context of the DSB and cellular conditions such as cell cycle phase. While 
homologous recombination (HR) is considered to be the most accurate mechanism, it 
does require a repair template with a homologous donor sequence. This template is 
usually the sister chromatid generated during replication and therefore only present in 
post-replicative cell cycle stages. HR in absence of a template fails or leads to mis-targeted 
recombination events that often go along with global mutagenic events like translocations 
or gross chromosomal rearrangements (GCR). In any case, genetic material that has been 
nucleolytically processed and cannot be restored by recombination due to absence of a 
donor sequence gets irreversibly lost. In diploid cells, the homologous chromosome can 
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in principle be used as recombination template, however this bears the risk of loss of 
heterozygosity and is therefore not favoured. Collectively, it is vital for the cell to prevent 
homologous recombination in absence of a proper template, and in order to do so, the 
repair pathway choice is tightly controlled during the cell cycle. Key to this regulation is 
the cell cycle kinase CDK, which becomes active when cells duplicate their genome in 
order to enter a new round of the cell cycle. In the following chapters I will highlight the 
molecular details of the mechanisms of the different steps of repair pathway choice, with 
a specific focus on their cell cycle regulation by CDK.  
1.2.1 Double-strand break repair pathways 
Cells have two basic regimes of DSB repair at their hands. One option is to repair DSBs 
by ligation-based mechanisms such as non-homologous end-joining (NHEJ) or micro-
homology-mediated end-joining (MMEJ). Alternatively, the broken sequence can be 
replaced by a copy derived from a homologous sequence in recombination-based repair 
mechanisms like homologous recombination (HR), synthesis-dependent strand annealing 
(SDSA), break-induced replication (BIR) and single-strand annealing (SSA). While 
ligation-dependent repair pathways are considered to be fast but error-prone, 
recombination is mechanistically more slow and complex but features the immense 
advantage of being templated and thereby highly accurate. The error-prone nature of 
ligation is based on the fundamental problem that it is sequence-independent, meaning 
that two lose ends are being re-connected no matter if DNA was lost or if they belong 
together in the first place. This in turn has the advantage of being independent of a repair 
template and therefore of the cell cycle stage in which the DNA damage is inflicted. 
Figure 4 provides an overview over occurrence and relationships between the different 
repair pathways (reviewed in (Ranjha, Howard, & Cejka, 2018)).  
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Fig.4 DNA repair  pathway choice within the cel l  cycle.  DNA repair pathways can be 
classified in resection-dependent (light blue) and resection-independent (grey) pathways. As resection is 
activated by CDK, the resection-dependent pathways are restricted to CDK-active cell cycle phases, 
while the resection-independent repair can occur throughout the cell cycle. Therefore, cells in G1 
exclusively rely on NHEJ. Since resection destroys the substrate for ligation-based repair such as NHEJ 
and MMEJ, it constitutes the switch between repair regimes (red arrow). Once resected, cells are 
committed to repair by HR, SSA, BIR or SDSA. These sub-pathways mainly rely on length and break-
distance of homologous sequences that can be used for annealing or recombination.  
 
For the purpose of this thesis, I will not go into detail about the specifics of the repair 
pathway sub-groups but talk about gene conversion recombination meaning (GC-) HR 
and ligation meaning NHEJ. Mechanistically, the processing of the DSB end is the first 
step in both repair pathways, and is thought to constitute the principle point of pathway 
choice regulation. While NHEJ requires no or – in case of complex, blocked DNA ends 
– little processing, homologous recombination needs extensive end processing by DNA 
end resection. DNA end resection is the nucleolytic digestion of both 5’ strands of the 
DSB ends, generating large stretches of 3’ single-stranded overhangs. These overhangs are 
a crucial structural intermediate of HR, while they strictly prevent repair by NHEJ. In 
other words, once resection is initiated, the template for HR is generated and at the same 
time the substrate for NHEJ is being destroyed. Thus, resection is the committing step in 
HR and therefore the main regulatory element to determine the choice of the correct 
repair mechanism (Fig. 4). As such, all steps of resection are under tight cell cycle 
control, as I will detail in the next chapter (chapter 1.2.2).  
The physiological balance of repair pathway occurrence is dictated by the cell cycle 
profile of the affected cell. Budding yeast cells are considered special, for they are highly 
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active in homologous recombination and use this as the preferred repair pathway of 
DSBs. In the lab, researchers greatly benefit from this feature of yeast cells since it allows 
easy and fast genome editing by HR. This however looks completely different in cultured 
human cells, which are largely post-mitotic with only low rates of recombination and 
usage of NHEJ as the preferred repair pathway ((Sonoda, Hochegger, Saberi, Taniguchi, 
& Takeda, 2006), (Mao, Bozzella, Seluanov, & Gorbunova, 2008), (Sargent, 
Brenneman, & Wilson, 1997)). In particular in the light of recent advances in 
recombination-based genome editing using CRISPR-Cas9 or similar systems, a low rate 
of recombination presents the bottleneck to efficiency (Orthwein et al., 2015).  
1.2.2 DNA end resection 
The process of DNA end resection can be sub-divided in two mechanistically distinct 
steps; the initiation of resection (or short-range resection) and the more processive long-
range resection. The enzymes involved in resection initiation generate but a few hundred 
basepairs of single-stranded DNA and additionally are specialized to deal with more 
complex molecular structures that might occur at DSB ends, such as hairpins or adducts 
(examples are trapped topoisomerases or Spo11-bound meiotic DSBs). It is generally 
believed that the initiation of resection is the limiting step of the overall resection 
reaction. The reaction is then handed over to the processive exonucleases carrying out 
long-range resection, which generates many kilobases of single-stranded DNA (Zhu, 
Chung, Shim, Lee, & Ira, 2008). Resection as such has two purposes: First, the ssDNA is 
the key signal for eliciting the cellular DNA damage response. Second, the ssDNA serves 
as primer for template-dependent DNA repair. How much of ssDNA is ultimately 
needed to fulfill these tasks is unclear. It has been suggested that as little as 2 kb of 
homology matched during homology search yield a high recombination rate and 
increasing the length does not enhance the efficiency further (C.-S. Lee et al., 2016). To 
date there is no in vivo evidence for a requirement of longer resected tracts. Interestingly, 
one study suggests that excessive resection can even be inhibitory to recombination (C.-S. 
Lee et al., 2016). This could be due to either the instability and loss of DNA at the 
overhanging 3’ strand (Zierhut & Diffley, 2008), or due to altered physical properties of 
an elongated Rad51-coated ssDNA filament that could slow or inhibit homology search. 
To date it is not known what defines the barriers to DNA end resection, if there actually 
is such a barrier or if not rather the repair of the lesion ends the resection reaction, and 
Introduction 
  
	 23	
how loss of genetic information due to excessive resection of long-persisting DSBs is 
prevented.  
1.2.2.1  INITIATION OF DNA END RESECTION BY THE MRX/SAE2 COMPLEX 
Initially, unprotected DNA ends are bound by the Ku complex, which shields them from 
nucleolytic processing and is therefore an inhibitor of DNA end resection and a pro-
NHEJ factor. In G1, Ku blocks the onset of resection and the eviction of Ku and 
recruitment of the resection machinery are preventing the direct repair of the DNA 
lesion by NHEJ and present the priming step for HR ((Mimitou & Symington, 2010), 
(Langerak, Mejia-Ramirez, Limbo, & Russell, 2011)).  In the absence of Ku or NHEJ 
proteins, cells show elevated levels of resection compared to the normally occurring 
resection in the respective cell cycle stage ((Clerici, Mantiero, Guerini, Lucchini, & 
Longhese, 2008), (Zierhut & Diffley, 2008)). Besides Ku, a second DNA end-binding 
protein complex regulates the initiation of resection and was found to be one of the first 
factors present at DSBs (Lisby et al., 2004): the Mre11-Rad50-Xrs2 complex (MRX). 
The MRX complex plays roles in DSB end tethering and checkpoint signaling via Xrs2-
Tel1 interaction. Through the Mre11 nuclease subunit, it has an additional function 
during resection initiation. Mre11 has ssDNA endo- and dsDNA exo-nuclease activity in 
vitro ((Paull & Gellert, 1998), (Hopfner et al., 2000), (Hopfner et al., 2001) and others). 
At obstructed DSB ends comprising secondary structures like hairpins or larger adducts, 
the Mre11 endonuclease activity in conjunction with a second endonuclease, Sae2, is 
required to clear this barrier to facilitate resection initiation ((Clerici, Mantiero, 
Lucchini, & Longhese, 2006), (Reginato, Cannavo, & Cejka, 2018)). Presumably, 
Mre11 opens hairpins, which are subsequently cleaved by Sae2 ((Lobachev, Gordenin, & 
Resnick, 2002), (Lengsfeld, Rattray, Bhaskara, Ghirlando, & Paull, 2007)). The 
endonuclease activity of Mre11 and its activation by Sae2 become distinctly important 
for the clearing of DSBs from covalently bound proteins, such as Spo11 during meiosis 
or trapped topoisomerase cleavage complexes ((Moreau, Ferguson, & Symington, 1999), 
(Neale, Pan, & Keeney, 2005), (Hoa et al., 2016), (Aparicio, Baer, Gottesman, & 
Gautier, 2016)).  
In contrast, the exonuclease activity of Mre11 is obscure since it generates 5’ ss-tails in 
vitro, while it seems required for the 5’-3’ resection generating 3’ ss-tails in vivo. 
Importantly, after stimulation by Sae2, Mre11 can set endonucleolytic cuts in a distance 
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to the DSB, releasing oligonucleotides. It is therefore tempting to hypothesize that the 
concerted action of the Mre11 endo- and 3’-5’ exonuclease activities in cooperation with 
the Exo1 5’-3’ exonuclease activity serve to generate ssDNA bi-directionally ((Garcia, 
Phelps, Gray, & Neale, 2011), (Cannavo, Cejka, & Kowalczykowski, 2013)). In cells 
lacking Mre11 or Sae2, Exo1 is partially able to compensate the defect in resection 
initiation (D. Nakada, Hirano, & Sugimoto, 2004). Additionally, the MRX complex was 
shown to recruit long-range resection factors in order to promote efficient long-range 
resection ((Niu et al., 2010), see chapter 1.2.2.2). Taken together, the MRX can 
contribute to DNA end resection by two mechanisms: the recruitment of long-range 
resection factors and the generation of their substrates ((Niu et al., 2010), (Cannavo & 
Cejka, 2014)). 
1.2.2.2  LONG-RANGE RESECTION BY EXO1- AND SGS1/DNA2- DEPENDENT 
PATHWAYS 
Long-range resection is defined as the processive, nucleolytic digestion of the 5’ strand at 
DSBs in order to extend the short stretches of 3’ ssDNA overhangs generated by the 
Sae2/Mre11 nucleases in the initiating step of resection. Long-range resection can result 
in tens of kilobases of ss-overhangs, which are generated with a speed of about 4 kb/h in 
cycling cells ((Zhu et al., 2008), (Eapen, Sugawara, Tsabar, Wu, & Haber, 2012), 
(Chung, Zhu, Papusha, Malkova, & Ira, 2010)). There are two independent pathways 
executing long-range resection, the Exo1- and STR (Sgs1-Top3-Rmi1)/Dna2 pathway 
((Mimitou & Symington, 2008), (Gravel, Chapman, Magill, & Jackson, 2008), (Zhu et 
al., 2008)). In the STR pathway, the RecQ helicase Sgs1 is thought to unwind the DNA 
while the helicase-nuclease Dna2 digests the 5’ strand (Zhu et al., 2008). It is unclear 
whether the Dna2 helicase activity is required for resection. In vitro studies suggest a 
translocase-like function of the Dna2 helicase, which seems to contribute to resection 
efficiency (Levikova, Pinto, & Cejka, 2017). The Dna2 action per se hereby fully 
depends on Sgs1 and RPA, while its 5’-3’ polarity is determined by RPA ((Niu et al., 
2010), (Cejka et al., 2010)). The XPG–family exonuclease Exo1 has so far not been 
genetically linked to a helicase activity, however the human Sgs1 homolog BLM can 
cooperate with human EXO1 during resection (Nimonkar, Ozsoy, Genschel, Modrich, 
& Kowalczykowski, 2008). The favoured substrates of Exo1 are 5’ ends with a 3’ 
overhang (Cannavo et al., 2013). Although classical models place long-range resection 
Introduction 
  
	 25	
downstream of the MRX/Sae2-dependent initiation step generating this substrate, Exo1 
and Sgs1/Dna2 are able to resect clean cuts as generated by endonucleases in absence of 
initiation enzymes, however with low efficiency (Llorente & Symington, 2004).  
Resection underlies a strong cell cycle control and is mainly acting during cell cycle 
phases in which CDK is active ((Zierhut & Diffley, 2008), (Barlow, Lisby, & Rothstein, 
2008), (Ira et al., 2004), (Trovesi, Falcettoni, Lucchini, Clerici, & Longhese, 2011)). 
This regulation is essential since once resection is initiated, the DSB is irreversibly 
channeled to recombination-based repair requiring a repair template ((Ira et al., 2004), 
(Aylon, Liefshitz, & Kupiec, 2004), (Y. Zhang, Shim, Davis, & Lee, 2009)). To this end, 
several layers of regulation operate by alteration of the activity of the resection enzymes, 
their DSB recruitment, and accessory factors which affect resection efficiency. The 
phosphorylation of resection factors by CDK constitutes the most important layer of 
resection control. Consequently, resection is suppressed when CDK-dependent enzyme 
activation lacks. Additionally, end protection by the Ku complex and enhanced activity 
of NHEJ factors prevent the initiation of resection in G1. When cells enter S phase, 
CDK phosphorylates several enzymes involved in resection and thereby favors end 
processing over re-ligation. CDK-dependent phosphorylation of Sae2 ((Huertas, Cortes-
Ledesma, Sartori, Aguilera, & Jackson, 2008), (Bonetti, Martina, Clerici, Lucchini, & 
Longhese, 2009), (Cannavo & Cejka, 2014))  and Dna2 (X. Chen et al., 2011) were 
shown to play an important role in this regulation. In human cells, also hsEXO1 is target 
of CDK phosphorylation (Tomimatsu et al., 2017). However, mutants bypassing the 
CDK-requirement for resection initiation were not able to fully restore efficient resection 
when CDK was inhibited (Huertas et al., 2008), suggesting the contribution of other 
CDK substrates. Indeed, by enhancing CDK activity via overexpression of the mitotic 
cyclin Clb2, the cell cycle regulation of resection can be partially overcome (Clerici et al., 
2008). Similarly, the deletion of resection-blocking proteins such as Rad9 and Ku does 
enhance resection in G1, but can not fully restore resection efficiency (Lazzaro et al., 
2008). All current efforts to overcome the cell cycle regulation have been concentrating 
on the resection nucleases and accessory protein blocks like Ku or Rad9. To date, the role 
of the resection substrate – the DNA in the context of chromatin – has not been factored 
in and will be discussed in Chapter 1.3.  
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1.2.3 Activation of the DNA damage checkpoint 
The DNA damage checkpoint is a signal transduction pathway with the major task to 
communicate occurrence and severity of DNA damage to the cell and activate the 
subsequent cellular response.  It is organized in a kinase cascade that locally assembles on 
damaged chromatin. This cascade is initiated by the sensor proteins Ku/MRX, RPA and 
9-1-1 which specifically associate with damage-specific DNA structures in order to 
recruit the apical kinases Mec1ATR and Tel1ATM and the mediator proteins Rad9 and 
Dpb11 providing the platform for further protein binding and regulation. The apical 
kinases phosphorylate a multitude of substrates at the damage site serving the double 
purpose of enhancing and regulating further checkpoint and repair protein binding and 
directly activating the effector kinases. Ultimately, the effector kinase Rad53 is recruited 
to the lesion site by binding to Rad9. This has two general effects: First, the effector 
kinase is brought into close proximity with the apical kinases mediating its activation. 
Second, this physical association of the effector kinase, which is critically required for its 
activation, provides an essential opportunity for regulation. Figure 5 provides an 
overview over the DNA damage checkpoint cascade in budding yeast.  
 
 
Fig.5 Architecture of the DNA damage checkpoint cascade.  The DNA damage checkpoint 
cascade is assembled on the basis of the sensor proteins RPA (red) and 9-1-1 (dark blue). RPA recruits the 
apical kinase Mec1-Ddc2 (brown), and the synergy of Mec1-and CDK-dependent phosphorylation steps 
mediates the assembly of the downstream checkpoint factors on 9-1-1. First, the scaffold Dpb11 (middle 
blue) binds to Mec1-modified 9-1-1 and then binds to CDK-phosphorylated Rad9 (light blue) with its 
second binding site. Rad9 then interacts with the effector kinase Rad53 (yellow) in a Mec1-dependent 
manner. Once Rad53 is in place, it becomes phosphorylated and thereby activated by Mec1 and 
enhanced by auto-phosphorylation.  
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The assembly of the checkpoint cascade largely follows protein-protein interactions 
induced by post-translational modifications (PTMs). In yeast, these are mainly 
phosphorylations, while higher eukaryotes additionally rely on ubiquitin signaling. 
Regulation of the checkpoint via PTMs has several intriguing advantages.  
A crucial aspect, that is vital to how the checkpoint functions, is the possibility of signal 
amplification by PTMs. In other words, one kinase molecule once activated has the 
propensity to phosphorylate hundreds of substrate molecules. Quantitatively this has as a 
consequence, that the checkpoint signal can be adjusted to the appropriate signal strength 
thoroughly. Qualitatively, this makes the checkpoint a switch-like mechanism, that can 
be switched on and off extremely fast and efficiently, controlled by the requirement for 
overcoming specific threshold levels.  
Furthermore, each interaction or protein activation facilitated by a PTM can be regulated 
on several levels: the localization of the enzyme and its substrate, activity of the enzyme 
and the reversal of the PTM for example by phosphatases. This allows a high sensitivity 
in fine-tuning of the DNA damage response and the checkpoint in particular.  
Taken together, the architecture of the checkpoint kinase cascade is tailored to provide a 
response that is perfectly adjusted to the needs of the affected cell. In the following 
subchapters, I will provide the molecular details of each step of DNA damage checkpoint 
activation and regulation.  
1.2.3.1  ROLE AND MECHANISM OF DNA DAMAGE SENSING 
Sensor proteins are the first factors that recognize and mark the lesion, and they do so by 
having a specific binding affinity for DNA structures being generated by DNA damage. 
Besides sensing such structures, sensor proteins provide the initial binding platforms for 
checkpoint and repair at the DSB. At a clean DNA double-strand break, the first 
structures present are the blunt DNA ends, which are bound and capped by Ku. Here, I 
will focus on structures and primary sensors that come into play one step later, once 
resection is ongoing, and which can therefore be rather attributed to the HR repair 
pathway. Resection reveals 3’ single-stranded DNA, which is rapidly covered by a 
filament of RPA, a trimeric protein complex consisting of the subunits Rfa1-3. The 
occurrence of single-stranded DNA is a key damage signal. Although multiple reactions 
during DNA metabolism generate transient ssDNA intermediates by unwinding of the 
helix in order to gain access to the genetic information, the DNA is never left uncovered 
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for reasons of protection, stability and prevention of secondary structure formation. RPA 
binds to the ssDNA with nanomolar affinity via OB fold domains (oligonucleotide-
/oligosaccharide-binding domains) (C. Kim, Paulus, & Wold, 2002). Interestingly, RPA 
recruitment to ssDNA acts as a positive enhancer of ssDNA formation. RPA prevents 
secondary structure formation and thereby stabilizes the 3’ overhang (H. Chen, Lisby, & 
Symington, 2013) and enhances the Exo1 processivity (Cannavo et al., 2013). 
Additionally, it recruits and modulates the activity of Sgs1 and Dna2 at DSBs ((H. Chen 
et al., 2013), (Cejka et al., 2010), (Niu et al., 2010)).  
The second DNA structure that is generated by resection is the ssDNA-dsDNA junction 
at the border of ongoing resection. This junction stimulates the recruitment of the 
PCNA-like 9-1-1 checkpoint clamp by a so far not fully understood mechanism. 9-1-1 is 
a heterotrimeric ring-shaped protein complex of Mec3, Rad17 and Ddc1 encircling the 
DNA, with the special feature of Ddc1 harboring a C-terminal extension that serves as 
protein-protein interaction domain. The 9-1-1 complex is loaded in its trimeric form 
(Majka & Burgers, 2005) by the RFC-Rad24 clamp loader ((Majka, Binz, Wold, & 
Burgers, 2006), (L. Zou, Liu, & Elledge, 2003)), which is a specialized form of the 
canonical RFC clamp loader that loads PCNA on replication forks, differing only in the 
replacement of the Rfc1 subunit by the damage-specific Rad24 subunit (homolog to 
human RAD17) (Green, Erdjument-Bromage, Tempst, & Lowndes, 2000). 9-1-1 
loading requires the presence of RFC-Rad24 and the RPA filament ((Majka et al., 2006), 
(Ellison & Stillman, 2003), (L. Zou et al., 2003)). Despite the fact that there are 
multiple protein-protein interactions between Rad24, 9-1-1 and RPA, respectively, the 
precise placement of the 9-1-1 to the junction and subsequent dynamics of binding are 
not understood on molecular level. It is particularly elusive how the recognition and 
binding to the junction is being coordinated with the nucleases that sit on the junction in 
order to proceed with resection, and whether resection and clamp loading can happen 
simultaneously or involve a temporary protein binding switch. Furthermore, we do not 
understand 9-1-1 dynamics in its DNA-loaded state, whether it is stably positioned or 
can diffuse along the ssDNA or even over the junction on dsDNA. In vitro, the 9-1-1 
loading gains its directionality by the influence of RPA. In absence of RPA, the clamp 
can be loaded to junctions of both directionalities (3’-5’ and 5’-3’) likewise (Majka et al., 
2006). It has also been suggested that 9-1-1 can directly interact with RPA via the C-
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terminal tail of the Ddc1 subunit in human cells (X. Wu, Shell, & Zou, 2005), and 
Ddc1 is in turn involved in stabilizing RPA (Sukhanova, D’Herin, Boiteux, & Lavrik, 
2014). 
Furthermore, it has been proposed that once loaded, 9-1-1 can slide across dsDNA in 
vitro (Majka et al., 2006). However, the physiological relevance of this sliding is unclear 
and needs to be assessed in vivo.  
Both checkpoint sensors, RPA and the 9-1-1, facilitate direct binding of checkpoint 
factors. While RPA is bound by the co-factor Ddc2 (L. Zou & Elledge, 2003), which 
brings the apical kinase Mec1 to the site of DNA damage ((Cortez, 2001), (Paciotti, 
Clerici, Lucchini, & Longhese, 2000)), the 9-1-1 fulfills a more complex role. Also the 9-
1-1 contributes to the recruitment and stability of Mec1-Ddc2 on the ssDNA, but it 
furthermore stimulates its kinase activity directly and indirectly by recruiting the 
checkpoint mediator Dpb11, which itself harbors a Mec1 activating activity. This 
mechanism is a self-enhancing feedback-loop, as the interaction between the 9-1-1 and 
Dpb11 is mediated by Mec1-dependent Ddc1 (9-1-1) phosphorylation on T602. The 
Ddc1- and the Ddc2- dependent sensing pathway were shown to act independently of 
each other to ensure rapid and sensitive damage recognition ((Melo et al., 2001), (Kondo 
et al., 2001)). Figure 6 provides details about protein-protein interactions involved in 
DNA damage sensing mechanisms.   
 
 
Fig.6 Functional interactions during the sensing of DNA damage structures.   RPA 
specifically binds to the ssDNA filament and subsequently interacts with Ddc2 to bring the Mec1 kinase 
to the DSB. Additionally, RPA interacts with the RFC-Rad24 clamp loader via Rfa1 ((Lindsey-Boltz, 
Reardon, Wold, & Sancar, 2012), (H. S. Kim & Brill, 2001), (Piya et al., 2015)), which enables loading 
of the 9-1-1 clamp to the ssDNA-dsDNA junction. To this end, RFC-Rad24 binds the 9-1-1 in an ATP-
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dependent manner, and this binding does not require the presence of DNA (Majka & Burgers, 2003). 
Upon ATP hydrolysis, the 9-1-1 clamp is being released from the clamp loader ((Majka & Burgers, 
2003), (Bermudez et al., 2003)). The 9-1-1 clamp itself can interact with RPA and becomes 
phosphorylated by Mec1 once loaded. This phosphorylation mediates the interaction between 9-1-1 and 
Dpb11 ((Navadgi-Patil & Burgers, 2009), (J. Lee, Kumagai, & Dunphy, 2007), (Delacroix, Wagner, 
Kobayashi, Yamamoto, & Karnitz, 2007), (Ohashi, Takeishi, Ueda, & Tsurimoto, 2014)). In turn, 9-1-1 
and Dpb11 harbor Mec1-activating domains, which boost Mec1 activity.  
 
One aspect of damage sensing should be specifically highlighted in this context; the 
involvement of the sensor pathways in transmission of quantitative information. It is 
established that RPA forms a filament around the ssDNA covering about 20-30 
nucleotides per trimer (Sugiyama, Zaitseva, & Kowalczykowski, 1997). Although it is 
likely that this filament is not strictly continuous, it offers a straight-forward model of 
how RPA binding can be quantitatively proportional to the amount of resection, and 
thereby add a quantitative measure to the checkpoint input sensing mechanism. The 
more ssDNA is formed, the more RPA trimers bind to elongate the RPA filament, and 
the more Mec1 molecules can be recruited to this filament. In contrast, we do not know 
whether the 9-1-1 is involved in quantitative damage sensing. It is unclear how many 9-
1-1 molecules are present at lesion sites and whether this corresponds to the length of the 
ssDNA. The activity of both sensor pathways is sufficient to elicit the DNA damage 
response even in absence of DNA damage (Bonilla, Melo, & Toczyski, 2008), but it is 
not clear to which extent they feed into overall checkpoint activity by quantitative means. 
Clearly, the two mechanisms of checkpoint sensing converge in the phosphorylation of 
Ddc1 by Mec1, and can therefore not be strictly separated when it comes to the 
quantitative nature of signaling.  
1.2.3.2  REGULATION OF THE APICAL CHECKPOINT KINASES MEC1-DDC2 AND 
TEL1 
The apical checkpoint kinases are recruited to DSBs by sensor proteins and become 
activated at the site of damage in order to phosphorylate a multitude of substrates. These 
phosphorylation events trigger checkpoint activation by mediating protein-protein 
interactions and effector kinase activation. The apical kinases belong to the family of 
PIKK kinases (Phosphatidylinositol 3-kinase related kinases) and specifically 
phosphorylate Ser/Thr residues in the context of the consensus sequence S/T-Q.  
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In yeast, the apical PIKK kinases to initiate and control checkpoint signaling are Mec1 
((Naiki, Wakayama, Nakada, Matsumoto, & Sugimoto, 2004), (Grenon, Magill, 
Lowndes, & Jackson, 2006)), structural homolog of the human ATR; and Tel1 
(Gobbini, Cesena, Galbiati, Lockhart, & Longhese, 2013),  the ATM homolog. 
Interestingly, the recruitment mechanisms of Mec1 and Tel1 seem mutually exclusive, so 
that a partial separation of function can be envisioned. Mec1, which is bound to its co-
factor Ddc2 ((Paciotti, Lucchini, Plevani, & Longhese, 1998)), is recruited to the 
ssDNA-RPA filament via a protein-protein interaction between Ddc2 and RPA (L. Zou 
& Elledge, 2003). Structural studies suggest a potential interaction mode in which a 
Mec1-Ddc2 dimer entity (comprising two Mec1 and two Ddc2 molecules) binds to two 
adjacent RPA molecules with a 1:1 stoichiometry (Deshpande et al., 2017). To date, we 
do not know about the in vivo stoichiometry of active kinase versus RPA filament length 
and the binding and activation dynamics, and it is not known whether the activated 
kinase is locally restricted to the ssDNA or can be soluble and diffuse in order to 
phosphorylate substrates in a larger radius around the DSB. What is however known is 
that Mec1 activation occurs locally at the site of the DSB involving several distinct 
activators (reviewed in (Navadgi-Patil & Burgers, 2011), (Wanrooij & Burgers, 2015), 
(Wanrooij, Tannous, Kumar, Navadgi-Patil, & Burgers, 2016)). In short, Mec1 is 
activated by a self-enhancing loop involving the 9-1-1 complex and the Dpb11 
checkpoint mediator (see chapter 1.2.3.1), and additionally stimulated by the nuclease 
Dna2. While the 9-1-1 complex can stimulate Mec1 activity throughout the cell cycle, 
Dpb11 acts only when CDK is active and Dna2 was suggested to be S-phase specific 
((Navadgi-Patil & Burgers, 2011), (Wanrooij & Burgers, 2015)). In contrast to Mec1, 
Tel1 as its human homolog ATM is stabilized at the DSB ends by direct interaction with 
the Xrs2 (human Nbs1) subunit of the Mre11-Rad50-Xrs2 complex (MRX, human 
MRN)((Falck, Coates, & Jackson, 2005), (D. Nakada, Matsumoto, & Sugimoto, 2003), 
(Mantiero, Clerici, Lucchini, & Longhese, 2007)), which is bound to the DSB end 
((Stracker & Petrini, 2011), (R. S. Williams, Williams, & Tainer, 2007), (Rojowska et 
al., 2014)). The MRX complex is thought to be destabilized at the DSB end once 
resection has been initiated. Ultimately, this means that the binding mechanism for Tel1 
is inactivated at the same time as the binding platform for Mec1 is generated, both by the 
process of DNA end resection. Thus, resection mediates a kinase switch from Tel1-
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dependent to Mec1-dependent kinase activity at the break site (Jazayeri et al., 2006), 
implying a high level of cell cycle regulation at the step of resection.  
 
 
Fig.7 Apical  kinase switch mediated by DNA end resection. Both yeast apical kinases, 
Mec1ATR-Ddc2ATRIP (brown) and Tel1ATM (purple), associate with DSBs via protein-protein interactions 
with checkpoint sensor proteins. Since these sensor proteins (MRX, green; RPA, red) recognize educt 
(DNA end) and product (ssDNA) of DNA end resection, respectively, resection automatically 
generates a switch from Tel1- to Mec1-dependent signaling.  
 
In cycling yeast cells, the damage response is therefore mainly governed by Mec1, while 
deletion of Tel1 has only very mild effects on checkpoint activation (Bantele et al, in 
revision, (Clerici et al., 2013), (Ira et al., 2004)). Conceptually, as discussed for RPA, the 
continuous accumulation of Mec1 molecules on the growing RPA filament presents an 
intuitive mechanism of how ssDNA signal strength can be quantified by the cell. It is 
however important to note that this model only factors in the presence of the kinase, 
thereby neglecting the requirement for substrate availability and kinase activation. In 
other words, it is not known how quantitative the Mec1 activation after RPA recruitment 
is, and in how far active Mec1 molecules have access to their substrates. Therefore it is 
not clear, whether Mec1 recruitment alone can fulfill the purpose of ssDNA signal 
strength quantification. 
1.2.4 Mediators in the DNA damage response 
A central feature of the DNA damage checkpoint cascade is the utilization of so-called 
scaffold proteins serving as checkpoint mediators. These scaffolds do not have intrinsic 
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enzymatic activity themselves but harbor several interaction sites for protein-protein 
interactions. Thereby, scaffolds act as multifunctional adaptors to physically bring 
together the checkpoint components like building blocks. Since the interaction sites 
underlie a regulation by phosphorylation (either cell cycle- specific or damage-
dependent), protein scaffolds spatially and temporally coordinate the assembly of specific 
complexes and thereby offer a handle to modulate signal transduction events. Key to this 
regulation is the interplay between specific binding sites on the scaffolds and PTMs on 
their binding partners. It is believed that complexes assembled in this way are rather of 
dynamic, transient nature, adding additional flexibility to the propagation of checkpoint 
signals. By this principle mechanism, cells are able to read and integrate several 
independent pieces of information such as cell cycle stage with the nature, presence and 
location of a DNA lesion and culminate these pieces of information into a tailored 
response.  
1.2.4.1  DPB11 AS MULTIFUNCTIONAL CDK READER 
The first scaffold protein to be recruited to the DSB is the particularly versatile 
replication adaptor Dpb11. Yeast Dpb11 has two tandem BRCT repeats at the N-
terminus and the middle domain, respectively (BRCT 1+2 and BRCT 3+4), to mediate 
protein-protein interactions (C. C. Y. Leung & Glover, 2014). With these domains, 
Dpb11 orchestrates and provides specificity to several processes of DNA metabolism. 
Among these are initiation of replication (Garcia, Furuya, & Carr, 2005), joint molecule 
(JM) resolution ((Gritenaite et al., 2014), (Princz et al., 2017)) and DNA damage 
checkpoint activation (Navadgi-Patil & Burgers, 2008), during which it cooperates with 
the damage-specific scaffold protein Rad9. Dpb11 is assembled at DSBs via an 
interaction between its central BRCT3+4 repeat and the Mec1-phosphorylated tail of the 
9-1-1 subunit Ddc1 ((Puddu et al., 2008), (Pfander & Diffley, 2011)). For most 
interactors, the Dpb11 BRCT repeats recognize CDK-dependent phosphorylation sites 
on the interacting partners, and it is therefore considered to be a reader of CDK activity. 
This ability to read CDK activity brings Dpb11 into focus of studying cell cycle 
regulation of DNA metabolism. Fig. 8 summarizes established Dpb11 complexes.  
 
 
 
Introduction 
  
	 34	
 
 
Fig.8 Dpb11 engages specif ic  protein pairs  into ternary complexes during various 
processes of DNA metabolism. Dpb11 has two BRCT domains, BRCT1+2 and BRCT3+4, which 
specifically bind to phosphorylated S/T residues of their interacting partners. The only essential complex 
formed by Dpb11 is the replication initiation complex with Sld3-Dpb11-Sld2 (Zegerman & Diffley, 
2007). In the center of checkpoint signaling, Dpb11 engages in a ternary checkpoint complex with Ddc1 
(9-1-1) and Rad9 (Pfander & Diffley, 2011). Further Dpb11 interactors involved in the DNA damage 
response such as the MRX complex, the scaffold protein Slx4 (Gritenaite et al., 2014) and others 
(Pfander, unpublished data) were identified. 
 
It is particularly interesting to note that at double-strand breaks, Dpb11 co-localizes 
partially opposing activities that counteract each other regarding DNA end resection and 
checkpoint activation. As such, the Dpb11 complexes may provide a buffering system, 
which can be tipped towards activating or inhibiting the respective activity dependent on 
the current needs and thereby adds to the fine-tuning of the DDR ((S. Bantele, Ferreira, 
Gritenaite, Boos, & Pfander, 2017), (Cussiol, Jablonowski, Yimit, Brown, & Smolka, 
2015), (Gritenaite et al., 2014), (Y. Liu et al., 2017)).  
Both checkpoint scaffolds, Rad9 and Dpb11, are evolutionary conserved up to humans. 
Human TopBP1Dpb11 harbors nine instead of four BRCT domains and is recruited to 
DSBs in a similar manner as the yeast Dpb11 (Wardlaw, Carr, & Oliver, 2014). 
However, its interaction with Rad9Ddc1 depends on constitutive CK2-dependent instead 
of damage-induced phosphorylation of Rad9Ddc1, and this interaction occurs via 
BRCT1+2 instead of BRCT3+4 in yeast (Takeishi et al., 2010). It has been proposed 
that human TopBP1 instead can directly interact with ssDNA-RPA, potentially 
facilitating its recruitment to DSBs (Acevedo, Yan, & Michael, 2016). 
1.2.4.2  DUAL ROLE OF THE CHECKPOINT SCAFFOLD RAD9 
Rad9 (structurally and functionally equivalent to human MDC1/BRCA1/53BP1) has 
been the first checkpoint player being identified (Weinert & Hartwell, 1988). 
Surprisingly, however, we still do not understand all aspects of its regulation and 
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function. Rad9 associates with damaged chromatin upon Mec1-/Tel1-dependent hyper-
phosphorylation ((Vialard, 1998), (Emili, 1998)), which depends on the formation of a 
ternary checkpoint complex comprising Mec1, Rad9 and Dpb11 (Pfander & Diffley, 
2011). Currently, two distinct Rad9 recruitment pathways are established. Rad9 is 
recruited to DSBs upon CDK phosphorylation (Granata et al., 2010) on S462 and T474 
by direct interaction with Dpb11 BRCT1+2 (Dpb11 pathway) (Pfander & Diffley, 
2011). Such a cell cycle regulation of Rad9-Dpb11 binding has first been observed in 
fission yeast (Du, Nakamura, & Russell, 2006). Alternatively, Rad9 can directly bind 
modified histones in order to localize to DSBs (histone pathway) in a dual mode (Toh et 
al., 2006). More precisely, it recognizes the damage-specific, Mec1/Tel1-dependent 
phosphorylation mark γH2A (H2A phospho-S129; mammalian γH2A.X) ((Hammet, 
Magill, Heierhorst, & Jackson, 2007), (Javaheri et al., 2006)), which spreads around a 
DSB over up to 50 kb (Shroff et al., 2004), with its BRCT repeats. Additionally, Rad9 
recognizes histone H3 when K79 is methylated by the methyltransferase Dot1 ((van 
Leeuwen, Gafken, & Gottschling, 2002), (Wysocki et al., 2005), (Giannattasio, Lazzaro, 
Plevani, & Muzi-Falconi, 2005)) via its Tudor domain (Grenon et al., 2007). This dual 
binding mode is conserved to the human functional ortholog, 53BP1, which binds 
H4K20me2 (Botuyan et al., 2006) and H2AK15ub (Fradet-Turcotte et al., 2013) with 
its Tudor- and UDR (ubiquitination-dependent recruitment motif)- domains, 
respectively. The histone pathway of yeast Rad9 recruitment is thought to operate cell 
cycle-independent being reinforced by the Dpb11 pathway in cell cycle stages where 
CDK is active. Fig. 9 provides an overview over protein-protein interactions that regulate 
Rad9 at DSBs.  
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Fig.9 Rad9 is  recruited to DSBs by two pathways.  Upon phosphorylation of ST462,474 by 
CDK, Rad9 can bind to the BRCT1+2 of Dpb11 and thereby engage in a ternary checkpoint complex 
(blue). This recruitment pathway is therefore cell cycle-regulated and termed the “Dpb11 pathway”. 
Additionally, Rad9 recognized modified histones in a bivalent mode, with its TUDOR domain binding 
to methylated H3K79 and its C-terminal BRCT domain binding to γH2A (orange). This recruitment 
pathway is not dependent on the cell cycle and termed the “histone pathway”. 
 
After DSB localization, Rad9 becomes hyper-phosphorylated by Mec1 on multiple S/T-
Q motifs within an N-terminal SCD cluster region, which is then recognized by the 
Rad53Chk2 FHA (forkhead-associated) domain in order to recruit Rad53 to the DSB and 
mediate its subsequent activation by Mec1 ((Emili, 1998), (Sun, Hsiao, Fay, & Stern, 
1998), (Vialard, 1998), (Schwartz et al., 2002), (Sweeney et al., 2005)). It has been 
suggested that Rad9 oligomerizes upon damage-dependent phosphorylation and thereby 
further contributes to the Rad53 enrichment at DSBs, stimulating its auto-
phosphorylation (Usui, Foster, & Petrini, 2009). In addition, the second effector kinase 
Chk1 is activated by Rad9 in a similar way as Rad53 (Y. Sanchez et al., 1999).  
Besides its central role in checkpoint activation, recent studies established Rad9 and its 
functional homolog 53BP1 as inhibitors of DNA end resection (Symington, 2014). 
While deletion of Rad9 strongly enhances resection efficiency in G2/M, it requires 
additional deletion of Ku in G1 to overcome the barrier to resection ((Lazzaro et al., 
2008), (Trovesi et al., 2011), (Ferrari et al., 2015), Bantele et al, in revision). Genetics 
suggest that it is rather the histone-related Rad9 sub-pool acting as resection inhibitor, 
but the mechanism remains unknown. One possibility would be the physical blocking of 
nuclease progression through the chromatin by histone-bound Rad9 itself or Rad9-
dependent stabilization of the chromatin structure. This model raises another interesting 
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question. Rad9 is recruited to histones after DNA damage in a cell cycle-independent 
manner. As consequence, the Rad9-dependent inhibition of resection should be present 
throughout the cell cycle. Yet, mitotic cells are highly resection-active, implying an active 
mechanism of Rad9 removal in G2/M in order to allow efficient DNA end resection. 
This aspect will be further discussed in Chapter 1.3.  
1.2.4.3  THE DNA REPAIR SCAFFOLDS SLX4 AND RTT107 
Similar to Dpb11, Rtt107 (Esc4) is a BRCT repeat containing scaffold protein required 
for the response to DNA damage and stalled replication forks  ((Hang & Zhao, 2016), 
(G. P. Leung, Brown, Glover, & Kobor, 2016)). Like  Rad9, Rtt107 can be localized to 
sites of DNA damage by two mechanisms: the direct interaction with γH2A (X. Li et al., 
2012) and the recruitment into a multiprotein complex together with yet another 
scaffolding protein, Slx4. Both Rtt107 and Slx4 play a conserved role in the response to 
stalled replication forks and seem to act in a concerted manner. Slx4 binds to the 
structure-specific endonucleases Slx1 and Rad1-Rad10 and thereby supports the 
resolution of joint molecule (JM) structures arising during the repair of stalled replication 
forks and as recombination intermediates ((Fricke & Brill, 2003), (Toh et al., 2010)). 
Slx4-Slx1 associate in a higher order complex with Dpb11 and Rtt107 bridged by Slx4, 
and this association critically depends on phosphorylation by several kinases. DNA 
damage-dependent phosphorylation is required for the complex association (Flott & 
Rouse, 2005), as well as CDK-dependent phosphorylation of Slx4 on S486 (Ohouo, 
Bastos de Oliveira, Almeida, & Smolka, 2010). This multiprotein complex has a 
proposed role in DNA damage checkpoint regulation in early G2/M phase, as it might 
potentially affect the assembly dynamics of the 9-1-1-Dpb11-Rad9 checkpoint complex 
((Ohouo et al., 2013), (Cussiol et al., 2015)). Interestingly, Rtt107 additionally 
coordinates the regulated activation of another nuclease activity, the structure-specific 
endonuclease Mus81-Mms4, which acts on Holliday junctions. In order to prevent 
untimely and mistargeted DNA cleavage by the Rtt107-associated nucleases, their 
recruitment and activation must be tightly controlled. To date it is poorly understood by 
which molecular mechanism the different nuclease activities centering around the 
Rtt107-Slx4-Dpb11 core are coordinated with the cell cycle, and how their activity is 
controlled in a spatial and temporal manner.  
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1.3  Role of Chromatin in the DSB Response 	
The genomic DNA is organized in a DNA-Protein complex called chromatin. The main 
protein components of chromatin are histone proteins building the globular core around 
which the DNA is wrapped, and harboring additional N- and C-terminal extensions that 
are often targeted by PTMs for architectural and regulatory functions. Eukaryotic cells 
use two molecules of four core histones (H2A, H2B, H3 and H4), respectively, to first 
build histone dimers (H2A/B and H3/H4), which then assemble in a histone octamer. 
Each octamer is being wrapped by 146 bp of DNA and this structure is then termed a 
nucleosome. Single nucleosomes are interconnected by a short stretch of DNA and 
additionally stabilized by the linker histone H1, often decorated with high-mobility 
group (HMG) proteins. The chain of nucleosomes, also referred to as “beads on a 
string”, further coils up in a regulated manner to form a 30 nm fiber, which is 
additionally condensed during mitosis generating the well-known X-shaped mitotic 
chromosome structures. In yeast, the chromosomes are spatially organized within the 
nucleus in a manner, whereby centromeres cluster opposite of the telomeres in proximity 
to the spindle pole body (SPB). Packaging the DNA in order to fit it into the nucleus 
and stabilization and protection of the DNA molecule are obvious functions of 
chromatin. However, a much more complex and active role of chromatin during almost 
all DNA metabolic processes is evident. It has long been known that chromatin helps 
regulating the activity of the DNA molecule, on the one hand by enabling the formation 
of sub-compartments characterized by euchromatin (an open, active form of chromatin) 
or heterochromatin (a more dense and inaccessible form of chromatin), and on the other 
hand by a whole variety of regulatory modifications summarized as epigenetics. 
Epigenetics describes the regulation of DNA loci as achieved by PTM modification of 
DNA and histone proteins, both events which in turn mediate binding of accessory 
proteins and chromatin regulators to facilitate or suppress transcription of the respective 
gene locus. The propagation and maintenance of such epigenetic modifications is a major 
challenge for the cell during DNA replication and can determine the fate of the cell and 
path of differentiation. In contrast to sites of transcription, which are defined by 
sequence, DNA lesions occur at random positions and have to be dealt with according to 
the chromatin state and cellular condition.  
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Traditionally, nucleosomes have rather been viewed as a barrier to the DNA damage 
response, restricting the accessibility of the DNA to repair and signaling proteins. The 
“access – repair – restore” model ((Green & Almouzni, 2002), (Soria, Polo, & Almouzni, 
2012)) describes the necessity to remove nucleosomes prior to repair and subsequently 
restore the chromatin in its original composition and structure once DNA repair is 
finished. However, this view has dramatically changed in the past ten years, when it has 
become evident that chromatin actively participates in damage signaling and repair. To 
this end, chromatin serves as PTM-regulated recruitment platform to enhance and 
modulate the binding and increase the local concentration of DDR factors, and therefore 
the “access” phase is now rather termed the “prime” phase (Soria et al., 2012). Finally, we 
begin to understand the impact of remodeling of chromatin in the context of DNA 
damage. This chapter will highlight the mechanisms by which chromatin and chromatin 
remodeling are involved in the DDR with a focus on DNA end resection, and how this 
converges with the cell cycle regulation of the DDR. 
1.3.1 Chromatin as substrate in the DNA damage response 
The substrate for all steps in the DNA damage response is chromatin. Accordingly, 
chromatin actively participates in damage signaling by different mechanisms. First, 
damage-specific post-translational modifications of the protruding histone tails, but also 
the histone bodies, serve to alter chromatin structure in order to prime it for the repair 
and to directly recruit DDR proteins. The most prominent example is the γH2A (human 
γH2A.X) mark, which is one of the first targets of the apical checkpoint kinases 
Mec1ATR/Tel1ATM at DSBs, spreading over large regions around a lesion site ((Shroff et 
al., 2004), (Rogakou, Pilch, Orr, Ivanova, & Bonner, 1998)). γH2A then recruits the 
checkpoint mediator and resection inhibitor Rad953BP1 (chapter 1.2.4.2), the repair 
scaffold Rtt107 (X. Li et al., 2012), and cohesion ((Unal et al., 2004), (Ström et al., 
2004)), which is involved in stabilizing sister chromatids to facilitate homology search 
during HR. Furthermore, a number of chromatin remodelers were suggested to be 
localized to DSBs by γH2A binding ((Paull et al., 2000),  chapter 1.3.4).  
γH2A is required to sustain checkpoint signaling, most likely by stabilizing Rad9, a 
mechanism that is conserved to the human checkpoint mediator MDC1 (Stucki et al., 
2005). Collectively, the data suggest that γH2A maintains the checkpoint in an active 
state rather than contributing to de novo checkpoint factor recruitment and activation 
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((Celeste et al., 2003), (Nakamura et al., 2004), (Downey & Durocher, 2006)). 
Alternatively, γH2A could have a non-essential checkpoint function, leading to a faster 
recovery in γH2A mutants after low doses of DNA damage.  
Notably, γH2A appears to be stably maintained in damaged chromatin without major 
turnover ((J.-A. Kim, Kruhlak, Dotiwala, Nussenzweig, & Haber, 2007), (Tsabar et al., 
2015)). Therefore, the alleviation of checkpoint-mediated cell cycle arrest after successful 
DNA repair requires the removal of γH2A, which critically depends on de-
phosphorylation by several phosphatases, such as PP4 and Ptc2/3 in yeast ((Keogh et al., 
2006), (S. Nakada, Chen, Gingras, & Durocher, 2008), (J. A. Kim, Hicks, Li, Tay, & 
Haber, 2011)). Taken together, γH2A levels appear to be primarily determined by the 
damage kinases and not by its phosphatase-dependent de-phosphorylation. Due to its 
ubiquitous nature, γH2A.X is widely used as biomarker for the presence of DNA 
damage, and has gained particular clinical importance as biodosimeter for measuring 
DNA damage inflicted during chemotherapy (reviewed in (Redon et al., 2012)). Besides 
γH2A, a corresponding modification of H2B (phospho-T129) has recently been 
described (C.-S. Lee, Lee, Legube, & Haber, 2013), but a possible function during DSB 
repair yet has to be elucidated. 
Other histone tail modifications with a potential role in the DNA damage response 
comprise acetylation, methylation and ubiquitylation. Acetylation in general has the 
propensity to control chromatin compaction, as it introduces negative charges that are 
thought to weaken the DNA-histone interactions or disrupt the folding of chromosomes 
and therefore open up the chromatin for transcription or repair. As an example, the 
acetylation of H3K56 by the Rtt109 histone acetyltransferase confers resistance towards 
genotoxic agents ((Ozdemir et al., 2005), (Masumoto, Hawke, Kobayashi, & Verreault, 
2005)) and was shown to enrich after DNA damage. H3K56 acetylation was connected 
to re-positioning of nucleosomes after DNA repair allowing checkpoint recovery (C.-C. 
Chen et al., 2008), and to contribute to HR repair template choice by promoting the 
usage of the sister chromatid for recombination (Muñoz-Galván, Jimeno, Rothstein, & 
Aguilera, 2013). During both DNA repair and DNA replication, the H3K56 acetylation 
mark is required for complete chromatin reconstitution and resolution of Rad52 foci 
(Wurtele et al., 2012). 
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Methylation in contrast is often but not always counteracting the adverse effect to 
histone acetylation by compacting chromatin, as exemplified by methyl-H3K9, the most 
prominent mark of heterochromatin. On top of regulating chromatin structure, histone 
methylation by the Dot1 methyltransferase affects the DDR. While this mark is 
apparently not regulated in a DNA damage-dependent fashion, it is required to target 
Rad9 to damaged chromatin ((Wysocki et al., 2005), (Grenon et al., 2007); chapter 
1.2.4.2). Therefore, the H3K79me mark appears to cooperate with γH2A. Together, 
both are essential to Rad9-dependent checkpoint signaling ((Giannattasio et al., 2005), 
(Toh et al., 2006)). The H3K79me modification by Dot1 is facilitated through H2B-
K123 ubiquitylation via Rad6/Bre1 ((Robzyk, 2000), (Wood, Schneider, Dover, 
Johnston, & Shilatifard, 2003)). Interestingly, H3K79 methylation is cell cycle-regulated 
with high levels of di-methylated H3K79 during mitosis in yeast and the exact inversed 
fluctuation in human cells (Feng et al., 2002). In how far this cell cycle regulation plays a 
role in the DNA damage response is not understood (Schulze et al., 2009).  In fission 
yeast and humans, the recruitment modes of the Rad9 homologs Crb2 and 53BP1 are 
similar and involve di-methylation of H4K20 ((Botuyan et al., 2006), (Pei et al., 2011)). 
While Crb2 is thought to be specific for H4K20me, also methyl-H3K79 was shown to 
interact with human 53BP1 (Huyen et al., 2004). In addition, Dot1 methylation of 
H3K79 might add to the DSB repair by enhancing cohesin recruitment in order to 
facilitate recombination (Conde et al., 2009).  
In human cells, a central regulatory cascade underlying checkpoint signaling is the multi-
step ubiquitylation of several targets by the E3 RING ubiquitin ligases RNF8 and 
RNF168. In short, H1 ubiquitylation by RNF8 recruits RNF168, which subsequently 
ubiquitylates H2AK13 and H2AK15, both of which contribute to the recruitment of the 
human Rad9 ortholog 53BP1 (for a detailed review, see (Panier & Durocher, 2009), 
(Panier & Durocher, 2013)).  
Along with PTM modification of the canonical histones, cells can incorporate histone 
variants in nucleosomes independent of DNA replication and thereby alter their 
function. In mammals, the most prominent histone variant connected to the DDR is 
H2A.X, which harbours the phosphorylation site for γH2A.X and replaces canonical 
H2A in about 2-25% of all nucleosomes throughout the whole genome (Rogakou et al., 
1998), strongly dependent on tissue type and cellular context. In yeast, this 
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phosphorylation takes place in the canonical H2A tail and a corresponding variant is 
therefore absent. Yet, another H2A variant – Htz1 or mammalian H2A.Z – has a well-
established function in the DDR ((Kalocsay, Hiller, & Jentsch, 2009), (Lademann, 
Renkawitz, Pfander, & Jentsch, 2017), (Xu et al., 2012)). Htz1 is specifically 
incorporated around DSBs by the chromatin remodeler Swr1 and required for re-
location of DSBs to perinuclear anchor sites in a manner that depends on Htz1 
SUMOylation ((Kalocsay et al., 2009), (Horigome et al., 2016)). In turn, Htz1 is 
removed by Ino80, and the interplay between Swr1 and Ino80 to balance Htz1 levels 
contributes to genome stability and DNA damage checkpoint control via γH2A 
stabilization (Papamichos-Chronakis, Krebs, & Peterson, 2006). During HR, Htz1 
controls the step of presynaptic filament formation (Lademann et al., 2017). 
Additionally, some studies describe early functions enhancing DNA end resection and 
checkpoint activation (Kalocsay et al., 2009). Other H2A variants that only exist in 
higher eukaryotes, such as macroH2A, contribute to DNA repair pathway choice by 
facilitating the accumulation of BRCA1 on damaged chromatin, a pro-HR factor 
(Khurana et al., 2014). 
Collectively, the definition of the nucleosome structure and function by histone PTMs 
and incorporation of histone variants is an integral part of the DNA damage response, 
adding additional layers of regulation to DNA end resection, checkpoint activation and 
DNA repair.  
1.3.2 Chromatin and DNA end resection 
The digestion of one DNA strand during end resection requires nucleases to access the 
DNA. There are two fundamental mechanisms by which chromatin can influence DNA 
end resection. First, chromatin can directly physically block nuclease access or 
progression. Second, chromatin can recruit accessory proteins to stimulate or suppress 
resection. In vitro data suggest that chromatin impedes resection (Adkins, Niu, Sung, & 
Peterson, 2013). However, it has not been demonstrated in vivo that nucleosomes 
actually do present a barrier to resection, nor has it been unambiguously shown that 
nucleosomes are evicted during the process. In fact, the relative loss of histones at regions 
of active transcription appears to be significantly higher than at DNA lesion sites, 
strongly pointing towards the residual presence of histones at resected loci ((Boeger, 
Griesenbeck, Strattan, & Kornberg, 2003), (Shroff et al., 2004), (Bennett, Papamichos-
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Chronakis, & Peterson, 2013)). In vitro studies suggest that nucleosomes can slow down 
nucleases, and this inhibition seems to have more pronounced effects on the Exo1-
dependent resection pathway than on the STR/Dna2 pathway (Adkins et al., 2013). 
While Exo1 is blocked by nucleosomes, STR/Dna2 mainly requires a nucleosome-free 
“entrance gap” to carry out resection (Adkins et al., 2013). This finding is perhaps not 
surprising, since in these in vitro studies, there is no helicase supporting Exo1, while 
Dna2 cooperates with the Sgs1 helicase and it could therefore be speculated that Sgs1 
promotes access for Dna2 to nucleosomal DNA. Notably, while the sheer presence of 
nucleosomes appears to counteract resection in these assays, unmodified nucleosomes 
lacking PTMs and accessory proteins were used, which most likely reflect only poorly the 
actual chromatin, which is substrate of resection in vivo. Interestingly, in vitro and in 
vivo, the histone variant Htz1 seems to enhance specifically Exo1-dependent resection 
(Adkins et al., 2013). Furthermore, in vitro studies have shown that per se, nucleosome 
octamers can assemble on single-stranded DNA de novo and are also retained on the 
ssDNA after Sgs1-dependent resection (Adkins et al., 2017). Intriguingly, such ssDNA-
nucleosome assemblies are more flexible than dsDNA-nucleosome structures, a feature 
that could potentially also play a role during subsequent repair steps (Adkins et al., 
2017). In vivo, this question is difficult to address since cells lacking histones are not 
viable. First insights about the role of chromatin during resection in vivo can be derived 
from experiments using chromatin remodeler mutants as discussed below (chapters 3.4 
and 3.5). To date, mobilization of only one histone directly at the DSB was observed in 
vivo, potentially by sliding or eviction ((Shim et al., 2007), (Tsabar, Hicks, Tsaponina, 
& Haber, 2016)), and there is no solid evidence for greater histone loss at DSBs.  
The second mechanism – recruitment of non-histone chromatin interactors affecting 
resection efficiency – has emerged recently as an important control mechanism, but 
remains mechanistically elusive. The checkpoint mediator Rad9 as well as its human 
homolog 53BP1, which both bind to histones after DNA damage (chapter 1.2.4.2), 
block resection. Phenotypically, Rad9 counter-acts the activity of the nucleosome 
remodeler Fun30 during end resection ((X. Chen et al., 2012), chapter 1.3.5), and 
Fun30 becomes fully dispensable for efficient resection when Rad9 is depleted. 
Interestingly, both proteins are targeted by CDK to enhance their DNA binding, 
suggesting a cell cycle-dependent regulation of a pro- and an anti-resection factor. How 
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this antagonism manifests in the control of resection, and by which mechanism Rad9 and 
its orthologs could inhibit resection on a molecular level, is under investigation. 
1.3.3 Chromatin architecture influences the DDR 
Besides local effects of nucleosomes and nucleosome binders on the DNA damage 
response, also the global architecture of chromatin and the larger chromosomal context 
in which a DSB occurs play a decisive role in the repair process. Factoring in is local 
chromatin structure (for example eu- versus heterochromatin), the mobility of the DSB 
ends, the location of the repair donor with respect to the lesion site (here, we can 
distinguish between intra-or inter-chromosomal recombination), and the 3D 
conformation of the affected locus.  
It has been long known that chromatin is not fixed in position but features plasticity 
(Marshall et al., 1997). Chromatin is inherently restricted in free diffusion, and this 
restriction derives from anchoring to nuclear structures, ATP levels, inter- and intra-
nucleosomal interactions, size of the chromosome (Neumann et al., 2012), nucleosome 
density (Hauer et al., 2017) and sister chromatid cohesion (Dion, Kalck, Seeber, 
Schleker, & Gasser, 2013). Upon DNA damage, chromatin visibly expands (Adam et al., 
2016). The induction of a DSB provokes changes in the physical properties and enhances 
plasticity not only of the affected genomic locus, but also genome-wide ((Seeber, Dion, 
& Gasser, 2013a), (Hauer et al., 2017), (Dion, Kalck, Horigome, Towbin, & Gasser, 
2012)). DSBs and likewise uncapped telomeres occupy a larger area in the nucleus 
compared to undamaged loci ((Dion et al., 2012), (Miné-Hattab & Rothstein, 2012), 
(Savage, 1996), (Dimitrova, Chen, Spector, & de Lange, 2008)). It has been 
demonstrated that DSBs become mobilized and are translocated to the nuclear periphery 
if not repaired in time ((Nagai et al., 2008), (Oza, Jaspersen, Miele, Dekker, & Peterson, 
2009)). Such mobilization is a double-sided coin: DSB repair efficiency during HR 
apparently benefits from DSB mobility, most likely because it drives homology search 
((Agmon, Liefshitz, Zimmer, Fabre, & Kupiec, 2013), (C.-S. Lee et al., 2016)). 
Importantly, this is not due to constitutive pairing of homologous loci, but happens in a 
damage-induced manner (Miné-Hattab & Rothstein, 2012). The re-localization of DSBs 
to the nuclear periphery, either to NPCs or Mps3 anchors, has a great benefit. It shifts 
the lesion from a random position into a defined environment, allowing the cell to 
channel the DSB repair to specific repair pathways. More precisely, at the nuclear 
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periphery recombination is repressed while template-switching, non-precise NHEJ and 
BIR are promoted ((Swartz, Rodriguez, & King, 2014), (Horigome et al., 2016)). On 
the downside, enhanced DSB mobility has the potential to increase unwanted 
recombination and result in genomic instability ((Roukos et al., 2013), (Aten et al., 
2004)). The mechanism of DSB mobilization is not yet fully established, but it seems to 
rely on the DNA damage checkpoint activation by Mec1ATR (Hauer et al., 2017) or ATM 
in mammals (Lottersberger, Karssemeijer, Dimitrova, & de Lange, 2015). Work in yeast 
proposes that Mec1 stimulates the Ino80 chromatin remodeler, which would then induce 
removal of histones from the damaged chromatin followed by proteasomal degradation 
and thereby enhance its mobility (Hauer et al., 2017). Studies in mammalian cells 
similarly report histone eviction at sites of DNA lesions (Adam et al., 2016). Lastly, 
histone loss has been linked to checkpoint activation via the Rad53 effector kinase, 
implying a positive feedback loop in the DNA damage response (Gunjan & Verreault, 
2003). In addition to inducing histone loss, Rad53 was reported to uncouple kinetochore 
attachments and thereby to enhance local and global chromatin mobility (Strecker et al., 
2016).  
The dependency on an active checkpoint seems an appropriate means to balance benefits 
for repairing long-persisting DSBs with the threat to genome instability by mistargeted 
recombination. To date, there is however a discrepancy in published data regarding 
whether DSB mobility is beneficial for homology search, and most likely the cellular 
conditions and nature of DNA damage induction is an underestimated component of the 
subsequent HR-dependent repair and effect of DSB mobility ((Strecker et al., 2016), 
(Neumann et al., 2012), (Rudin & Haber, 1988)).  
Intriguingly, it is not only the chromatin changes induced by DNA damage that can 
affect DSB repair, but also the chromosome conformation that was established before the 
damage occurred. Recent studies have described so-called topologically associated 
domains (TADs), defined as loci that are in close spatial proximity, potentially physically 
tethered, but not necessarily adjacent in the primary sequence or on the same 
chromosome ((Caron et al., 2015), (Caron et al., 2012), (Aymard et al., 2017)). The 
propagation of checkpoint signals such as γH2A appears to be restricted to a TAD and as 
such clearly distributes in three dimensions instead of linearly along the broken 
chromosome. This model goes along with observations in yeast, where the monitoring of 
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homology search by Rad51 recombinase ChIP revealed spreading of Rad51 and γH2A 
guided by 3D clustering ((Renkawitz, Lademann, Kalocsay, & Jentsch, 2013b),(Agmon 
et al., 2013)). 
A principle challenge for the cell are DNA lesions occurring in repetitive DNA sequences 
such as telomere or centromeric repeats. In order to prevent unwanted recombination 
between repeats and the resulting genomic instability (Peng & Karpen, 2008), these 
regions are typically heterochromatic or otherwise restricted as exemplified by the 
compartmentalization of rDNA repeats to the nucleolus in yeast. It has been shown that 
while recombination can act on heterochromatic loci, this occurs only after they become 
physically separated, so that repair can be carried out without losing repeats ((Chiolo et 
al., 2011), (Chiolo, Tang, Georgescu, & Costes, 2013)). Similarly, rDNA repeats have to 
be moved out of the restrictive environment of the nucleolus in order to complete DSB 
repair, and for both rDNA and heterochromatic repeats, the Smc5/6 complex is required 
to do so ((Torres-Rosell, Machin, & Aragón, 2005), (Torres-Rosell et al., 2007)). 
Additionally, chromatin remodelers help to open the heterochromatin structure in order 
to support strand invasion during HR ((M. Sinha & Peterson, 2009), chapter 1.3.4.2).  
1.3.4 Remodeling of DNA double-strand breaks 
ATP-dependent nucleosome remodelers are large, mostly multiprotein-containing 
machineries that modify the properties of chromatin by sliding, evicting and spacing 
nucleosomes on the DNA, or by altering its composition via histone dimer or octamer 
exchange, using the energy released by ATP hydrolysis. First insights about the function 
of chromatin remodelers have emerged from studies of gene transcription. Nucleosome 
remodelers were observed to bind to DNA lesions and are therefore thought to be 
involved in the DNA damage response. However, until now there is relatively little 
mechanistic understanding about chromatin remodeling at DNA damage sites. It seems 
reasonable to assume that functions during transcription can be extrapolated and applied 
to the DNA damage response.  
Over time, chromatin remodeling was shown to influence a vast variety of distinct steps 
during DSB processing, signaling and repair (reviewed in (Seeber, Hauer, & Gasser, 
2013b)). In this chapter, individual nucleosome remodelers are discussed regarding their 
activity at DSBs. These are subdivided in early remodeling steps, mainly thought to 
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enhance DDR protein binding, and late remodeling steps with potentially more complex 
functions reaching several kilobases into the chromatin adjacent to the DNA damage site.  
1.3.4.1  EARLY DSB REMODELING  
Ku and the MRX complex immediately bind DSB ends in order to initiate ligation-based 
repair (NHEJ) or DNA end resection, as discussed earlier. These recruitment steps 
require opening of the local chromatin structure, and indeed, nucleosomes were shown to 
be repositioned around DSBs ((Kent, Chambers, & Downs, 2007), (Shim et al., 2007), 
(Liang, Qiu, Ratnakumar, & Laurent, 2007)). RSC, a SWI2/SNF2 remodeler of the 
Snf2-like family, was shown to change nucleosome positioning around DSBs by sliding 
(Kent et al., 2007) prior to and independent of DNA end resection, and this 
repositioning is needed to allow Ku and MRX binding (Shim et al., 2007), as well as for 
apical checkpoint kinase recruitment and checkpoint activation (Liang et al., 2007). As a 
consequence, the efficiency of the entire downstream break processing, signaling and 
repair seems hampered in absence of RSC (Shim et al., 2007). Defects in resection 
initiation in cells with impeded RSC activity are minor and can be attributed to lacking 
Mre11 enrichment at the DSB (Chambers & Downs, 2012). Notably, also the Swi/Snf 
remodeler appears to enhance MRX binding to DSBs, with similar phenotypes as RSC 
mutants (Wiest, Houghtaling, Sanchez, Tomkinson, & Osley, 2017). Overall, the 
current model of RSC function during early DSB repair steps pictures nucleosome 
mobilization by RSC as general enhancer of DDR factor recruitment, consistent with 
RSC contributing to NHEJ and HR ((Shim et al., 2007), (Chambers & Downs, 2012)).  
Two remodelers of the Swr1-like family of SWI2/SNF2 remodelers are the conserved 
Ino80 and Swr1 complexes, which are the key regulators of Htz1 levels in chromatin. As 
discussed earlier, the histone variant Htz1 (H2A.Z) plays a multifaceted role in the DNA 
damage response. Htz1 is incorporated into chromatin by Swr1 (Luk et al., 2010), and 
this reaction is being reversed by Ino80 (Papamichos-Chronakis, Watanabe, Rando, & 
Peterson, 2011). Both remodelers are required for resistance against genotoxic agents 
((Kobor et al., 2004), (Shen, Mizuguchi, Hamiche, & Wu, 2000)). Interestingly, the 
removal of canonical H2A/H2B seems to be at least partially uncoupled from the 
deposition of Htz1/H2B dimers, since Swr1 induces genome instability in absence of 
Htz1, most likely thanks to incomplete remodeling (Morillo-Huesca, Clemente-Ruiz, 
Andújar, & Prado, 2010).  
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Similar to the mild defect in resection initiation in cells with defective RSC function, 
Ino80 seems to contribute to resection initiation to a limited extent ((van Attikum, 
Fritsch, & Gasser, 2007), (X. Chen et al., 2012), (Lademann et al., 2017)). Both 
remodelers are dispensable for later resection steps and initial resection defects are 
additive with mutants specifically affecting long-range resection (X. Chen et al., 2012). 
In conclusion, current models place Ino80 and RSC in the initiating step of resection, 
while other remodeling activities contribute to processive resection as discussed in the 
next section. This model is supported by the finding that repair pathways such as single-
strand annealing (SSA), which specifically rely on long-range resection, are not affected 
by mutants in Ino80 or RSC (Eapen et al., 2012).  
1.3.4.2  LATE DSB REMODELING  
In addition to establishment of open, accessible chromatin close to the DSB, also later 
steps in the DDR require chromatin changes. This sub-chapter focuses on two particular 
reactions, which both involve large parts of the damaged chromosome or even the whole 
genome, and therefore impose an enhanced need for chromatin restructuring: long-range 
DNA end resection and homology search during HR.  
Until recently, there has been no chromatin remodeler associated with enhancing long-
range resection, and it was unclear whether at all and if yes, to what extent additional 
remodeling or helicase activity besides Sgs1 is required to support long-range resection. A 
series of pioneering studies in 2012 has elucidated a pivotal, conserved role of the 
nucleosome remodeler Fun30/SMARCAD1 in the Exo1- and Sgs1-dependent long-
range resection of DNA double-strand breaks and resection-coupled repair ((X. Chen et 
al., 2012), (Eapen et al., 2012), (Costelloe et al., 2012)), as discussed further in the next 
chapter.  
Homology search describes the complex task for the DSB ends to find and pair with a 
homologous donor sequence, which can be located anywhere in the genome, in order to 
initiate the templated DNA synthesis that will restore the sequence. Due to the 
complexity of this step, homology search was coined the “search for the needle in the 
haystack” ((Renkawitz et al., 2013b), (Renkawitz, Lademann, & Jentsch, 2013a)). 
Homology search requires the loading of the recombinase Rad51, which forms a filament 
around the resected DNA replacing RPA in a Rad52-dependent manner. Availability of 
Rad51 for specific DSB localization is ensured by the single-subunit Swi/Snf-family 
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remodeler Rad54, which displaces Rad51 from unspecific binding sites ((Chi et al., 
2011), (M. Sinha & Peterson, 2009)) and establishes stability of the resulting Rad51 
filament (Ceballos & Heyer, 2011). Rad51 assembly by Rad54 is ATP-independent 
(Wolner & Peterson, 2005) and apparently acts in a self-enhancing manner, as Rad51 
does stimulate Rad54 DSB-binding (Dion et al., 2012). To date it is not clear how the 
two ssDNA-binding proteins coexist on the single-stranded DSB overhang. Rad51 
filament formation drives homology search and a recent study nicely demonstrates that 
Rad51 spreading from a DSB critically depends on Htz1 removal by Ino80 ((Lademann 
et al., 2017), (Tsukuda, Fleming, Nickoloff, & Osley, 2005)). A similar requirement for 
Ino80-dependent H2A.Z removal to complete HR was observed in human cells 
((Tsukuda et al., 2009), (Alatwi & Downs, 2015)), suggesting a conserved function of 
Ino80 at the step of synaptic filament formation. Indeed, control of H2A.Z occupancy 
by Ino80 and Swr1 is required for genomic stability ((Papamichos-Chronakis et al., 
2011), (Van, Williams, Kunkel, & Peterson, 2015)).  
Rad54 also appears to act after strand invasion, as conclusion of HR-dependent repair is 
dependent on Rad54, which is required for ATP-dependent histone mobilization prior to 
gap fill DNA synthesis ((Sugawara, Wang, & Haber, 2003), (Wolner & Peterson, 
2005)). 
The last step in the DSB repair process is the restoration of chromatin. Notably, the two 
H3-H4 histone chaperones Asf1 and Caf1, which both have well-defined functions 
during the re-establishment of chromatin after replication and transcription ((Tyler et al., 
1999), (Tyler et al., 2001)), are similarly involved the re-establishment of nucleosome 
occupancy at repaired DNA damage sites in yeast and mammalian cells ((J. A. Kim & 
Haber, 2009), (Soria et al., 2012), (Tsabar et al., 2016), (Mello et al., 2002)).  
1.3.5 The chromatin remodeler Fun30SMARCAD1 
The Snf2-like Etl1-subfamily, single-subunit chromatin remodeler Fun30 (function 
unknown now) and its fission yeast homolog Fft3 have been characterized for their role 
in silencing of certain gene loci and preserving heterochromatic structures, the repression 
of unwanted transcription over centromeres, repression of euchromatin formation, 
distribution of the histone variant Htz1, and for a general function in chromatin 
organization at centromeres and subtelomeric regions ((Steglich et al., 2015), (Strålfors, 
Walfridsson, Bhuiyan, & Ekwall, 2011), (Neves-Costa, Will, Vetter, Miller, & Varga-
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Weisz, 2009), (Byeon et al., 2013), (Durand-Dubief et al., 2012), (Yu, Zhang, & Bi, 
2011)). First insights into an actual molecular mechanism behind these functions was 
provided recently by Taneja et al (2017), who showed that fission yeast Fun30, Fft3, 
inhibits histone turnover in heterochromatin, thereby preserving density of 
heterochromatic histone marks. Generally it is likely that Fun30 homologs act during 
transcription, replication and DNA repair, as they were shown to directly interact with 
proteins involved in these processes ((Taneja et al., 2017), (J. Lee et al., 2017), 
(Rowbotham et al., 2011)). 
In vitro, Fun30 possesses nucleosome sliding and histone dimer exchange activity 
((Awad, Ryan, Prochasson, Owen-Hughes, & Hassan, 2010), (Byeon et al., 2013)). The 
gene-repressive function of Fun30 was described to be due to Fun30-mediated changes 
in the 5’ flanking region of affected genes, to which Fun30 was also shown to localize, 
most likely catalyzed by ATP-dependent nucleosome sliding (Byeon et al., 2013). Fun30 
purifies as homodimer and its ATPase activity is being stimulated likewise by naked and 
chromatinized DNA (Awad et al., 2010). When compared to the in vitro activity of 
RSC, it seems that the primary reaction catalyzed by Fun30 is H2A/H2B dimer exchange 
(Awad et al., 2010). Therefore, it is not unlikely to assume that Fun30 could also be 
involved in the incorporation or removal of Htz1, consistent with a described role in 
genome-wide Htz1 distribution particularly to ensure centromere structure and function 
(Durand-Dubief et al., 2012). Furthermore, Fun30 possesses remarkable sequence 
homology with the Ino80 and Swr1 chromatin remodelers (Flaus, 2006), which 
themselves exchange Htz1-containing dimers.  
Notably, Fun30 is one of few single-subunit chromatin remodelers, which needs to unite 
all catalytic and regulatory assets in one polypeptide chain. Its domain structure can be 
roughly divided in a catalytic domain at the C-terminus comprising Walker DNA 
binding motifs in conjunction with a helC helicase domain, thus comprising the Snf2 
nucleosome remodeling domain, and a regulatory unit at the N-terminus (Fig. 10). The 
N-terminus harbours protein-protein interaction sites such as a CUE domain and CDK 
consensus phosphorylation sites (S20, S28, S34), suggesting that Fun30 might be 
subjected to cell cycle control by CDK phosphorylation ((Ubersax et al., 2003), (X. Chen 
et al., 2016)). The catalytic domain of Fun30 was structurally analyzed revealing a 
Fun30-specific insert that might support functional alterations compared to other Snf2 
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remodelers (L. Liu & Jiang, 2017). Fun30 is functionally conserved from yeast to higher 
eukaryotes, and human Fun30 (SMARCAD1, formerly human helicase 1; hHel1) has 
been analogously implicated in chromatin silencing and compaction. It is remarkable 
that besides the catalytic domain, all Fun30 homologs carry one or more CUE domains, 
which are putative binding sites for ubiquitylated proteins. Interaction partners of these 
CUE domains on Fun30 still need to be elucidated (Neves-Costa et al., 2009).  
 
 
 
Fig.10 Domain structure of Fun30 and its  homologs (modified from (Neves-Costa et al., 2009)). 
All homologs of Fun30 execute nucleosome remodeling via a central SF2 ATPase (purple) in synergy with a 
hel-c helicase domain (orange). Additionally, except for the plant and worm Fun30, an N-terminal CUE 
domain (blue) was mapped in all homologs. 
 
Fun30 has first been connected to the DNA damage response by the observation that 
fun30∆ mutants are sensitive to the topoisomerase I inhibitor camptothecin (Neves-
Costa et al., 2009), which generates covalent DNA-topoisomerase I adducts. It was also 
identified in a screen searching for genes that would affect gene targeting efficiency (X. 
Chen et al., 2012). As gene targeting requires functional homologous recombination and 
resection, this phenotype is consistent with a resection defect of fun30∆ mutants. Based 
on this seminal discovery by Chen et al (2012), Fun30 was characterized as resection-
promoting chromatin remodeler ((Eapen et al., 2012), (X. Chen et al., 2012), (Costelloe 
et al., 2012)). Importantly, Fun30 could be specifically attributed to the long-range 
resection pathway, as it supports resection beyond 5 kb without affecting the initiation of 
resection, consistent with deficiencies in repair pathways relying on long-range resection 
(X. Chen et al., 2012). This specificity distinguishes Fun30 from other chromatin 
remodelers implicated in early steps of DNA end resection (chapter 1.3.4).  
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Despite the growing understanding of the importance of Fun30-dependent chromatin 
remodeling for DNA end resection, there is a number of intriguing questions yet to be 
answered. Fun30 has been demonstrated to localize genome-wide and specifically to 
telomeric and centromeric regions, gene-flanking regions at both ends ((Durand-Dubief 
et al., 2012), (Byeon et al., 2013)), and to DNA double-strand breaks ((Eapen et al., 
2012), (X. Chen et al., 2012), (S. Bantele et al., 2017)). In vitro, Fun30 displays the 
propensity to bind to histone H2A (Eapen et al., 2012) and was suggested to 
preferentially interact with nucleosomes that are placed on single-stranded DNA (Adkins 
et al., 2017). However, we do not understand how Fun30 is specifically targeted to DNA 
double-strand breaks, how this targeting is integrated within the cell cycle, and by which 
molecular mechanism Fun30 acts to enhance DNA end resection once it has been 
recruited to the DSB.  
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Objectives of these studies 
 
Targeting of the Fun30 nucleosome remodeller by the Dpb11 scaffold 
facil itates cell  cycle-regulated DNA end resection.  
 
Bantele, S.C.S., Ferreira, P., Gritenaite, D., Boos, D. & Pfander, B.  
 
eLife . pii: e21687. doi: 10.7554/eLife.21687 (2017).  
 
DNA end resection is the nucleolytic degradation of the 5’ ends at DNA double-strand 
breaks, which uncovers long stretches of single-stranded DNA needed for homologous 
recombination (HR). Therefore, this type of DSB processing constitutes the critical 
switch between ligation-dependent DSB repair and HR. Resection must be kept under 
tight cell cycle control, as aberrant resection in cells that have not yet duplicated 
chromosomes during S-phase and therefore do not possess a suitable recombination 
donor can cause large genome rearrangements and ultimately corrupts genome stability. 
Past research has identified a multitude of mechanisms by which resection is cell cycle-
regulated, all of which target the enzymes executing resection and none the substrate of 
resection, damaged chromatin. In a series of seminal publications, the chromatin 
remodeler Fun30 was found to specifically support resection ((Eapen et al., 2012), (X. 
Chen et al., 2012), (Costelloe et al., 2012)). However, it was unclear whether this process 
is under cell cycle control. In this work, we identified Fun30 as a target of cell cycle-
dependent CDK phosphorylation, and therefore set out to establish the molecular 
mechanism of this regulation, with a focus on Fun30 targeting to DSBs, and to which 
extent it contributes to the overall cell cycle regulation of DNA end resection.     
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Quantitative signaling mechanisms in response to DNA damage. 
 
Bantele S.C.S., Lisby M. and Pfander B.  
 
manuscript in revision  
 
Every cell frequently encounters damages to its DNA, and therefore has to constantly 
monitor its “DNA damage status” so that a suitable response can be set off. High damage 
loads or difficult-to-repair lesions persisting for a long time call for cell cycle arrest and 
up-regulation of DNA repair activity, both of which are triggered by activation of the 
DNA damage checkpoint. At the same time, cells need to grow and proliferate when the 
damage load is tolerable.  
Taken together, DNA damage checkpoint activation needs to balance genome integrity 
with proliferation. The basic phenomenon that gives a measure of the cells’ damage load 
is the occurrence of single-stranded DNA, a typical structure generated at lesion sites that 
accumulates locally at long-persisting damage sites (for example DSBs) and when 
quantified could serve as a global signal of the cellular DNA damage load. Cells use 
sensor proteins to signal the presence of ssDNA in the cell ((Bonilla et al., 2008), (Kondo 
et al., 2001)), but whether and how these signals are quantified is unknown. A possible 
quantitative sensor could be the recruitment of the checkpoint initiator kinase Mec1-
Ddc2 to RPA-covered ssDNA (Deshpande et al., 2017). However, we found that a 
distinct Mec1 phosphorylation target –the histone mark γH2A – does not quantitatively 
respond to the ssDNA signal. Here, we set out to characterize the two modes of Mec1 
signaling and moreover to unveil the molecular mechanism underlying the quantitative 
reading of the ssDNA signal and according transmission of DNA damage checkpoint 
signals. 
 
 
Objectives of these studies 
  
	 55	
A cell  cycle-independent mode of the Rad9-Dpb11 interaction is induced 
by DNA damage. 
 
Di Cicco, G., Bantele, S.C.S., Reusswig, K-U. and Pfander, B.  
 
Sci Rep  7(1):11650. doi:10.1038/s41598-017-11937-z (2017). 
 
Rad9 fulfills two distinct functions at DNA double-strand breaks. First, it mediates 
checkpoint activation and second, it inhibits DNA end resection. While resection and 
thus probably also the associated Rad9 activity are cell cycle regulated, the DNA damage 
checkpoint has to be able to become active throughout the entire cell cycle. Thus, the 
two Rad9 functions might have distinct cell cycle requirements.  
Interestingly, Rad9 associates with damaged chromatin via two pathways. First, it can 
bind to histones in a damage-dependent and cell cycle-independent mode ((Hammet et 
al., 2007), (Grenon et al., 2007)). Second, it associates with Dpb11 upon cell cycle-
dependent phosphorylation of Rad9 by CDK, which occurs in S-, G2-, and M-phases of 
the cell cycle (Pfander & Diffley, 2011). So far it was not clear, whether the Rad9-
Dpb11 interaction can also take place in G1 and whether such an interaction would 
influence resection and checkpoint signaling. 
Furthermore, it was not clear whether the two Rad9 DSB recruitment pathways act 
independently or interact, and if certain functions of Rad9 can be specifically attributed 
to one of the two complexes.  
We identified a new Rad9 recruitment mode that mediates interaction between Rad9 
and Dpb11 in G1. Interestingly, this interaction requires DNA damage and the same 
CDK sites on Rad9 as the cell cycle-regulated interaction, however occurs when CDK is 
inactive. In this study, we set out to identify the genetic and cellular requirements for this 
novel Rad9-Dpb11 complex formation and clarify its role during DNA end resection 
and checkpoint activation. 
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A cell  cycle-regulated Slx4-Dpb11 complex promotes the resolution of 
DNA repair intermediates l inked to stal led replication.  
 
Gritenaite, D., Princz, L. N., Szakal, B., Bantele, S. C. S., Wendeler, L., Schilbach, S., 
Habermann B.H., Matos J., Lisby M., Branzei D. and Pfander B. 
 
Genes & Development , 28(14), 1604–1619. doi:10.1101/gad.240515.114. (2014). 
 
The scaffold protein Dpb11 acts as a reader of CDK-dependent PTMs, and thereby 
engages in a number of specific protein-protein complexes, all of which serve to assemble 
proteins in a cell cycle-regulated manner. Dpb11-mediated complexes govern a variety of 
DNA metabolic processes such as DNA replication, repair and damage signaling. One of 
these Dpb11 complexes involves the DNA damage scaffold proteins Slx4 and Rtt107 
(Ohouo et al., 2013).  
In this project, we aimed to elucidate the mechanism by which this multi-scaffold protein 
complex regulates the structure-specific endonuclease Mus81-Mms4 within the cell cycle. 
Complex formation between Dpb11 and Slx4/Rtt107 was suggested to have a function 
as dampener of the DNA damage checkpoint by direct competition with the checkpoint-
essential Dpb11-Rad9 complex (Ohouo et al., 2013). Therefore, my specific aim for this 
work was to analyse the connection between DNA damage checkpoint activity and its 
potential regulation by Dpb11-Slx4-Rtt107. In particular, I asked whether mutants 
abolishing the interaction between Dpb11 and Slx4 would affect checkpoint activity after 
exposure to MMS relative to the number of lesion sites. 
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Cumulative Thesis: Summary of publications 
Publication 1 |  Targeting of the Fun30 nucleosome remodeller by 
the Dpb11 scaffold facil itates cel l  cycle-regulated DNA end 
resection.  
 
Bantele, S.C.S., Ferreira, P., Gritenaite, D., Boos, D. & Pfander, B.  
eLife . pii: e21687. doi: 10.7554/eLife.21687 (2017).  
 
DSB repair by HR requires a homologous DNA template, which is usually the sister 
chromatid. As G1 cells lack this recombination template, it is strictly necessary to restrict 
resection and HR to cell cycle phases outside of G1. So far, studies analyzing the cell 
cycle regulation of resection have focused on the cell cycle regulation of resection 
nucleases.  
In this paper, we show that the actual bottleneck in the resection reaction lies within the 
resection substrate itself, the damaged chromatin. We demonstrate that the chromatin 
remodeler Fun30, which is essential to efficient long-range resection, becomes targeted 
by CDK and then interacts with the scaffold protein Dpb11. This interaction is strictly 
required for the resection-promoting function of Fun30.  
A Dpb11 interaction-deficient mutant of Fun30, which contains non-phosphorylatable 
alanines in stead of the CDK-targeted serines is not properly recruited to DSBs and fails 
to support DNA end resection and resection-coupled DSB repair.  
We furthermore show that Fun30 and Dpb11 engage in a complex with the 9-1-1 
checkpoint clamp, which thereby brings Fun30 to its place of action at the DSB. 
Importantly, we achieve a hyper-activation of DNA end resection by making the Fun30-
Dpb11-9-1-1 complex constitutive (using a covalent protein fusion between 9-1-1 and 
Fun30). Intriguingly, this mutant condition also leads to a bypass of DNA end resection, 
which is activated in G1. These data do not only support the hypothesis that chromatin 
is a barrier to resection and therefore actively influences DNA repair pathway choice, but 
also provides the first genetic tool to ectopically activate resection independent of the cell 
cycle. 
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The human Fun30 homolog SMARCAD1 was reported to function in DNA end 
resection, too. Here, we show that the interaction between the Dpb11 homolog 
TOPBP1 and SMARCAD1, its CDK regulation and the Fun30SMARCAD1 interaction 
surface are highly conserved, suggesting that human and yeast cells share this regulatory 
mechanism.  
Overall, we therefore propose a model by which CDK-dependent recruitment of 
Fun30SMARCAD1 to DSBs through interaction with Dpb11TOPBP1 is key to the regulation of 
Fun30 at DNA double-strand breaks and is an essential factor in the cell cycle regulation 
of DNA end resection. 
 
Publication 2 |  Quantitative signaling mechanisms in response to 
DNA damage. 
 
Bantele S.C.S., Lisby M. and Pfander B.  
manuscript in revision  
 
Cells have to accurately judge their DNA damage load in order to make decisions such as 
whether cell cycle arrest and up-regulation of DNA repair are required or not. In other 
words: cells have to quantify their damage load.  
With this paper we provide the first study of quantitative aspects of checkpoint signaling 
at DSBs. We report that the apical checkpoint kinase Mec1, which is recruited to DSBs 
in a manner that depends on RPA-ssDNA – generated by DNA end resection, feeds into 
two distinct signaling circuits. On the one hand, it mediates – in the local circuit – 
phosphorylation of H2A (γH2A). On the other hand it phosphorylates and triggers 
activation of the checkpoint effector kinase Rad53 and thereby participates in the global 
checkpoint circuit. 
Interestingly, we observe that while the global checkpoint signaling strongly depends on 
the amount of ssDNA, the local signaling circuit seems to be irresponsive to changes in 
the ssDNA signal. Consequently, the recruitment of the apical kinase Mec1 cannot be 
the only determinant of the quantitative checkpoint output.  
Moreover, we find that the checkpoint clamp 9-1-1 is a quantitative sensor for the 
amount of the ssDNA signal. Importantly, artificial hyper-activation of 9-1-1-dependent 
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signaling using a covalent protein fusion of 9-1-1 and its downstream target Rad9 leads 
to checkpoint hyper-activation, even under conditions where less Mec1 apical kinase is 
recruited. By uncoupling Mec1 recruitment from 9-1-1-dependent checkpoint activation 
we establish the 9-1-1 complex as a key sensor for the quantification of checkpoint input 
signals and their transmission to the effector kinase. 
 
Publication 3 |  A cell  cycle-independent mode of the Rad9-Dpb11 
interaction is induced by DNA damage. 
 
Di Cicco, G., Bantele, S.C.S., Reusswig, K-U. and Pfander, B.  
Sci Rep  7(1):11650. doi:10.1038/s41598-017-11937-z (2017). 
 
Rad9 is a central DNA damage checkpoint mediator with a dual functionality at DSBs: it 
activates global checkpoint signaling and blocks end resection throughout the cell cycle. 
So far, it is unclear whether and which of these functions require cell cycle regulation of 
Rad9, as both activities are present throughout the cell cycle.  
Interestingly, one Rad9 DSB recruitment mechanism appears to be cell cycle regulated. 
This pathway involves the CDK-dependent phosphorylation of Rad9 on two CDK 
consensus sites S462 and T474, which once phosphorylated are bound by the Dpb11 N-
terminal BRCT repeats. 
We find that these Rad9 CDK sites cannot be phosphorylated solely by CDK, but also in 
a DNA damage-induced manner, even in G1 – when CDK is inactive. Most likely, this 
phosphorylation involves a chromatin-associated kinase, since chromatin recruitment of 
Rad9 is required for its phosphorylation. Following this phosphorylation, Rad9 is then 
able to interact with Dpb11 independently of the cell cycle phase.  
The DNA damage-dependent interaction between Rad9 and Dpb11 in G1 is neither 
required for the DNA damage checkpoint, nor for inhibition of DNA end resection. Yet, 
this work clearly shows that the current model of two separate and independent 
checkpoint pathways needs to be revised, which opens the possibility for a new 
mechanism of regulation of the scaffold protein Rad9 that could likely also apply to other 
DNA damage response proteins.  
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Publication 4 |  A cell  cycle-regulated Slx4-Dpb11 complex 
promotes the resolution of DNA repair intermediates l inked to 
stal led replication.  
 
Gritenaite, D., Princz, L. N., Szakal, B., Bantele, S. C. S., Wendeler, L., Schilbach, 
S., Habermann B.H., Matos J., Lisby M., Branzei D. and Pfander B. 
Genes & Development , 28(14), 1604–1619. doi:10.1101/gad.240515.114. (2014). 
 
The resolution of joint molecules generated during template-switch at stalled replication 
forks involves the endonuclease complex Mus81-Mms4. We identified a two-step 
mechanism, by which the action of Mus81-Mms4 on JMs is coordinated and regulated 
within the cell cycle. First, we found that the two scaffold proteins Slx4 and Dpb11 
interact after Slx4 is phosphorylated by CDK on S486, and this complex formation is 
required for the response to replication fork-stalling agents such as MMS. In a second 
step facilitated by the Polo kinase Cdc5 in late mitosis, this complex binds to Mus81-
Mms4, requiring Cdc5-dependent Mms4 phosphorylation. Thus, two regulatory 
branches governed by CDK and Cdc5, respectively, converge in the control of the 
Mus81-Mms4 nuclease to allow efficient resolution of joint molecules in mitosis and 
unhampered progression of DNA replication and subsequent chromosome segregation. 
Interestingly, in absence of the Dpb11-Slx4 complex, the DNA damage checkpoint is 
hyper-activated and it was previously suggested that the prime function of Slx4 is that of 
a checkpoint regulator, for example by interfering with Dpb11 binding to Rad9. Here, 
we demonstrate, however, that in the absence of the Dpb11-Slx4 complex DNA 
lesions/DNA repair intermediates accumulate. More precisely, we could demonstrate that 
specific structures containing RPA-ssDNA after MMS exposure are highly enriched in 
cells expressing a non-phosphorylatable mutant of SLX4, which cannot interact with 
Dpb11 anymore. Our work therefore offers an alternative mechanism in which Slx4 does 
not target the checkpoint directly, but rather indirectly by the removal of DNA repair 
intermediates.  
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Discussion 
1 Cell  cycle regulation of DNA end resection 	
A vast variety of studies have demonstrated the strict repression of DNA end resection in 
cell cycle stages with low CDK activity in order to prevent genomic instability induced 
by spurious recombination. However, we still lack sufficient mechanistic understanding 
of both short- and long-range resection and their cell cycle regulation to be able to 
overcome this regulation. Current models appreciate the influence of chromatin and 
chromatin-bound factors as regulators of resection efficiency, while they view activation 
of the resection enzymes as central targets of CDK regulation. To date it remains a 
central question in the field which aspects of regulation on the enzymes – such as 
activating phosphorylations by CDK – synergize with cell cycle- and damage-dependent 
changes in the substrate of the reaction, damaged chromatin, to generate efficient 
resection rates when needed but strictly prevent unwanted resection. Accordingly, an 
efficient bypass of the cell cycle regulation of DNA end resection has not been 
accomplished yet.  
Besides in vitro studies, first evidence for the crucial role of chromatin as resection 
inhibitor in vivo stems from the observation that the chromatin remodeler Fun30 seems 
critical for efficient DNA end resection. The direct involvement of a chromatin 
remodeler in facilitating resection implies a potential function of the remodeled substrate, 
damaged chromatin, in the repression of resection. Likewise, these data suggest that 
chromatin changes catalyzed by Fun30 shift the chromatin into a resection-permissive 
conformation.  
Here, I will discuss the cell cycle regulation of Fun30 and how our novel understanding 
of Fun30 regulation adds a decisive piece to the puzzle of overcoming the cell cycle 
regulation of DNA end resection.  
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1.1 Fun30 DSB recruitment mechanisms 	
Enzymes acting at DNA double-strand breaks are positively regulated from two angles: 
their recruitment to DSBs, and their activation. In the case of Fun30, these two steps are 
merged since the Fun30 enzymatic activity is stimulated by chromatin or DNA ((Awad 
et al., 2010), (Byeon et al., 2013)), and we do not know about additional factors 
influencing the activity of Fun30. Therefore, understanding the mechanism of DSB 
recruitment of Fun30 is key to understanding its regulation. Moreover, trying to gain 
knowledge about the role of a chromatin remodeler at DSBs imposes an additional 
challenge: we cannot use deletion mutants, as they exhibit highly pleiotropic phenotypes. 
Changes in damage-independent chromatin organization, transcription of certain genes, 
silencing and chromatin composition as caused by deletion of remodeler/s (subunits) 
might impact on the DSB-related phenotypes without necessarily being directly linked to 
the action of the remodeler at the DSB.  
1.1.1  FUN30 TARGETING BY THE DPB11-9-1-1 COMPLEX 
With our work, we established two extremely powerful tools to address this problem. By 
elucidating the molecular mechanism of Fun30 recruitment via binding to 9-1-1-Dpb11 
after CDK-dependent phosphorylation on Fun30 (Fig. 11a), we were able to generate a 
highly specific separation-of-function mutant of Fun30 (fun30-SS20,28AA), which 
exclusively abolishes the DSB-related Fun30 functions in enhancing DNA end resection 
and resection-coupled repair, without impacting on other chromatin changes such as 
silencing, which are compromised in fun30∆ mutants (S. Bantele et al., 2017). Using this 
separation-of-function mutant, we are now equipped to study the molecular function of 
Fun30 at DSBs.  
Importantly, we were also able to generate a gain-of-function mutant exploiting the 
newly discovered recruitment pathway, by directly fusing Fun30 to the 9-1-1 complex 
subunit Ddc1, which naturally would bind to Dpb11 and thereby promote Fun30 
recruitment. This artificial construct, the DDC1-FUN30 fusion, strongly stabilizes 
Fun30 at DSBs and therefore enhances its local concentration (S. Bantele et al., 2017). 
As discussed below, using this fusion as a tool did not only prove extreme value for 
studying Fun30, but also elucidated the critical impact of Fun30 targets on DNA end 
resection.  
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So far, these genetic backgrounds are the only available separation-of-function mutants of 
chromatin remodelers at DSBs, providing a unique opportunity to study remodeling at 
DSBs. Alternatively, one could make use of the requirement of histone modifications or 
variants for remodeler recruitment, as for example γH2A mutation or htz1∆ (human 
H2A.Z) depletion. Such approaches have the fundamental disadvantage of strongly 
impacting on many aspects of chromatin regulation and therefore help us very little to 
understand DSB remodeling. A similar strategy to target the Ino80 remodeler has been 
published recently, however this system uses an “anchor away” strategy by LacO-lacI-
mediated tethering and therefore requires ectopic introduction of the operator repeats in 
the genome, representing a less physiological environment as achieved in our system 
((Neumann et al., 2012),(S. Bantele et al., 2017)).  
1.1.2  ALTERNATIVE FUN30 DSB RECRUITMENT MECHANISMS 
Despite the fact that Dpb11-dependent Fun30 targeting clearly constitutes the basis for 
Fun30 cell cycle regulation, it seems not to be the only mechanism stabilizing Fun30 at 
DSBs (Fig. 11). We observed residual binding of Fun30 to DSBs in ChIP experiment 
using mutants that would specifically abrogate the 9-1-1-Dpb11-Fun30 complex 
formation, such as the ddc1-T602A and the dpb11∆ SLD3-dpb11∆N mutant (S. Bantele 
et al., 2017). It is therefore plausible that other protein-protein interactions add to Fun30 
stability at DSBs.  
Previous studies showed an interaction between Fun30 and histone H2A, with a 
preference for un-phosphorylated H2A over γH2A (Eapen et al., 2012). This interaction 
could serve two needs: association with chromatin and molecular basis for Fun30-
dependent nucleosome remodeling. For the association with nucleosomes, the proposed 
dimerization of Fun30 allowing the interaction with both H2A subunits of the 
nucleosome might play a role (Fig. 11b). So far, we do not understand the requirements 
for Fun30 dimerization (for example involvement of PTMs) and thus a dimerization-
deficient mutant is not available to address this question.  
However, there are several other potential recruitment pathways for Fun30 to DSBs. 
First, biochemical analysis has shown that Fun30 directly binds to the resection-related 
proteins Exo1, Dna2 and RPA (X. Chen et al., 2012)(Fig. 11c). Although the biological 
importance of these interactions is not clear, it is extremely exciting to imagine a self-
enhancing loop within DNA end resection, by which Fun30 promotes resection and 
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consequently more Fun30 gets recruited. There is one observation arguing in favor of 
this model. In the fun30-SSAA mutant, in which Fun30 can’t bind to Dpb11 anymore, 
we observe a stronger DNA binding defect at positions distal to the break, while 
recruitment to break-proximal locations seems hardly affected (S. Bantele et al., 2017), 
arguing for a mechanism involving the resected chromatin, on which RPA is located. It is 
still possible that nucleosomes are involved, as current research is suggesting the presence 
of nucleosomes in single-stranded DNA (Adkins et al., 2017).  
Yet another hypothesis for how Fun30 gets recruited to chromatin in addition to Dpb11-
dependent targeting stems from research on the mammalian homolog of Fun30, 
SMARCAD1. Both proteins harbor one or – in case of SMARCAD1 – two N-terminal 
CUE domains, which interact with ubiquitylated proteins (Fig. 11d). The SMARCAD1 
CUE domains interact with BRCA1-ubiquitylated H2A, and this interaction promotes 
DSB binding of SMARCAD1 and is essential to enhancement of DNA end resection by 
SMARCAD1 (Densham et al., 2016). However, such a mechanism is unlikely to be 
evolutionary conserved, since mutation of the yeast Fun30 CUE domain does neither 
affect DNA binding, nor enhancement of DNA end resection. However, recruitment 
pathways could be synergistic and it remains to be tested whether the reduced DSB 
binding of fun30-SSAA is further enhanced by CUE domain mutation. The interaction 
partners of the Fun30 CUE domain remain to be elucidated, but it seems unlikely that 
CUE-mediated interactions play an important role at DSBs, as they neither affect DSB 
binding, nor Fun30 activity or contribute to conferring DNA damage resistance ((S. 
Bantele et al., 2017),(X. Chen et al., 2012)).  
Possible Fun30 recruitment and stabilization mechanisms at DSBs are summarized in 
Figure 11. 
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Fig.11 Model of putative recruitment pathways to target and stabil ize Fun30 at DNA 
double-strand breaks.  (a) Cell cycle-dependent Fun30 targeting via the 9-1-1-Dpb11-Fun30 
complex. (b) Direct interaction between Fun30 and histones, either as a monomer or a dimer. (c) 
Protein-protein interactions of Fun30 with Exo1, Dna2 and RPA. (d) CUE-dependent recognition of 
modified histones or histone-bound proteins by Fun30. (e) So-far unknown mechanisms contributing to 
Fun30 targeting.  
 
1 .1.3  CONSERVATION OF THE FUN30-DPB11 INTERACTION 
While the CUE-dependent targeting seems newly evolved, the CDK-dependent 
regulation of Fun30 is highly conserved and also depends on CDK phosphorylation of 
SMARCAD1 to promote TopBP1 binding (S. Bantele et al., 2017). We did not only 
identify the responsible phosphorylation site on T71, but also generated a chimera 
merging the TopBP1-interaction surface of SMARCAD1 with the catalytic domain of 
Fun30. This chimera was fully able to rescue DNA damage sensitivity of fun30∆ cells in 
vivo, emphasizing the remarkably high degree of conservation of the Fun30-Dpb11 
complex (S. Bantele et al., 2017). Whether the regulation of resection by CDK is 
similarly exploiting this interaction in human cells as it does in yeast will be focus of 
future research.  
Both yeast Fun30 and human SMARCAD1 are targeted by DNA damage-dependent 
phosphorylation. While ATM-mediated SMARCAD1 phosphorylation contributes to its 
DNA binding ((Densham et al., 2016),(Chakraborty et al., 2018)), it remains unclear 
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which role Mec1/Tel1-dependent Fun30 phosphorylation plays, as it is largely 
dispensable for DSB recruitment (X. Chen et al., 2012).  
Despite the fact that several molecular mechanisms might contribute to Fun30 
recruitment and stabilization around DNA double-strand breaks, the 9-1-1-Dpb11-
Fun30 complex is the only mechanism subjected to cell cycle regulation that we know of 
to date and therefore fulfills a unique, essential role in the targeting of Fun30 and the cell 
cycle regulation of DNA end resection. 
 
1.2 Cell  cycle regulation of resection by the Dpb11-Fun30 complex 	
Fun30 has been identified as a substrate of CDK phosphorylation ((Ubersax et al., 
2003),(X. Chen et al., 2016)) and previous studies showed that CDK is required to 
recruit Fun30 to DSBs and promote DNA end resection ((X. Chen et al., 2016), (X. 
Chen et al., 2012)), however by a so-far unknown mechanism. In our work, we do not 
only provide the molecular mechanism of this CDK regulation, but also introduce a 
Fun30-hyperactivating mutant that is able to bypass this regulation and uncouple 
Fun30-dependent resection from the cell cycle (S. Bantele et al., 2017). More precisely, 
we force-recruit Fun30 to DSBs using a covalent fusion between the 9-1-1 checkpoint 
clamp subunit Ddc1 and Fun30, taking advantage of the Fun30 recruitment mechanism 
we identified in our work (S. Bantele et al., 2017). The fusion achieves two effects. First, 
it bypasses the CDK-dependent phosphorylation of Fun30 and thereby the CDK 
requirement for Fun30 DSB recruitment. Second, it bypasses yet another, DNA damage-
dependent phosphorylation of Ddc1, and thereby greatly stabilizes and concentrates 
Fun30, leading to an increased activity at DSBs. Consequently, the DDC1-FUN30 
fusion hyperactivates Fun30 throughout the cell cycle.  
Other approaches to uncouple resection from cell cycle regulation targeting the Sae2 
nuclease with a CDK phosphorylation-mimicking mutant or the inhibitory Ku complex 
by yku70∆ deletion were less efficient ((S. Bantele et al., 2017),(Trovesi et al., 2011)). 
Notably, both Sae2 and Ku are involved in initiation of resection. Consistent with an 
exclusive function of Fun30 as a long-range resection enhancer, combination of the 
yku70∆ deletion or the sae2-S267E phospho-mimicking version with the Fun30 CDK-
Discussion 
  
	 67	
bypass fusion additively enhances the overall resection efficiency ((S. Bantele et al., 
2017); Bantele and Pfander, unpublished data).  
1.2.1  CHARACTERIZATION OF RESECTION PHENOTYPES BY RPA CHIP 
In order to assess resection phenotypes, we quantified the RPA-coated ssDNA. To this 
end, we performed RPA ChIPs to a stable, inducible DSB. Here, it is crucial to 
distinguish between the spreading of RPA into chromatin and the fold-enrichment of 
RPA. The spreading of RPA correlates with the reach of DNA end resection and this is 
substantiated by a concurrent loss of DNA at these sites due to resection. The 
interpretation of the fold enrichment of RPA is more difficult. ChIP qPCR signals derive 
from millions of DSBs being averaged, and as resection initiation is a stochastic event, we 
always look at a heterogenic signal. Therefore, the fold enrichment can either represent 
the amount of cells that have gone through resection at this location at the time being 
measured, or a lower level of resection at the respective location in all cells of the 
population. This distinction would require single cell assays such as microscopic analysis 
of RPA foci, which has been successfully used before ((Gritenaite et al., 2014), Bantele 
and Pfander, in revision).  
1.2.2  FUN30 SUBSTRATES AS KEY BARRIER TO END RESECTION 
In the hyperactive DDC1-FUN30 fusion mutant we observe a strong enhancement of 
RPA spreading from a DSB throughout the cell cycle, which reaches G2M-like distances 
in G1 arrested cells and strongly pushes resection further compared to WT cells (S. 
Bantele et al., 2017). However, the fold enrichment of RPA in the G1-arrested mutant 
does not reach the levels measured in G2M WT cells.  
We interpret this result as follows: Unambiguously, the enhanced RPA spreading 
throughout the cell cycle shows that Fun30 targets are limiting to end resection 
throughout the cell cycle, and this limitation can be overcome with our fusion mutant. 
Despite being hyper-active, this mutant does not act un-physiologically. On the one 
hand, the mutant only causes to G2M-like RPA spreading in G1 in the sub-population 
of cells, which have initiated resection, and this is reflected by the mild increase of the 
RPA fold enrichment. On the other hand, also non-homologous end-joining remains 
unchanged. Thirdly, all effects of the DDC1-FUN30 fusion depend on the catalytic 
activity of Fun30 and are lost in an ATPase mutant (S. Bantele et al., 2017). 
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Taken together, these data do not only establish chromatin as a main regulator of 
resection efficiency, but also show that the cell cycle regulation of Fun30 by the 9-1-1- 
Dpb11 targeting complex are a pivotal aspect of cell cycle regulation of DNA end 
resection and might constitute the bottleneck to the onset of long-range resection.  
Besides the biological implications of this work, overcoming resection barriers is of 
tremendous interest to biologists. Tools like the DDC1-FUN30 fusion could prove 
invaluable to enhance the efficiency of gene targeting methodologies based on 
recombination, such as CRISPR-Cas9, particularly in post-mitotic cells. Indeed, first 
attempts to enhance gene targeting efficiency in human cells involve removal of the 
resection inhibitor 53BP1 (Orthwein et al., 2015), an ortholog of yeast Rad9, which is 
potentially the main target of Fun30/SMARCAD1 on damaged chromatin, as discussed 
below. It is highly tempting to test whether a hRad9-SMARCAD1 fusion or an H2A-
SMARCAD1 fusion protein would allow resection and gene targeting in G1 in the 
presence of 53BP1, and hopefully future experiments will test this possibility. 
 
1.3 Enzymatic function of Fun30 at DSBs 
1.3.1  PUTATIVE HISTONE DIMER EXCHANGE BY FUN30 
It is established that the SWI/SNF ATPase activity of Fun30 is critically required for 
promoting DNA long-range resection (X. Chen et al., 2012). Together with the fact that 
Fun30 has the highest sequence similarity to the SWR1/Ino80 remodelers, which among 
others exchange H2A/H2B dimers and H2A.Z/H2B dimers, and that it seems to be 
active in histone dimer exchange in vitro itself (Awad et al., 2010), it seems plausible that 
histone dimer exchange by Fun30 could be involved in enhancing end resection (Fig. 
12a). Whether this is directed against specific dimer compositions, for example in H2A.Z 
deposition or removal, or removal of γH2A - containing dimers, is not clear. 
Interestingly, Fun30 has a binding preference between non-phosphorylated and γH2A-
phosphorylated H2A (Eapen et al., 2012), and we observe an increase of the γH2A ChIP 
enrichment in fun30∆ cells that is most likely not due to the resection defect since it does 
not display in break-proximal regions as expected for resection-deficient mutants, but all 
over the measured γH2A domain (Bantele and Pfander, unpublished data). We observe 
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the same increase in γH2A on chromatin when performing chromatin fractionation in 
fun30∆ mutant cells (Bantele and Pfander, unpublished data).  
Interestingly, in vitro, Fun30 shows a higher affinity to nucleosomes on single- than on 
double-stranded DNA (Adkins et al., 2017). Thus, a potential model could suggest an 
ssDNA-H2A-dependent Fun30 binding mechanism that acts to enhance Fun30 
recruitment during resection and might contribute to the removal of γH2A on resected 
DNA in addition to the (partial) histone loss. A direct testing of this hypothesis is 
however not trivial, as all DSB-related FUN30 mutants cause resection defects, which in 
turn generate higher levels of γH2A. 
When the phosphorylatable serine in H2A is mutated to prevent γH2A formation, 
resection efficiency is enhanced ((Eapen et al., 2012), (Clerici et al., 2013)). Previous 
studies have established Rad9 and its human ortholog 53BP1 as well as the fission yeast 
homolog Crb2 as resection inhibitors ((Chapman, Sossick, Boulton, & Jackson, 2012), 
(Ferrari et al., 2015), (Bonetti et al., 2015), (Symington, 2016), (Leland, Chen, Zhao, 
Wharton, & King, 2018)). γH2A provides a binding site for Rad9 homologs on 
damaged chromatin ((Hammet et al., 2007), (Javaheri et al., 2006)), and could therefore 
explain the enhanced resection in γH2A-deficient cells by removal of Rad9 from 
damaged chromatin.  
1.3.2  ANTAGONISTIC ACTION OF FUN30 AND RAD9 
Intriguingly, genetic data suggest that Rad9 and Fun30 are counteracting each other ((S. 
Bantele et al., 2017),(X. Chen et al., 2012)), and cells lacking Fun30 recruit more Rad9 
to DSBs and vice versa. These data raise the possibility that Fun30 acts by removing 
Rad9 from chromatin, either directly or indirectly by removing Rad9 binding sites as 
discussed in the previous subchapter (Fig. 12a,b).  
It is particularly interesting that besides the chromatin-associated Rad9 recruitment 
pathway, also the Dpb11-dependent Rad9 recruitment might be corrupted by Fun30, as 
Rad9 and Fun30 bind to the same BRCT repeat 1+2 of Dpb11 ((S. Bantele et al., 
2017),(Pfander & Diffley, 2011)). So far we do not have evidence for binding 
competition on Dpb11, as Rad9 overexpression does not weaken the Yeast Two-Hybrid 
interaction between Dpb11 and Fun30 (Bantele and Pfander, unpublished data). Still, 
binding competition on H2A cannot be excluded to date (Fig.12c).  
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Whether a potential γH2A removal by Fun30 is directed or just a byproduct of the 
enhanced enrichment of γH2A around DSBs is not clear. Similarly, a potential specificity 
towards H2A.Z-containing histone dimers has not been tested yet and could generate a 
similar decrease in γH2A levels. So far, we do not observe changes in the turnover of 
H2A.Z in damaged chromatin in mutants lacking Fun30 (Bantele and Pfander, 
unpublished data). 
Importantly, the mechanism by which Fun30 promotes efficient DNA end resection at 
DSBs is fully elusive to date and a potential histone dimer exchange is only one possible 
mechanism.  
In general, data do argue against a mechanism by which Fun30 would catalyze one 
particular step of the resection reaction, since resection defects in fun30∆ mutants can be 
compensated by overexpression of EXO1 ((Eapen et al., 2012), (Costelloe et al., 2012), 
(X. Chen et al., 2012)). Thus we believe that Fun30 rather primes the chromatin for 
resection by transforming it into a more resection-permissive state, potentially by 
alleviating Rad9 inhibition.  
If truly Rad9 is the key antagonist of Fun30, one could also envision a more direct 
eviction mechanism acting on Rad9. Figure 12 provides an overview over possible 
mechanisms by which Fun30 might enhance resection and oppose Rad9 inhibition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
  
	 71	
 
 
Fig.12 Model of possible mechanisms of resection enhancement by Fun30, opposing 
the Rad9-dependent obstruction. (a) Fun30 could counteract Rad9 indirectly through 
chromatin changes, for example H2A/H2B dimer exchange concomitant with changes in the 
nucleosome composition, particularly γH2A and H2A.Z, or by nucleosome mobilization potentially 
rendering it a worse binding platform for Rad9. (b) Alternatively, a direct removal of Rad9 by Fun30 
involving the Fun30 ATPase and helicase activity could be envisioned. (c) Thirdly, a binding 
competition between Fun30 and Rad9, either on Dpb11 BRCT1+2 or on H2A could be possible.  
 
1 .3.3  MECHANISM OF RAD9 RESECTION INHIBITION 
We showed in our study that clearly the Fun30 target at DSBs, potentially Rad9, 
strongly contributes to resection inhibition throughout the cell cycle (S. Bantele et al., 
2017). We favor a model in which this inhibition is present in all cell cycle phases.  
When CDK becomes active and mediates resection enzyme activation on the one hand, 
and Fun30 recruitment on the other hand, the inhibition is overcome. Two findings 
Discussion 
  
	 72	
support this model. First, Rad9 binding to histones is not subject of cell cycle regulation. 
Second, we clearly demonstrate in our new manuscript that γH2A is not cell cycle-
regulated either (Bantele et al, in revision). Therefore, histone-bound Rad9 is a bona fide 
candidate for a constitutive resection inhibitor.  
As mentioned before, Rad9 can also be recruited to DSBs via CDK-dependent 
interaction with Dpb11 (Pfander & Diffley, 2011). Three arguments point towards 
histone-bound rather than Dpb11-bound Rad9 as resection inhibitor. First, we have little 
evidence for a binding competition between Rad9 and Fun30 on Dpb11 (Bantele and 
Pfander, unpublished data). Second, mutation of the Rad9 CDK sites interacting with 
Dpb11 does not affect end resection (di Cicco, Bantele, Reusswig, & Pfander, 2017). 
Third, the deletion of Rad9 also enhances resection in G1 when CDK is inactive 
(Trovesi et al., 2011). 
Another argument supporting this model stems from the observation that similar to 
γH2A mutation, the deletion of the Dot1 methyl-transferase, which generates the second 
binding site for Rad9 on chromatin (methyl-H3K79), increases the efficiency of end 
resection (Lazzaro et al., 2008). All together, genetics suggest that the H3/H2A-Rad9 
complex acts as the resection-inhibiting unit.  
It is particularly puzzling that we also do not understand the mechanism by which Rad9 
inhibits resection, and whether this converges to the same target as Fun30 or works 
completely independent. Several scenarios are possible. Histone-bound Rad9 could alter 
the chromatin structure and thereby make it a worse substrate for the resection nucleases 
(Fig. 13d). Alternatively, Rad9 itself could physically block the passage of the nucleases 
and prevent their progression into chromatin (Fig. 13a). Thirdly, Rad9 could impede 
Fun30-dependent chromatin remodeling (Fig. 13c).  
Similar to the DDC1-FUN30 hyperactive fusion system, we generated a DDC1-RAD9 
fusion and to our great surprise, this fusion is a very strong resection inhibitor (Bantele et 
al, in revision). These data are particularly interesting since the DDC1-RAD9 fusion is 
most likely not associated with chromatin but accumulates via the 9-1-1 complex. This 
raises the possibility for yet another potential mechanism by which Rad9 could inhibit 
resection. A well-established binding partner of Rad9 at DSBs is the checkpoint effector 
kinase Rad53, which indeed is hyper-activated in the DDC1-RAD9 fusion mutant 
(Bantele et al, in revision). Previous experiments suggest that Rad53 might trigger a 
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negative feedback inhibition on resection by phosphorylating Exo1 in order to dampen 
its activity (Morin et al., 2008). However, we do not observe hyper-resection in cells 
lacking Rad53 (Bantele and Pfander, unpublished data). As Rad9 itself is a protein 
scaffold, it could recruit a so far unknown protein to DSBs, which negatively affects 
resection (Fig. 13b).  
Figure 13 summarizes potential modes of Rad9 resection inhibition.  
 
 
Fig.13 Model of possible mechanisms of resection inhibit ion by Rad9 (a) Rad9 could 
either inhibit the nucleases or physically block the progression of the nucleases, acting s a roadblock. (b) 
Rad9 could act as a protein scaffold and recruit resection inhibiting activities, as for example Rad53. (c) 
Rad9 might inhibit Fun30-dependent remodeling, either by preventing chromatin access, or by directly 
inhibiting Fun30 activity. (d) Finally, Rad9-bound chromatin might change in its physical properties in 
a way that it becomes a worse substrate for DNA end resection, for example by compaction.  
 
1.3.4  CONSERVATION OF CHROMATIN-RELATED RESECTION REGULATION 
Interestingly, the antagonistic action of Fun30 and Rad9 appears to be conserved to the 
mammalian homologs SMARCAD1 and 53BP1 ((Densham et al., 2016), (Costelloe et 
al., 2012)). SMARCAD1 depletion leads to 53BP1 stabilization at DSBs generated by 
laser cuts, and this depends on the CUE domains and ATPase activity of SMARCAD1, 
suggesting an active role of SMARCAD1 in repositioning 53BP1 (Densham et al., 
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2016). Whether such an eviction is direct or an indirect effect of SMARCAD1-
dependent nucleosome remodeling is not clear. Similar to yeast, 53BP1 depletion renders 
SMARCAD1/Fun30 function dispensable (Densham et al., 2016). In addition to the 
discussed roles during repressing long-range resection, Rad9 as well as 53BP1 have been 
recently implicated with suppressing the initiation of resection.  
In human cells, we have a better understanding of the mechanistic details of 53BP1-
dependent resection inhibition. As both 53BP1 and the resection-enhancing counterpart 
BRCA1 are recruited in a ubiquitylation-dependent manner, 53BP1 accumulates one of 
its effectors, RIF1, which impedes chromatin binding of BRCA1 and consequently 
blocks SMARCAD1 accumulation and the onset of resection ((Escribano-Díaz et al., 
2013), (Densham et al., 2016)). Once CtIP becomes activated by CDK, it replaces RIF1 
from chromatin, facilitating cell cycle-regulated end resection.  
Intriguingly, the inhibition of resection in mammalian cells seems to be enforced in G1 
by yet another, 53BP1-independent mechanism. Human cells employ a negative 
feedback regulation in which the helicase HELB is recruited to RPA-ssDNA and inhibits 
both Exo1- and Dna2-dependent resection. When CDK becomes active at the onset of S 
phase, HELB is displaced from ssDNA and permits processive resection (Tkáč et al., 
2016).  
1.3.5  RESECTION PATHWAY-SPECIFICITY OF FUN30  
Yet another interesting aspect of Fun30 function is whether it generally enhances all 
resection pathways or is specifically coupled to one of the two pathways. This idea is 
primed by the fact that the Dna2 nuclease is genetically linked to the Sgs1 helicase 
activity during end resection, while the redundant resection pathway carried out by the 
Exo1 nuclease seems to act without strict requirement for a helicase activity at DSBs. 
These differential requirements also reflect in in vitro experiments, where purified Exo1 
alone can carry out DSB resection, while Dna2 requires among others the STR complex 
(Adkins et al., 2013).  
In contrast to yeast Exo1, human Exo1 seems to readily cooperate with helicases. 
Previous studies showed that in vitro, the human RecQ helicases BLM and WRN 
stimulate hExo1 activity by direct interaction, which supposedly facilitates targeting of 
the exonuclease to its substrates ((Nimonkar et al., 2008), (Aggarwal, Sommers, Morris, 
& Brosh, 2010)). Moreover, in the absence of RNaseH2, hExo1 synergizes with the 
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helicase Srs2 in the removal of Top1-dependent nicks at sites of aberrant insertion of 
ribonucleoside monophosphates into the DNA (Potenski, Niu, Sung, & Klein, 2014).  
Fun30 possesses a conserved, helicase-like domain (Flaus, 2006), but it is not clear to 
date whether Fun30 does at all act as a helicase in vivo. Current genetic data argue 
against a pathway-specific action of Fun30 since DNA damage sensitivity and resection 
efficiency are both additively affected when the fun30∆ deletion is combined with 
mutants of either of the two resection pathways, exo1∆ or sgs1∆ ((Eapen et al., 2012), 
(Costelloe et al., 2012), Bantele and Pfander, unpublished data).  
 
1.4 Repair pathway regulation by Fun30 and Rad9 	
The initiation of resection constitutes the decision point between NHEJ and HR. 
Therefore, mutants affecting the initiation of resection are able to shift this balance and 
result in altered repair pathway usage, potentially with genotoxic consequences. As 
discussed, Fun30 clearly is not involved in this early step of resection and in agreement 
with that, neither mutants with decreased, nor with increased Fun30 activity do affect 
rates of NHEJ ((Eapen et al., 2012),(S. Bantele et al., 2017)).  
Importantly, also the different recombination-based repair pathways have different 
requirements for resection efficiency. Gene conversion (GC) only requires short stretches 
of ssDNA ((C.-S. Lee et al., 2016)), although it is possible that longer overhangs might 
promote recombination. In contrast, single-strand annealing (SSA) requires the efficient 
resection of longer DNA tracts, depending on the positioning of the annealing site. In 
fact, while Fun30 seems dispensable for SSA with a 5 kb spacer between the DSB and the 
annealing site, it is vital for completion of SSA with a 25 kb spacer, indicating that 
resection efficiency is not sufficient to pass through 25 kb of chromatin in absence of 
Fun30 ((Eapen et al., 2012), (S. Bantele et al., 2017)).  
SSA and also MMEJ, which both rely on removal of DNA tracts separating a 
homologous region to the break site from the actual DSB, go along with DNA loss and 
are as such the highly mutagenic alternatives to gene conversion once a DSB has initiated 
resection. In contrast, NHEJ is a much safer repair alternative as it has reasonable 
accuracy with only a low rate of small deletions or mutations (0.06% at a clean DSB (S. 
Bantele et al., 2017)). Consequently, controlling the switch between homology-directed 
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repair pathways may be as crucial for genome integrity as the switch between NHEJ and 
HR.  
Notably, deregulation of Fun30 has only minor effects on the overall prevalence of 
NHEJ events at clean DSBs, however it increases the rate of mutagenic NHEJ about 50-
fold ((S. Bantele et al., 2017)). The mechanism of these mutagenic events is not clear and 
the role of Fun30 during the execution of NHEJ is not yet understood.  
Interestingly, a recent study discovered a similar role of the Rad9 ortholog 53BP1 in 
balancing the usage of GC and SSA in human cells (Ochs et al., 2016). The authors 
observe that the hyper-resection, occurring when levels of 53BP1 are artificially low, 
triggers a shift from gene conversion to SSA. Since also in human cells, 53BP1Rad9 is 
opposed by SMARCAD1Fun30, it would be highly tempting to test whether deregulation 
of SMARCAD1 affects the balance between GC and SSA likewise. Such a finding would 
further emphasize the tremendous importance of properly balancing repair pathway 
choice. 
Together, these data suggest that a two-step surveillance mechanism at DSBs controlling 
(a) the usage of NHEJ versus HR at the step of resection initiation and (b) the usage of 
GC versus SSA at the step of long-range resection efficiency is at place in order to ensure 
the usage of the respective high-fidelity repair pathway.  
 
1.5 Roles of Fun30/SMARCAD1 beyond DSBs 	
1.5.1  FUN30 IN THE RESPONSE TO CAMPTOTHECIN 
One facet of FUN30 phenotypes is exceptionally fascinating and fully elusive until now. 
Cells with compromised Fun30 function or lacking interaction between Fun30 and 
Dpb11 are exclusively sensitive to the topoisomerase 1 inhibitor Camptothecin (CPT), 
but not to any other DNA damaging drugs ((S. Bantele et al., 2017)). CPT stalls the 
covalently linked Top1-DNA intermediate that occurs naturally transiently during the 
catalytic cycle of Top1 and by this generates DNA-protein crosslinks (DPCs). Such 
crosslinks present an obstacle to other DNA metabolic machineries and can cause single- 
and secondary double-strand breaks upon collision with transcription and replication 
machineries as well as stalled replication forks.  
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The Top1-DNA adducts are either directly hydrolysed by tyrosyl-DNA 
phosphodiesterase (Tdp1), cleaved at the DNA part by the MRX complex or removed in 
a protease-dependent manner by the Wss1/SPARTAN protease ((Stingele, Schwarz, 
Bloemeke, Wolf, & Jentsch, 2014), (Stingele et al., 2016), (Lopez-Mosqueda et al., 
2016)).  
Given the DSB resection function, genetic interactions between Fun30 and the MRX 
complex are inherently difficult to analyse. However, fun30∆ cells display additive 
genetic interactions upon cronic exposure to CPT with the respective protease, Wss1, as 
well as Tdp1, suggesting functions in parallel pathways (Bantele and Pfander, 
unpublished data). Additionally, fun30∆ cells are not sensitive to other forms of DNA-
protein crosslinks such as induced by formaldehyde treatment (Bantele and Pfander, 
unpublished data). It seems therefore unlikely that Fun30 generally enhances repair of 
DPCs by the canonical repair pathways, but rather is specifically linked to 
topoisomerase1-dependent DNA damage, potentially in the context of stalled replication 
forks. This idea is substantialized by the observation that CPT-induced checkpoint 
activation is prolonged in cells lacking FUN30 and this is restricted to Rad53 activation 
during S-phase (Bantele and Pfander, unpublished data).  
Interestingly, dealing with replication fork stalling by other drugs like MMS or HU does 
not require Fun30 ((S. Bantele et al., 2017)). Taken together, it will be highly interesting 
to study the role of Fun30 at Top1-stalled replication forks and Top1-dependent DPCs.  
1.5.2  INVOLVEMENT OF FUN30 IN DNA MISMATCH REPAIR 
Besides Top1-DPC removal and DSB end resection, Fun30 might very well impact on 
other DNA repair-related processes. Genetic screening has revealed interactions with a 
vast variety of chromatin modifying complexes such as the histone acetyl transferase 
Rtt109, components of the NuA4, SAS, NatA and SAGA histone acetyl transferases, base 
and nucleotide excision repair proteins, replication fork components and chromatin 
remodeling factors such as Rad54, the RSC, ISWI and Ino80 chromatin remodeling 
complexes ((Costanzo et al., 2010), (Krogan et al., 2003), (Krogan et al., 2006), (Collins 
et al., 2007), (Beltrao et al., 2009)). A recent study describes a genetic link between 
Fun30 and enzymes connected to mismatch repair (MMR), Msh2,3 and 6 (Terui et al., 
2018). Intriguingly, the human Fun30 homolog SMARCAD1 has recently been linked 
to MMR. Both yeast Fun30 and SMARCAD1 seem to be involved in the disposition of 
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nucleosomes around mismatched basepairs, opposing the activity of Caf1 (Terui et al., 
2018). The proposed mechanism depends on the MMR factor Msh2 and is important 
for the following repair of the lesion (Terui et al., 2018). Furthermore, Msh2 was shown 
to be involved specifically in HR-dependent DSB repair ((Franchitto et al., 2003), 
(Pichierri, Franchitto, Piergentili, Colussi, & Palitti, 2001)) and is required for CPT 
recovery in human cells (Burdova, Mihaljevic, Sturzenegger, Chappidi, & Janscak, 
2015), offering an alternative explanation for the genetic interaction with Fun30.  
Altogether, future studies should be directed towards a universal understanding of Fun30 
functions and dissect whether the chromatin changes catalysed by Fun30/SMARCAD1 
are identical at lesions of all different natures or whether specific mechanisms of 
regulation funnel Fun30 activity dependent on the origin of the lesion.  
 
1.6 Establishing a genetic toolbox to study regulation of DNA end 
resection, chromatin dynamics during end resection, and mechanism of 
the Rad9-Fun30 axis 	
On a final note regarding our studies of Fun30 and its role in resection enhancement, it 
should be emphasized that the artificial protein fusions we generated during this study 
may constitute invaluable tools for future studies on DNA resection ((S. Bantele et al., 
2017); Bantele et al, in revision,(di Cicco et al., 2017)). Figure 14 shows the ability of 
these covalent protein fusions to manipulate DNA end resection. 
 
 
 
Fig.14. The toolbox of Ddc1 fusion proteins.  (a) Force-localization of Fun30 by the DDC1-
FUN30 fusion induces hyper-resection throughout the cell cycle (not shown here), and uncouples 
resection from its cell cycle regulation by promoting a G2M-like resection range in G1-arrested cells. 
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(b) Force-localization of Rad9 by the DDC1-RAD9 fusion effectively represses resection in G2M 
arrested cells. 
We are only beginning to understand, whether chromatin changes are accompanying or 
preceding end resection, and to distinguish between changes required for or induced by 
end resection is inherently difficult.  
Ddc1 fusion proteins offer the genetic means to on the hand make chromatin susceptible 
or repressive towards end resection and on the other hand to analyze resection uncoupled 
from its cell cycle regulation ((S. Bantele et al., 2017); Bantele et al, in revision). This 
offers the potential to find novel factors involved in resection regulation and to gain a 
comprehensive understanding of resection-associated changes in chromatin. To take it 
one step further, other enzymatic activities might be targeted to DSB using the Ddc1 
fusion strategy in order to investigate their impact on DSB-related processes, resection 
being only one of them. In conclusion, we believe that the Ddc1 fusions will have future 
impact on our research field that goes beyond the biological findings we present in our 
studies here.  
 
2 DNA damage checkpoint signaling mechanisms 	
2.1 Regulation of Mec1 and its substrates 	
We showed that independent of the extent of DNA end resection and CDK activity, a 
subset of Mec1 targets, represented by γH2A, is phosphorylated to similar levels, even 
under extreme conditions such as the absence of long-range resection (exo1∆ sgs1∆ cells) 
or upon hyper-resection (DDC1-FUN30 cells) (Fig. 15) (Bantele et al, in revision). As 
Mec1 kinase recruitment requires resection, a major question arising from our data is 
how such dramatically different amounts of Mec1 kinase at a DSB can lead to the same 
amount of phosphorylation of substrate molecules, and how Mec1 targets differ?  
2.1.1  DYNAMICS OF ΓH2A PHOSPHORYLATION DURING RESECTION 
γH2A (H2A phospho-S129) is one of the earliest Mec1 kinase targets and decorates a 
broad region around a DSB, ranging from around 20 kb in yeast to several hundreds of 
kb in human cells ((Shroff et al., 2004),(S. Bantele et al., 2017), (Rogakou et al., 1998)). 
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This region can be subdivided in two: the resected region comprising RPA-ssDNA, and 
the adjacent intact chromatin (Fig. 15). These two regions behave profoundly different 
regarding the dynamics of γH2A phosphorylation. In this section, the inverse 
relationship between resection and γH2A signal intensity will be discussed below as well 
as potential mechanisms underlying resection-independent spreading of γH2A into the 
adjacent chromatin. Together, both phenomena show that γH2A phosphorylation is 
primarily regulated from the side of the substrate, but not from the side of the kinase.  
 
In the resected area, we observe a pronounced correlation of resection with γH2A signal 
loss (Fig. 15; Bantele et al, in revision). Accordingly, γH2A is greatly enriched at break-
proximal regions in absence of resection. γH2A phosphorylation depends on the 
availability of H2A for the kinase reaction. According to the prevalent model, histones 
are at least partially evicted during DNA end resection, creating a respective lack of H2A 
substrate in the resected region. It is therefore likely that histone loss in resected regions 
reflects in a decreased γH2A signal.  
 
 
 
Fig.15. Anti-correlat ion between RPA and γH2A ChIP signals  at  a  DSB. RPA ChIP signals 
(red) demark the border of resection, which is around 10 kb from the DSB in WT mitotic cells after 4 
hours of break induction (left panel) and at under 1 kb in exo1∆sgs1∆ mitotic cells (right panel). 
Correspondingly, the γH2A ChIP signals (green) remain unchanged at regions beyond the resection border, 
while they show a decrease at RPA-enriched ssDNA. In regions outside of RPA enrichment, which are 
supposedly double-stranded and have not undergone resection yet, the signals are highly similar between 
both conditions.  
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It is currently under debate to which degree histones are being lost around a DSB. 
Notably, we observe almost complete loss of the γH2A signal directly at the DSB (Fig. 
15; Bantele et al, in revision). Should this be representative of histone loss, these data 
would point towards major histone loss in these regions. In vitro data suggest the 
existence of nucleosomes in single-stranded DNA (Adkins et al., 2017), but whether they 
are being bypassed by the resecting nucleases or deposited after resection is not clear. One 
could speculate that such an ssDNA-nucleosome complex could participate in signaling 
actively or indirectly by alteration of the physical properties of the ssDNA. Indeed, 
single-stranded DNA tracts, which are assembled with nucleosomes in vitro, seem to 
adapt structural features similar to normal double-stranded nucleosomes but display a 
more dynamic behavior (Adkins et al., 2017). 
In vivo experiments suggest a rather moderate loss of histones around DSBs, compared to 
the complete removal at transcriptional start sites ((Bennett et al., 2013), (van Attikum et 
al., 2007), (C.-C. Chen et al., 2008), (Boeger et al., 2003).  A recent study proposes that 
histones are actively deposited on resected DNA and subsequently facilitate Rad51 
loading and completion of recombination (Huang et al., 2018).  However, due to the 
ubiquitous presence of histones on the DNA, histone ChIPs are inherently difficult to 
analyse and normalize, calling for a more sophisticated methodology to finally determine 
occupancy and dynamics of nucleosomes on resected DNA.  
2.1.2  THE BOTTLENECK TO ΓH2A PHOSPHORYLATION 
Outside the region of resection we measure highly similar γH2A signals independently of 
the amount of ssDNA (Fig. 15; Bantele et al, in revision). In contrast, proteins involved 
in the Rad53 activation cascade do strongly depend on DNA end resection for their 
recruitment to DSBs and their subsequent Mec1 activation (Bantele et al, in revision). 
Thus, Mec1 activity seems to target those factors by a different mechanism than γH2A. 
This apparent contradiction suggests the presence of distinct, parallel Mec1 signaling 
mechanisms operating at DSBs. 
A central question arising from these data is how – if not by channeling of Mec1 activity 
– γH2A phosphorylation is limited.  In our work we ruled out redundancy between the 
apical kinases Mec1 and Tel1 as well as saturation of H2A molecules to account for this 
enigmatic relationship (Bantele et al, in revision). As neither substrate nor enzyme seem 
to limit the γH2A phosphorylation reaction, additional factors must play in. The 
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phosphorylation reaction requires the physical encounter of the Mec1 kinase with its 
substrate, and these encounters are limiting to the rate of the γH2A phosphorylation. 
Here, three potential factors influencing contact frequencies between Mec1 and H2A are 
discussed.  
First, DSBs are not locally fixed structures but have a certain propensity to move in the 
nucleus. Compared to undamaged DNA loci, DSBs can probe a larger volume in the 
nucleus ((Dion et al., 2012), (Miné-Hattab & Rothstein, 2012)). Mechanistically, this 
boils down to DNA damage checkpoint-dependent histone loss enhancing DSB mobility 
(Hauer et al., 2017). The precise mechanism of this DSB mobility enhancement remains 
to be clarified. In principle, DSB end-tethered Mec1 kinase could reach H2A substrates 
in a wider radius when the DSB is more mobile, and consequently mutants interfering 
with the DSB mobilization could restrict the γH2A domain. However, using checkpoint-
dead cells such as the rad9∆ or rad53∆ mutant, we could not observe changes in γH2A 
levels or spreading and therefore exclude enhancement of DSB mobility as a major factor 
influencing γH2A levels (Bantele et al, in revision).  
Second, chromatin is organized in distinct 3D volumes, forming so-called topologically 
associated domains (TADs) ((Caron et al., 2012), (Caron et al., 2015), (Aymard et al., 
2017)). In human cells it was shown earlier that γH2A spreads within the confinement of 
TADs (Caron et al., 2012). Until now, we do not have access to genome contact data 
after a DSB in yeast, and studies correlating 3D contacts of DNA loci with DSB-related 
events such as repair efficiency used 3D contact maps of undamaged yeast cells as a 
reference ((R. W. Wang, Lee, & Haber, 2017), (Duan et al., 2010)). While such an 
approach might give first insights into correlations between local events such as γH2A 
modification with the chromosome conformation, a genome-wide mapping of γH2A and 
3D contacts from the same conditions will finally be required to draw conclusions. In 
principle, Mec1 has the propensity to act in trans ((Renkawitz et al., 2013b), (C.-S. Lee 
et al., 2013)), which is a basic requirement for the proposed mechanism to work, and we 
therefore think a TAD-guided definition of the γH2A domain is not unlikely. 
Third, localization and amount of activated Mec1 molecules will obviously be decisive to 
shape the γH2A signal. Mec1 requires recruitment to ssDNA meditated via a direct 
interaction between RPA and the Mec1 cofactor Ddc2 in order to get activated. 
However, we have no understanding of whether all Mec1 molecules recruited to DSBs 
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are being activated, and whether active Mec1 stays bound to the ssDNA or can be 
released afterwards to reach substrates by diffusion. Such a diffusion mechanism would 
generate a “cloud” of Mec1 activity, which would not necessarily be different in size and 
activity between cells that resect to different extents.  
One aspect of our γH2A ChIP data argues in favor of such a mechanism. We usually 
measure timecourse experiments, in which we monitor protein recruitment or γH2A 
phosphorylation around a DSB within four hours. We typically observe two effects: first, 
the enrichment of the protein gets higher. Second, the protein moves into chromatin 
away from the DSB in a vectorial manner, and this coincides with resection. This 
movement is perfectly explained by checkpoint protein localization to the borders of 
resection or resected DNA. Notably, we observe a completely different behavior for 
γH2A, which also increases over time, but evenly rises over the entire γH2A domain, 
without showing any vectorial movement along the chromosome arm. This observation 
can give us several hints towards Mec1 substrate regulation. The “cloud” model of Mec1 
activity would readily explain the phenomenon of the homogenously distributed γH2A 
enrichment, as most likely Mec1 diffusion is faster than the γH2A phosphorylation 
reaction, and could therefore reach H2A molecules all over the diffusion radius with a 
relatively similar timing. As we cannot distinguish between the spreading of Mec1 
activity by Mec1 diffusion or by TAD formation experimentally, both mechanisms could 
contribute to in cis and trans spreading of γH2A.  
 
Overall, Mec1 substrate phosphorylation is therefore not dependent on Mec1 regulation 
but rather Mec1 phosphorylation could be viewed as being primarily channeled from the 
side of its substrates, as very few Mec1 molecules seem sufficient to phosphorylate its 
substrates at the DSB (Bantele et al, in revision). In agreement with this model, 
checkpoint proteins of the Rad53 activation cascade, such as 9-1-1, Dpb11 and Rad9, 
which do depend on resection, require a primary recruitment step in order to be available 
for Mec1 phosphorylation. This recruitment step constitutes the basis for the regulation 
by resection, and not necessarily Mec1 kinase activity. In contrast, H2A is inherently 
present around the DSB and as such a more direct readout for Mec1 activity.  
If this model was true, overall Mec1 activity would be similar whenever a DSB is present, 
independent of the amounts of resection, and the pool of DSB recruited Mec1 does not 
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inherently correlate with the pool of active Mec1.  Consequently, one could make every 
Mec1 substrate a resection-independent substrate by bypassing the resection-dependent 
recruitment step, for example by addition of a γH2A binding domain.  
On the contrary, one could artificially generate a γH2A-like phosphorylation event that 
is resection-dependent by fusing the H2A histone tail to one of the checkpoint proteins 
that requires resection for its DSB association. Future studies using these tools therefore 
have the potential to provide deeper understanding of the ultimate point of regulation of 
the Mec1 kinase reactions at DSBs.  
2.1.3  LOCAL AND GLOBAL MEC1 SIGNALING CIRCUITS 
The differential regulation of Mec1 substrates demonstrates that Mec1 feeds into at least 
two distinct signaling circuits, one that follows quantitative inputs in the form of the 
amount of ssDNA generated by DNA end resection and activates the effector kinase to a 
proportional degree, and another that does not integrate quantitative information but is 
activated at every lesion site likewise. We think that the purposes of these two circuits are 
global, quantitative checkpoint activation, and local regulation of damage repair (Fig. 16; 
Bantele et al, in revision).  
γH2A representing the local circuit was indeed demonstrated to act locally, as it is 
regulated individually at each lesion site where it coordinates DNA repair ((Tsabar et al., 
2015), (J.-A. Kim et al., 2007)), and independently of other lesion sites is required for 
efficient DNA repair ((Unal et al., 2004), (Downs, Lowndes, & Jackson, 2000)). 
Currently, there is no evidence for communication of γH2A signals from different sites. 
We therefore term the resection-independent γH2A signaling mechanism the “local” 
checkpoint circuit (Fig. 16a).  
In contrast, Rad53 activation very well responds to the amount of resection ((Mantiero et 
al., 2007), (Zierhut & Diffley, 2008)), and this sensitive response is essential to balance 
out cell proliferation and genome maintenance. As activated Rad53 targets a large variety 
of checkpoint effectors and this is not locally connected to the DSB after its activation, 
we term this checkpoint signaling pathway the “global” circuit (Fig. 16b).  
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Fig.16. Model of local  and global DNA damage checkpoint s ignaling circuits .  Mec1-
Ddc2 triggers (a) local checkpoint signaling to ensure efficient repair of the lesion, as for example γH2A 
phosphorylation. Local signaling is not responsive to the extent of resection and does not participate in 
Rad53 activation. In parallel, Mec1-Ddc2 sets off the global checkpoint response (b), which cumulates 
in Rad53 activation and acts proportional to the extent of resection.  
 
Previous studies have raised the possibility that checkpoint signaling is cell cycle-
regulated not only due to resection, but also because of other mechanisms. Indeed in S-
phase, where inherently high levels of RPA-ssDNA are present, full Rad53 activation 
requires a higher damage load compared to in mitosis, providing a tailored checkpoint 
response that prevents unwanted checkpoint activation by single-stranded replication 
intermediates ((Shimada, Pasero, & Gasser, 2002), (Tercero, Longhese, & Diffley, 
2003)). If this was true, the tolerance towards the presence of ssDNA as checkpoint 
activator would be adjusted to the basal level of ssDNA in the respective cell cycle stage. 
Taken together, the mechanistic separation of events that mediate repair and events that 
mediate global signaling at DSBs establishes a buffering system in which the cell initiates 
the full repair force from the moment a lesion is introduced, while the cost-intense global 
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response acts as emergency signal when fast repair fails. As these two branches of 
signaling are mechanistically separated but elicited by the same kinase, it is inversely 
ensured that no matter what, both signaling circuits are in principle ready to react.  
From these ideas several highly interesting questions arise. How are signaling thresholds 
defined in the cell? Is the global checkpoint response coordinated genome-wide, and how 
do locally separated lesions communicate with each other? And finally, it remains 
unresolved by which molecular mechanism the damage load of a cell is being 
quantitatively read. This last point will be discussed in the following. 
 
2.2 Signal integration by checkpoint sensor proteins 	
2.2.1  CONTRIBUTION OF CHECKPOINT INPUT SIGNALS 
DNA damage checkpoint activation follows a threshold-based mechanism and therefore 
requires quantitative sensing of input signals, i.e. damage-specific DNA structures. A very 
important checkpoint signal is RPA-ssDNA, which in case of DSBs is generated 
processively by end resection as long as the lesion remains unrepaired. A second damage 
signal is the ssDNA-dsDNA junction at the border of resection. In a simplified view, one 
such structure exists per DSB end and therefore is not suited to measure lesion 
persistence. However, it is tempting to speculate that discontinuous resection could 
include new entrypoints for example by the endonuclease activity of the MRX-Sae2 
complex and as such also ss-dsDNA junctions could accumulate over time and provide a 
signal that correlates with the amount of end resection.  
Thus, RPA-ssDNA and potentially ss-dsDNA junctions provide necessary features to be 
quantitative checkpoint input signals that rise in number at long-persisting DSBs, 
providing the mechanistic foundation for a selective, quantitatively adjusted checkpoint 
response.  
2.2.2  THE CHECKPOINT SENSORS DDC2 AND DDC1 
The checkpoint is equipped with two sensor proteins that are characterized by direct 
binding to the damage-specific structures. The first sensor is the Mec1 cofactor Ddc2, 
which directly binds RPA-ssDNA. The second sensor is the 9-1-1 checkpoint clamp 
consisting of Ddc1, Rad17 and Mec3, that specifically associates with ss-dsDNA 
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junctions. Both checkpoint sensor complexes accumulate at DSBs via distinct 
mechanisms and independent of each other ((Melo et al., 2001), (Kondo et al., 2001)). 
Ddc2-Mec1 directly binds to RPA and is therefore a good candidate for a quantitative 
checkpoint sensor, reflecting the amount of RPA-ssDNA. Our data demonstrate for the 
first time that the 9-1-1 is a quantitative checkpoint sensor as well. In this section, the 
potential roles of both sensor pathways in quantifying checkpoint inputs are discussed.  
 
We define checkpoint activity by the amount of effector kinase activation, which is 
mediated through a Mec1-activated kinase cascade assembly on 9-1-1. As detailed in the 
previous chapter, we have evidence that at least in the case of γH2A very little Mec1 is 
sufficient for full phosphorylation (Bantele et al, in revision). In strong contrast, the 
recruitment of the checkpoint complex comprising Dpb11, Rad9, and the effector kinase 
Rad53 on the 9-1-1 complex is strictly dependent on resection and quantitatively 
increases with ongoing resection (Bantele et al, in revision). Although it might seem 
trivial, a central question is to how this increase of the 9-1-1-dependent checkpoint 
cascade at a DSB is achieved. Here, I would like to provide two plausible hypotheses. 
9-1-1 has been suggested to be loaded at ss-dsDNA junctions (Majka & Burgers, 2003), 
and it was shown in vitro that it can diffuse along the DNA in the loaded state (Majka et 
al., 2006). Whether diffusion happens in vivo, and if yes, whether the 9-1-1 can enter 
chromatinized regions or RPA-ssDNA filaments, should be assessed in future research. 
Independent of this potential relocalization of 9-1-1, subsequent loading of several clamp 
molecules in a time- and resection-dependent manner would lead to an accumulation of 
9-1-1 that reflects the progression of resection. Such progressive loading guided by RPA-
ssDNA generation could be supported by the direct protein-protein interaction between 
RPA and Rad24-RFC, the 9-1-1-specific clamp loader (Lindsey-Boltz et al., 2012). In 
this model, the growing RPA-ssDNA filament would enrich the clamp loader, which 
subsequently would catalyze consecutive rounds of 9-1-1 loading, causing a quantitative 
enrichment of 9-1-1 (and consequently the whole checkpoint effector cascade) on the 
resecting DSB.  
Alternatively, a discontinuous resection mechanism involving several internal resection 
start sites with the corresponding ss-dsDNA junctions could provide the basis for 
resection-dependent 9-1-1 enrichment. In this model, each resection tract would interact 
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with Rad24-RFC and harbor two ss-dsDNA junctions with the propensity to load 9-1-1. 
Obviously, one could envision also a combination of both models, with consecutive 
loading of 9-1-1 molecules on multiple resected tracts. Figure 17 visualizes the factors 
that may contribute to resection-dependent 9-1-1 loading. 
 
 
Fig.17. Model for a putative mechanism of resection-dependent 9-1-1 loading. Resection 
could promote a corresponding amount of 9-1-1 loading by enhancing the local concentration of the 9-1-1 
clamp loader Rad24-RFC (orange) via direct interaction with RPA (red). Such a mechanism could be 
enhanced in a discontinuous resection mode, where several ss-dsDNA junctions are available for 9-1-1 
loading.  
 
With our work we would like to put forward a new model of quantitative checkpoint 
input signal sensing (Bantele et al, in revision). Two components are required to set off 
the checkpoint signaling: Mec1 kinase activation and Rad53 recruitment via 9-1-1. Each 
of these steps is supported by one checkpoint sensor with the potential of being a 
quantitative sensor. Intriguingly, the Ddc2-Mec1-dependent step occurs upstream of the 
Ddc1-Rad53-dependent step, the latter additionally depending on Mec1-catalyzed 
phosphorylations on Ddc1, Rad9 and Rad53. Together, both sensor pathways converge 
at the step of Ddc1 (9-1-1) phosphorylation. A model of the two checkpoint sensor 
pathways and their interconnection is presented in Figure 18. 
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Fig.18. Dissection of Ddc2- and 9-1-1-dependent sensing pathways.  The Ddc2-dependent 
checkpoint sensor pathway (red) reads the length of the RPA filament and accumulates the apical Mec1 
kinase activity at the DSB. Independently of Mec1-Ddc2, the 9-1-1 sensor is loaded to ss-dsDNA junctions 
and assembles the checkpoint cascade in consecutive recruitment steps (blue), which mostly require Mec1-
dependent phosphorylation. Therefore, Ddc2- and Ddc1-mediated sensing pathways converge on 
checkpoint protein phosphorylation downstream of Mec1 recruitment.  
 
As discussed before, Mec1 most likely contributes to, but alone is not decisive for making 
this step proportional to the amount of resection (Bantele et al, in revision). Here, I 
would like to discuss a piece of evidence showing that manipulation of the 9-1-1 sensing 
can modulate the checkpoint output, even when Ddc2 sensing is partially reduced. 
We utilized two different fusion proteins to enhance Rad53 activation independent of 
resection by manipulation of the Ddc1-, but not the Mec1-dependent signaling (Bantele 
et al, in revision). First, we fused Dpb11 to Rad9. This mutant background partially 
blocks resection and at the same times stabilizes Rad9-Rad53 at DSBs. Additionally, in 
this mutant Rad53 is hyperactive despite the fact that only minimal amounts of Mec1 are 
present (Bantele et al, in revision).  
These data make two points: First, Mec1 phosphorylation appears to be saturated at the 
step of Ddc1 phosphorylation. Second, enhancing the 9-1-1-dependent sensing by 
hyper-recruitment of the 9-1-1 downstream factors leads to hyper-activation of the 
checkpoint, demonstrating the strong ability of the 9-1-1 axis to modulate Rad53 
activation levels. In a reciprocal experiment, where we up-regulate Mec1-dependent 
signaling by inducing hyper-resection using the DDC1-FUN30 fusion protein, the 
checkpoint is normal.  
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Correspondingly, when we further enhance the 9-1-1 signaling axis using the even more 
potent DDC1-RAD9 fusion, which at the same time also strictly blocks resection and 
Mec1 loading, we achieve even higher checkpoint hyper-activation (Bantele et al, in 
revision).  
Lastly, an argument that weakens the model that Mec1-Ddc2 itself acts as quantitative 
checkpoint sensor comes from the existence of a second apical checkpoint kinase – Tel1. 
Intriguingly, Tel1 can not only target the same substrates as Mec1 with a certain degree 
of redundancy, but moreover is inhibited by resection as it is recruited to DSBs via the 
MRX complex. In principle, one could therefore propose that this inverse regulation 
might ensure a constant level of kinase activity at the break independent of its resection 
status. In how far such a redundancy plays a role on checkpoint substrates in vivo still 
needs to be assessed.  
Collectively, these data support a model by which the 9-1-1 complex is recruited to DSBs 
in a resection-dependent manner and modulates the quantitative checkpoint output. 
Whether Mec1-Ddc2 can also act as quantitative sensor in checkpoint signaling as would 
be intuitive based on its interaction with RPA needs to be tested. 
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Targeting of the Fun30 nucleosome
remodeller by the Dpb11 scaffold
facilitates cell cycle-regulated DNA end
resection
Susanne CS Bantele1, Pedro Ferreira2, Dalia Gritenaite1, Dominik Boos2,
Boris Pfander1*
1DNA Replication and Genome Integrity, Max Planck Institute of Biochemistry,
Martinsried, Germany; 2Centre for Medical Biotechnology, Molecular Genetics II,
University Duisburg-Essen, Essen, Germany
Abstract DNA double strand breaks (DSBs) can be repaired by either recombination-based or
direct ligation-based mechanisms. Pathway choice is made at the level of DNA end resection, a
nucleolytic processing step, which primes DSBs for repair by recombination. Resection is thus
under cell cycle control, but additionally regulated by chromatin and nucleosome remodellers.
Here, we show that both layers of control converge in the regulation of resection by the
evolutionarily conserved Fun30/SMARCAD1 remodeller. Budding yeast Fun30 and human
SMARCAD1 are cell cycle-regulated by interaction with the DSB-localized scaffold protein Dpb11/
TOPBP1, respectively. In yeast, this protein assembly additionally comprises the 9-1-1 damage
sensor, is involved in localizing Fun30 to damaged chromatin, and thus is required for efficient
long-range resection of DSBs. Notably, artificial targeting of Fun30 to DSBs is sufficient to bypass
the cell cycle regulation of long-range resection, indicating that chromatin remodelling during
resection is underlying DSB repair pathway choice.
DOI: 10.7554/eLife.21687.001
Introduction
DNA end resection – the nucleolytic digestion of the 5’ strands of a DSB – is essential for the initia-
tion of homologous recombination (HR) or related recombination-based mechanisms (reviewed in
[Cejka, 2015; Symington, 2014; Symington and Gautier, 2011]). At the same time, resection inter-
feres with ligation-based repair (non-homologous end-joining, NHEJ) and thus is the critical step for
repair pathway choice. In mitotically dividing cells, recombination-based repair critically depends on
the presence of a sister-chromatid. DSB repair pathway choice and accordingly DNA end resection
are therefore highly regulated during the cell cycle: in G1 phase, little resection occurs and NHEJ is
therefore favoured. Conversely, in S, G2 and M phase, resection is up-regulated and HR becomes
more prevalent (Cejka, 2015; Ira et al., 2004; Symington, 2014; Symington and Gautier, 2011).
The nucleases that mediate resection can be subdivided into resection initiation (by Mre11-
Rad50-Xrs2 and Sae2 in budding yeast) and long-range resection (by Exo1 or Dna2 with Sgs1-Top3-
Rmi1 in budding yeast) pathways (Cannavo and Cejka, 2014; Cejka et al., 2010; Mimitou and
Symington, 2008; Niu et al., 2010; Zhu et al., 2008). So far, Sae2 and Dna2 were shown to be cell
cycle - controlled by cyclin-dependent kinase (CDK) phosphorylation in yeast (Chen et al., 2011;
Huertas et al., 2008) and EXO1 in human cells (Tomimatsu et al., 2014). Notably, however, a
bypass of this control is not sufficient to allow efficient end resection to occur in G1, suggesting that
other factors may be involved in the cell cycle control of DNA end resection.
Bantele et al. eLife 2017;6:e21687. DOI: 10.7554/eLife.21687 1 of 21
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Resection is also influenced by the surrounding chromatin. Nucleosomes themselves can be inhib-
itory to resection enzymes (Adkins et al., 2013). Additionally, nucleosome-associated proteins such
as budding yeast Rad9 or its functional ortholog in humans, 53BP1, can inhibit resection
(Bunting et al., 2010; Lazzaro et al., 2008; Trovesi et al., 2011). Consistent with a barrier function
of chromatin and/or Rad9, nucleosome remodellers are recruited to DSBs and promote resection,
although the mechanism is poorly understood (Bennett and Peterson, 2015; Bennett et al., 2013;
Chai et al., 2005; Morrison et al., 2004; van Attikum et al., 2007, 2004). The Swr1-like family
remodeller Fun30 (SMARCAD1 in humans) was found to be a critical regulator of resection
(Chen et al., 2012; Costelloe et al., 2012; Eapen et al., 2012). Fun30 localizes to chromatin sur-
rounding DSBs and fun304 mutant cells show a pronounced defect in long-range resection
(Chen et al., 2012; Costelloe et al., 2012; Eapen et al., 2012). Importantly, also SMARCAD1 pro-
motes DNA end resection in human cells, suggesting evolutionary conservation (Costelloe et al.,
2012). Fun30 itself is a substrate for CDK phosphorylation (Chen et al., 2012, 2016; Ubersax et al.,
2003), but it has remained unclear by which mechanism Fun30 function is regulated during the cell
cycle, how Fun30 is targeted to DNA lesions and if this regulation imposes a bottleneck in the regu-
lation of DNA end resection.
Here, we show that CDK phosphorylation enables Fun30 to form a complex with the phospho-
protein-binding scaffold protein Dpb11 and the DNA damage sensor 9-1-1. Formation of this
complex is required for proper localization of Fun30 and for efficient long-range resection in M
eLife digest DNA is continually exposed to chemicals and radiation that cause various forms of
DNA damage. One of the most toxic forms of DNA damage is the double strand break, in which
both strands of the double helix are broken. These breaks can be mended in two ways: by directly
joining the broken ends together, or via a process called homologous recombination. In
homologous recombination, a duplicate DNA molecule is used as a template to repair the broken
DNA strands. These duplicates only form during particular phases of the cell division cycle, which
limits when homologous recombination can take place.
A cell can choose which pathway it uses to repair double strand breaks. However, the first step of
homologous recombination – trimming the broken DNA ends in a process called resection –
commits a cell to the homologous recombination repair pathway. Cell cycle kinases regulate the cell
division cycle and control DNA end resection. This control takes two forms: on the one hand by
regulating whether the enzymes that trim the DNA ends are active; and on the other hand by
regulating the remodelling of the structure into which DNA is packaged, which is called chromatin.
However, it is not known which of these two targets is the limiting factor that determines whether
homologous recombination occurs.
A protein called Fun30 that remodels chromatin had been found to be important for promoting
resection in budding yeast. Bantele et al. now reveal how the activity of Fun30 is regulated by the
cell cycle to limit extensive resection to certain cell cycle phases, where homologous recombination
is wanted. During those stages, cell cycle kinases add phosphate groups to Fun30. This enables
Fun30 to engage in a protein complex that directs Fun30 to the site of a double strand break to
facilitate the resection process.
Bantele et al. also studied artificial versions of Fun30 that were directly fused to components of
the protein complex, and so bypassed the controls that limit homologous recombination to
particular phases of the cell cycle. These forms of Fun30 enabled resection to take place in phases of
the cell cycle where it does not normally occur. This suggests that the remodelling of chromatin by
Fun30 is a critical step at which resection is regulated by the cell cycle.
Further experiments showed that the cell cycle regulation of human proteins that are equivalent
to Fun30 and another protein in the resection complex is similar to that seen for the yeast proteins.
In the future, knowing how these proteins are regulated during resection could help researchers to
develop new gene editing methods based on homologous recombination that can be used in cells
at any stage of the cell cycle.
DOI: 10.7554/eLife.21687.002
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phase cells. Notably, when we bypass the CDK requirement by directly fusing Fun30 to a subunit
of the 9-1-1 complex, we observe long-range resection even in G1–arrested cells. This suggests
that the cell cycle regulation of long-range resection can be bypassed solely by artificially target-
ing Fun30 to DSBs. Finally, we show that also human SMARCAD1 binds to TOPBP1 (human ortho-
log of Dpb11) in a CDK phosphorylation-dependent manner that involves conserved interaction
surfaces, suggesting that the formation of a Fun30-Dpb11 complex is a conserved mechanism of
cell cycle regulation that could control DNA end resection and repair pathway choice throughout
eukaryotes.
Results
Cell cycle-dependent targeting of Fun30 by Dpb11
We identified Fun30 in a two-hybrid screen for interactors of the scaffold protein Dpb11. Dpb11 is a
critical regulator of genome stability in budding yeast and as such is found in several distinct protein
complexes (Gritenaite et al., 2014; Ohouo et al., 2010, 2013; Pfander and Diffley, 2011;
Puddu et al., 2008; Tanaka et al., 2007; Zegerman and Diffley, 2007). Crucial for the formation of
these complexes are the two tandem BRCT domains of Dpb11, which are phospho-protein binding
modules (Leung and Glover, 2011) specific for discrete sets of phosphorylation-dependent interac-
tors. In case of Fun30, the interaction is mediated by BRCT1+2, but not BRCT3+4 (Figure 1A, Fig-
ure 1—figure supplement 1). Using Dpb11 expressed from the strong GPD promoter, we also
observed an interaction between Fun303FLAG and Dpb11 in co-immunoprecipitation (Co-IP) experi-
ments (Figure 1B). All Dpb11 complexes characterized so far are cell cycle-regulated
(Gritenaite et al., 2014; Ohouo et al., 2013; Pfander and Diffley, 2011; Tanaka et al., 2007;
Zegerman and Diffley, 2007). Thus, we tested the interaction between Dpb11 and Fun30 from cells
at different cell cycle stages. We observed that Fun30 interacted with Dpb11 only during late S to M
phase, but not in G1 (Figure 1B–C, Figure 1—figure supplement 2) and this interaction was not
influenced by DNA damage (Figure 1D).
Since Fun30 is phosphorylated by CDK (Chen et al., 2012, 2016; Ubersax et al., 2003) and
Dpb11 was shown to bind several CDK targets (Gritenaite et al., 2014; Pfander and Diffley,
2011; Tanaka et al., 2007; Zegerman and Diffley, 2007), we tested if CDK phosphorylation
mediates the Fun30-Dpb11 interaction. Indeed, upon CDK inhibition (using the cdc28-as1 allele
and 1-NMPP1 inhibition) Dpb11 binding to Fun30 was strongly reduced (Figure 1E). Accordingly,
purified Fun303FLAG was able to interact with GSTDpb11-BRCT1+2 in vitro but only after pre-phos-
phorylation by CDK (Figure 1F), suggesting that the Fun30-Dpb11 interaction as well as its regula-
tion by CDK phosphorylation are direct. Therefore, we sought to identify the CDK phosphorylation
sites on Fun30, which are relevant for Dpb11 binding. Interaction mapping using truncated con-
structs placed the Dpb11 interaction site close to the N-terminus of Fun30 (Figure 1G, Figure 1—
figure supplement 3). Within this region, we identified S20 as well as S28 as critical residues for
the Fun30-Dpb11 interaction by two-hybrid and Co-IP binding assays using non-phosphorylatable
versions of Fun30 (Figure 1H–I, Figure 1—figure supplement 4). This suggests that phosphoryla-
tion of both residues may create a composite binding surface for Dpb11 BRCT1+2, perhaps similar
to the Dpb11-binding surfaces on Rad9 and Sld3 (Pfander and Diffley, 2011; Tanaka et al.,
2007; Zegerman and Diffley, 2007; Zegerman et al., 2010).
It seemed likely that Dpb11 is involved in targeting Fun30 to DNA lesions. We therefore tested
recruitment of WT Fun303FLAG or the corresponding fun30-SSAA variant to a site-specific, non-
repairable DSB using chromatin immunoprecipitation (ChIP). Indeed, we observed that Fun30-SSAA
binding to regions distal of the DSB was reduced compared to WT (8–20 kb, Figure 1J, Figure 1—
figure supplement 5), while both versions bound similarly to the immediate vicinity of the DSB (1–3
kb, Figure 1J, Figure 1—figure supplement 5). This result thus confirms recent observations show-
ing a DSB recruitment defect of fun30-S20A and fun30-S28A mutants (Chen et al., 2016).
Importantly, we could expand these data by generating an experimental tool, which restores the
Fun30-Dpb11 interaction in a phosphorylation-independent manner. Since conventional phospho-
mimetic mutations failed to promote binding (data not shown), we generated a covalent fusion of
the Fun30-SSAA protein directly to Dpb114N lacking BRCT1+2 (FUN30-AA-DPB11-276-
C expressed as the only copy of Fun30 from the endogenous promoter, referred to as FUN30-
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Figure 1. Fun30 and Dpb11 interact in a cell cycle- and CDK phosphorylation-dependent manner and this targets Fun30 to DSBs. (a) Two-hybrid assay
with GAL4-AD and -BD constructs as indicated reveals a physical interaction between the N-terminal region of Fun30 (aa 1–188) and the BRCT1+2
domain of Dpb11. Rad9 and Ddc1 represent known interactors of BRCT1+2 and BRCT3+4, respectively. (b–e) Characterization of the Fun30-Dpb11
interaction by Fun303FLAG Co-IP experiments. Dpb11 was expressed from the strong, constitutive GPD promoter. (b) Fun303FLAG specifically binds
Figure 1 continued on next page
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DPB11 fusion in the following). Importantly, the fusion protein localized efficiently to damaged chro-
matin and thus restored the defect of the fun30-SSAA mutation (Figure 1J, Figure 1—figure sup-
plement 5). This finding suggests that the interaction with Dpb11 is indeed involved in targeting
Fun30 to DSBs and that the covalent fusion is sufficient to bypass the CDK regulation of Fun30.
Notably, DSB recruitment of the Fun30-Dpb11 fusion protein was stronger than Fun30 consistent
with the replacement of a transient, PTM-dependent interaction by a covalent interaction. Therefore,
we reason that the FUN30-DPB11 fusion deregulates Fun30 in two ways: first, it uncouples Fun30
from its cell cycle regulation. Second, it leads to enhanced DSB localization to DSBs, thus potentially
enhancing Fun30 activity at damaged chromatin.
We also note that the apparently normal recruitment of Fun30-SSAA to the immediate vicinity of
the DSB could be explained by an additional CDK phosphorylation-independent, but resection-
dependent recruitment mechanism, such as via binding to RPA (Chen et al., 2012). Our data thus
suggest the existence of two Fun30–targeting mechanisms: one that is Dpb11-dependent and
recruits Fun30 to sites of ongoing resection, and a second that is Dpb11-independent and tethers
Fun30 to DNA that has already been resected.
The Fun30-Dpb11 complex is required for efficient long-range resection
We utilized our system of abolishing and constitutively forcing Fun30 binding to Dpb11 in order to
investigate the biological function of the Dpb11-dependent Fun30 targeting mechanism and its role
in regulating DNA end resection. We measured resection at an HO-induced, non-repairable DSB in
M phase-arrested cells using the combined read-out of (a) the accumulation of the ssDNA-binding
protein RPA (Figure 2A, upper panel) around the DSB by ChIP and (b) the specific DNA loss (occur-
ring due to ssDNA formation, Figure 2A, lower panel). Indeed, compared to WT cells, fun304
mutants showed a pronounced defect in long-range resection, visible by a reduced spreading of
both RPA-ChIP and DNA loss, to regions greater than 10 kb away from the break (Figure 2A, Fig-
ure 2—figure supplement 1), confirming previous observations (Chen et al., 2011,
2012; Costelloe et al., 2012; Eapen et al., 2012). Notably, the same defect in long-range resection
Figure 1 continued
Dpb11 in cells arrested in M but not G1 phase. (c) Fun303FLAG purified from cells synchronously progressing through the cell cycle binds Dpb11 only at
45’ and 90’ time points corresponding to late S and M phase (Figure 1—figure supplement 2 for FACS analysis and western analysis of cell cycle
progression). (d) No enhancement of the Fun30-Dpb11 interaction by CPT or phleomycin treatment as measured by Fun303FLAG Co-IP. For DNA
damage treatment, 50 mM CPT or 50 mg/ml phleomycin were added to asynchronously dividing yeast cells. DNA damage checkpoint activation was
measured by Rad53 phosphorylation in IP extracts (lowest blot panel). (e) CDK inhibition using the cdc28-as1 allele and 1-NMPP1 treatment diminishes
the Fun303FLAG-Dpb11 interaction in M phase arrested cells. (f) Purified Fun30 interacts with a BRCT1+2 fragment of Dpb11 in the presence of CDK
phosphorylation. Purified Fun303FLAG or the positive control MBPRad9 (Pfander and Diffley, 2011) were incubated with a model CDK and ATP before
binding to bead-bound GSTDpb11 BRCT1+2. (g) Mapping analysis of the two-hybrid interaction between Fun30 and Dpb11 reveals a binding site close
to the N-terminus of Fun30. (h–i) Putative CDK sites on Fun30 (S20 and S28) are required for Dpb11 binding. (h) Two-hybrid assay as in (a) but in five-
fold serial dilution and with WT, S20A, S28A and SS20,28AA variants of Gal4-AD-Fun301-188. (i) Co-IP as in (b) but with mutant variants of Fun303FLAG
growing asynchronously. (j) Efficient Fun30 localization to damaged chromatin requires the Dpb11-Fun30 interaction. ChIP of Fun303FLAG to chromatin
locations 3, 8, 10 and 15 kb distant of a non-repairable DSB induced at the MAT locus in M phase-arrested cells. fun30 mutants were expressed from
the endogenous promoter as only copy of FUN30. The FUN30-DPB11 fusion contains fun30-SSAA and dpb114N mutations. WT, fun30-SSAA and
FUN30-DPB11 fusion cells were crosslinked at indicated timepoints after DSB induction. Plotted values represent means from two independent
experiments, error bars represent standard deviations.
DOI: 10.7554/eLife.21687.003
The following figure supplements are available for figure 1:
Figure supplement 1. Expression control of two-hybrid constructs used in Figure 1A.
DOI: 10.7554/eLife.21687.004
Figure supplement 2. Control of the cell cycle states of the experiment in Figure 1C.
DOI: 10.7554/eLife.21687.005
Figure supplement 3. Expression control of two-hybrid constructs used in Figure 1G.
DOI: 10.7554/eLife.21687.006
Figure supplement 4. Expression control of two-hybrid constructs used in Figure 1H.
DOI: 10.7554/eLife.21687.007
Figure supplement 5. Efficient Fun30 localization to damaged chromatin requires the Dpb11-Fun30 interaction.
DOI: 10.7554/eLife.21687.008
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was also observed in the Dpb11-binding deficient fun30-SSAA mutant and was fully restored by the
FUN30-DPB11 fusion (Figure 2A, Figure 2—figure supplement 1). To corroborate these findings,
we also analysed resection-dependent DSB repair in a single-strand annealing (SSA) assay, where
cellular survival upon an HO-induced DSB in the absence of Rad51 critically depends on the efficient
resection of 25 kb of DNA (Figure 2B, [Vaze et al., 2002]). In fact, Dpb11-binding deficient fun30
mutants were deficient in SSA-mediated survival and this defect was completely rescued by covalent
fusion of Fun30-SSAA to Dpb11 (Figure 2B). Thus, the CDK-regulated interaction between Fun30
and Dpb11 is required for efficient long-range resection as well as subsequent resection-coupled
repair.
Fun30 participates in chromatin organization in the absence of DNA damage (Neves-
Costa et al., 2009) and previous studies could therefore not rule out the possibility that the DNA
end resection defect of the fun304 mutant is a consequence of general changes in chromatin orga-
nization (Chen et al., 2012; Costelloe et al., 2012; Eapen et al., 2012). However, we found that the
fun30-SSAA mutant (unlike the fun304 mutant) did not display any defect in silencing at telomeres
or at the silent mating type locus and thus differs from the fun304 mutant (Figure 3). The fun30-
SSAA mutant thus separates Fun30 functions and the associated resection phenotype of this mutant
therefore provides strong support for a direct role of Fun30 and the Fun30-Dpb11 complex during
DNA end resection.
Mutants with DNA end resection defects such as exo14 sgs14, sae24 or fun304 are hypersensi-
tive towards the Top1 inhibitor camptothecin (CPT) (Chen et al., 2012; Costelloe et al., 2012;
Eapen et al., 2012; Neves-Costa et al., 2009) (Figure 4A–C), most likely because of repair defects
Figure 2. The Fun30-Dpb11 complex is required for efficient long-range resection. (a) Long-range resection of a DSB is dependent on the Fun30-
Dpb11 interaction. A non-repairable DSB at MAT was induced in M phase-arrested WT, fun304, fun30-SSAA and FUN30-DPB11 fusion strains and DNA
end resection measured at indicated times. Upper panel: fold enrichment of a given locus in an RPA ChIP relative to undamaged control loci. Lower
panel: DNA loss relative to control loci located in non-damaged chromatin. (b) Single-strand annealing (SSA) is dependent on the Fun30-Dpb11
interaction. FUN30 mutants as indicated were combined with the rad514 deletion, a DSB at the leu2::HO cutsite was induced by plating cells on
galactose. Cells need to resect 25 kb up to the homologous his4::leu2 locus in order to survive by SSA.
DOI: 10.7554/eLife.21687.009
The following figure supplement is available for figure 2:
Figure supplement 1. The Fun30-Dpb11 interaction is required for efficient long-range resection.
DOI: 10.7554/eLife.21687.010
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of replication-borne DSBs at CPT-induced Top1 stall sites. Indeed, also the fun30-SSAA mutant
showed hyper-sensitivity to CPT albeit not as strong as the fun30 deletion. Importantly, the CPT sen-
sitivity of fun30-SSAA was rescued by expressing the covalent FUN30-DPB11 fusion (Figure 4A, Fig-
ure 4—figure supplement 1), emphasizing again the importance of the Fun30-Dpb11 interaction
for DSB repair.
Genetic evidence suggests that Fun30 may promote DNA end resection by antagonizing the
resection inhibitor Rad9 (Chen et al., 2012). Similar to what has been described for the fun304
mutant, we observed that the CPT-hypersensitivity of the fun30-SSAA was suppressed by an addi-
tional rad9 deletion (Figure 4D), suggesting that the Fun30-Dpb11 complex antagonizes Rad9.
Interestingly, Rad9 also binds to Dpb11, and Fun30 and Rad9 share the same interaction site on
Dpb11 (Pfander and Diffley, 2011). While it is currently unknown whether Dpb11-associated Rad9
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Figure 3. The Fun30-Dpb11 interaction is not involved in Fun30-dependent gene silencing at telomeric
heterochromatin and a silent mating type locus. The silencing defect of the fun30D mutant is not recapitulated by
the fun30-SSAA mutant. Two silencing tester strains were used: the first (upper panels) had URA3 integrated in
telomeric heterochromatin at the end of the left arm of chromosome VII, the second (lower panels) had URA3
integrated at the HML silent mating type locus. A silencing defect leads to enhanced growth on –Ura medium and
less growth on medium supplemented with 5-FOA (e.g. fun30D). Shown is a spotting in 5-fold serial dilutions on
non-selective medium, medium lacking uracil or containing 5-FOA.
DOI: 10.7554/eLife.21687.011
Figure 4. The Fun30-Dpb11 interaction is required for the response towards CPT, as is functional long- and short-range resection. (a) The Fun30-Dpb11
interaction is required for the response towards CPT. WT, fun304, fun30-SSAA and FUN30-DPB11 fusion were spotted in five-fold serial dilutions on
plates containing indicated amounts of CPT and incubated at 37˚C for two days. (b) A double mutant of exo1D and sgs1D is hyper-sensitive to low
doses of CPT. Spotting in 5-fold serial dilutions was incubated for two days at 30˚C. (c) The fun30D/fun30-SSAA mutants enhance the CPT hyper-
sensitivity of sae2D mutants. Cells were spotted in 5-fold serial dilutions and incubated for two days at 30˚C. (d) A rad9D deletion rescues CPT hyper-
sensitivity of fun30D and fun30-SSAA mutant alleles.
DOI: 10.7554/eLife.21687.012
The following figure supplements are available for figure 4:
Figure supplement 1. Mutants of Fun30 show no discernable phenotype upon chronic exposure to HU, MMS or phleomycin.
DOI: 10.7554/eLife.21687.013
Figure supplement 2. The catalytic activity of Fun30 is required for the suppression of the CPT phenotype in the context of the FUN30-DPB11 fusion.
DOI: 10.7554/eLife.21687.014
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(in contrast to nucleosome-associated Rad9) contributes to the inhibition of DNA end resection, the
overlapping binding site raised the possibility that Fun30 may interfere with Rad9 function via com-
petition. Therefore, in order to exclude that the FUN30-DPB11 fusion rescues resection simply by
blocking the Rad9-Dpb11 interaction, we inactivated the ATPase activity of Fun30 by a Walker A
motif mutation (K603R) in the context of the FUN30-DPB11 fusion and found the K603R mutant
fusion did not restore WT resistance to CPT (Figure 4—figure supplement 2). Therefore, competi-
tion does not explain the effects of the FUN30-DPB11 fusion and the catalytic activity of Fun30 is
required for the resection-promoting function of the Fun30-Dpb11 complex. Overall, these data
thus suggest that cell cycle-regulated targeting of Fun30 by Dpb11 is required for efficient DNA end
resection.
The 9-1-1 complex targets Fun30 to DSBs and – as artificial fusion with
Fun30 - can be utilized to promote long-range resection in G1
In several organisms, recruitment of Dpb11 and its orthologs to DSBs has been shown to be
facilitated by the 9-1-1 complex (Delacroix et al., 2007; Du et al., 2006; Furuya et al., 2004;
Pfander and Diffley, 2011; Puddu et al., 2008), a signalling platform (Parrilla-Castellar et al.,
2004) which is loaded at DNA damage sites. Given that 9-1-1 interacts with BRCT3+4 of Dpb11
(Wang and Elledge, 2002), we tested whether Dpb11 could simultaneously bind to Fun30 and
9-1-1. Indeed, Fun303FLAG co-precipitated the 9-1-1 subunits Mec3 and Ddc1 and this binding
was absent in cells arrested in G1 or in the respective Dpb11 interaction-deficient mutants (ddc1-
T602A or fun30-SSAA; Figure 5A–B, Figure 5—figure supplement 1). We thus conclude that
Fun30, Dpb11 and 9-1-1 can form a ternary complex, which is regulated by the cell cycle stage
(model in Figure 5—figure supplement 2). Moreover, we observed a reduction of the Fun30
binding in the proximity of a DSB by ChIP, when we interfered either with the 9-1-1-Dpb11 inter-
action (ddc1-T602A mutant) or with the Fun30-Dpb11 interaction (SLD3-DPB11DN mutant strain,
which expresses as only copy of DPB11 a truncated version of Dpb11 lacking the Fun30 binding
site, Zegerman and Diffley, 2007), further supporting a role of 9-1-1 in targeting Fun30 to DSBs
(Figure 5C).
Given that Dpb11 seems to function as an adaptor between Fun30 and 9-1-1, we also generated
a covalent fusion of Fun30-SSAA and the 9-1-1 subunit Ddc1 (referred to as DDC1-FUN30 fusion).
Also this fusion rescued the CPT phenotype of the fun30-SSAA mutant in a manner that depended
on the catalytic activity of Fun30 (Figure 6A, Figure 6—figure supplement 1). The DDC1-FUN30
fusion targeted Fun30 even more efficiently to damaged chromatin than the FUN30-DPB11 fusion
and, notably, the corresponding strain was able to survive at very high CPT concentrations, where lit-
tle growth could be detected even for WT cells, indicating that the DDC1-FUN30 fusion promotes
hyper-resistance to CPT (Figure 6A). It is thus possible to at least partially overcome the limits of cel-
lular resistance to CPT by providing very efficient targeting of Fun30 to damaged chromatin and
uncoupling it from cell cycle control.
DNA end resection is up-regulated in S, G2, M phases of the cell cycle, thus shifting the DSB
repair pathway choice from NHEJ to recombination-dependent mechanisms (Cejka, 2015;
Symington and Gautier, 2011). Previous efforts to bypass this regulation have focussed on nucle-
ases (Huertas et al., 2008). Thus, we tested if the CDK-regulation of Fun30 may contribute to the
cell cycle regulation of DNA end resection or may even be a limiting factor for this regulation. We
used the DDC1-FUN30 fusion, which in contrast to WT Fun30 efficiently localized to a DSB in G1
(Figure 6B, Figure 6—figure supplement 3). This indicates that the fusion may in principle allow
Fun30 to act on damaged chromatin in G1, consistent with 9-1-1 being loaded to damaged chroma-
tin in G1 (Barlow et al., 2008; Janke et al., 2010). Indeed, the DDC1-FUN30 fusion protein pro-
moted resection in G1 to a significantly larger reach compared to WT Fun30, since RPA recruitment
could be observed up to 25 kb distance from the DSB (Figure 6C, Figure 6—figure supplement 3).
Notably, the spreading of resection under the DDC1-FUN30 conditions was even more pronounced
than in WT cells arrested in M phase (Figure 6C, Figure 6—figure supplement 3). This effect is thus
consistent with the very efficient targeting of Fun30 to DNA damage sites by the DDC1-FUN30
fusion. This hyperactivation of resection thus indicates that forced tethering of Fun30 to DSB sites is
able to bypass the bottleneck that limits long-range resection in G1.
It needs to be pointed out that within the resected region the fold enrichment of RPA recruitment
and the extent of DNA loss was not restored to similar levels as observed in M phase (Figure 6C).
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Moreover, precise ligation of a cut plasmid by NHEJ did not appear to be influenced by the DDC1-
FUN30 fusion (Figure 7). These data thus suggest that the overall cell cycle regulation of DNA end
resection was not bypassed completely, presumably because other resection proteins and in particu-
lar resection initiation are additional targets of cell cycle regulation (Albuquerque et al., 2008;
Chen et al., 2011; Huertas et al., 2008; Pfander and Diffley, 2011; Zhang et al., 2009). We there-
fore compared G1 resection in the DDC1-FUN30 strain to another mutant – sae2-S267E – that is
thought to at least partially bypass the CDK regulation of resection initiation (Cannavo and Cejka,
2014; Huertas, 2010). Notably, the sae2-S267E mutant showed no increase in the reach of resection
and only led to a slight increase in the fold enrichment of the RPA ChIP, both in WT and DDC1-
FUN30 background (Figure 8). Overall, these data are thus consistent with a model, whereby sae2-
S267E partially bypasses the cell cycle regulation of resection initiation, while the DDC1-FUN30
Figure 5. The 9-1-1 complex forms a ternary complex with Fun30-Dpb11. (a) Fun30, Dpb11 and 9-1-1 form a
ternary complex. The 9-1-1 subunit Mec3 interacts with Fun303FLAG when purified from M phase cells, where also
Dpb11 binds to Fun30. (b) The ddc1-T602A mutation abolishes binding of Mec3 to Fun30-Dpb11 in Fun303FLAG
Co-IPs, but leaves the Fun30-Dpb11 interaction intact. (c) Mutants disrupting the interaction between 9-1-1 and
Dpb11 (ddc1-T602A) or Fun30 and Dpb11 (SLD3-dpb11DN, lacks Fun30 binding site, only copy of Dpb11) impair
efficient localization of Fun30 to DSBs in Fun303FLAG ChIPs of M phase-arrested cells. Experiment performed as in
Figure 1J, plotted values represent means of two independent experiments, error bars represent standard
deviations.
DOI: 10.7554/eLife.21687.015
The following figure supplements are available for figure 5:
Figure supplement 1. The interaction between Fun30 and 9-1-1 depends on mutual interactions with Dpb11,
suggesting that Dpb11 forms a molecular bridge in the Fun30-Dpb11-9-1-1 complex.
DOI: 10.7554/eLife.21687.016
Figure supplement 2. Model of the Fun30-Dpb11-9-1-1 association and its regulation.
DOI: 10.7554/eLife.21687.017
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fusion bypasses the cell cycle regulation of long-range resection. This highlights that chromatin has a
barrier function towards resection and that formation of the Fun30-Dpb11 complex is the limiting
step that needs to be up-regulated during recombination-permissive cell cycle phases in order to
overcome this barrier.
Figure 6. A covalent fusion of Fun30 to the 9-1-1 subunit Ddc1 generates a bypass of the cell cycle regulation of
long-range resection. (a) The DDC1-FUN30 fusion confers cellular hyper-resistance to CPT. Spotting of indicated
strains as in Figure 4A, but using CPT concentrations of up to 12 mg/ml. (b) The DDC1-FUN30 fusion localizes
efficiently to a DSB in G1-arrested cells. Fun303FLAG ChIPs from WT, fun30-SSAA, FUN30-DPB11 and DDC1-FUN30
cells as in Figure 1J, but from G1 or M phase-arrested cells. Additional Fun303FLAG ChIP data can be
found in Figure 6—figure supplement 3. (c) The DDC1-FUN30 fusion enhances long-range resection in G1-
arrested cells. Resection assay as in Figure 2A, but with G1 or M phase-arrested cells. Additional resection assay
data can be found in Figure 6—figure supplement 3.
DOI: 10.7554/eLife.21687.018
The following figure supplements are available for figure 6:
Figure supplement 1. The DDC1-FUN30 fusion rescues the CPT sensitivity of the fun304 mutant in a manner that
depends on the Fun30 catalytic activity.
DOI: 10.7554/eLife.21687.019
Figure supplement 2. Flow cytometric analysis of DNA content for experiments shown in Figure 6B–C
and Figure 6—figure supplement 3.
DOI: 10.7554/eLife.21687.020
Figure supplement 3. The DDC1-FUN30 fusion protein efficiently localizes to DSBs and promotes hyper-resection
in M phase as well as allowing long-range resection in G1 phase.
DOI: 10.7554/eLife.21687.021
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Conservation of Fun30 regulation
to human SMARCAD1
Fun30’s role in promoting DNA end resection is
conserved to its human ortholog SMARCAD1
(Costelloe et al., 2012; Densham et al., 2016).
Strikingly, in an independent screen we identified
an N-terminal fragment of SMARCAD1 (aa 55–
274) as interactor of TOPBP1 (using a TOPBP1
BRCT0-2 construct), the human ortholog of
Dpb11. Furthermore, we found this interaction to
require the phospho-protein binding sites of
TOPBP1 BRCT1+2 (Figure 9A, Figure 9—figure
supplement 1). We verified the SMARCAD1-
TOPBP1 interaction in a pulldown approach using
purified GST-TOPBP1-BRCT0/1/2 fragments and
in vitro phosphorylation of cell extracts with puri-
fied CDK. GFP-SMARCAD1-55-445 bound effi-
ciently to GST-TOPBP1-BRCT0/1/2, but only after
addition of active CDK to the cell extract
(Figure 9B). This suggests that CDK phosphoryla-
tion promotes the interaction, similar to the regu-
lation in yeast. We therefore queried for the
TOPBP1 interaction site on SMARCAD1 using
mutagenesis of CDK consensus motifs. Using this
approach, we found that the T71A variant, but
none of the other S/TP site mutants tested
caused strongly reduced TOPBP1 binding in two-
hybrid and Co-IP (Figure 9C–D, Figure 9—figure
supplement 2). These data therefore suggest that SMARCAD1 interacts with TOPBP1 via the CDK-
site T71. To our surprise, we observed in two-hybrid experiments that human SMARCAD1 also inter-
acted with yeast Dpb11 and in a manner that was dependent on the T71 phosphorylation site
(Figure 9E, Figure 9—figure supplement 3), despite low sequence conservation. This raised the
possibility that SMARCAD1 and FUN30 could also functionally complement each other. Expression
of SMARCAD1 from the inducible GAL-promoter lead only to a slight suppression of the CPT sensi-
tivity of a fun304 strain (data not shown), suggesting that there is an aspect of Fun30 function or
regulation that is not recapitulated by SMARCAD1. In contrast, when we generated a SMARCAD1-
Fun30 chimera lacking the Dpb11-binding region of Fun30 but containing the TOPBP1-binding
region of SMARCAD1 (SMARCAD1-1-300-FUN30-30-C), this chimera was largely able to rescue the
CPT sensitivity of the fun304 mutant (Figure 9F, Figure 9—figure supplement 5). In contrast, the
Figure 7. The DDC1-FUN30 fusion does not
significantly inhibit non-homologous end-joining
(NHEJ). Precise re-ligation of BamHI-cut pRS316 as
measured by cell viability on SC-Ura plates and
subsequent sequencing of single colonies was
dependent on Ku70 but not significantly affected in
DDC1-FUN30 of fun30D mutant cells. Plotted are values
from three independent experiments representing the
viability rate of cells on SC-Ura plates relative to the
total cell number and the transformation efficiency of
the mock-digested plasmid. Error bars represent
standard deviations.
DOI: 10.7554/eLife.21687.022
Figure 8. The DDC1-FUN30 fusion specifically enhances long-range resection in G1, while the sae2-S267E phospho-mimicry leads to a small increase in
resection initiation. The sae2-S267E mutant has little effect on the spreading of DNA end resection in G1, but slightly stimulates the RPA fold
enrichment in WT and the DDC1-FUN30 fusion mutant. This suggests that sae2-S267E in contrast to the DDC1-FUN30 fusion does not affect long-
range resection. DNA end resection in the indicated strains was analysed by RPA ChIP as in Figure 5C but with G1 arrested cells.
DOI: 10.7554/eLife.21687.023
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Figure 9. Yeast Fun30 and human SMARCAD1 underlie a conserved regulation. (a) SMARCAD1 and TOPBP1
interact and their interaction depends on functional phospho-binding pockets in BRCT1 and BRCT2 of TOPBP1.
lexA-BD TOPBP1 1–360 (harbouring BRCT0/1/2) or lexA-BD TOPBP1 1–766 (harbouring BRCT0-5) were tested as
WT versions or as K155E, KK154,155AM (affecting BRCT1) or K250E (affecting BRCT2) mutant derivatives.
Interaction was tested against the Gal4-AD SMARCAD1 55–274. 3AT was added to –His plates to suppress auto-
activation and to increase the stringency of the two-hybrid. Two-hybrid interactions with the lexA-BD TOPBP1 1–
360 construct were generally stronger compared to lexA-BD TOPBP1 1–766, leading to milder effects of the K155E
and K250E single-mutants, particularly at low 3AT concentrations. (b) SMARCAD1 interacts with TOPBP1 after CDK
phosphorylation. GFPSMARCAD1 (55-445) was bound to a GSTTOPBP1 BRCT0/1/2 construct after phosphorylation
with CDK. This CDK-dependent interaction was seen with several N-terminal SMARCAD1 constructs, but not with
FL, perhaps due to low expression. (c–d) Threonine 71 of SMARCAD1, a putative CDK phosphorylation site, is
required for TOPBP1 binding. (c) Two-hybrid analysis of ADSMARCAD1 (1-220) and phospho-mutant derivatives to
BDTOPBP1 BRCT0/1/2. (d) Co-IP as in (a), but additionally using a T71A variant of GFPSMARCAD1 (55-274). (e)
Dpb11 can bind to human SMARCAD1, and T71 is important for the interaction. Two-hybrid analysis as in (b), but
using a BDDpb11 BRCT1+2 construct. (f) A SMARCAD1-Fun30 chimera lacking the Dpb11-binding site of Fun30,
but containing the TOPBP1-binding site of SMARCAD1 restores sensitivity to CPT. The SMARCAD1-Fun30 chimera
is expressed from the pGAL1-10 promoter and induced by galactose. Spotting on CPT medium as in Figure 4A.
DOI: 10.7554/eLife.21687.024
The following figure supplements are available for figure 9:
Figure supplement 1. The interaction between SMARCAD1 and TOPBP1 depends on functional phospho-binding
pockets in BRCT1 and 2 of TOPBP1.
DOI: 10.7554/eLife.21687.025
Figure 9 continued on next page
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Fun30-30-C fragment alone was unable to provide a rescue and showed reduced protein stability as
well (without tag or GFP-tagged, figure Figure 9—figure supplements 4,6). This experiment may
thus indicate that the TOPBP1-binding region of SMARCAD1 could replace the Dpb11-binding
region of Fun30 in vivo. Overall, we therefore conclude from the data in Figure 9 that the Fun30/
SMARCAD1 interaction with Dpb11/TOPBP1, its regulation by CDK phosphorylation and the corre-
sponding interaction surfaces show a remarkable conservation over more than a billion years of
eukaryotic evolution.
Discussion
Our study reveals that the function of Fun30/SMARCAD1 at DSBs is cell cycle-regulated via interac-
tion with Dpb11/TOPBP1. In budding yeast, this interaction seems to facilitate localization of Fun30
to damaged chromatin in a manner that depends on the 9-1-1 complex. Notably, other interactions
may also contribute to Fun30 targeting or function, given that Fun30 was shown to interact with RPA
and nucleases (Chen et al., 2012) and that SMARCAD1 was recently shown to interact with H2A-
ubiquitin (Densham et al., 2016). Importantly, however, our data suggests that the interaction with
Dpb11 and 9-1-1 is essential for the resection function of Fun30 during the cell cycle. In contrast to
the Fun30-Dpb11 complex, the other interactions are seemingly cell cycle-independent and future
research will need to show whether they are at all critical for Fun30/SMARCAD1 function.
Once recruited to a lesion, Fun30 will then promote the action of the long-range resection
machinery by generating resection-permissive chromatin. It seems clear that Fun30 antagonizes the
resection inhibitor Rad9 (Chen et al., 2012), but different, non-exclusive mechanisms remain possi-
ble. For example, Fun30 could directly remove Rad9 from DNA damage sites or render Rad9-con-
taining chromatin resection-permissive, but also could interfere with Rad9 recruitment by changing
chromatin composition. We predict that our system of forced targeting Fun30 to damaged chroma-
tin will be useful to discriminate between these possibilities in the future.
It is furthermore possible that a direct competition for Dpb11 binding between Fun30 and Rad9
contributes to the functional antagonism, similar to what has been suggested for Slx4 and Rad9
(Cussiol et al., 2015; Dibitetto et al., 2016; Ohouo et al., 2013). Dpb11 thus interacts with pro-
and anti-resection factors, and the same is true for TOPBP1 (Cescutti et al., 2010; Moudry et al.,
2016). It will thus be interesting to figure out in the future, how binding of potential antagonizing
factors is balanced.
Overall, our data suggest that at least two layers of cell cycle regulation of DNA end resection
can be distinguished. First, nucleases and nuclease-associated factors are substrate for CDK phos-
phorylation (Chen et al., 2011; Huertas et al., 2008) and this may directly activate these enzymes,
as has for example been shown for the endonuclease activity of MRX-Sae2 (Cannavo and Cejka,
2014). Second, chromatin and nucleosome remodellers may be regulated in a way that generates
resection-permissive chromatin at damage sites in cell cycle phases when resection is favoured. The
Fun30-Dpb11 complex clearly falls in this second category, as does perhaps Rad9/53BP1, the cell
Figure 9 continued
Figure supplement 2. Threonine 71 of SMARCAD1, a putative CDK phosphorylation site, is required for TOPBP1
binding.
DOI: 10.7554/eLife.21687.026
Figure supplement 3. Dpb11 can bind to human SMARCAD1, and T71 is important for the interaction.
DOI: 10.7554/eLife.21687.027
Figure supplement 4. A SMARCAD-FUN30 chimera lacking the Dpb11 binding site of Fun30 but containing the
putative TOPBP1 binding site of SMARCAD1 restores sensitivity to CPT, while expression of the Fun30 construct
lacking the Dpb11 binding site does not.
DOI: 10.7554/eLife.21687.028
Figure supplement 5. Expression control of the SMARCAD1-FUN30 chimera in Figure 9F.
DOI: 10.7554/eLife.21687.029
Figure supplement 6. Expression control of the SMARCAD1-FUN30 chimera, FUN30-30-C and GFP-FUN30 30-C
in Figure 9—figure supplement 4 .
DOI: 10.7554/eLife.21687.030
Bantele et al. eLife 2017;6:e21687. DOI: 10.7554/eLife.21687 13 of 21
Research article Biochemistry Cell Biology
cycle regulation of which we are only beginning to understand (Cescutti et al., 2010; Pfander and
Diffley, 2011). Notably, deregulation of the second layer such as in the experiments with the DDC1-
FUN30 fusion has so far been the most successful strategy to bypass the cell cycle regulation of
DNA end resection (Figure 6). This emphasizes the importance of resection regulation by its chro-
matin substrate and suggests that chromatin (more specifically the Fun30 target on chromatin) is the
factor that limits long-range resection in G1 phase cells.
Experimentally manipulating DSB repair pathway choice is a key challenge for future research,
because it may allow gene targeting in G1/post-mitotic cells, which are currently refractory to this
type of approach, since HR is inefficient under these conditions (Orthwein et al., 2015). Notwith-
standing the overall complexity of DSB repair pathway choice, our results suggest that modification
of the DSB-surrounding chromatin by Fun30/SMARCAD1 should be explored further – particularly in
higher eukaryotes – as a tool to experimentally channel DSBs into the HR pathway independently of
cell cycle stage.
Materials and methods
Yeast strains, cell lines and plasmids
All yeast strains used in this study derive from W303 MATa (strains listed in Supplementary file 1A)
and were constructed using standard methods (Janke et al., 2004). Cells were grown in YP glucose
or YP raffinose media at 30˚C. For sensitivity spottings on camptothecin, plates were incubated at
37˚C for 2 days. The inhibitor-sensitive CDK allele cdc28-as1 (Bishop et al., 2000) was inhibited by
supplementing 1NM-PP1 (final concentration 1.5 mM) to the medium. Cell cycle synchronization was
performed using alpha-factor (5mg/ml) or nocodazole (5mg/ml) for 2–3 hr.
HEK293-T cells were used in mammalian cell culture experiments. Cells were obtained from the
cell services facility of CRUKs London Research Institute, authenticated using STR profiling
(Promega Mannheim, Germany) and species determination. They were also tested negative for
mycoplasma contamination.
For molecular cloning, genes were amplified from yeast genomic DNA and inserted in plasmids
using the In-Fusion HD cloning kit (Clontech Saint-Germain-en-Laye, France). For site-directed muta-
genesis, a PCR-based protocol with mutagenic oligonucleotides was used. All plasmids used in this
study are listed in Supplementary file 1B.
Yeast two-hybrid interaction assays
The yeast two-hybrid analyses of the protein-protein interactions were performed using either the
Gal4-based plasmid system (pGAD-C1, pGBD-C1 [James et al., 1996]) in PJ69-7a cells, or the lexA-
based plasmid system (pBTM116, Clontech Saint-Germain-en-Laye, France) in L40 cells
(Invitrogen Schwerte, Germany).
Transformants were spotted in serial (1:5) or single dilution either on SC-Leu-Trp plates (control)
or on SC-Leu-Trp-His plates (selection) and grown at 30˚C for 2–4 days. For a specific interaction
between TOPBP1 1–360 and SMARCAD1 55–247, spotting plates were supplemented with different
concentrations of 3-Amino-1,2,4-triazole (3-AT) (2.5–10 mM). To assess the phosphorylation-specific
interaction between SMARCAD1 and Dpb11, cells were additionally spotted on SC-Leu-Trp-His-Ade
plates.
All experiments (Figure 1A,G and H; Figure 9A,C,E) were performed in three technical repeti-
tions per biological repetition (spotting of the same yeast cultures on three separate selection
plates) and each interaction was observed in several (2-10) independent experiments (a biological
replicate corresponds to a fresh transformation of the Y2H expression vectors, raising of the trans-
formed cells and spotting on selective plates).
Fun30 Co-Immunoprecipitation
Yeast cells were freshly transformed with pUK1 (pAG416 GPD-Dpb11) and grown to log-phase
(OD600 0.5) in SC-Ura medium + 2% glucose (YPD) at 30˚C. Cells were cell cycle synchronized as
describe above, the arrest was controlled by flow cytometry. To release cells from G1 (Figure 1C,
Figure 1—figure supplement 2), BAR1+ cells were synchronized with 5 mg/ml alpha-factor, washed
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twice in pre-warmed SC-Ura medium and resuspended in pre-warmed SC-Ura medium supple-
mented with nocodazole.
For preparation of extracts, 300 OD yeast cells were harvested, washed in ice-cold sorbitol buffer
(1 M sorbitol, 25 mM Hepes pH 7.6), and resuspended in 2 ml lysis buffer with protease and phos-
phatase inhibitors (100 mM Hepes, 200 mM KOAc, 0.1 % NP-40, 10% glycerol, 2 mM b-mercaptoe-
thanol, 100 nM ocadaic acid, 10 mM NaF, 20 mM b-glycerophosphate, 400 mM PMSF, 4 mM
aprotinin, 4 mM benzamidin, 400 mM leupeptin, 300 mM pepstatin A) and prepared for lysis using
a Spex Sample Prep cryo mill. The extracts were cleared by centrifugation and incubated with anti-
-FLAG agarose resin (Sigma Munich, Germany) for 30 min (4˚C, rotation). After six washes with lysis
buffer, Fun30-3FLAG was eluted twice with 0.5 mg/ml 3X FLAG peptide (Sigma Munich, Germany).
The elutions were pooled and proteins were precipitated with TCA prior to analysis on 4–12%
NuPAGE gradient gels (Invitrogen Schwerte, Germany) and standard Western blotting.
Yeast in vivo co-immunoprecipitation experiments were not performed in technical replicates.
The number of biological replicates (fresh transformation with the GPD-Dpb11 overexpressing plas-
mid, raising of the cells, lysis and IP) was two or more, with the exception of Figures 1C and
5B, Figure 5—figure supplement 1.
Protein purification
Purification of bacterially expressed CDK2/cycADN170
CDK/cycA was purified as described previously (Brown et al., 1995).
Purification of Fun30 from S. cerevisiae
YSB784 was grown in 6 L YP medium + 2% raffinose at 30˚C until mid-log phase before expression
was induced by addition of 2% galactose. After 3 hr of induction, yeast cells were harvested and
washed with 1 M Sorbitol + 25 mM HEPES pH 7.6. Cells were resuspended in 20 ml of Lysis Buffer
(500 mM NaCl, 100 mM HEPES pH 7.6, 0.1% NP-40, 10% glycerol, 2 mM b-mercaptoethanol, 400
mM PMSF, 4 mM aprotinin, 4 mM benzamidin, 400 mM leupeptin, 300 mM pepstatin A, 1x complete
protease inhibitor cocktail, EDTA-free) and frozen to drops in liquid nitrogen. Cells were lysed using
a cryo mill (Spex Sample Prep). The lysate was thawed and cleared by centrifugation. The extract
was incubated with 2 ml equilibrated slurry of anti-FLAG M2 resin (Sigma Munich, Germany). After 2
hr of incubation, the resin was washed six times with 15 CV of lysis buffer. Two elution steps were
performed by adding 2 ml 0.5 mg/mL 3FLAG peptide in lysis buffer and incubation for 30 min at
4˚C. Next, Fun303FLAG was further purified using a 1 ml MonoQ column. To this end, Fun30 was first
brought to 100 mM NaCl, bound to the column and eluted on a 100 mM to 1 M salt gradient over
20 CV. Fun30 containing fractions were pooled, snap-frozen and stored at  80˚C.
Purification of GST-Dpb11 1–275 from E.coli
GST-Dpb11-1-275 was purified as described previously (Pfander and Diffley, 2011).
Purification of GST-TOPBP1-1-360 from E.coli
GST-TOPBP1-1-360 was purified as described previously (Boos et al., 2011).
In vitro analysis of protein-protein interactions
In vitro experiments (Figure 1F; Figure 9B,D) as depicted were performed once, but confirmed in
several different experimental setups (Figure 9B and D).
In vitro CDK phosphorylation and pulldown of Fun30
For in vitro pulldown of Fun30 with Dpb11 after in vitro CDK phosphorylation, GST-Dpb11-N or GST
(approx. 18 mg per reaction) were immobilized on Sepharose beads for 1 hr at 4˚C. The beads were
washed twice in lysis buffer (200 mM KOAc, 100 mM HEPES KOH pH 7.6, 10% glycerol, 0.1% NP-
40, 2 mM b-mercaptoethanol) and resuspended in 100 ml lysis buffer per reaction. For phosphoryla-
tion of Fun30 and Rad9 (control), 5 mg purified protein per reaction were dialyzed against lysis buffer
(4˚C) and supplied with 4 mM ATP and 5 mM MgOAc. Buffer or CDK (2.5 mg per reaction) were
added and the reactions were incubated for 30 min at 24˚C. Then, the pre-bound Dpb11/GST-beads
were added to the phosphorylated proteins and incubated for 1 hr at 4˚C. The beads were washed
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five times in lysis buffer and eluted by boiling in 2x Laemmli buffer. Proteins were separated by SDS-
PAGE and analyzed with standard Western Blotting techniques.
In vitro CDK phosphorylation and pulldown of SMARCAD1
CDK-dependent pulldowns of SMARCAD1-TOPBP1 (Figure 9B and D) were carried out as
described (Boos et al., 2011) for TRESLIN-TOPBP1 with modifications. HEK293T cells were trans-
fected with pCS2-SMARCAD1-55-275 or pCS2-SMARCAD1-55-445 (carrying an N-terminal GFP tag)
and native cell lysates were prepared by lysing the cell pellets in 5x lysis buffer (20 mM HEPES
pH 7.5, 250 mM KCl, 0.1% Triton X-100, 5 mM b-mercaptoethanol, 5% glycerol and Complete
EDTA-free Protease Inhibitor Cocktail (Roche Mannheim, Germany)). For CDK phosphorylation, the
extract was supplemented with 5 mM ATP, 5 mM MgCl2 and approx. 67 ng/ml cycA/CDK2 or buffer
(as control) and incubated for 5 min at 25˚C. 200 ml of cell extract were incubated with approx. 10
mg immobilized GST-TopBP1-BRCT0/1/2 for 2 hr at 4˚C. The beads were washed with lysis buffer
and WCE and bound material were analysed by SDS PAGE, Western Blotting and ponceau staining.
Chromatin immunoprecipitation (ChIP) and qPCR analysis
For chromatin immunoprecipitation of Fun30 and RPA, cells were grown in YP-Raffinose to an OD of
0.5 and - as indicated for the individual experiments- cell cycle arrest was induced. A double-strand
break was introduced by inducing the HO endonuclease from the galactose promoter by addition of
galactose to the cultures (2% final). 100 ml samples were crosslinked with formaldehyde (final 1%)
for 16 min at indicated timepoints and the reaction was quenched with glycine. Cells were harvested
by centrifugation, washed in ice-cold PBS and snap-frozen (RPA ChIPs) or directly processed
(Fun30-3FLAG ChIPs). For lysis, cell pellets were resuspended in 800 ml lysis buffer (50 mM HEPES
KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycolate, 0.1% SDS) and
grinded with zirconia beads using a bead beating device. The chromatin was sonified to shear the
DNA to a size of 200–500 bp. Subsequently the extracts were cleared by centrifugation, 1% was
taken as input sample and 40% were incubated with either anti FLAG M2 magnetic beads
(Sigma Munich, Germany) for 2 hr (Fun30-3FLAG ChIPs) or 1.5 hr with anti RFA antibody (AS07-214,
Agrisera Va¨nna¨s, Sweden) followed by 30 min with Dynabeads ProteinA (Invitrogen Schwerte, Ger-
many, for RPA ChIPs). The beads were washed 3x in lysis buffer, 2x in lysis buffer with 500 mM NaCl,
2x in wash buffer (10 mM Tris-Cl pH 8.0, 0.25 M LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% Na-deoxycho-
late) and 2x in TE pH 8.0. DNA-protein complexes were eluted in 1% SDS, proteins were removed
with Proteinase K (3 hr, 42˚C) and crosslinks were reversed (8 hr or overnight, 65˚C). The DNA was
subsequently purified using phenol-chloroform extraction and ethanol precipitation and quantified
by quantitative PCR (Roche LightCycler480 System, KAPA SYBR FAST 2x qpCR Master Mix, KAPA
Biosystems London, UK) at indicated positions with respect to the DNA double-strand break. As
control, 2–3 control regions on other chromosomes were quantified and used for normalization.
Chromatin Immunoprecipitation (ChIP) experiments were generally performed in technical repli-
cates (on the qPCR level, each sample was measured three times). Our experimental design (exclud-
ing Figure 1J and figure Figure 1—figure supplement 5) includes further replicates, which can be
considered as technical as well as biological replicates: we took samples at different timepoints after
induction of the DNA break, which showed a consistent trend over the experiment. Additionally, we
measured signals with 15–20 qPCR primer pairs over the damaged chromosome including three con-
trol regions on unaffected chromosomes. Therefore, we plot results from single experiments and
timepoints and do not include error bars. Nonetheless, 2–6 repetitions (independent cell growth and
crosslinking) were performed for mutants analysed in Figure 2A; Figure 6B–C; Figure 2—figure
supplement 1, Figure 8 with the exception of Figure 6—figure supplement 3. The ChIP experi-
ment in Figure 1J and figure Figure 1—figure supplement 5 was performed three times, error bars
represent the standard deviation.
Yeast growth assays
Yeast growth assays (DNA damage sensitivity spottings Figures 2B and 4A–D; Figure 6A,
9F; Figure 4—figure supplements 1,2; Figure 6—figure supplement 1; Figure 9—figure supple-
ment 5 and URA3 silencing assay Figure 3) were performed in three technical repetitions per bio-
logical repetition (spotting of the same yeast cultures on three separate selection plates), biological
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replicates refer to raising of the mutant strains and spotting on plates with indicated conditions. The
genotypes were additionally confirmed by comparing several clones of each strain. Each experiment
was spotted with three technical replicates.
Single strand annealing spotting assay
Derivates of the YMV80 strain (Vaze et al., 2002) carrying a 25 kb spacer between a galactose-
inducible HO cutsite and repair locus with a rad514 deletion to prevent DSB repair by gene conver-
sion were grown to stationary phase in YP-Raffinose and spotted in a 5-fold serial dilution on plates
containing glucose or galactose. The plates were incubated for 2–3 days at 30˚C.
DNA damage sensitivity spotting assay
Cells were grown to stationary phase in YP-Glucose and spotted in a 5-fold serial dilution on plates
containing camptothecin (concentrations as indicated, typically between 4 and 12 mg/ml) or other
drugs at the indicated concentrations. The plates were incubated for 2 days at 30˚C or 37˚C (for
camptothecin, if not indicated differently).
Plasmid re-ligation assay
In order to assay for precise non-homologous end-joining, 40 OD of transformation-competent yeast
cells were transformed with 500 ng BamHI-linearized or mock-digested pRS316. Transformed cells
were plated in a five-fold serial dilution on SC-Ura and SC-complete agar plates and grown for two
days. Clones on plates containing 50–200 clones were counted to calculate the re-ligation rate (ratio
of clones from +BamHI –Ura by +BamHI +Ura divided by the equivalent ratio of mock digested plas-
mid transformations). Each sample was plated in triplicates and the experiment was independently
repeated three times. Error bars represent standard deviations.
50–75 clones from the BamHI-digest transformation on –Ura plates were sequenced to analyse
the precise NHEJ event. We found that the majority of cells had precisely re-joined the BamHI over-
hangs, with a subset having added a single G-C basepair at the cutsite (shown as rate in %). yku70D
cells are NHEJ-deficient and showed very low NHEJ rates with exclusively precisely re-joined plasmid
sequences, indicating that this number represents the background of uncut plasmid in the reactions.
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Targeting of the Fun30 nucleosome remodeller by the Dpb11 scaffold facilitates
cell cycle-regulated DNA end resection
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Figure 1. Fun30 and Dpb11 interact in a cell cycle- and CDK phosphorylation-dependent manner and this targets Fun30 to DSBs. (a) Two-hybrid assay
with GAL4-AD and -BD constructs as indicated reveals a physical interaction between the N-terminal region of Fun30 (aa 1–188) and the BRCT1+2
Figure 1 continued on next page
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Figure 1 continued
domain of Dpb11. Rad9 and Ddc1 represent known interactors of BRCT1+2 and BRCT3+4, respectively. (b–e) Characterization of the Fun30-Dpb11
interaction by Fun303FLAG Co-IP experiments. Dpb11 was expressed from the strong, constitutive GPD promoter. (b) Fun303FLAG specifically binds
Dpb11 in cells arrested in M but not G1 phase. (c) Fun303FLAG purified from cells synchronously progressing through the cell cycle binds Dpb11 only at
45’ and 90’ time points corresponding to late S and M phase (Figure 1—figure supplement 2 for FACS analysis and western analysis of cell cycle
progression). (d) No enhancement of the Fun30-Dpb11 interaction by CPT or phleomycin treatment as measured by Fun303FLAG Co-IP. For DNA
damage treatment, 50 mM CPT or 50 mg/ml phleomycin were added to asynchronously dividing yeast cells. DNA damage checkpoint activation was
measured by Rad53 phosphorylation in IP extracts (lowest blot panel). (e) CDK inhibition using the cdc28-as1 allele and 1-NMPP1 treatment diminishes
the Fun303FLAG-Dpb11 interaction in M phase arrested cells. (f) Purified Fun30 interacts with a BRCT1+2 fragment of Dpb11 in the presence of CDK
phosphorylation. Purified Fun303FLAG or the positive control MBPRad9 (Pfander and Diffley, 2011) were incubated with a model CDK and ATP before
binding to bead-bound GSTDpb11 BRCT1+2. (g) Mapping analysis of the two-hybrid interaction between Fun30 and Dpb11 reveals a binding site close
to the N-terminus of Fun30. (h–i) Putative CDK sites on Fun30 (S20 and S28) are required for Dpb11 binding. (h) Two-hybrid assay as in (a) but in five-
fold serial dilution and with WT, S20A, S28A and SS20,28AA variants of Gal4-AD-Fun301-188. (i) Co-IP as in (b) but with mutant variants of Fun303FLAG
growing asynchronously. (j) Efficient Fun30 localization to damaged chromatin requires the Dpb11-Fun30 interaction. ChIP of Fun303FLAG to chromatin
locations 3, 8, 10 and 15 kb distant of a non-repairable DSB induced at the MAT locus in M phase-arrested cells. fun30 mutants were expressed from
the endogenous promoter as only copy of FUN30. The FUN30-DPB11 fusion contains fun30-SSAA and dpb114N mutations. WT, fun30-SSAA and
FUN30-DPB11 fusion cells were crosslinked at indicated timepoints after DSB induction. Plotted values represent means from two independent
experiments, error bars represent standard deviations.
DOI: 10.7554/eLife.21687.003
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Figure 1—figure supplement 1. Expression control of two-hybrid constructs used in Figure 1A. Two-hybrid
constructs are detected with anti-Gal4-AD (AD-Fun30 1–188, AD-Ddc1, AD-Rad9) and with anti-Gal4-BD (for BD-
Dpb11 constructs) antibodies.
DOI: 10.7554/eLife.21687.004
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Figure 1—figure supplement 2. Control of the cell cycle states of the experiment in Figure 1C. Left panel: DNA
content measurements with FACS. Right panel: Western Blot analysis using S/M-phase (hyperphosphorylated Sld2)
or M-phase (Clb2) markers. Asterisk indicates a cross reactive band.
DOI: 10.7554/eLife.21687.005
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Figure 1—figure supplement 3. Expression control of two-hybrid constructs used in Figure 1G. Two-hybrid
constructs are detected with anti-Gal4-AD (AD-Fun30 constructs) and with anti-lexA-BD (for BD-Dpb11 BRCT1 +2
construct) antibodies.
DOI: 10.7554/eLife.21687.006
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Figure 1—figure supplement 4. Expression control of
two-hybrid constructs used in Figure 1H. Two-hybrid
constructs are detected with anti-Gal4-AD (AD-Fun30
1–188 and mutant derivatives) and with anti-Gal4-BD
(for BD-Dpb11 BRCT1 +2 constructs) antibodies.
DOI: 10.7554/eLife.21687.007
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Figure 1—figure supplement 5. Efficient Fun30 localization to damaged chromatin requires the Dpb11-Fun30 interaction. ChIP of Fun303FLAG to
chromatin in proximity of a non-repairable DSB induced at the MAT locus in M phase arrested cells. Same experiment as in Figure 1J, using WT,
fun30-SSAA and FUN30-DPB11 fusion cells, but here Fun30 ChIP is shown at additional loci (1.1, 3, 8, 10, 15 and 20 kb distance from break). Cells were
crosslinked at distinct time points after DSB induction. Plotted values represent error bars from three independent experiments.
DOI: 10.7554/eLife.21687.008
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Figure 2. The Fun30-Dpb11 complex is required for efficient long-range resection. (a) Long-range resection of a DSB is dependent on the Fun30-
Dpb11 interaction. A non-repairable DSB at MAT was induced in M phase-arrested WT, fun304, fun30-SSAA and FUN30-DPB11 fusion strains and DNA
end resection measured at indicated times. Upper panel: fold enrichment of a given locus in an RPA ChIP relative to undamaged control loci. Lower
panel: DNA loss relative to control loci located in non-damaged chromatin. (b) Single-strand annealing (SSA) is dependent on the Fun30-Dpb11
interaction. FUN30 mutants as indicated were combined with the rad514 deletion, a DSB at the leu2::HO cutsite was induced by plating cells on
galactose. Cells need to resect 25 kb up to the homologous his4::leu2 locus in order to survive by SSA.
DOI: 10.7554/eLife.21687.009
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Figure 2—figure supplement 1. The Fun30-Dpb11 interaction is required for efficient long-range resection. Long-range resection of a site-specific
DSB is partially deficient in CDK-phosphorylation site mutants that are deficient in the Fun30-Dpb11 interaction. A non-repairable DSB at MAT was
induced in M-phase arrested WT, fun30-S20A3FLAG, fun30-S28A3FLAG, fun30-SSAA3FLAG and fun30D cells. DNA end resection was measured at indicated
time points by RPA ChIP. Plotted is the fold enrichment of a given locus relative to three undamaged control loci.
DOI: 10.7554/eLife.21687.010
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Figure 3. The Fun30-Dpb11 interaction is not involved in Fun30-dependent gene silencing at telomeric
heterochromatin and a silent mating type locus. The silencing defect of the fun30D mutant is not recapitulated by
the fun30-SSAA mutant. Two silencing tester strains were used: the first (upper panels) had URA3 integrated in
telomeric heterochromatin at the end of the left arm of chromosome VII, the second (lower panels) had URA3
integrated at the HML silent mating type locus. A silencing defect leads to enhanced growth on –Ura medium and
less growth on medium supplemented with 5-FOA (e.g. fun30D). Shown is a spotting in 5-fold serial dilutions on
non-selective medium, medium lacking uracil or containing 5-FOA.
DOI: 10.7554/eLife.21687.011
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Figure 4. The Fun30-Dpb11 interaction is required for the response towards CPT, as is functional long- and short-range resection. (a) The Fun30-Dpb11
interaction is required for the response towards CPT. WT, fun304, fun30-SSAA and FUN30-DPB11 fusion were spotted in five-fold serial dilutions on
plates containing indicated amounts of CPT and incubated at 37˚C for two days. (b) A double mutant of exo1D and sgs1D is hyper-sensitive to low
doses of CPT. Spotting in 5-fold serial dilutions was incubated for two days at 30˚C. (c) The fun30D/fun30-SSAA mutants enhance the CPT hyper-
sensitivity of sae2D mutants. Cells were spotted in 5-fold serial dilutions and incubated for two days at 30˚C. (d) A rad9D deletion rescues CPT hyper-
sensitivity of fun30D and fun30-SSAA mutant alleles.
DOI: 10.7554/eLife.21687.012
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Figure 4—figure supplement 1. Mutants of Fun30 show no discernable phenotype upon chronic exposure to HU, MMS or phleomycin. Spotting in 5-
fold serial dilutions on medium containing indicated dosages of DNA damaging agents. Plates were incubated two days at 30˚C.
DOI: 10.7554/eLife.21687.013
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Figure 4—figure supplement 2. The catalytic activity of Fun30 is required for the suppression of the CPT
phenotype in the context of the FUN30-DPB11 fusion. Spotting of strains with indicated genotypes in 5-fold serial
dilutions on CPT containing medium. The K603R mutation is located in the Walker A motif of Fun30. Plates were
incubated for two days at 37˚C.
DOI: 10.7554/eLife.21687.014
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Figure 5. The 9-1-1 complex forms a ternary complex with Fun30-Dpb11. (a) Fun30, Dpb11 and 9-1-1 form a
ternary complex. The 9-1-1 subunit Mec3 interacts with Fun303FLAG when purified from M phase cells, where also
Dpb11 binds to Fun30. (b) The ddc1-T602A mutation abolishes binding of Mec3 to Fun30-Dpb11 in Fun303FLAG
Co-IPs, but leaves the Fun30-Dpb11 interaction intact. (c) Mutants disrupting the interaction between 9-1-1 and
Dpb11 (ddc1-T602A) or Fun30 and Dpb11 (SLD3-dpb11DN, lacks Fun30 binding site, only copy of Dpb11) impair
efficient localization of Fun30 to DSBs in Fun303FLAG ChIPs of M phase-arrested cells. Experiment performed as in
Figure 1J, plotted values represent means of two independent experiments, error bars represent standard
deviations.
DOI: 10.7554/eLife.21687.015
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Figure 5—figure supplement 1. The interaction between Fun30 and 9-1-1 depends on mutual interactions with
Dpb11, suggesting that Dpb11 forms a molecular bridge in the Fun30-Dpb11-9-1-1 complex. The fun30-SSAA
mutation abolishes binding of Dpb11 and also Ddc19myc in Fun303FLAG Co-IPs. Cells were either left untreated or
treated with 50 mg/ml phleomycin, which induced the DNA damage checkpoint (Rad53 activation), but did not
influence Dpb11 or Ddc1 binding.
DOI: 10.7554/eLife.21687.016
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Figure 5—figure supplement 2. Model of the Fun30-
Dpb11-9-1-1 association and its regulation.
DOI: 10.7554/eLife.21687.017
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Figure 6. A covalent fusion of Fun30 to the 9-1-1 subunit Ddc1 generates a bypass of the cell cycle regulation of
long-range resection. (a) The DDC1-FUN30 fusion confers cellular hyper-resistance to CPT. Spotting of indicated
strains as in Figure 4A, but using CPT concentrations of up to 12 mg/ml. (b) The DDC1-FUN30 fusion localizes
efficiently to a DSB in G1-arrested cells. Fun303FLAG ChIPs from WT, fun30-SSAA, FUN30-DPB11 and DDC1-FUN30
cells as in Figure 1J, but from G1 or M phase-arrested cells. Additional Fun303FLAG ChIP data can be
found in Figure 6—figure supplement 3. (c) The DDC1-FUN30 fusion enhances long-range resection in G1-
arrested cells. Resection assay as in Figure 2A, but with G1 or M phase-arrested cells. Additional resection assay
data can be found in Figure 6—figure supplement 3.
DOI: 10.7554/eLife.21687.018
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Figure 6—figure supplement 1. The DDC1-FUN30 fusion rescues the CPT sensitivity of the fun304 mutant in a
manner that depends on the Fun30 catalytic activity. WT, fun30D, DDC1-FUN30 fusion and DDC1-FUN30 (K603R)
fusion mutants are spotted on CPT as in Figure 4A.
DOI: 10.7554/eLife.21687.019
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Figure 6—figure supplement 2. Flow cytometric analysis of DNA content for experiments shown in Figure 6B–C
and Figure 6—figure supplement 3.
DOI: 10.7554/eLife.21687.020
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Figure 6—figure supplement 3. The DDC1-FUN30 fusion protein efficiently localizes to DSBs and promotes hyper-resection in M phase as well as
allowing long-range resection in G1 phase. Cells (WT, fun30D and DDC1-FUN30 fusion) were arrested in G1 or M phase prior to DSB induction. Fun30
localization was investigated by anti-FLAG ChIP after break induction (upper panels). DNA end resection was investigated by the combined read-out of
RPA ChIP and DNA loss (lower panels).
DOI: 10.7554/eLife.21687.021
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Figure 7. The DDC1-FUN30 fusion does not significantly inhibit non-homologous end-joining (NHEJ). Precise re-
ligation of BamHI-cut pRS316 as measured by cell viability on SC-Ura plates and subsequent sequencing of single
colonies was dependent on Ku70 but not significantly affected in DDC1-FUN30 of fun30D mutant cells. Plotted are
values from three independent experiments representing the viability rate of cells on SC-Ura plates relative to the
total cell number and the transformation efficiency of the mock-digested plasmid. Error bars represent standard
deviations.
DOI: 10.7554/eLife.21687.022
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Figure 8. The DDC1-FUN30 fusion specifically enhances long-range resection in G1, while the sae2-S267E phospho-mimicry leads to a small increase in
resection initiation. The sae2-S267E mutant has little effect on the spreading of DNA end resection in G1, but slightly stimulates the RPA fold
enrichment in WT and the DDC1-FUN30 fusion mutant. This suggests that sae2-S267E in contrast to the DDC1-FUN30 fusion does not affect long-
range resection. DNA end resection in the indicated strains was analysed by RPA ChIP as in Figure 5C but with G1 arrested cells.
DOI: 10.7554/eLife.21687.023
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Figure 9. Yeast Fun30 and human SMARCAD1 underlie a conserved regulation. (a) SMARCAD1 and TOPBP1
interact and their interaction depends on functional phospho-binding pockets in BRCT1 and BRCT2 of TOPBP1.
lexA-BD TOPBP1 1–360 (harbouring BRCT0/1/2) or lexA-BD TOPBP1 1–766 (harbouring BRCT0-5) were tested as
WT versions or as K155E, KK154,155AM (affecting BRCT1) or K250E (affecting BRCT2) mutant derivatives.
Interaction was tested against the Gal4-AD SMARCAD1 55–274. 3AT was added to –His plates to suppress auto-
activation and to increase the stringency of the two-hybrid. Two-hybrid interactions with the lexA-BD TOPBP1 1–
360 construct were generally stronger compared to lexA-BD TOPBP1 1–766, leading to milder effects of the K155E
and K250E single-mutants, particularly at low 3AT concentrations. (b) SMARCAD1 interacts with TOPBP1 after CDK
phosphorylation. GFPSMARCAD1 (55-445) was bound to a GSTTOPBP1 BRCT0/1/2 construct after phosphorylation
with CDK. This CDK-dependent interaction was seen with several N-terminal SMARCAD1 constructs, but not with
FL, perhaps due to low expression. (c–d) Threonine 71 of SMARCAD1, a putative CDK phosphorylation site, is
required for TOPBP1 binding. (c) Two-hybrid analysis of ADSMARCAD1 (1-220) and phospho-mutant derivatives to
BDTOPBP1 BRCT0/1/2. (d) Co-IP as in (a), but additionally using a T71A variant of GFPSMARCAD1 (55-274). (e)
Dpb11 can bind to human SMARCAD1, and T71 is important for the interaction. Two-hybrid analysis as in (b), but
using a BDDpb11 BRCT1+2 construct. (f) A SMARCAD1-Fun30 chimera lacking the Dpb11-binding site of Fun30,
but containing the TOPBP1-binding site of SMARCAD1 restores sensitivity to CPT. The SMARCAD1-Fun30 chimera
is expressed from the pGAL1-10 promoter and induced by galactose. Spotting on CPT medium as in Figure 4A.
DOI: 10.7554/eLife.21687.024
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Figure 9—figure supplement 1. The interaction between SMARCAD1 and TOPBP1 depends on functional
phospho-binding pockets in BRCT1 and 2 of TOPBP1. Expression control for two-hybrid constructs in Figure 9A
using anti-lexA-BD and anti-Gal4-AD antibodies.
DOI: 10.7554/eLife.21687.025
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Figure 9—figure supplement 2. Threonine 71 of SMARCAD1, a putative CDK phosphorylation site, is required
for TOPBP1 binding. Expression control for two-hybrid constructs in Figure 9C using anti-lexA-BD and anti-Gal4-
AD antibodies.
DOI: 10.7554/eLife.21687.026
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Figure 9—figure supplement 3. Dpb11 can bind to
human SMARCAD1, and T71 is important for the
interaction. Expression control for two-hybrid
constructs in Figure 9E using anti-Gal4-BD and anti-
Gal4-AD antibodies.
DOI: 10.7554/eLife.21687.027
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Figure 9—figure supplement 4. A SMARCAD-FUN30 chimera lacking the Dpb11 binding site of Fun30 but
containing the putative TOPBP1 binding site of SMARCAD1 restores sensitivity to CPT, while expression of the
Fun30 construct lacking the Dpb11 binding site does not. The SMARCAD1-FUN30 chimera, FUN30 30–C and GFP-
FUN30 30–C constructs are expressed from the pGAL1-10 promoter and induced by galactose. Spotting on CPT
medium as in Figure 4A.
DOI: 10.7554/eLife.21687.028
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Figure 9—figure supplement 5. Expression control of the SMARCAD1-FUN30 chimera in Figure 9F.
SMARCAD1-FUN30 3FLAG chimerais expressed from the GAL1-10 promoter by addition of galactose. Fun30 3FLAG
expressed from the endogenous promoter serves as control to visualize expression levels of the chimera.
DOI: 10.7554/eLife.21687.029
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Figure 9—figure supplement 6. Expression control of
the SMARCAD1-FUN30 chimera, FUN30-30-C and
GFP-FUN30 30-C in Figure 9—figure supplement 4 .
SMARCAD1-FUN303FLAG chimera, FUN30-30-C and
GFP-FUN30 30 C are expressed from the GAL1-10
promoter by addition of galactose, which however
leads to a stronger expression of the chimera
constructs than the truncated FUN30 fragment alone.
DOI: 10.7554/eLife.21687.030
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Supplementary	file	1		Table	1.	Yeast	strains	used	in	this	study.		Strain	 Relevant	genotype	 Source	W303a	 MATa	ade2-1	ura3-1	his3-11,15	trp1-1	leu2-3,112	can1-100	 (Thomas	and	Rothstein,	1989)	pJ69-7a	 MATa	trp1-∆901	leu2-3,112	901	ura3-52	his3-∆200	gal4∆	gal8∆	GAL2-ADE2	LYS2::GAL1-HIS3	met2::GAL7-lacZ		 (James	et	al,	1996)	YSB117	 MATa	lys1∆::natNT2	pep4∆::LEU2	bar1∆::TRP1	 this	study	YSB220	 MATa	lys1∆::natNT2	pep4∆::LEU2	bar1∆::TRP1	Fun30-3FLAG::hphNT1	 this	study	YBP388	 MATa	pep4∆::LEU2	 this	study	YSB760	 MATa	pep4∆::LEU2	Fun30-3FLAG::hphNT1	 this	study	YSB707	 MATa	cdc28-as1	bar1∆::trp1	pep4∆::leu2	Fun30-3FLAG	 this	study	YSB708	 MATa	cdc28-as1	bar1∆::trp1	pep4∆::leu2	 this	study	YSB714	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::Fun30-S20A-3FLAG::hphNT1	 this	study	YSB718	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::Fun30-S28A-3FLAG::hphNT1	 this	study	YSB719	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::Fun30-SS20,28AA-3FLAG::hphNT1	 this	study	YSB723	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::	Fun30-SS20,28AA-dpb11∆N-3FLAG::hphNT1	 this	study	YSB745	 MATa	bar1∆::TRP1	pep4∆::LEU2	Fun30-3FLAG::hphNT1	 this	study	YSB743	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	Fun30-3FLAG::hphNT1	 this	study	YSB725	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	natNT2::Fun30-S20A-3FLAG::hphNT1	 this	study	YSB727	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	natNT2::Fun30-S28A-3FLAG::hphNT1	 this	study	YSB728	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	natNT2::Fun30-SS20,28AA-3FLAG::hphNT1	 this	study	YSB731	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	natNT2::Fun30-SS20,28AA-dpb11∆N-3FLAG::hphNT1	 this	study	L40	 MATa	his3∆200	trp1-901	leu2-3,112	ade2	LYS2::(4lexAop-HIS3)	URA3::(8lexAop-lacZ)	GAL4	 Invitrogen	YSB782	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::Fun30-SS20,28AA-3FLAG::hphNT1	ddc1-9myc::kanMX4	 this	study	YSB771	 MATa	lys1∆::natNT2	pep4∆::LEU2	bar1∆::TRP1	ddc1-9myc::kanMX4	 this	study	YSB772	 MATa	lys1∆::natNT2	pep4∆::LEU2	bar1∆::TRP1	Fun30-3FLAG::hphNT1	ddc1-9myc::kanMX4	 this	study	YSB753	 MATa	bar1∆::TRP1	pep4∆::LEU2	Fun30-3FLAG::hphNT1	ddc1-T602A::kanMX4	 this	study	YSB517	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	 this	study	YSB525	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	fun30∆::hphNT1	 this	study	YSB260	 YMV80	rad51∆::hphNT1	 this	study	
YSB329	 YMV80	fun30-S20A::TRP1	rad51∆::hphNT1	 this	study	YSB330	 YMV80	fun30-S28A::TRP1	rad51∆::hphNT1	 this	study	YSB331	 YMV80	fun30-SS20,28AA::TRP1	rad51∆::hphNT1	 this	study	YSB253	 YMV80	fun30∆::kanMX4	rad51∆::hphNT1	 this	study	UCC3511	 hmr::URA3		 (Singer	et	al,	1996)	YSB248	 hmr::URA3	fun30∆::hphNT1	 this	study	YSB335	 hmr::URA3	fun30∆::hphNT1	Fun30	SS20,28AA::LEU2	 this	study	AEY1017	 ChrVII-L-TEL::URA3	 (Meijsing	et	al,	2001)	YSB246	 ChrVII-L-TEL::URA3	fun30∆::hphNT1	 this	study	YSB294	 ChrVII-L-TEL::URA3	fun30∆::hphNT1	Fun30::TRP1	 this	study	YSB297	 ChrVII-L-TEL::URA3	fun30∆::hphNT1	Fun30	SS20,28AA::TRP1	 this	study	YSB314	 MATa	lys1∆::natNT2	pep4∆::LEU2	bar1∆::TRP1	fun30∆::hphNT1	 this	study	YJW031	 MATa	rad9∆::kanMX4	 this	study	YDG148		 MATa	fun30∆::hphNT1	 this	study	YSB183	 MATa	fun30∆::hphNT1	Fun30	SS20,28AA::TRP1	 this	study	YJW032	 MATa	fun30∆::hphNT1	rad9∆::kanMX4	 this	study	YJW035	 MATa	fun30∆::hphNT1	rad9∆::kanMX4	Fun30	SS20,28AA::TRP1	 this	study	YSB758	 MATa	fun30∆::kanMX4	 this	study	YSB761	 MATa	fun30∆::kanMX4	Ddc1-Fun30-	SS20,28AA-3FLAG::hphNT1	 this	study	YSB777	 MATa	fun30∆::kanMX4	Ddc1-Fun30-	SS20,28AA-K603R-3FLAG::hphNT1	 this	study	YSB791	 MATa	bar1∆::TRP1	pep4∆::LEU2	natNT2::	Fun30-SS20,28AA-K603R-dpb11∆N-3FLAG::hphNT1	 this	study	YSB797	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	fun30∆::kanMX4	Ddc1-Fun30-	SS20,28AA-3FLAG::hphNT1	 this	study	YSB819	 MATa	fun30∆::kanMX4	pGAL-SMARCAD1	1-300-FUN30	30-C-3FLAG::URA3	 this	study	YSB784	 MATa	bar1∆::TRP1	pep4∆::LEU2	GAL4	pGAl1-10	Fun30-3FLAG::HIS3	 this	study	YSB910	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	Fun30-3FLAG::hphNT1	ura3::Sld3-dpb11∆N	dpb11∆::kanMX4	 this	study	YSB911	 MATa	fun30∆::kanMX4	pGAL-GFP-FUN30	30-C-3FLAG::URA3	 this	study	YSB832	 MATa	hml∆::prS	hmr∆::pRS	bar1∆::trp1	pGal-HO::ade3	yku70∆::natNT2	 this	study			 	
	Table	2.	Plasmids	used	in	this	study.		name	 description	pDG1	 pGAD-C1	Fun30	1-188	pAD25	 pGAD-C1	Rad9	pAD30	 pGAD-C1	Ddc1	pBD23	 pGBD-C1	Dpb11	pBD26	 pGBD-C1	Dpb11	1-276	pUK211	 pB66	Dpb11	271-582	pGAD-C1	 pGAD-C1	(James	et	al,	1996)	pGBD-C1	 pGBD-C1	(James	et	al,	1996)	pUK1	 pAG416	GPD-Dpb11	pBP91	 pMALp2x	RAD9	pKR347	 pRS303	Fun30-3FLAG	pGAL1-10	GAL4		(Fun30	ORF	codon	optimized	for	yeast	expression)	pBP48	 pGex4T1	DPB11	1-275	pSB035	 pGAD-C1	Fun30	1-188	S20A	pSB036	 pGAD-C1	Fun30	1-188	S28A	pSB029	 pGAD-C1	Fun30	1-188	SS20,28AA	pSB075	 pGAD-C1	Fun30	29-188	pAP3	 pGAD-C1	Fun30	pKS8	 pGAD-C1	Fun30	1-420	pKS10	 pGAD-C1	Fun301-500	pKS12	 pGAD-C1	Fun30	1-555	pSB181	 pBTM116	Dpb11	1-276	pSB31	 pRS304	Fun30	S20A	pSB32	 pRS304	Fun30	S28A	pSB33	 pRS304	Fun30	SS20,28AA	pSB140	 pRS304	Fun30	SS20,28AA-Dpb11	276-C		pSB38	 pRS305	Fun30	SS20,28AA	pDB104	 pB27	TOPBP1	1-360	pSB190	 pB6	SMARCAD1	1-220	pSB191	 pB6	SMARCAD1	1-220	T24A	pSB192	 pB6	SMARCAD1	1-220	S34A	pSB193	 pB6	SMARCAD1	1-220	T54A	pSB194	 pB6	SMARCAD1	1-220	T71A	pSB195	 pB6	SMARCAD1	1-220	T103A	pSB205	 pB6	SMARCAD1	55-274		pSB174	 pB6	SMARCAD1	55-274	T71A	pSB189	 Yiplac211	pGAL-SMARCAD1	1-300-FUN30	30-C-3FLAG	pSB196	 Yiplac211	pGAL-FUN30	30-C-3FLAG	pSB247	 Yiplac211	pGAL-GFP-FUN30	30-C-3FLAG	pSB242	 Yiplac211	pSld3-oSld3-dpb11∆N	pSB206	 pB27	TOPBP1	1-766	pSB197	 pB27	TOPBP1	1-360	K155E	pSB198	 pB27	TOPBP1	1-360	KK154,155AM	pSB199	 pB27	TOPBP1	1-360	K250E	pSB202	 pB27	TOPBP1	1-766	K155E	pSB203	 pB27	TOPBP1	1-766	KK154,155AM	pSB204	 pB27	TOPBP1	1-766	K250E	
pPF345	 pCS2-GFP-SMARCAD1-55-445	pPF348	 pCS2-GFP-SMARCAD1-55-274	pPF351	 pCS2-GFP-SMARCAD1-55-274-T71A		
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The	  DNA	  damage	  checkpoint	  senses	  the	  presence	  of	  DNA	  lesions	  and	  controls	  the	  cellular	  23	  
response	  thereto.	  A	  crucial	  DNA	  damage	  signal	  is	  single-­‐stranded	  DNA	  (ssDNA),	  which	  is	  24	  
frequently	  found	  at	  sites	  of	  DNA	  damage	  and	  recruits	  the	  sensor	  checkpoint	  kinase	  Mec1-­‐25	  
Ddc2.	   	   However,	   how	   this	   signal	   –	   and	   therefore	   the	   cells’	   DNA	   damage	   load	   –	   is	  26	  
quantified,	  is	  poorly	  understood.	  27	  
Here,	  we	  use	   genetic	  manipulation	  of	  DNA	  end	   resection	   at	   a	   site-­‐specific	  DNA	  double-­‐28	  
strand	   break	   (DSB)	   in	   budding	   yeast	   to	   generate	   quantitatively	   different	   DNA	   damage	  29	  
(ssDNA)	   signals.	   Interestingly,	   two	  major	   targets	  of	   the	  Mec1-­‐Ddc2	  kinase	   –	  Rad53	  and	  30	  
γH2A	   –	   differ	   in	   their	   dependency	   on	   the	   ssDNA	   signal,	   indicating	   distinct	   signalling	  31	  
circuits	  within	   the	  checkpoint.	  The	  “local”	  checkpoint	  signalling	  circuit	   leading	   to	  γH2A	  32	  
phosphorylation	  is	  non-­‐quantitative	  and	  unresponsive	  to	  increased	  amounts	  of	  damage-­‐33	  
associated	   Mec1-­‐Ddc2	   kinase.	   In	   contrast,	   the	   “global”	   checkpoint	   signalling	   circuit,	  34	  
which	  triggers	  Rad53	  activation,	  integrates	  the	  ssDNA	  signal	  in	  a	  quantitative	  manner.	  	  35	  
We	   find	   that	   in	   the	   global	   circuit	   not	   only	   Mec1-­‐Ddc2,	   but	   also	   the	   9-­‐1-­‐1	   co-­‐sensor	  36	  
complex	  is	  recruited	  to	  DNA	  damage	  sites	  in	  a	  manner	  that	  correlates	  with	  ssDNA	  signal	  37	  
strength.	  Intriguingly,	  we	  can	  uncouple	  global	  checkpoint	  activation	  from	  the	  amount	  of	  38	  
Mec1-­‐Ddc2	  kinase	  at	  the	  lesion	  by	  using	  mutant	  conditions	  that	  hyper-­‐activate	  the	  9-­‐1-­‐1	  39	  
signalling	  axis	  and	  at	  the	  same	  time	  reduce	  the	  amount	  of	  damage-­‐associated	  Mec1-­‐Ddc2	  40	  
kinase.	   We	   therefore	   propose	   that	   a	   key	   function	   of	   the	   9-­‐1-­‐1	   complex	   and	   the	  41	  
downstream	   checkpoint	   mediators	   is	   to	   generate	   a	   checkpoint	   response,	   which	   is	  42	  
quantitative	  and	  proportional	  to	  the	  cellular	  DNA	  damage	  load.	  	  43	  
	  	  44	  
	   	  45	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Introduction	  46	   	  47	   DNA	  damage	  elicits	  a	  signalling	  response	  termed	  the	  DNA	  damage	  checkpoint.	  Once	  activated,	  48	   the	   checkpoint	   induces	   several	   global	   changes	   to	   cell	   physiology,	   including	   cell	   cycle	   arrest,	  49	   transcriptional	  up-­‐regulation	  of	  DNA	  repair	  genes	  and	  modulation	  of	  DNA	  replication	  pathways	  50	   1-­‐4.	  Furthermore,	  the	  checkpoint	  locally	  controls	  DNA	  repair	  5,6.	  51	   Sensing	   of	   DNA	   damage	   occurs	   by	   so-­‐called	   apical	   or	   sensor	   kinases,	   which	   are	   recruited	   to	  52	   specific	   DNA	   structures	   arising	   at	   DNA	   lesions.	   Budding	   yeast	   has	   two	   apical	   kinases:	   Mec1-­‐53	   Ddc2	   (orthologs	   of	   human	   ATR-­‐ATRIP)	   and	   Tel1	   (ortholog	   of	   human	   ATM).	   Tel1	   recognizes	  54	   DNA	   double	   strand	   breaks	   (DSBs)	   by	   interaction	   with	   the	   DSB-­‐binding	   Mre11-­‐Rad50-­‐Xrs2	  55	   complex	   7-­‐9,	   while	   Mec1-­‐Ddc2	   senses	   the	   presence	   of	   single	   stranded	   DNA	   (ssDNA)	   via	  56	   interaction	   with	   RPA	   10,11.	   ssDNA	   can	   be	   readily	   found	   at	   many	   lesion	   sites	   due	   to	   damage	  57	   processing	   (for	   example	   DNA	   end	   resection)	   or	   stalling	   of	   replication	   forks	   12,13.	   In	   fact,	   in	  58	   budding	   yeast,	   the	   response	   to	   DSBs	   is	   even	   dominated	   by	  Mec1-­‐Ddc2	   due	   to	   high	   resection	  59	   rates	   14.	   Upon	   sensing	   of	   the	   damage	   site,	   the	   apical	   kinases	   trigger	   a	   kinase	   cascade,	   which	  60	   leads	   to	   phosphorylation	   and	   activation	   of	   downstream	   acting	   factors.	   Among	   them	   are	   the	  61	   Rad53	  and	  Chk1	  effector	  kinases,	  which	  mediate	  cell-­‐wide	  responses	  4,15,	  or	  histone	  H2A,	  which	  62	   upon	  phosphorylation	  forms	  the	  γH2A	  mark	  of	  damaged	  chromatin	  16.	  In	  this	  context,	  the	  apical	  63	   checkpoint	  kinases	  face	  two	  tasks.	  On	  the	  one	  hand,	  they	  directly	  phosphorylate	  factors	  in	  the	  64	   vicinity	   of	   the	   lesion	   site	   and	   thereby	   control	   the	   local	   response.	   On	   the	   other	   hand,	   they	  65	   facilitate	   activation	   of	   the	   effector	   kinases,	  which	   after	   activation	  will	   localize	   throughout	   the	  66	   entire	  nucleus	  and	  even	  into	  the	  cytoplasm	  17	  and	  phosphorylate	  checkpoint	  effectors.	  Thereby	  67	   apical	  kinases	  set	  off	  the	  global	  response,	  although	  in	  indirect	  fashion.	  68	   Additionally,	  so-­‐called	  mediators	  are	  required	  for	  checkpoint	  activation.	  Among	  these,	  the	  9-­‐1-­‐1	  69	   complex	   is	   loaded	  at	   the	  boarder	  of	   the	   ssDNA	  region	   (ss-­‐dsDNA	   junction)	  by	   the	  Rad24-­‐RFC	  70	   clamp	  loader	  complex	  in	  a	  manner	  that	  appears	  independent	  of	  Mec1-­‐Ddc2	  association	  17-­‐20.	  The	  71	   9-­‐1-­‐1	  complex	  serves	  as	  a	  platform	  for	  the	  association	  of	  additional	  checkpoint	  mediators	  (the	  72	   9-­‐1-­‐1	  axis),	  such	  as	  Dpb11	  (TOPBP1	  in	  human)	  and	  Rad9	  (53BP1	  in	  human),	  which	  are	  critically	  73	   required	   for	   recruitment,	   phosphorylation	   and	   activation	   of	   the	   effector	   kinase	   Rad53	   21-­‐27.	  74	   Notably,	   the	   checkpoint	   is	   artificially	   activated	   even	   in	   the	   absence	   of	   DNA	   damage,	   if	  Mec1-­‐75	   Ddc2	   and	   the	   9-­‐1-­‐1	   complex	   are	   forced	   to	   colocalize	   on	   chromatin,	   suggesting	   a	   sensor/co-­‐76	   sensor	  relationship	  28.	  77	   It	   is	   logical	   to	   assume	   that	   the	   checkpoint	   not	   only	   qualitatively	   senses	   the	   presence	   of	   DNA	  78	   lesions,	  but	  that	  quantitative	  signalling	  inputs	  are	  utilized	  to	  shape	  the	  cellular	  response	  to	  DNA	  79	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damage.	  A	  highly	  quantitative	  signal	  integration	  is	  necessary,	  given	  the	  abundant	  occurrence	  of	  80	   DNA	  lesions	  (with	  estimates	  ranging	  to	  up	  to	  100,000	  lesions	  per	  day	  in	  a	  human	  cell,	  29,30).	  Most	  81	   likely,	  cells	  are	  never	  entirely	  free	  of	  DNA	  lesions	  and	  thus	  require	  a	  dose-­‐dependent	  response	  82	   with	   a	   defined	   threshold	   of	   a	   tolerable	   DNA	   damage	   load.	   However,	   we	   do	   currently	   not	  83	   understand	  how	  DNA	  damage	  signals	  are	  quantified.	  84	   Here,	  we	   investigate	  how	  the	  checkpoint	  quantifies	   the	  ssDNA	  signal	  at	  DNA	  damage	  sites.	  To	  85	   this	  end	  we	  utilized	  a	  system	  of	  an	  enzyme-­‐induced	  DSB	  in	  budding	  yeast	  31,	  which	  allowed	  us	  86	   to	  manipulate	  the	  amount	  of	  ssDNA	  formed	  at	  a	  DSB	  using	  genetic	  manipulation	  of	  the	  DNA	  end	  87	   resection	  process.	   Intriguingly,	  we	   find	   that	   specific	   checkpoint	   targets	   respond	  differently	   to	  88	   quantitatively	   different	   ssDNA	   signals.	   Local	   γH2A	   phosphorylation	   appears	   unresponsive	   to	  89	   changes	   in	   the	   ssDNA	   signal,	   while	   activation	   of	   the	   Rad53	   effector	   kinase	   responds	   very	  90	   strongly	  to	  changes	  in	  the	  ssDNA	  signal.	  Quantitative	  signal	  transduction	  appears	  to	  depend	  on	  91	   at	  least	  to	  factors,	  as	  we	  observe	  that	  association	  not	  only	  of	  the	  Mec1-­‐Ddc2	  kinase	  but	  also	  of	  92	   the	  9-­‐1-­‐1	  complex	  and	  its	  downstream	  factors	  correlate	  with	  the	  ssDNA	  signal.	  Notably,	  we	  find	  93	   that	  artificial	  hyper-­‐activation	  of	  the	  9-­‐1-­‐1	  axis	  triggers	  hyper-­‐activation	  of	  the	  Rad53	  effector	  94	   kinase.	   This	   occurs	   even	  under	   conditions	   of	   reduced	  Mec1-­‐Ddc2	   association,	   suggesting	   that	  95	   the	  9-­‐1-­‐1	  complex	  acts	  as	  a	  quantitative	  sensor	  of	  the	  ssDNA	  signal.	  	  96	   	  97	  
Results	  98	   	  99	   Single-­‐stranded	  DNA	  is	  a	  universal	  DNA	  damage	  signal	  1-­‐3.	  To	  investigate	  how	  the	  ssDNA	  signal	  100	   is	  quantified,	  we	  studied	  the	  checkpoint	  response	  to	  a	  single	  site-­‐specific	  DSB.	  At	  DSBs,	  3’	  ssDNA	  101	   is	   generated	   by	   DNA	   end	   resection,	   a	   processive,	   nucleolytic	   digestion	   of	   the	   5’	   strand	   32.	  102	   Formation	   of	   ssDNA	   therefore	   is	   an	   active	   process,	  which	   allows	   genetic	  manipulation	   of	   the	  103	   ssDNA	   signal	   using	   DNA	   end	   resection	  mutants.	   In	   order	   to	   induce	   a	   site-­‐specific	   DSB	   at	   the	  104	   MAT	   locus,	   we	   used	   galactose-­‐induced	   expression	   of	   the	   HO-­‐endonuclease	   31.	   In	   M	   phase	  105	   arrested	  cells,	  DSB	  induction	  resulted	  in	  processive	  DNA	  end	  resection	  that	  reached	  up	  to	  20	  kb	  106	   distal	   of	   the	  DSB	   in	   a	  4h	   timecourse,	   as	   visualized	  by	  ChIP	   against	  RPA	   (Fig.	   1A).	   In	   contrast,	  107	  
exo1Δ	  sgs1Δ	  cells	  deficient	   in	   long-­‐range	  resection	  restricted	  ssDNA	  formation	  to	  less	  than	  1.5	  108	   kb	  (Fig.	  1A,	  see	  also	  33-­‐35).	  Mec1-­‐Ddc2	  directly	  interacts	  with	  RPA	  10.	  Consistently,	  in	  exo1Δ	  sgs1Δ	  109	   cells	   Mec1-­‐Ddc2	   association	  with	   the	   DNA	   damage	   site	   was	   strongly	   reduced	   and	   correlated	  110	   with	  the	  amount	  of	  the	  ssDNA	  signal	  (Fig.	  1A).	  Due	  to	  its	  direct	  interaction	  with	  RPA	  10,	  Mec1-­‐111	   Ddc2	   was	   our	   best	   candidate	   for	   a	   quantitative	   sensor	   of	   the	   ssDNA	   signal.	   Therefore,	   we	  112	   expected	   the	   checkpoint	   response	   to	   be	   diminished	   in	   resection-­‐defective	   exo1Δ	   sgs1Δ	   cells.	  113	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Indeed,	  exo1Δ	  sgs1Δ	  cells	  were	  unable	  to	  phosphorylate	  and	  activate	  the	  Rad53	  effector	  kinase	  114	   over	  the	  time	  course	  of	  our	  experiment	  (Fig.	  1B,	  see	  also	  35,36).	   In	  contrast,	  when	  we	  looked	  at	  115	   another	  Mec1-­‐Ddc2	  phosphorylation	  target	  -­‐	  histone	  H2A	  -­‐	  using	  ChIP	  with	  an	  antibody	  specific	  116	   for	  the	  γH2A	  mark,	  we	  surprisingly	  observed	  highly	  similar	  induction	  of	  γH2A	  phosphorylation	  117	   in	  WT	   and	   exo1Δ	   sgs1Δ	   cells	   (Fig.	   1A).	   This	   suggests	   that	   γH2A	   phosphorylation	   is	   neither	  118	   quantitatively	   responding	   to	   the	   amount	   of	   ssDNA	   signal	   (in	   the	   range	   tested),	   nor	   to	   the	  119	   amount	  of	  damage-­‐associated	  Mec1-­‐Ddc2.	  120	   The	  only	  differences	  in	  γH2A	  formation	  were	  observed	  close	  to	  the	  DSB	  (up	  to	  7.6	  kb	  for	  the	  4h	  121	   timepoint,	  Fig	  1A),	  where	  the	  γH2A	  ChIP	  signal	  was	  consistently	  lower	  in	  WT	  than	  exo1Δ	  sgs1Δ	  122	   cells.	  Given	  that	  RPA	  and	  γH2A	  ChIP	  signals	  appear	  anti-­‐correlated	  (see	  Fig.	  S1A	  for	  an	  overlay),	  123	   we	  suggest	  that	  this	  reduction	  in	  the	  γH2A	  signal	  occurs	  due	  to	  loss	  of	  histones	  on	  resected	  DNA.	  124	   Otherwise,	   the	   γH2A	  ChIP	   signals	   (50-­‐100	  kb	  of	  DNA	   to	   both	   sides	   of	   the	  DSB	  on	   the	  broken	  125	   chromosome)	  were	  remarkably	  similar	   in	  WT	  and	  exo1Δ	  sgs1Δ,	  also	  when	  we	  measured	  γH2A	  126	   distribution	  using	  either	  ChIP-­‐qPCR	  (Fig,	  S1B)	  or	  over	   the	  entire	  damaged	  chromosome	  using	  127	   ChIP-­‐seq	  methodology	  (Fig.	  1C,	  Fig.	  S1C-­‐E).	  We	  also	  found	  this	  robustness	  of	  γH2A	  distribution	  128	   to	  be	  independent	  of	  the	  availability	  of	  a	  donor	  template	  for	  repair	  (Fig.	  S2A).	  129	   To	   ensure	   that	   the	   observed	   effects	  were	  not	   influenced	  by	   the	  mutant	   background	  used,	  we	  130	   employed	  cell	  cycle	  arrest	  as	  an	  alternative	  means	  to	  manipulate	  the	  ssDNA	  signal.	  Consistent	  131	   with	   DNA	   end	   resection	   being	   highly	   cell	   cycle-­‐regulated,	  we	   observed	   very	   little	   RPA	   at	   the	  132	   DNA	  damage	  site	  in	  WT	  cells	  that	  were	  arrested	  in	  G1	  consistent	  with	  a	  strongly	  reduced	  ssDNA	  133	   signal	  (Fig.	  1D).	  Accordingly,	  Mec1-­‐Ddc2	  association	  and	  Rad53	  activation	  were	  impaired	  in	  G1-­‐134	   arrested	   cells,	   as	   has	   been	   observed	   before	   (Fig.	   1D-­‐E,	   37).	   In	   contrast,	   γH2A	  phosphorylation	  135	   was	   induced	   to	   similar	   extent	   in	   G1	   and	   M	   arrested	   cells	   (Fig.	   1D),	   suggesting	   that	   γH2A	  136	   phosphorylation	  is	  unresponsive	  to	  changes	  of	  the	  strength	  of	  the	  ssDNA	  signal	  and	  the	  amount	  137	   of	  Mec1-­‐Ddc2	  associated	  with	  the	  DNA	  lesion	  during	  the	  cell	  cycle.	  We	  also	  find	  a	  very	  similar	  138	   pattern	  of	  γH2A	  phosphorylation,	  when	  a	  DSB	  is	   introduced	  at	  another	  genomic	   location	  (Chr.	  139	   VI,	   close	   to	   ARS607,	   Fig.	   S2B).	   Moreover,	   we	   see	   a	   damage-­‐dependent,	   but	   ssDNA	   signal-­‐140	   unresponsive	   association	   of	   Rtt107	   (Fig,	   S2C),	   which	   serves	   as	   a	   proxy	   for	   γH2A	  141	   phosphorylation,	  as	  it	  directly	  binds	  to	  the	  γH2A	  mark	  38.	  	  	  142	   Finally,	  we	  manipulated	  DNA	  end	  resection	  using	  mutants	   in	   the	  resection	  agonist	  Fun30	  and	  143	   the	  resection	  antagonist	  Rad9	  39-­‐43.	  Fun30	  and	  Rad9	  are	  recruited	  in	  a	  manner	  that	  depends	  on	  144	   interaction	   with	   Dpb11-­‐Ddc1	   22,39,44,	   and	   we	   have	   previously	   shown	   that	   covalent	   protein	  145	   fusions	  with	  Dpb11	  or	  Ddc1	  can	  be	  used	  to	  artificially	  target	  Rad9	  or	  Fun30	  to	  DSBs	  and	  hyper-­‐146	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activate	   their	   respective	   function	   as	   resection	   regulators	   39,45.	   We	   find	   that	   the	   Ddc1-­‐Fun30	  147	   fusion	  hyper-­‐activated	  DNA	  end	  resection	  similar	   to	  a	  RAD9	  deletion,	  whereas	   the	  Ddc1-­‐Rad9	  148	   fusion	  blocked	  resection	  to	  an	  even	  greater	  extent	  than	  a	  FUN30	  deletion	  (Fig.	  1F,G).	  However,	  149	   the	  damage-­‐induced	  formation	  of	  γH2A	  was	  unchanged	  in	  these	  mutants	  (Fig.	  1F,G).	  150	   Previous	  studies	  have	  shown	  that	  Mec1-­‐Ddc2,	  and	  apical	  checkpoint	  kinases	  in	  general,	  have	  a	  151	   dual	   function	   in	   the	   local	   response	   at	   the	   lesion	   site	   and	   in	   the	   global,	   cell-­‐wide	   response	   via	  152	   activation	  of	  the	  effector	  kinases	  4,15.	  Our	  data	  collectively	  show	  that	  the	  two	  best-­‐characterized	  153	   outputs	   of	   these	   responses,	   phosphorylated	   Rad53	   and	   γH2A,	   have	   fundamentally	   different	  154	   dependencies	  on	   the	   strength	  of	   the	   ssDNA	  signal.	  We	  hypothesize	   that	   the	   signalling	   circuits	  155	   leading	  to	  phosphorylation	  of	  Rad53	  and	  to	  phosphorylation	  of	  H2A	  are	  different	  (see	  Fig.	  S3	  for	  156	   a	   model).	   We	   will	   refer	   to	   the	   circuit	   leading	   to	   γH2A	   phosphorylation	   as	   local	   checkpoint	  157	   circuit,	   since	   it	   is	   involved	   in	   controlling	   local	   action	   of	   repair	   factors.	   The	   circuit	   leading	   to	  158	   Rad53	  phosphorylation	  we	  will	  refer	  to	  as	  global	  checkpoint	  circuit,	  as	  it	  controls	  the	  cell-­‐wide	  159	   checkpoint	  response.	  Notably,	  our	  data	  indicate	  that	  already	  minimal	  ssDNA	  signals	  are	  able	  to	  160	   elicit	   a	   full-­‐blown	   local	   response	   that	   does	   not	   appear	   to	   correlate	   with	   the	   strength	   of	   the	  161	   ssDNA	  signal.	  In	  contrast,	  the	  global	  response	  appears	  to	  feature	  a	  dose-­‐dependent	  relation	  with	  162	   the	  ssDNA	  signal.	  	  163	   Given	  that	  signalling	  in	  the	  local	  checkpoint	  circuit	  appeared	  to	  occur	  independent	  of	  DNA	  end	  164	   resection	   and	   the	   ssDNA	   signal,	   we	   tested	   other	   factors	   that	   might	   quantitatively	   determine	  165	  
γH2A	  phosphorylation.	  First,	  we	  tested	  whether	  H2A	  phosphorylation	  sites	  adjacent	  to	  the	  DSB	  166	   were	   saturated.	   We	   noted	   that	   the	   γH2A	   ChIP	   signal	   increased	   over	   the	   timepoints	   of	   our	  167	   experiments	   (Fig.	  1A,	  1D,	  2A),	   strongly	  arguing	  against	  saturation.	  Additionally,	  we	  addressed	  168	   saturation	  by	  reducing	  the	  density	  of	  H2A	  phosphorylation	  sites	  on	  chromatin.	  We	  made	  use	  of	  169	   the	  fact	  that	  H2A	  is	  expressed	  from	  two	  gene	  copies	  (HTA1	  and	  HTA2)	  in	  budding	  yeast	  and	  that	  170	   both	  copies	  contribute	  similarly	  to	  the	  pool	  of	  H2A	  protein	  (1/3	  and	  2/3,	  46).	  By	  introducing	  the	  171	  
S129STOP	   mutation	   in	   either	   HTA1	   or	   HTA2	   we	   therefore	   reduced	   the	   amount	   of	   H2A	  172	   phosphorylation	  sites	  on	  chromatin	  accordingly.	  Yet,	  γH2A	  phosphorylation	  after	  DSB	  induction	  173	   was	   highly	   similar	   in	  WT,	   hta1-­‐S129STOP	   and	   hta2-­‐S129STOP	   cells	   (Fig.	   2A),	   suggesting	   that	  174	   phosphorylation	  sites	  are	  not	  limiting.	  175	   Second,	   we	   tested	   the	   possibility	   that	   the	   two	   sensor	   kinases	   Mec1-­‐Ddc2	   and	   Tel1	   might	  176	   differentially	   contribute	   to	   γH2A	   phosphorylation	   in	   resection-­‐proficient	   and	   –deficient	  177	   conditions.	   A	   resection-­‐dependent	   switch	   from	   Tel1	   to	  Mec1-­‐Ddc2	   is	  well-­‐documented	   16,17,47	  178	   and	   Tel1	   activity	   might	   compensate	   for	   Mec1-­‐Ddc2	   in	   absence	   of	   resection.	   In	   contrast,	   we	  179	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observed	   that	   the	   overall	   γH2A	   ChIP	   signal	   after	   DSB	   induction	  was	   unchanged	   in	   tel1Δ	   and	  180	  
tel1Δ	  exo1Δ	  sgs1Δ	  cells,	  with	  the	  exception	  of	  the	  region	  closest	  to	  the	  break,	  which	  is	  directly	  181	   affected	  by	  histone	  loss	  due	  to	  resection	  (Fig.	  2A).	  Furthermore,	  we	  observed	  only	  a	  minor	  role	  182	   for	   Tel1	   in	   γH2A	  phosphorylation	   in	   response	   to	   phleomycin-­‐induced	  DNA	  breaks	   (Fig.	   S4A).	  183	   However,	  the	  γH2A	  phosphorylation	  signal	  in	  ChIP	  was	  largely	  abolished	  in	  the	  absence	  of	  Mec1	  184	   (Fig.	  S4B;	  this	  includes	  basal	  levels	  of	  γH2A	  phosphorylation	  without	  DSB	  induction,	  Fig.	  S4C).	  185	   Lastly,	   we	   tested	   whether	   any	   of	   the	   established	   Mec1	   activators	   22,25,26,48,49	   was	   involved	   in	  186	  
γH2A	  phosphorylation	  and	  may	   influence	   the	  γH2A	  ChIP	  signal.	  We	  used	  a	  dna2-­‐WYAA	  ddc1Δ	  187	   strain	  to	  abolish	  Mec1	  activation	  by	  either	  Dpb11,	  Ddc1	  or	  Dna2.	  In	  these	  cells	  Ddc1	  is	  absent,	  188	   Dpb11	  fails	  to	  be	  recruited	  to	  DSBs	  and	  Dna2	  cannot	  interact	  with	  Mec1-­‐Ddc2	  21,49,50.	  However,	  189	   while	  we	   observed	   a	   slight	   reduction	   in	  DNA	   end	   resection,	   the	   γH2A	  phosphorylation	   signal	  190	   after	  DSB	  induction	  was	  not	  influenced	  (Fig.	  2C).	  Consistently,	  we	  observed	  normal	  phleomycin-­‐191	   induced	  γH2A	  phosphorylation	  in	  ddc1Δ,	  dpb11ΔC	  and	  dna2-­‐WYAA	  cells	  even	  in	  absence	  of	  Tel1	  192	   (Fig.	  S4D),	  indicating	  that	  γH2A	  phosphorylation	  is	  independent	  of	  the	  known	  Mec1	  activators.	  	  193	   Overall,	   our	   data	   are	   consistent	   with	   a	   model	   in	   which	   limited	   amounts	   of	   Mec1-­‐Ddc2	   are	  194	   sufficient	   to	   facilitate	   efficient	   γH2A	   phosphorylation	   and	   γH2A	   phosphorylation	   occurs	  195	   independent	  of	   additional	   activators	  or	   checkpoint	  mediators.	  We	   furthermore	  note	   that	  H2A	  196	   and	  Mec1-­‐Ddc2	   (Fig.	  1A)	  are	  anchored	  at	   specific	   locations	  within	   the	  damaged	  chromosome.	  197	   Thereby,	   enzyme	   substrate	   encounters	   will	   be	   dependent	   on	   chromosome	   architecture	   and	  198	   perhaps	  mobility	  of	  these	  locations	  51-­‐56,	  which	  may	  pose	  a	  bottleneck	  to	  γH2A	  phosphorylation.	  199	   Mec1-­‐Ddc2	   association	   with	   the	   damaged	   chromosome	   mirrored	   the	   ssDNA	   signal	   and	  200	   correlated	  with	  Rad53	  phosphorylation	  (Fig.	  1A,B).	  Thus,	  Mec1-­‐Ddc2	  levels	  at	  the	  DSB	  correlate	  201	   with	  signalling	  in	  the	  global	  checkpoint	  circuit.	  Given	  our	  results	  on	  γH2A	  phosphorylation,	  we	  202	   questioned	  whether	  other	  factors	  may	  contribute	  to	  the	  quantitative	  transduction	  of	  the	  ssDNA	  203	   signal	   in	   the	  global	  checkpoint	  circuit.	  Notably,	  Rad53	  phosphorylation	   in	  response	  to	  DSBs	   is	  204	   dependent	   on	   additional	   checkpoint	   proteins,	   namely	   the	   9-­‐1-­‐1	   complex	   (consisting	   of	   Ddc1,	  205	   Mec3	   and	   Rad17	   in	   budding	   yeast)	   and	   the	   scaffold	   proteins	   Dpb11	   and	   Rad9.	   For	   each	   we	  206	   tested	   localization	   to	   the	   DSB	   by	   ChIP	   and	   found	   that	   in	   exo1Δ	   sgs1Δ	   cells,	   localization	   of	   all	  207	   three	  factors	  was	  restricted	  to	  the	  resected	  DSB	  end	  and	  was	  overall	  reduced	  (Fig.	  3A).	  Also	  in	  208	   resection-­‐deficient	  G1	  cells	  we	  observed	  a	  reduction	  of	  DSB	  recruitment	   for	   the	  9-­‐1-­‐1	  subunit	  209	   Ddc1	  and	  Dpb11	  (Fig.	  S5A).	  These	  data	  show	  that	  the	  DSB	  association	  of	  checkpoint	  mediators	  210	   is	  influenced	  by	  the	  amount	  of	  ssDNA	  and	  resection.	  	  211	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We	  therefore	  reasoned	  that	  the	  9-­‐1-­‐1	  axis	  could	  be	  involved	  in	  the	  quantitative	  transduction	  of	  212	   the	  ssDNA	  signal.	  Previous	  data	  suggested	  that	  of	  all	  checkpoint	  mediators,	  the	  9-­‐1-­‐1	  complex	  is	  213	   furthest	  upstream	  17,21,22,50.	  Our	  data	  are	  in	  agreement	  with	  this	  model,	  since	  we	  observed	  a	  loss	  214	   of	  the	  DSB	  association	  for	  Dpb11	  or	  Rad9	  in	  ddc1-­‐T602A	  cells	  (Fig.	  3B).	  	  215	   We	   therefore	   followed	   the	   hypothesis	   that	   9-­‐1-­‐1	   acts	   as	   a	   quantitative	   sensor	   of	   the	   ssDNA	  216	   signal	  and	  tested	  DSB	  association	  of	  the	  9-­‐1-­‐1	  complex	  in	  single	  cells.	  In	  case	  of	  an	  HO-­‐induced	  217	   DSB	  we	  could	  follow	  the	  association	  of	  proteins	  with	  the	  DSB	  as	  the	  appearance	  of	  a	  single,	  HO-­‐218	   dependent	   focus.	   (Fig.	   3D,	   S5B,	   see	   also	   17,20,57,58).	   In	  M	   phase-­‐arrested	   cells,	   we	   observed	   an	  219	   increase	  in	  the	  number	  of	  cells	  containing	  an	  RPA	  focus	  (Rfa1-­‐CFP)	  over	  time	  (>50%,	  4h	  after	  220	   HO	  induction).	  In	  contrast,	  in	  a	  G1	  arrest	  much	  fewer	  cells	  showed	  an	  RPA	  focus	  (<12%,	  4h	  after	  221	   HO	   induction),	   suggesting	   that	   already	   the	   presence	   of	   an	   RPA	   focus	   is	   a	   good	   indicator	   of	  222	   whether	  cells	  engage	  in	  DNA	  end	  resection	  (Fig.	  3E,	  S5C).	  Interestingly,	  the	  large	  majority	  of	  M	  223	   phase	  cells	  with	  an	  RPA	  focus	  contained	  a	  colocalizing	  9-­‐1-­‐1	  focus,	  supporting	  the	  idea	  that	  the	  224	   9-­‐1-­‐1	   complex	  may	   localize	   to	   ssDNA	  and	   act	   as	   an	   ssDNA	   sensor.	   To	  determine	  quantitative	  225	   association	  we	  measured	  the	  fluorescence	  intensity	  of	  colocalizing	  Rfa1-­‐CFP	  and	  Ddc1-­‐YFP	  foci	  226	   as	  an	  indicator	  of	  the	  number	  of	  recruited	  protein	  molecules.	  Notably,	  we	  find	  that	  HO-­‐induced	  227	   foci	  accumulate	  Ddc1-­‐YFP	  over	  time	  in	  M	  phase,	  as	  they	  do	  for	  RPA	  (Fig.	  3F).	  Futhermore,	  we	  228	   find	   a	   correlation	   (R2	   =	   0.37)	   between	   the	   number	   of	   DSB-­‐recruited	   9-­‐1-­‐1	   and	   RPA	   4h	   after	  229	   induction	   of	   resection	   (Fig.	   3G),	   suggesting	   that	   the	   ssDNA	   signal	   translates	   into	   quantitative	  230	   association	  not	  only	  of	  RPA	  and	  Mec1-­‐Ddc2,	  but	  also	  of	  9-­‐1-­‐1.	  We	  also	  note	  that	  the	  abundance	  231	   of	  DSB-­‐associated	  9-­‐1-­‐1	  complexes	  and	  RPA	  differs	  by	  at	   least	  an	  order	  of	  magnitude	  (Fig.	  3F,	  232	   S5D).	   The	   DSB	   foci	   contain	   between	   300-­‐2000	   molecules	   of	   RPA	   4h	   after	   DSB	   induction,	  233	   consistent	  with	   resection	   rates	   of	   4-­‐5	   kb/h	   33	   and	   an	  RPA	   footprint	   of	   20/30	  bases	   59.	   At	   the	  234	   same	  time,	  they	  accumulate	  fewer	  than	  30	  9-­‐1-­‐1	  molecules	  (Fig.	  3F,	  S5D).	  Overall,	  we	  conclude	  235	   that	  resecting	  DSBs	  accumulate	  proportional	  amounts	  of	  ssDNA-­‐bound	  RPA	  (and	  by	   inference	  236	   Mec1-­‐Ddc2)	  and	  9-­‐1-­‐1	  complexes	  over	   time,	  suggesting	  that	  cells	  may	  combine	  both	  pieces	  of	  237	   information	  to	  accordingly	  shape	  the	  global	  checkpoint	  response.	  	  	  	  238	   Our	   data	   thus	   indicates	   that	   not	   only	   Mec1-­‐Ddc2,	   but	   also	   the	   9-­‐1-­‐1	   complex	   and	   its	  239	   downstream	  factors	  (the	  9-­‐1-­‐1	  axis)	  associate	  with	  DSBs	   in	  a	  manner	   that	  correlates	  with	   the	  240	   ssDNA	  signal.	  We	  wanted	  to	  test	  whether	  the	  9-­‐1-­‐1	  complex	  contributes	  to	  transduction	  of	  the	  241	   ssDNA	  signal	   in	  a	  quantitative	  manner.	  Therefore,	  we	  enhanced	  9-­‐1-­‐1-­‐dependent	  signalling	  by	  242	   expressing	  a	   covalent	   fusion	  of	   the	  9-­‐1-­‐1	  complex	   to	   its	  downstream	   factor	  Rad9	   (Ddc1-­‐Rad9	  243	   fusion).	  These	  cells	  showed	  markedly	  enhanced	  Rad9	  recruitment	  to	  the	  DSB	  compared	  to	  WT	  244	   cells	  (Fig.	  4A).	  Moreover,	  resection	  was	  blocked	  and	  consequently	  also	  Ddc2-­‐Mec1	  recruitment,	  245	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consistent	   with	   the	   role	   of	   Rad9	   as	   resection	   inhibitor	   (Fig.	   1F-­‐G,	   Fig.	   4A).	   Intriguingly,	   and	  246	   despite	  the	  decrease	  of	  the	  ssDNA	  signal	  and	  concomitant	  decrease	  in	  Mec1-­‐Ddc2	  recruitment,	  247	   global	  checkpoint	  signalling	  as	  determined	  by	  Rad53	  phosphorylation	  was	  hyper-­‐activated	  (Fig.	  248	   4B).	  Thus,	  mutant	  conditions,	  which	  show	  enhanced	  9-­‐1-­‐1	  signalling	  and	  decreased	  Mec1-­‐Ddc2	  249	   DSB	   recruitment	   hyper-­‐activate	   the	   global	   checkpoint,	   suggesting	   that	   loading	   of	   the	   9-­‐1-­‐1	  250	   complex	   and	   signalling	   along	   the	   9-­‐1-­‐1	   axis	   quantitatively	   contribute	   to	   global	   checkpoint	  251	   signalling.	  	  252	   The	   Ddc1-­‐Rad9	   fusion	   bypasses	   the	   phosphorylation	   of	   the	   9-­‐1-­‐1	   complex	   by	   Mec1-­‐Ddc2.	  253	   Therefore,	   we	   utilized	   a	   second	   construct,	   in	   which	   Rad9	   is	   fused	   to	   Dpb11	   (Rad9-­‐dpb11∆N	  254	   fusion,	   22,45)	   and	  which	   is	   at	   least	  partly	  dependent	  on	  9-­‐1-­‐1/Ddc1	  phosphorylation	  by	  Mec1-­‐255	   Ddc2	  (Fig.	  S6A).	  	  Cells	  expressing	  this	  fusion	  protein	  showed	  a	  remarkably	  similar	  phenotype	  as	  256	   the	  Ddc1-­‐Rad9	   fusion	  mutant.	   Rad9	   recruitment	   to	   the	  DSB	  was	   increased,	  while	  Mec1-­‐Ddc2	  257	   recruitment	   and	  DNA	  end	   resection	  were	  decreased.	   Importantly,	   however,	   global	   checkpoint	  258	   signalling	   was	   hyper-­‐activated	   (Fig.	   1F-­‐G,	   Fig.	   4C-­‐D).	   In	   summary,	   we	   discovered	   synthetic	  259	   conditions	   that	   boost	   signalling	   specifically	   in	   the	   9-­‐1-­‐1	   axis.	   These	   conditions	   lead	   to	   hyper-­‐260	   activated	   global	   checkpoint	   signalling	   despite	   decreased	   recruitment	   of	   Mec1-­‐Ddc2.	   This	  261	   establishes	  the	  9-­‐1-­‐1	  complex	  as	  a	  quantitative	  sensor	  of	  the	  ssDNA	  signal,	  which	  appears	  to	  be	  262	   limiting	  for	  Rad53	  activation	  and	  signalling	  in	  the	  global	  checkpoint	  circuit.	  263	   	  264	  
	   	  265	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Discussion	  266	   	  267	   DNA	   damage	   checkpoint	   signalling	   involves	   a	   two-­‐layered	   control	   in	   the	   form	   of	   apical	   and	  268	   effector	  kinases.	  Interestingly,	  the	  apical	  kinases	  do	  not	  only	  transduce	  the	  checkpoint	  signal	  to	  269	   the	  effector	  kinases,	  but	  phosphorylate	  checkpoint	   targets	  on	   their	  own.	  Targets	  of	  apical	  and	  270	   effector	  kinases	  can	  be	  distinguished	  by	  their	  localization.	  Apical	  kinase	  targets	  such	  as	  histone	  271	   H2A	  act	  locally	  on	  the	  damaged	  chromosome	  and	  can	  be	  visualized	  as	  a	  focus	  surrounding	  the	  272	   site	  of	  the	  DNA	  damage	  16.	  The	  effector	  kinases	  in	  contrast	  act	  cell-­‐wide	  after	  a	  local	  activation	  273	   step	   4,17,60.	  Our	   study	  demonstrates	  a	   second	   fundamental	  difference,	   as	  we	   find	   that	   the	  DNA	  274	   damage	   signal	   (single-­‐stranded	  DNA)	   is	   quantified	  differentially	   in	   the	   two	   signalling	   circuits.	  275	   The	   “local”	   checkpoint	   circuit	   leading	   to	   γH2A	   phosphorylation	   is	   hypersensitive	   and	   already	  276	   fully	  active	  at	  low	  (<1.5	  kb)	  ssDNA	  signals.	  In	  contrast,	  the	  “global”	  checkpoint	  circuit	  leading	  to	  277	   phosphorylation	  and	  activation	  of	  the	  Rad53	  effector	  kinase	  is	  able	  to	  quantitatively	  respond	  to	  278	   a	  broad	  range	  of	  ssDNA	  signals	  and	  at	  even	  	  >20	  kb	  of	  ssDNA	  is	  not	  fully	  active.	  	  279	   Our	  data	   is	   thus	  consistent	  with	  a	  model,	   in	  which	  the	  DNA	  damage	  checkpoint	   is	  not	  a	  single	  280	   pathway,	   but	   rather	   an	   amalgamation	   of	   at	   least	   two	   distinct	   signalling	   circuits	   that	   can	   be	  281	   discriminated	  by	  their	  ability	  to	  quantify	  DNA	  damage	  (Fig.	  S3).	  It	  seems	  plausible	  that	  the	  local	  282	   checkpoint	  response	  needs	  to	  be	  sensitive	  to	  the	  presence	  of	  DNA	  damage	  in	  order	  to	  steer	  local	  283	   DNA	  repair,	  but	  not	  necessarily	  needs	   to	   integrate	   the	  DNA	  damage	  signal	  quantitatively.	  The	  284	   global	   checkpoint	   response	   in	   contrast	   needs	   to	   accurately	   quantify	   the	   cellular	  DNA	  damage	  285	   load	  in	  order	  to	  control	  cell-­‐wide	  processes,	  such	  as	  cell	  cycle	  progression	  or	  DNA	  replication.	  286	   For	   the	   local	   circuit	   we	   find	   that	   γH2A	   phosphorylation	   sites	   are	   not	   saturated	   under	   our	  287	   experimental	  conditions	  (Fig.	  2A),	  suggesting	  that	  a	  bottleneck	  is	  limiting	  H2A	  phosphorylation,	  288	   which	   is	   neither	   the	   amount	   of	   damage-­‐associated	   kinase,	   nor	   the	   availability	   of	  289	   phosphorylation	  sites.	  We	   furthermore	   ruled	  out	   that	   this	  bottleneck	  may	  be	  posed	  by	  any	  of	  290	   the	   known	  Mec1	   activators.	   One	   possibility	   is	   that	   this	   bottleneck	   is	   formed	   by	   chromosome	  291	   architecture	  and	  mobility.	  Given	  that	  substrate	  and	  kinase	  are	  tethered	  to	  specific	  chromosomal	  292	   locations,	   chromosome	   mobility	   may	   contribute	   to	   the	   frequency	   of	   substrate-­‐kinase-­‐293	   encounters	  52-­‐56.	  However,	  mutants	  known	  to	  markedly	  decrease	  chromosome	  mobility	  such	  as	  294	   the	  RAD9	   deletion	  mutant	   53	   do	   not	   impact	   on	   the	   γH2A	  phosphorylation	   in	   our	   experiments	  295	   (Fig.	  1F	  and	  G).	  In	  an	  alternative	  model,	  active	  Mec1-­‐Ddc2	  molecules	  are	  not	  strictly	  tethered	  to	  296	   the	   ssDNA	   stretch	   and	   can	   target	   substrates	   within	   a	   certain	   diffusion	   range.	   In	   this	   case,	  297	   chromosome	  architecture,	  but	  not	  necessarily	  mobility	  will	  impact	  on	  the	  spreading	  of	  γH2A.	  In	  298	   fact,	   data	   from	   mammalian	   cells	   point	   towards	   restriction	   of	   the	   γH2A	   signal	   within	  299	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topologically	   associated	   domains	   51.	  We	   suggest	   therefore	   that	   chromosome	   architecture	   and	  300	   perhaps	  mobility	  could	   influence	  how	   far	   the	  γH2A	  damage	  mark	  spreads	   into	  chromatin	  and	  301	   could	  as	  such	  shape	  the	  response	  quantitatively.	  	  	  302	   The	   global	   signalling	   circuit	   leading	   to	   the	   activation	   of	   the	   Rad53	   effector	   kinase	   is	   more	  303	   complex.	   Most	   critically,	   it	   involves	   so-­‐called	   mediator	   proteins	   (9-­‐1-­‐1	   complex,	   Dpb11	   and	  304	   Rad9;	   9-­‐1-­‐1	   signalling	   axis),	   which	   facilitate	   signal	   transduction	   to	   the	   effector	   kinase.	  305	   Importantly,	  DNA	  damage	  recruitment	  of	  Mec1-­‐Ddc2	  and	  the	  9-­‐1-­‐1	  complex	  occur	  by	  separate	  306	   mechanisms	   10,19,20,28.	   Therefore,	   the	   global	   DNA	   damage	   signalling	   circuit	   relies	   on	   two	  307	   independent	  DNA	  damage	   sensors	   20,28.	   Qualitatively,	   the	   involvement	   of	   two	   sensors	   (sensor	  308	   and	  co-­‐sensor,	  respectively)	  provides	  for	  a	  fail-­‐safe	  mechanism.	  Our	  data	  suggest,	  however,	  that	  309	   additionally	  the	  involvement	  of	  two	  sensors	  is	  critical	  to	  quantify	  the	  ssDNA	  signal	  and	  to	  yield	  a	  310	   proportional	  response.	  311	   How	  can	  it	  be	  envisioned	  that	  the	  9-­‐1-­‐1	  complex	  quantitatively	  senses	  the	  ssDNA	  signal?	  First	  of	  312	   all,	   formation	  of	  a	  DSB-­‐associated	  9-­‐1-­‐1	   focus	  was	  shown	  to	  depend	  on	  RPA	  17.	  Our	  ChIP	  data	  313	   suggest	   that	   the	  9-­‐1-­‐1	  complex	  associates	  –	  possibly	   in	   its	   loaded,	  DNA	  encircling	   form	  –	  with	  314	   the	   area	   of	   resection,	   where	   it	   colocalizes	   with	   RPA.	   This	   suggests	   that	   the	   9-­‐1-­‐1	   encircles	  315	   ssDNA.	   It	   is	   possible	   that	   9-­‐1-­‐1	   is	   loaded	   on	   ssDNA,	   perhaps	   guided	   by	   a	   strong	   interaction	  316	   between	   RPA	   and	   the	   Rad24-­‐RFC	   clamp	   loader	   complex	   61,	   at	   discontinuities	   in	   the	   RPA	  317	   filament.	   However,	   biochemical	   studies	   rather	   suggest	   that	   9-­‐1-­‐1	   is	   loaded	   at	   5’	   ss-­‐dsDNA	  318	   junctions,	  the	  leading	  edge	  of	  DNA	  end	  resection	  18,19.	  It	  is	  currently	  unclear,	  how	  9-­‐1-­‐1	  loading	  319	   at	   the	   5’	   ss-­‐dsDNA	   junction	   is	   coordinated	  with	   the	   activity	   of	   resecting	   nucleases,	   but	  most	  320	   likely	   this	   would	   involve	   dissociation	   of	   the	   nucleases.	   After	   loading	   and	   dissociation	   of	   the	  321	   clamp	  loader,	  the	  9-­‐1-­‐1	  could	  subsequently	  slide	  into	  the	  ssDNA	  region.	  In	  the	  dynamic	  setting	  322	   of	  ongoing	  resection,	  consecutive	  cycles	  of	  9-­‐1-­‐1	  loading	  could	  thereby	  generate	  a	  9-­‐1-­‐1	  signal	  323	   on	  resected	  DNA	  that	  correlates	  with	  the	  amount	  of	  ssDNA.	  	  324	   We	  conclude	  that	  a	  main	  task	  of	  all	  upstream	  factors	  (apical	  kinase,	  co-­‐sensor	  and	  scaffolds)	  in	  325	   the	  global	  checkpoint	  circuit	  is	  to	  relay	  the	  DNA	  damage	  signal	  to	  the	  checkpoint	  effectors	  in	  a	  326	   quantitative	  manner.	   This	   will	   allow	   cells	   to	   integrate	   the	   DNA	   damage	   load	   over	   the	   entire	  327	   genome	   and	   tailor	   an	   appropriate	   cell-­‐wide	   response.	   Such	   a	   mechanism	   appears	   essential	  328	   given	  the	  abundance	  of	  endogenous	  DNA	  damage	  29,30,	  where	  checkpoint	  signalling	  will	  typically	  329	   arise	   at	  multiple	  DNA	   damage	   sites.	   Importantly,	   by	   generating	   a	   global	   checkpoint	   response	  330	   that	   correlates	   with	   the	   ssDNA	   signal,	   different	   types	   of	   DNA	   lesions	   with	   different	   ssDNA	  331	   signals	   will	   contribute	   differentially	   to	   the	   overall	   checkpoint	   response,	   depending	   on	   how	  332	   much	  ssDNA	  is	   formed.	  Moreover,	   this	  mechanism	  also	  hyper-­‐sensitizes	   the	  global	  checkpoint	  333	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response	   to	   S-­‐phase,	   since	   an	   abundant	   ssDNA	   signal	   is	   formed	   by	   replication	   fork	   stalling,	  334	   consistent	  with	  the	  essential	  function	  of	  Mec1-­‐Ddc2	  and	  Rad53	  in	  S	  phase	  regulation.	  335	   Lastly,	   we	   note	   that	   certain	   cell-­‐wide	   responses	   such	   as	   cell	   cycle	   arrest	   or	   –	   in	   higher	  336	   eukaryotes	  –	  apoptosis	   29	  are	  binary	  switches.	  This	   implies	   the	  existence	  of	   thresholds,	   above	  337	   which	   a	   certain	   response	   is	   triggered.	  We	   are	   only	   beginning	   to	   understand	   the	   quantitative	  338	   nature	  of	  checkpoint	  signalling,	  but	  it	  will	  be	  critical	  to	  reveal	  how	  such	  thresholds	  are	  formed,	  339	   how	   big	   a	   DNA	   damage	   load	   cells	   tolerate	   and	   whether	   these	   thresholds	   differ	   between	  340	   organisms,	   cell	   types	   or	   during	   development.	   We	   think	   that	   this	   question	   is	   also	   of	   central	  341	   relevance	   for	   our	   understanding	   of	   cancer	   development,	   since	   the	   DNA	   damage	   checkpoint	  342	   forms	  an	  important	  barrier	  that	  is	  often	  overcome	  by	  mutation	  during	  tumorigenesis	  62,63.	  	  	  343	  
	  344	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Online	  Methods	  	  368	  
	  369	  
Yeast	  strains	  and	  plasmids	  370	   All	   yeast	   strains	   used	   in	   this	   study	   derive	   from	  W303	  MATa	   (strains	   listed	   in	   Supplemental	  371	   Table	  1)	  and	  were	  constructed	  using	  standard	  methods	  64.	  Cells	  were	  grown	  in	  YP	  glucose	  or	  YP	  372	   raffinose	   media	   at	   30	   °C.	   Cell	   cycle	   synchronization	   was	   performed	   using	   alpha-­‐factor	   or	  373	   nocodazole	  for	  2-­‐3	  hours	  and	  controlled	  by	  Flow	  Cytometry.	  	  374	   For	  molecular	  cloning,	  genes	  were	  amplified	  from	  yeast	  genomic	  DNA	  and	  inserted	  in	  plasmids	  375	   using	   the	   In-­‐Fusion	   HD	   cloning	   kit	   (Clontech).	   For	   site-­‐directed	   mutagenesis,	   a	   PCR-­‐based	  376	   protocol	  with	  mutagenic	  oligonucleotides	  was	  used.	  All	  plasmids	  used	  in	  this	  study	  are	  listed	  in	  377	   Supplemental	  Table	  2.	  378	   	  379	  
Chromatin	  Immunoprecipitation	  (ChIP)	  and	  qPCR	  analysis	  380	   For	  chromatin	  immunoprecipitation	  of	  γH2A,	  FLAG-­‐tagged	  proteins	  and	  RPA,	  cells	  were	  grown	  381	   in	   YP-­‐Raffinose	   to	   an	   OD	   of	   0.5	   and	   –as	   indicated	   for	   the	   individual	   experiments-­‐	   cell	   cycle	  382	   arrest	  was	   induced.	   A	   double-­‐strand	   break	  was	   introduced	   by	   inducing	   the	  HO	   endonuclease	  383	   from	  the	  galactose	  promoter	  by	  addition	  of	  galactose	  to	  the	  cultures	  (2%	  final).	  100	  ml	  samples	  384	   were	   crosslinked	   with	   formaldehyde	   (final	   1%)	   for	   16	   min	   at	   indicated	   timepoints	   and	   the	  385	   reaction	  was	  quenched	  with	  glycine.	  Cells	  were	  harvested	  by	  centrifugation,	  washed	  in	  ice-­‐cold	  386	   PBS	   and	   snap-­‐frozen.	   For	   lysis,	   cell	   pellets	   were	   resuspended	   in	   800	   μl	   lysis	   buffer	   (50	  mM	  387	   HEPES	  KOH	  pH	  7.5,	  150	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  Na-­‐deoxycolate,	  0.1%	  388	   SDS)	  and	  grinded	  with	  zirconia	  beads	  using	  a	  bead	  beating	  device.	  The	  chromatin	  was	  sonified	  389	   to	   shear	   the	   DNA	   to	   a	   size	   of	   200-­‐500	   bp.	   Subsequently	   the	   extracts	   were	   cleared	   by	  390	   centrifugation,	  1%	  was	   taken	  as	   input	  sample	  and	  40%	  were	   incubated	  with	  either	  anti	  FLAG	  391	   M2	  magnetic	  beads	  (Sigma)	  for	  2	  hours	  or	  1.5	  hours	  with	  anti	  RFA	  (AS07-­‐214,	  Agrisera)	  or	  anti	  392	   γH2A	   (ab15083,	   Abcam)	   antibody	   followed	   by	   30	   min	   with	   additional	   Dynabeads	   ProteinA	  393	   (Invitrogen,	   for	   RPA	   and	   γH2A	   ChIPs).	   The	   beads	  were	  washed	   3x	   in	   lysis	   buffer,	   1x	   in	   lysis	  394	   buffer	  with	  500	  mM	  NaCl,	  1x	   in	  wash	  buffer	  (10	  mM	  Tris-­‐Cl	  pH	  8.0,	  0.25	  M	  LiCl,	  1	  mM	  EDTA,	  395	   0.5%	  NP-­‐40,	  0.5%	  Na-­‐deoxycholate)	  and	  1x	  in	  TE	  pH	  8.0.	  DNA-­‐protein	  complexes	  were	  eluted	  396	   in	  1%	  SDS,	  proteins	  were	  removed	  with	  Proteinase	  K	  (3h,	  42°C)	  and	  crosslinks	  were	  reversed	  397	   (8h	   or	   overnight,	   65°C).	   The	   DNA	   was	   subsequently	   purified	   using	   phenol-­‐chloroform	  398	   extraction	  and	  ethanol	  precipitation	  and	  quantified	  by	  quantitative	  PCR	  (Roche	  LightCycler480	  399	   System,	  KAPA	  SYBR	  FAST	  2x	  qpCR	  Master	  Mix,	  KAPA	  Biosystems)	  at	   indicated	  positions	  with	  400	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respect	  to	  the	  DNA	  double-­‐strand	  break.	  As	  control,	  2-­‐3	  control	  regions	  on	  other	  chromosomes	  401	   were	  quantified.	  	  402	  
	  403	  
Chromatin	  Immunoprecipitation	  (ChIP)	  and	  sequencing	  analysis	  404	   For	  the	  ChIP-­‐seq	  experiment	  shown	  in	  Fig.	  1C	  and	  S1C-­‐E,	  cells	  were	  treated	  as	  described	  above	  405	   for	   the	   ChIP-­‐qPCR	   experiments.	   Before	   de-­‐crosslinking	   of	   eluted	   DNA-­‐protein	   complexes,	  406	   samples	  were	  digested	  with	  RNAse	  A.	  The	  sequencing	  library	  was	  prepared	  using	  the	  MicroPlax	  407	   Library	   Preparation	   kit	   v2	   (Diagenode)	   according	   to	   the	  manufacturers	  manual.	   Size	   analysis	  408	   and	   sequencing	   were	   performed	   by	   the	   genomics	   division	   of	   the	   LAFUGA	   lab	   (GeneCenter,	  409	   Munich).	  The	  sequencing	  data	  was	  analysed	  in	  collaboration	  with	  Assa	  Yeroslawitz	  and	  plotted	  410	   using	  the	  Integrative	  Genome	  Browser	  (IGB)	  software.	  	  411	   	  412	  
Western	  Blot	  analysis	  of	  γH2A	  and	  Rad53	  activation	  413	   For	  protein	  detection	  by	  Western	  Blot,	  1	  OD	  of	  cells	  were	  harvested	  at	  the	  indicated	  time	  points	  414	   and	   snap	   frozen.	   Protein	   lysates	   were	   prepared	   by	   glass	   bead	   lysis	   and	   subsequent	   TCA	  415	   precipitation.	  For	  analysis	  of	  γH2A,	  samples	  were	  run	  on	  pre-­‐cast	  NuPage	  gels	  (4-­‐12%	  Bis-­‐Tris,	  416	   Invitrogen)	  using	  MES	  buffer	  for	  35	  min	  at	  200	  V.	  To	  detect	  checkpoint	  activation	  by	  analysis	  of	  417	   the	  Rad53	  phosphorylation	  shift,	  samples	  were	  run	  on	  10%	  SDS-­‐PAGE	  gels	  for	  180	  min	  at	  160	  418	   V.	   Western	   blotting	   was	   performed	   with	   standard	   methods.	   The	   γH2A	   phosphorylation	   was	  419	   detected	   using	   anti	   γH2A	   (Abcam,	   ab15083)	   antibody,	   for	   Rad53	   shift	   detection	   anti	   Rad53	  420	   (Abcam,	   ab104232)	   was	   used.	   	   As	   loading	   control,	   the	   membranes	   were	   washed	   and	   re-­‐421	   incubated	  with	  anti-­‐PGK1	  antibody	  (22D5C8,	  Invitrogen).	  422	  
	  423	  
Yeast	  live	  cell	  imaging	  424	   Rfa1	   was	   tagged	   with	   cyan	   fluorescent	   protein	   (CFP,	   clone	   W7)	   and	   Ddc1	   with	   yellow	  425	   fluorescent	  protein	  (YFP,	  clone	  10C)	  17.	  For	  live	  cell	  microscopy	  of	  Rfa1	  and	  Ddc1	  recruitment	  to	  426	   an	  HO-­‐induced	  DSB,	   cells	  were	   grown	   shaking	   in	   liquid	   SC+Ade	  medium	   (synthetic	   complete	  427	   medium	  supplemented	  with	  100	  µg/ml	  adenine)	  with	  2%	  raffinose	  at	  25°C	  to	  OD600	  =	  0.2–0.3	  428	   and	  arrested	  either	  in	  G1	  phase	  with	  10	  µg/ml	  α-­‐factor	  or	  in	  M	  phase	  with	  15	  µg/ml	  nocodazole	  429	   for	  2	  hours	  before	  addition	  of	  galactose	  to	  a	  final	  concentration	  of	  2%.	  Cells	  were	  processed	  for	  430	   fluorescence	   microscopy	   at	   the	   indicated	   times	   after	   addition	   of	   galactose	   as	   described	  431	   previously	   65.	   Fluorophores	   were	   visualized	   on	   a	   Deltavision	   Elite	   microscope	   (Applied	  432	   Precision,	  Inc)	  equipped	  with	  a	  100X	  objective	  lens	  (Olympus	  U-­‐PLAN	  S-­‐APO,	  NA	  1.4),	  a	  cooled	  433	   Evolve	  512	  EMCCD	  camera	  (Photometrics,	  Japan),	  and	  an	  Insight	  solid-­‐state	  illumination	  source	  434	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(Applied	   Precision,	   Inc).	   Images	   were	   acquired	   using	   softWoRx	   (Applied	   Precision,	   Inc)	  435	   software.	   Image	   analysis	   and	   fluorescence	   intensity	   quantification	   were	   done	   using	   Volocity	  436	   software	   (PerkinElmer)	   and	   presented	   as	   scatter	   plots	   using	   Prism	   software	   (GraphPad	  437	   software,	   Inc.).	   Images	   were	   pseudocoloured	   according	   to	   the	   approximate	   emission	  438	   wavelength	  of	  the	  fluorophores.	  439	   	  440	  
Table	  1.	  Yeast	  strains:	  441	   	  442	   Strain	   Relevant	  genotype	   Source	  W303a	   MATa	  ade2-­‐1	  ura3-­‐1	  his3-­‐11,15	  trp1-­‐1	  leu2-­‐3,112	  can1-­‐100	   1	  YSB117	   MATa	  lys1∆::natNT2	  pep4∆::LEU2	  bar1∆::TRP1	   this	  study	  YSB5	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	   this	  study	  YSB147	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1∆::natNT2	  sgs1∆::kanMX4	   this	  study	  YSB87	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Ddc2-­‐3FLAG::hphNT1	   this	  study	  YSB380	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1∆::natNT2	  sgs1∆::kanMX4	  Ddc2-­‐3FLAG::hphNT1	   this	  study	  YSB633	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   HOcs-­‐ChrIV::hphNT1	   pGal-­‐HO::ade3	  exo1∆::natNT2	  sgs1∆::kanMX4	   this	  study	  YSB643	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  HOcs-­‐ChrIV::hphNT1	   this	  study	  YSB336	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  fun30∆::kanMX4	   this	  study	  YSB6	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  rad9∆::hphNT1	   this	  study	  YSB1046	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	   fun30∆::kanMX4	  Ddc1-­‐Fun30-­‐3FLAG::hphNT1	   this	  study	  YSB1064	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   Yiplac128-­‐Ddc1-­‐Rad9-­‐3FLAG::LEU2	   this	  study	  YSB165	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  tel1∆::hphNT1	   this	  study	  YSB245	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   sml1∆::kanMX4	  mec1∆::hphNT1	   this	  study	  YSB374	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   sml1∆::kanMX4	  mec1∆::hphNT1	  sgs1∆::natNT2	  exo1∆::ura3	   this	  study	  YSB371	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   tel1Δ::hphNT1	  sgs1∆::natNT2	  exo1∆::ura3	   this	  study	  YSB1098	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   hta1-­‐S129STOP::hphNT1	   this	  study	  YSB1100	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   hta2-­‐S129STOP::kanMX4	   this	  study	  YSB171	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Ddc1-­‐3FLAG::hphNT1	   this	  study	  YSB243	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1::natNT2	  sgs1::kanMX4	  Ddc1-­‐3FLAG::hphNT1	   this	  study	  YSB15	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Dpb11-­‐3FLAG::natNT2	   this	  study	  YSB381	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1::natNT2	   this	  study	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sgs1::kanMX4	  Dpb11-­‐3FLAG::hphNT1	  YSB9	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Rad9-­‐3FLAG::hphNT1	   this	  study	  YSB146	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1::natNT2	  sgs1::kanMX4	  Rad9-­‐3FLAG::hphNT1	   this	  study	  YSB210	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   Dpb11-­‐3FLAG::natNT2	  ddc1-­‐T602A::hphNT1	   this	  study	  YSB75	   MatA	  ade3::pGAL::HO	  bar1Δ::TRP1	  	  hmlΔ::pRS-­‐1	  hmrΔpRS-­‐2	  Rad9-­‐3FLAG::hphNT1	  ddc1-­‐T602A::	  natNT2	   this	  study	  YSB218	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Rtt107-­‐3FLAG::hphNT1	   this	  study	  YSB219	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   exo1∆::natNT2	  sgs1∆::kanMX4	  Rtt107-­‐3FLAG::hphNT1	   this	  study	  YSB388	   MatA	  ade3::pGAL::HO	  bar1Δ::TRP1	  	  HML	  hmrΔpRS-­‐2	  Rtt107-­‐3FLAG::natNT2	  ddc1-­‐T602A::natNT2	   this	  study	  YSB404	   MatA	  ade3::pGAL::HO	  bar1Δ::TRP1	  	  HML	  	  hmrΔpRS-­‐2	  Ddc1-­‐3FLAG::hphNT1	  lys1∆::ura3	  pep4∆::leu2	   this	  study	  YSB1105	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  Ddc2-­‐9myc::hphNT1	   this	  study	  YSB1106	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   Yiplac128-­‐Ddc1-­‐Rad9-­‐3FLAG::LEU2	  Ddc2-­‐9myc::hphNT1	   this	  study	  YSB1107	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   Rad9-­‐dpb11∆N-­‐3FLAG::kanMX4	   this	  study	  YSB1108	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   Rad9-­‐dpb11∆N-­‐3FLAG::kanMX4	  ddc1-­‐T602A::natNT2	   this	  study	  YCZ173	   ade3::PGAL::HO	   ARS607::HOcs::KanMX	   bar1Δ::TRP1	   hmlΔ::pRS-­‐1	  hmrΔ::pRS-­‐2	  matHOcsΔ::pBR-­‐1	  	   66	  YSB517	   MATa	  hml∆::prS	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	   this	  study	  YSB519	   hml∆::prS	   hmr∆::pRS	   bar1∆::trp1	   	   pGal-­‐HO::ade3	   exo1∆::natNT2	  sgs1∆::kanMX4	   this	  study	  YSB522	   bar1∆::trp1	  	  pGal-­‐HO::ade3	   this	  study	  YSB524	   bar1∆::trp1	  	  pGal-­‐HO::ade3	  	  exo1∆::natNT2	  sgs1∆::kanMX4	   this	  study	  YSB397	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  dpb11∆C::hphNT1	   this	  study	  YSB412	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   dpb11∆C::hphNT1	  tel1∆::kanMX4	   this	  study	  YSB406	   MATa	  HML	  hmr∆::pRS	  bar1∆::trp1	  pGal-­‐HO::ade3	  ddc1∆::kanMX4	   this	  study	  YSB413	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   ddc1∆::kanMX4	  tel1∆::natNT2	   this	  study	  YSB407	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   	   dna2∆::hphNT1	  Yiplac211-­‐dna2-­‐WYAA::URA3	   this	  study	  YSB414	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   	   dna2∆::hphNT1	  Yiplac211-­‐dna2-­‐WYAA::URA3	  tel1∆::natNT2	   this	  study	  YSB408	   MATa	   HML	   hmr∆::pRS	   bar1∆::trp1	   pGal-­‐HO::ade3	   	   dna2∆::hphNT1	  Yiplac211-­‐dna2-­‐WYAA::URA3	  ddc1∆::kanMX4	   this	  study	  ML891-­‐5A	  	   MATa	   ADE2	   ade3::pGAL::HO	   trp1-­‐1	   hmrΔpRS-­‐2	   DDC1-­‐4ala-­‐YFP	   RFA1-­‐8ala-­‐CFP	  RAD5	   this	  study	  W5094-­‐1C	   MATa	  ADE2	  trp1-­‐1	  LYS2	  RAD52-­‐YFP	  RAD5	   67(	  	  ML187-­‐1D	   MATa	  ADE2	  trp1-­‐1	  LYS2	  RAD52-­‐CFP	  RAD5	   this	  study	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  443	   	  444	  
Table	  2:	  Plasmids:	  445	   	  446	   name	   description	  pSB251	   Yiplac128-­‐pDdc1-­‐Ddc1-­‐Rad9-­‐3FLAG	  pSB143	   Yiplac211-­‐pDna2o+t	  WY128,130AA	  
	  447	  
	  448	   	  449	  
	   	  450	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Main	  Figure	  Legends:	  451	  
	  452	  
Figure	  1	  453	   Differential	  regulation	  of	  DNA	  damage	  checkpoint	  effectors:	  DSB-­‐induced	  γH2A	  phosphorylation	  454	   is	  independent	  of	  DNA	  end	  resection,	  while	  Rad53	  phosphorylation	  is	  resection-­‐dependent.	  455	  
(A)	   Different	   amounts	   of	   Mec1-­‐Ddc2	   kinase	   on	   the	   damaged	   DNA	   phosphorylate	   H2A	   with	  456	   similar	  efficiency.	  A	  non-­‐repairable	  DSB	  at	  MAT	  was	  induced	  by	  Gal-­‐HO	  expression	  in	  M	  phase-­‐457	   arrested	   WT	   and	   long-­‐range	   deficient	   exo1∆	   sgs1∆	   strains	   and	   protein	   recruitment	   was	  458	   measured	   at	   indicated	   times.	   Upper	   panel:	   fold	   enrichment	   of	   a	   given	   locus	   in	   an	   RPA	   ChIP	  459	   relative	  to	  undamaged	  control	   loci.	  All	  RPA	  ChIPs	  in	  this	  paper	  were	  performed	  using	  an	  anti-­‐460	   RFA	   antibody	   directed	   against	   all	   three	   subunits	   of	   RPA.	   Middle	   panel:	   Mec1-­‐Ddc2	   kinase	  461	   recruitment.	  In	  order	  to	  detect	  Mec1-­‐Ddc2,	  a	  ChIP	  against	  Ddc2-­‐3FLAG	  was	  performed	  using	  an	  462	   anti-­‐FLAG	   antibody.	   Lower	   panel:	   H2A-­‐S129	   phosphorylation	   (γH2A	   phosphorylation).	   γH2A	  463	   phosphorylation	  was	  measured	  with	   an	   antibody	   directed	   against	   S129-­‐phosphorylated	  H2A.	  464	   The	   experiment	  was	  performed	  with	  different	  numbers	   of	   biological	   replicates,	   the	  RPA	  ChIP	  465	   three	  times,	  the	  Ddc2	  ChIP	  once,	  and	  the	  γH2A	  ChIP	  four	  times.	  	  466	  
(B)	  The	  checkpoint	  kinase	  Rad53	   is	  activated	   in	  a	   resection-­‐dependent	  manner.	  Western	  blot	  467	   detecting	  the	  phosphorylation-­‐dependent	  shift	  of	  activated	  Rad53	  with	  an	  anti-­‐Rad53	  antibody.	  	  468	   The	  samples	  were	  obtained	  at	  indicated	  time	  points	  after	  Gal-­‐HO	  induction	  in	  M	  phase-­‐arrested	  469	   cells.	  470	  
(C)	  γH2A	  phosphorylation	  around	  a	  DSB	   is	  not	  dependent	  on	  DNA	  resection.	  Overlay	  of	  ChIP-­‐471	   seq	   profiles	   of	   γH2A	   phosphorylation	   around	   a	   DSB	   at	   the	  MAT	   locus	   in	  WT	   cells	   (blue)	   and	  472	  
exo1∆	  sgs1∆	  cells	  (purple).	  The	  enrichment	  is	  plotted	  relative	  to	  the	  whole	  genome	  average.	  The	  473	   DSB	  was	  induced	  for	  4h	  in	  M	  phase-­‐arrested	  cells.	  	  474	  
(D,E)	   γH2A	  phosphorylation	   is	  not	   influenced	  by	   the	   cell	   cycle.	  WT	   strains	   as	   in	   (a),	   but	   cells	  475	   were	  arrested	  either	  in	  G1	  by	  alpha-­‐factor	  treatment	  (left	  panel),	  or	  in	  M	  phase	  by	  nocodazole	  476	   treatment	   (right	   panel).	   The	   experiment	  was	   performed	  with	   different	   numbers	   of	   biological	  477	   replicates,	   the	   RPA	   and	   Ddc2	   ChIPs	   three	   times	   and	   the	   Ddc2	   ChIP	   twice.	   (E)	   Western	   blot	  478	   analysis	  of	  Rad53	  activation	  as	  in	  (B),	  but	  with	  G1-­‐	  and	  M	  phase	  -­‐arrested	  cells.	  	  479	  
(F)	   Genetic	   manipulation	   of	   DNA	   end	   resection	   by	   de-­‐regulation	   of	   the	   resection	   regulators	  480	   Fun30	  and	  Rad9	  does	  not	  affect	  γH2A	  phosphorylation	  around	  a	  DSB.	  	  481	  
WT	   cells,	   strains	   with	   hyper-­‐active	   resection	   (rad9∆,	   DDC1-­‐FUN30	   fusion),	   or	   strains	   with	  482	   inhibited	   resection	   (fun30∆,	   DDC1-­‐RAD9	   fusion)	   were	   arrested	   in	   M	   phase	   and	   a	   DSB	   was	  483	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induced.	  The	  two	  fusion	  proteins	  carry	  a	  3FLAG	  tag	  at	  their	  C-­‐terminus	  for	  detection.	  Resection	  484	   (left	  panel,	  ChIP	  against	  RPA)	  and	  γH2A	  phosphorylation	  (right	  panel,	  ChIP	  against	  H2A-­‐S129	  485	   phosphorylation)	  were	  measured	   at	   indicated	   time	  points.	   The	   experiment	  was	  performed	   in	  486	   independent	  biological	  duplicates.	  	  487	  
(G)	  Overlay	  of	  ChIP-­‐qPCR	  traces	  of	  RPA	  and	  γH2A	  after	  4h	  of	  DSB	  induction	  from	  panel	  (F).	  The	  488	   blue	  lines	  represent	  enrichments	  in	  WT	  cells,	  while	  strains	  with	  resection	  defects	  are	  depicted	  489	   in	  red	  and	  hyper-­‐resecting	  strains	  in	  shades	  of	  green.	  490	   	  491	  
Figure	  2	  492	  
γH2A	  phosphorylation	  is	  unresponsive	  to	  the	  ssDNA	  signal,	  but	  not	  because	  of	  phosphorylation	  493	   site	  saturation,	  contribution	  of	   the	  sensor	  kinase	  Tel1	  or	   the	   involvement	  of	  any	  known	  Mec1	  494	   activator.	  	  495	  
(A)	  The	  number	  of	  γH2A	  phosphorylation	  sites	  (H2A-­‐S129)	  on	  chromatin	  is	  not	  limiting	  to	  γH2A	  496	   phosphorylation	  efficiency.	  γH2A	  phosphorylation	  was	  measured	  in	  strains	  with	  either	  normal	  497	  
γH2A	   phosphorylation	   site	   availability	   (WT)	   or	   in	   strains	   in	   which	   the	   number	   of	  498	   phosphorylation	  sites	  is	  reduced	  by	  mutation	  of	  either	  one	  of	  the	  two	  H2A	  coding	  genes	  (hta1-­‐499	  
S129STOP,	  hta2-­‐S129STOP,	  respectively).	  	  500	  
(B)	  γH2A	  is	  mainly	  phosphorylated	  by	  Mec1-­‐Ddc2.	  ChIP-­‐qPCR	  analysis	  of	  γH2A	  phosphorylation	  501	   around	   a	   DSB	   in	  M	   phase.	  WT,	   tel1∆	   and	   tel1∆	   exo1∆	   sgs1∆	   mutant	   strains	  were	   analysed	   at	  502	   indicated	  timepoints.	  	  503	  
(C)	  Specific	  Mec1	  activators	  do	  not	  influence	  γH2A	  phosphorylation.	  ChIP-­‐qPCR	  analysis	  of	  DNA	  504	   resection	  (upper	  panels,	  RPA	  ChIPs)	  and	  γH2A	  phosphorylation	  (lower	  panels,	  γH2A	  ChIPs)	   in	  505	  
WT	  cells	  and	  dna2-­‐WYAA	  ddc1∆	  mutant	  cells	  arrested	  in	  M	  phase.	  	  506	  
	  507	  
	  508	  
Figure	  3	  509	   The	  9-­‐1-­‐1	  complex	  is	  a	  quantitative	  sensor	  of	  the	  ssDNA	  signal.	  	  510	  
(A)	   The	  major	   checkpoint	   cascade	  proteins	  9-­‐1-­‐1	   (Ddc1),	  Dpb11	   and	  Rad9	   are	   recruited	   to	   a	  511	   DSB	   in	   a	   resection-­‐dependent	  manner.	   ChIP-­‐qPCR	   analysis	   of	  WT	   (left	   panel)	   or	   exo1∆	   sgs1∆	  512	   (right	  panel)	  strains	  arrested	  in	  M	  phase	  at	  indicated	  time	  points.	  Ddc1,	  Dpb11	  and	  Rad9	  were	  513	   tagged	   at	   the	   C-­‐terminus	   with	   3FLAG	   tags,	   respectively,	   and	   the	   ChIP	   was	   subsequently	  514	   performed	  against	  the	  FLAG	  tag.	  515	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(B,C)	  9-­‐1-­‐1	  (Ddc1)	  phosphorylation	  site	  T602	  is	  required	  to	  recruit	  the	  checkpoint	  factors	  Rad9	  516	   and	  Dpb11	  (9-­‐1-­‐1	  axis).	  (B)	  WT	  and	  ddc1-­‐T602A	  cells	  (right	  panels)	  were	  arrested	  in	  M	  phase	  517	   and	  protein	  recruitment	  was	  analysed	  by	  ChIP-­‐qPCR.	  To	  this	  end,	  Rtt107,	  Rad9	  and	  Dpb11	  were	  518	   C-­‐terminally	  tagged	  with	  a	  3FLAG	  tag,	  which	  was	  used	  as	  affinity	  tag	  for	  the	  ChIP	  experiment.	  519	  
(C)	  Analysis	  of	  Rad53	  phosphorylation	  by	  Western	  Blot	  against	  Rad53	  as	  in	  Fig.	  1B,	  but	  in	  WT	  520	   and	  ddc1-­‐T602A	  cells.	  	  521	  
(D)	  Ddc1	   and	  RPA	   form	  DSB-­‐induced	   foci.	  Representative	  microscopy	   images	   from	   the	  Rfa1-­‐	  522	   and	  Ddc1-­‐foci	  analysis.	  A	  DSB	  was	  induced	  at	  the	  MAT	  locus	  in	  M	  phase-­‐arrested	  cells	  using	  Gal-­‐523	   HO	  and	  cells	  were	  microscopically	  analysed	  for	  Ddc1-­‐YFP	  foci	  (yellow,	  left	  panel)	  and	  Rfa1-­‐CFP	  524	   foci	   (blue,	   second	  to	   the	   left	  panel)	  at	   indicated	   times.	  An	  overlay	  of	  both	   imaging	  channels	   is	  525	   shown	  in	  panel	  three	  and	  a	  bright	  field	  image	  of	  the	  yeast	  cells	  in	  panel	  four.	  Pictures	  represent	  526	   cells	  before	  DSB	  induction	  (upper	  line)	  and	  4	  hours	  after	  DSB	  induction	  (lower	  line).	  527	  
(E)	  Ddc1	  and	  RPA	  foci	  formation	  depends	  on	  DNA	  end	  resection.	  Plots	  show	  the	  percentage	  of	  528	   cells	  with	  foci	  at	  0,	  2	  and	  4	  hours	  after	  DSB	  induction,	  values	  are	  from	  the	  same	  experiment	  as	  in	  529	   (D).	  After	  4	  hours,	  about	  55%	  of	  M	  phase-­‐arrested	  cells	  show	  foci,	  while	  only	  15%	  of	  cells	  in	  G1	  530	   show	   foci.	   In	   both	   cases,	   most	   of	   the	   foci	   contain	   Ddc1	   and	   RPA	   (black	   fraction).	   Error	   bars	  531	   represent	  95%	  confidence	  intervals.	  	  532	  
(F)	  RPA	  and	  Ddc1	  recruitment	  to	  a	  DSB	  increases	  over	  time.	  Scatter	  plot	  depicting	  the	  number	  533	   of	   RPA	   (left	   graph)	   or	   Ddc1	   (right	   graph)	   molecules	   per	   focus	   after	   2	   hours	   DSB	   (left,	  534	   respectively)	  and	  4	  hours	  DSB	  (right,	  respectively).	  We	  quantified	  the	  number	  of	  molecules	  per	  535	   focus	   using	   nucleus-­‐wide	   signals	   of	   Rfa1-­‐CFP	   and	   Ddc1-­‐YFP	   (normalized	   against	   Rad52-­‐536	   CFP/YFP	   signals	   (Fig.	   S5D))	   as	   standard.	  Same	   experiment	   as	   in	   (D)	   and	   (E).	   The	   red	   lines	  537	   represent	  the	  mean,	  error	  bars	  represent	  95%	  confidence	  intervals.	  538	  
(G)	  Correlation	  of	  the	  recruitment	  of	  RPA	  and	  Ddc1	  to	  a	  DSB.	  Scatter	  plot	  showing	  the	  number	  539	   of	   Ddc1-­‐YFP	   molecules	   plotted	   against	   the	   number	   of	   Rfa1-­‐CFP	   molecules	   per	   focus.	   Same	  540	   experiment	  as	  (D)-­‐(F).	  The	  black	  line	  represents	  a	  linear	  regression	  line	  with	  the	  corresponding	  541	   95%	  confidence	  intervals	  in	  red.	  	  542	  
	  543	  
	  544	  
Figure	  4	  545	   Mutant	   conditions	   that	   hyper-­‐activate	   the	   9-­‐1-­‐1	   axis	   lead	   to	   hyper-­‐activation	   of	   the	   effector	  546	   kinase	  Rad53,	  despite	  reduced	  Mec1-­‐Ddc2	  recruitment	  to	  the	  DSB.	  	  	  547	  
(A)	   A	   covalent	   Ddc1-­‐Rad9	   interaction	   hyper-­‐recruits	   Rad9	   and	   blocks	   Mec1-­‐Ddc2	   kinase	  548	   recruitment	  to	  a	  DSB.	  WT	  cells	  and	  cells	  expressing	  a	  Ddc1-­‐Rad9-­‐fusion	  (same	  fusion	  as	  used	  in	  549	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Fig.	  1F+G)	  were	  arrested	  in	  M	  phase	  and	  analysed	  at	  indicated	  times.	  ChIP-­‐qPCR	  measurements	  550	   of	  Mec1-­‐Ddc2	  recruitment	  (upper	  panels,	  ChIP	  directed	  against	  Ddc2-­‐3FLAG	  using	  an	  anti-­‐FLAG	  551	   antibody)	   and	   Rad9	   recruitment	   to	   a	   DSB	   (lower	   panels,	   ChIP	   directed	   against	   Rad9	   or	   the	  552	   fusion	  which	  both	  carry	  a	  3FLAG	  tag	  for	  detection).	  553	  
(B)	   Rad53	   activation	   in	   response	   to	   a	   DSB	   is	   strongly	   enhanced	   in	   Ddc1-­‐Rad9-­‐fusion	   cells.	  554	   Western	  blot	  analysis	  of	  Rad53	  activation	  at	   indicated	  times	  after	  DSB	   induction,	  strains	  as	   in	  555	   (A).	  	  556	  
(C)	  A	   covalent	  Rad9-­‐Dpb11	   fusion	  protein	   enhances	  Rad9	   recruitment	   to	   the	  DSB	  and	  blocks	  557	   DNA	  end	  resection.	  WT	  cells	  and	  cells	  expressing	  a	  Rad9-­‐dpb11∆N-­‐fusion	  (lacking	  BRCT	  1+2	  of	  558	   Dpb11	   which	   normally	   bind	   to	   Rad9)	   were	   arrested	   in	   M	   phase	   and	   analysed	   at	   indicated	  559	   timepoints.	  ChIP-­‐qPCR	  measurements	  of	  DNA	  resection	  (upper	  panels)	  and	  Rad9	  recruitment	  to	  560	   a	  DSB	   (lower	  panels).	   To	  measure	  Rad9	   recruitment,	   the	   fusion	   and	  Rad9,	   respectively,	  were	  561	   tagged	  C-­‐terminally	  with	  a	  3FLAG	  tag.	  	  562	  
(D)	  Rad53	  activation	  in	  response	  to	  a	  DSB	  is	  enhanced	  in	  Rad9-­‐dpb11∆N-­‐fusion	  cells.	  Western	  563	   blot	  analysis	  of	  Rad53	  activation	  at	  indicated	  times	  after	  DSB	  induction,	  strains	  as	  in	  (C).	  	  564	   	  565	  
Supplemental	  Figure	  Legends:	  566	   	  567	  
Figure	  S1	  568	  
γH2A	  phosphorylation	  is	  not	  correlating	  with	  ssDNA	  signal	  strength.	  569	  
(A)	  RPA	  and	  γH2A	  enrichments	  around	  a	  DSB	  are	  anti-­‐correlated,	  suggesting	  	  that	  resection	  as	  570	   read	  by	  RPA	  enrichment	  evicts	  histones	  and	  thereby	  the	  substrate	  for	  γH2A	  	  phosphorylation.	  571	   Overlay	  of	  RPA	  (red)	  and	  γH2A	  (blue)	  ChIP	  signals	  after	  4h	  of	  DSB	  in	  WT	  (left	  panel)	  and	  exo1∆	  572	  
sgs1∆	  cells	  (right	  panel)	  cells	  arrested	  in	  M	  phase.	  573	  
(B)	  γH2A	  phosphorylation	  spreads	  over	  a	  large	  distance	  from	  a	  DSB	  (>75	  kb)	  in	  WT	  and	  exo1∆	  574	  
sgs1∆	  cells.	  With	  the	  exception	  of	  the	  area	  of	  resection	  (Fig.	  S1A),	  resection	  has	  no	  influence	  on	  575	  
γH2A	   phosphorylation.	   ChIP-­‐qPCR	   analysis	   of	  WT	   cells	   or	   exo1∆	   sgs1∆	   cells	   after	   4h	   of	   DSB	  576	   induction.	  577	  
γH2A	  phosphorylation	  and	  RPA	  enrichment	  around	  two	  distinct	  DSBs	  anti-­‐correlate	  in	  ChIP-­‐seq	  578	   experiments	  (C)	  and	  depend	  on	  the	  presence	  of	  the	  DSBs	  (D).	  579	  
(C)	   Overlay	   of	   ChIP-­‐seq	   profiles	   from	   the	   same	   experiment	   as	   shown	   in	   Fig.	   1C.	   RPA	  580	   enrichments	  are	  plotted	  in	  blue,	  γH2A	  phosphorylation	  is	  plotted	  in	  yellow.	  The	  positions	  of	  the	  581	   HO-­‐induced	  DSBs	  on	  chromosome	  3	  (upper	  two	  panels)	  and	  chromosome	  4	  (lower	  two	  panels)	  582	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are	   indicated	   by	   the	   red	   dotted	   line.	  WT	   cells	   (upper	   traces)	   are	   compared	  with	   exo1∆	   sgs1∆	  583	   mutant	  cells	  (lower	  traces).	  	  584	  
(D)	  ChIP-­‐seq	  profiles	  of	   the	  0h	   time	  point	  before	   induction	  of	  DSB.	  Samples	  were	  obtained	   in	  585	   the	  same	  experiment	  as	  data	  shown	  in	  Fig.	  1B	  and	  Fig.	  S1A.	  Analysis	  of	  the	  enrichment	  of	  RPA	  586	   (upper	  panel,	  respectively)	  and	  γH2A	  phosphorylation	  (lower	  panel,	  respectively).	  	  587	  
(E)	  Overlay	  of	  ChIP-­‐qPCR	  and	  ChIP-­‐seq	  signals.	  WT	   and	  exo1∆	   sgs1∆	   cells	  were	  arrested	   in	  M	  588	   phase	  and	  analysed	  for	  γH2A	  phosphorylation	  after	  4h	  of	  DSB	  induction.	  qPCR	  signals	  (red)	  are	  589	   from	  the	  same	  experiment	  as	   in	  (B).	  Sequencing	  data	  (blue)	   is	   from	  the	  experiment	  plotted	   in	  590	   Fig.	  1C	  and	  Fig.	  S1C	  and	  S1D.	  591	   	  592	   	  593	  
Figure	  S2	  594	  
γH2A	  phosphorylation	  is	  not	  correlating	  with	  ssDNA	  signal	  strength	  –	  additional	  controls.	  595	  
	  (A)	  DNA	  end	  resection	  (left	  panel)	  and	  γH2A	  phosphorylation	  (right	  panel)	  were	  measured	  by	  596	   ChIP	  in	  WT	  strains	  or	  exo1∆	  sgs1∆	  strains	  with	  both	  mating	  type	  loci	  deleted,	  or	  intact	  HML	  or	  597	   intact	   HML	   and	   HMR	   loci.	   All	   strains	   used	   in	   this	   study	   were	   HML	   hmr∆	   if	   not	   indicated	  598	   differently.	  Samples	  were	  analysed	  after	  4	  h	  of	  DSB	  induction.	  	  599	  
(B)	  Also	  at	  an	  independent	  locus	  (ARS607),	  γH2A	  phosphorylation	  around	  a	  DSB	  is	  not	  showing	  600	   a	   response	   that	   correlates	   with	   the	   ssDNA	   signal.	   ChIP-­‐qPCR	   analysis	   of	   strains	   carrying	   an	  601	   ectopic	   HO	   cutsite	   on	   ARS607	   arrested	   in	   G1	   (left	   panels)	   or	   M	   phase	   (right	   panels).	   RPA	  602	   enrichment	   (upper	   panels)	   and	   γH2A	   phosphorylation	   (lower	   panels)	   were	   analysed	   at	  603	   indicated	  times.	  	  604	  
(C)	   Manipulation	   of	   DNA	   end	   resection	   by	   de-­‐regulation	   of	   the	   Sgs1	   helicase	   does	   not	   affect	  605	  
γH2A	  phosphorylation.	  ChIP-­‐qPCR	  analysis	  of	  a	  WT	  strain	   arrested	   in	  G1	   (left	  panels)	  or	   in	  M	  606	   phase	  (middle	  panels)	  and	  an	  sgs1-­‐ss	  mutant	  strain	  in	  M	  phase	  (right	  panels).	  Resection	  (upper	  607	   panels)	  and	  γH2A	  phosphorylation	  (lower	  panels)	  were	  analysed	  at	  indicated	  times.	  	  608	  
(D)	  Rtt107	  is	  associating	  with	  a	  DSB	  in	  a	  resection-­‐independent	  manner.	  Rtt107	  recruitment	  to	  609	   a	  DSB	  was	  measured	  at	  indicated	  times	  in	  WT	  strains	  arrested	  in	  G1	  (left	  panel)	  or	  in	  M	  phase	  610	   (middle	   panel),	   or	   in	   exo1∆	   sgs1∆	   cells	   arrested	   in	  M	   phase	   (right	   panel).	   Rtt107	  was	   tagged	  611	   with	  a	  C-­‐terminal	  3FLAG	  tag	  and	  detected	  by	  a	  ChIP	  directed	  against	  the	  FLAG	  tag.	  	  612	   	  613	  
Figure	  S3	  614	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DNA	   damage	   checkpoint	   signalling	   can	   be	   subdivided	   in	   two	   separate,	   Mec1-­‐dependent	  615	   signaling	  circuits.	  Models	  of	  local	  (A)	  and	  global	  (B)	  checkpoint	  signalling	  circuits.	  	  616	  
(A)	  Mec1-­‐Ddc2	   (orange)	  bound	   to	  RPA	   (red)	  phosphorylates	  γH2A	  as	  a	   substrate	  of	   the	   local	  617	   checkpoint	  signalling	  circuit	  (green)	  in	  a	  resection-­‐independent	  manner.	  	  618	  
(B)	  Mec1-­‐Ddc2	  (orange)	  bound	  to	  RPA	  (red)	  phosphorylates	  the	  checkpoint	  proteins	  of	  the	  9-­‐1-­‐619	   1	   axis	   (Ddc1,	  Dpb11,	  Rad9	   and	  Rad53,	   shades	   of	   blue)	   as	   substrates	   of	   the	   global	   checkpoint	  620	   signalling	  circuit,	  which	  depends	  on	  DNA	  end	  resection	  and	  culminates	  in	  the	  activation	  of	  the	  621	   Rad53	  effector	  kinase.	  	  622	  
	  623	  
Figure	  S4	  624	  
γH2A	   phosphorylation	   is	   strongly	   dependent	   on	   Mec1,	   but	   only	   weakly	   on	   Tel1,	   and	   is	   not	  625	   influenced	  by	  specific	  Mec1	  activators.	  	  626	  
(A)	   γH2A	   and	   Rad53	   phosphorylation	   after	   phleomycin	   treatment	   are	   strongly	   decreased	   in	  627	   cells	   lacking	  Mec1,	  but	  almost	  unaffected	   in	  cells	   lacking	  Tel1.	  Western	  blot	  analysis	  of	  Rad53	  628	   phosphorylation	   (upper	   panels,	   respectively),	   γH2A	   phosphorylation	   (middle	   panels,	  629	   respectively)	  and	  PGK1	  as	  a	  control	  for	  protein	  levels	  (lower	  panels,	  respectively)	  in	  WT	  cells	  or	  630	  
exo1∆	   sgs1∆,	  mec1∆	   sml1∆,	   exo1∆	   sgs1∆	   mec1∆	   sml1∆,	   tel1∆,	   exo1∆	   sgs1∆	   tel1∆	   mutant	   cells	  631	   arrested	  in	  M	  phase	  after	  treatment	  with	  50	  µg/ml	  phleomycin	  for	  the	  indicated	  times.	  	  632	  
(B)	  γH2A	  formation	  at	  a	  DSB	  strongly	  depends	  on	  the	  Mec1	  kinase.	  IP/input	  ratios	  of	  the	  ChIP-­‐633	   qPCR	   analysis	   of	   γH2A	   (upper	   panels)	   and	   RPA	   (lower	   panels)	   after	   indicated	   times	   of	   DSB	  634	   induction	   in	   M	   phase-­‐arrested	   cells.	   sml1∆	   mec1∆	   cells	   (right	   panels,	   respectively)	   were	  635	   compared	  to	  sml1∆	  cells	  (left	  panels,	  respectively).	  636	  
(C)	   Damage-­‐independent	   levels	   of	   γH2A	   phosphorylation	   at	   two	   independent	   loci	   on	   non-­‐637	   broken	   chromosomes	   are	   reduced	   in	   cells	   lacking	  Mec1.	   γH2A	  ChIP	   IP/input	   ratios	   from	   two	  638	   loci	  on	  distinct,	  undamaged	  chromosomes	  are	  plotted.	  The	  values	  are	  from	  the	  same	  experiment	  639	   as	  in	  (B).	  	  640	  
(D)	   γH2A	  phosphorylation	   is	   not	   influenced	   by	   the	   absence	   of	   a	   specific	  Mec1	   activator	   after	  641	   phleomycin	   treatment.	   Western	   blot	   analysis	   of	   γH2A	   phosphorylation	   (upper	   panels,	  642	   respectively)	  and	  PGK1	  as	  a	  control	   for	  protein	  concentrations	   (lower	  panels,	   respectively)	   in	  643	  
WT	  cells	  or	  ddc1∆,	  dpb11∆C	  or	  dna2-­‐WYAA	  mutant	  cells,	  either	   in	  a	  WT	  background	  or	  a	  tel1∆	  644	   background	  arrested	  in	  M	  phase.	  Samples	  were	  analysed	  at	  indicated	  time	  points.	  	  645	   	  646	  
Figure	  S5	  647	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Regulators	  of	  the	  global	  checkpoint	  circuit	  (9-­‐1-­‐1	  axis)	  differentially	  localize	  to	  a	  DSB	  in	  G1	  and	  648	   M	  phase-­‐arrested	  cells.	  	  649	  
(A)	  Recruitment	  of	  9-­‐1-­‐1	   (Ddc1),	  Dpb11	  and	  Rad9	   is	   enhanced	   in	  M	  phase.	  ChIP-­‐qPCR	  of	  WT	  650	   strains	  arrested	  in	  G1	  (left	  panels)	  or	  M	  phase	  (right	  panels)	  at	   indicated	  times.	  For	  detection,	  651	   Ddc1,	   Dpb11	   and	   Rad9	   were	   tagged	   with	   a	   C-­‐terminal	   3FLAG	   tag,	   and	   ChIPs	   were	   directed	  652	   against	  the	  FLAG	  tag.	  	  653	  
(B)-­‐(D)Additional	  information	  to	  the	  microscopical	  Ddc1-­‐	  and	  RPA-­‐	  foci	  analysis	  in	  Fig.	  3D-­‐G.	  654	  
(B)	   Representative	  microscopy	   images	   from	   the	   Rfa1-­‐	   and	   Ddc1-­‐foci	   analysis	   in	   G1-­‐arrested	  655	   cells.	   A	  DSB	  was	   induced	   at	   the	  MAT	   locus	   in	   G1	   phase-­‐arrested	   cells	   using	  Gal-­‐HO	   and	   cells	  656	   were	  microscopically	   analysed	   for	  Ddc1-­‐YFP	   foci	   (yellow,	   left	   panel)	   and	  Rfa1-­‐CFP	   foci	   (blue,	  657	   second	   to	   the	   left	  panel)	   from	  4h	   timepoint.	  An	  overlay	  of	  both	   imaging	  channels	   is	   shown	   in	  658	   panel	  three	  and	  a	  bright	  field	  image	  of	  the	  yeast	  cells	  in	  the	  right	  panel.	  	  659	  
(C)	  FACS	  analysis	  of	  G1	  arrest.	  Cells	  were	  fixed	  for	  FACS	  analysis	  before	  addition	  of	  alpha-­‐factor	  660	   at	  0,	  2	  and	  4	  hours	  of	  DSB	  induction.	  The	  graphs	  show	  the	  DNA	  content	  per	  cell.	  	  661	  
(D)	  Normalization	  of	  Rfa1	   and	  Ddc1	   foci	   intensity	   against	  Rad52	   as	   a	   standard.	   YFP	  and	  CFP	  662	   intensities	  were	  quantified	   throughout	   the	  nucleus	   and	   the	   total	   number	  of	   tagged	  molecules	  663	   was	   calculated	   by	   comparing	   the	   values	   to	   the	   intensity	   of	   the	   respectively	   tagged	   Rad52	  664	   molecules.	  	  665	   	  666	  
Figure	  S6	  667	   The	  Rad9-­‐dpb11∆N	  fusion	  is	  partly	  dependent	  on	  Ddc1	  phosphorylation.	  	  668	  
(A)	  ChIP-­‐qPCR	  analysis	  of	  DNA	  resection	  (upper	  panels)	  and	  Rad9	  recruitment	  (lower	  panels)	  669	   in	  WT	  cells,	  Rad9-­‐dpb11∆N	   fusion	   cells	   and	  Rad9-­‐dpb11∆N	   fusion	  ddc1-­‐T602A	  cells.	  All	   strains	  670	   were	  arrested	  in	  M	  phase	  and	  samples	  were	  taken	  at	  indicated	  time	  points.	  For	  detection,	  Rad9	  671	   and	   the	  Rad9	   fusion	  were	   tagged	  C-­‐terminally	  with	  a	  3FLAG	   tag	  and	   the	  ChIPs	  were	  directed	  672	   against	  the	  3FLAG	  tag.	  The	  data	  in	  the	  left	  and	  middle	  panels	   is	   identical	  to	  the	  data	  shown	  in	  673	   Fig.	  4C.	  	  674	  
(B)	  The	  same	  strains	  as	  in	  (A)	  were	  analysed	  for	  checkpoint	  activation	  in	  a	  Rad53	  Western	  Blot,	  675	   including	  a	  ddc1-­‐T602A	  mutant	  strain.	  The	  Western	  Blot	  samples	  are	  from	  the	  same	  experiment	  676	   as	  shown	  in	  Fig.	  4D.	  	  677	   	  678	   	   	  679	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Figure	  S1	  
γH2A	  phosphorylation	  is	  not	  correlating	  with	  ssDNA	  signal	  strength.	  
(A)	  RPA	  and	  γH2A	  enrichments	  around	  a	  DSB	  are	  anti-­‐correlated,	  suggesting	  	  that	  resection	  as	  read	  by	  RPA	  enrichment	  evicts	  histones	  and	  thereby	  the	  substrate	  for	  γH2A	  	  phosphorylation.	  Overlay	  of	  RPA	  (red)	  and	  γH2A	  (blue)	  ChIP	  signals	  after	  4h	  of	  DSB	  in	  WT	  (left	  panel)	  and	  exo1∆	  
sgs1∆	  cells	  (right	  panel)	  cells	  arrested	  in	  M	  phase.	  
(B)	  γH2A	  phosphorylation	  spreads	  over	  a	  large	  distance	  from	  a	  DSB	  (>75	  kb)	  in	  WT	  and	  exo1∆	  
sgs1∆	  cells.	  With	  the	  exception	  of	  the	  area	  of	  resection	  (Fig.	  S1A),	  resection	  has	  no	  influence	  on	  
γH2A	   phosphorylation.	   ChIP-­‐qPCR	   analysis	   of	  WT	   cells	   or	   exo1∆	   sgs1∆	   cells	   after	   4h	   of	   DSB	  induction.	  
γH2A	  phosphorylation	  and	  RPA	  enrichment	  around	  two	  distinct	  DSBs	  anti-­‐correlate	  in	  ChIP-­‐seq	  experiments	  (C)	  and	  depend	  on	  the	  presence	  of	  the	  DSBs	  (D).	  
(C)	   Overlay	   of	   ChIP-­‐seq	   profiles	   from	   the	   same	   experiment	   as	   shown	   in	   Fig.	   1C.	   RPA	  enrichments	  are	  plotted	  in	  blue,	  γH2A	  phosphorylation	  is	  plotted	  in	  yellow.	  The	  positions	  of	  the	  HO-­‐induced	  DSBs	  on	  chromosome	  3	  (upper	  two	  panels)	  and	  chromosome	  4	  (lower	  two	  panels)	  are	   indicated	   by	   the	   red	   dotted	   line.	  WT	   cells	   (upper	   traces)	   are	   compared	  with	   exo1∆	  sgs1∆	  mutant	  cells	  (lower	  traces).	  	  
(D)	  ChIP-­‐seq	  profiles	  of	   the	  0h	   time	  point	  before	   induction	  of	  DSB.	  Samples	  were	  obtained	   in	  the	  same	  experiment	  as	  data	  shown	  in	  Fig.	  1B	  and	  Fig.	  S1A.	  Analysis	  of	  the	  enrichment	  of	  RPA	  (upper	  panel,	  respectively)	  and	  γH2A	  phosphorylation	  (lower	  panel,	  respectively).	  	  
(E)	  Overlay	  of	  ChIP-­‐qPCR	  and	  ChIP-­‐seq	  signals.	  WT	   and	  exo1∆	  sgs1∆	   cells	  were	  arrested	   in	  M	  phase	  and	  analysed	  for	  γH2A	  phosphorylation	  after	  4h	  of	  DSB	  induction.	  qPCR	  signals	  (red)	  are	  from	  the	  same	  experiment	  as	   in	  (B).	  Sequencing	  data	  (blue)	   is	   from	  the	  experiment	  plotted	   in	  Fig.	  1C	  and	  Fig.	  S1C	  and	  S1D.	  	  	  
Figure	  S2	  
γH2A	  phosphorylation	  is	  not	  correlating	  with	  ssDNA	  signal	  strength	  –	  additional	  controls.	  
	  (A)	  DNA	  end	  resection	  (left	  panel)	  and	  γH2A	  phosphorylation	  (right	  panel)	  were	  measured	  by	  ChIP	  in	  WT	  strains	  or	  exo1∆	  sgs1∆	  strains	  with	  both	  mating	  type	  loci	  deleted,	  or	  intact	  HML	  or	  intact	   HML	   and	   HMR	   loci.	   All	   strains	   used	   in	   this	   study	   were	   HML	   hmr∆	   if	   not	   indicated	  differently.	  Samples	  were	  analysed	  after	  4	  h	  of	  DSB	  induction.	  	  
(B)	  Also	  at	  an	  independent	  locus	  (ARS607),	  γH2A	  phosphorylation	  around	  a	  DSB	  is	  not	  showing	  a	   response	   that	   correlates	   with	   the	   ssDNA	   signal.	   ChIP-­‐qPCR	   analysis	   of	   strains	   carrying	   an	  ectopic	   HO	   cutsite	   on	   ARS607	   arrested	   in	   G1	   (left	   panels)	   or	   M	   phase	   (right	   panels).	   RPA	  enrichment	   (upper	   panels)	   and	   γH2A	   phosphorylation	   (lower	   panels)	   were	   analysed	   at	  indicated	  times.	  	  
(C)	   Manipulation	   of	   DNA	   end	   resection	   by	   de-­‐regulation	   of	   the	   Sgs1	   helicase	   does	   not	   affect	  
γH2A	  phosphorylation.	  ChIP-­‐qPCR	  analysis	  of	   a	  WT	  strain	   arrested	   in	  G1	   (left	  panels)	  or	   in	  M	  phase	  (middle	  panels)	  and	  an	  sgs1-­‐ss	  mutant	  strain	  in	  M	  phase	  (right	  panels).	  Resection	  (upper	  panels)	  and	  γH2A	  phosphorylation	  (lower	  panels)	  were	  analysed	  at	  indicated	  times.	  	  
(D)	  Rtt107	  is	  associating	  with	  a	  DSB	  in	  a	  resection-­‐independent	  manner.	  Rtt107	  recruitment	  to	  a	  DSB	  was	  measured	  at	  indicated	  times	  in	  WT	  strains	  arrested	  in	  G1	  (left	  panel)	  or	  in	  M	  phase	  (middle	   panel),	   or	   in	   exo1∆	   sgs1∆	   cells	   arrested	   in	  M	   phase	   (right	   panel).	   Rtt107	  was	   tagged	  with	  a	  C-­‐terminal	  3FLAG	  tag	  and	  detected	  by	  a	  ChIP	  directed	  against	  the	  FLAG	  tag.	  	  	  
Figure	  S3	  DNA	   damage	   checkpoint	   signalling	   can	   be	   subdivided	   in	   two	   separate,	   Mec1-­‐dependent	  signaling	  circuits.	  Models	  of	  local	  (A)	  and	  global	  (B)	  checkpoint	  signalling	  circuits.	  	  
(A)	  Mec1-­‐Ddc2	   (orange)	  bound	   to	  RPA	   (red)	  phosphorylates	  γH2A	  as	  a	   substrate	  of	   the	   local	  checkpoint	  signalling	  circuit	  (green)	  in	  a	  resection-­‐independent	  manner.	  	  
(B)	  Mec1-­‐Ddc2	  (orange)	  bound	  to	  RPA	  (red)	  phosphorylates	  the	  checkpoint	  proteins	  of	  the	  9-­‐1-­‐1	   axis	   (Ddc1,	  Dpb11,	  Rad9	   and	  Rad53,	   shades	   of	   blue)	   as	   substrates	   of	   the	   global	   checkpoint	  signalling	  circuit,	  which	  depends	  on	  DNA	  end	  resection	  and	  culminates	  in	  the	  activation	  of	  the	  Rad53	  effector	  kinase.	  	  
	  
Figure	  S4	  
γH2A	   phosphorylation	   is	   strongly	   dependent	   on	   Mec1,	   but	   only	   weakly	   on	   Tel1,	   and	   is	   not	  influenced	  by	  specific	  Mec1	  activators.	  	  
(A)	   γH2A	   and	   Rad53	   phosphorylation	   after	   phleomycin	   treatment	   are	   strongly	   decreased	   in	  cells	   lacking	  Mec1,	  but	  almost	  unaffected	   in	  cells	   lacking	  Tel1.	  Western	  blot	  analysis	  of	  Rad53	  phosphorylation	   (upper	   panels,	   respectively),	   γH2A	   phosphorylation	   (middle	   panels,	  respectively)	  and	  PGK1	  as	  a	  control	  for	  protein	  levels	  (lower	  panels,	  respectively)	  in	  WT	  cells	  or	  
exo1∆	   sgs1∆,	  mec1∆	   sml1∆,	   exo1∆	   sgs1∆	   mec1∆	   sml1∆,	   tel1∆,	   exo1∆	   sgs1∆	   tel1∆	   mutant	   cells	  arrested	  in	  M	  phase	  after	  treatment	  with	  50	  µg/ml	  phleomycin	  for	  the	  indicated	  times.	  	  
(B)	  γH2A	  formation	  at	  a	  DSB	  strongly	  depends	  on	  the	  Mec1	  kinase.	  IP/input	  ratios	  of	  the	  ChIP-­‐qPCR	   analysis	   of	   γH2A	   (upper	   panels)	   and	   RPA	   (lower	   panels)	   after	   indicated	   times	   of	   DSB	  
induction	   in	   M	   phase-­‐arrested	   cells.	   sml1∆	   mec1∆	   cells	   (right	   panels,	   respectively)	   were	  compared	  to	  sml1∆	  cells	  (left	  panels,	  respectively).	  
(C)	   Damage-­‐independent	   levels	   of	   γH2A	   phosphorylation	   at	   two	   independent	   loci	   on	   non-­‐broken	   chromosomes	   are	   reduced	   in	   cells	   lacking	  Mec1.	   γH2A	  ChIP	   IP/input	   ratios	   from	   two	  loci	  on	  distinct,	  undamaged	  chromosomes	  are	  plotted.	  The	  values	  are	  from	  the	  same	  experiment	  as	  in	  (B).	  	  
(D)	   γH2A	  phosphorylation	   is	   not	   influenced	   by	   the	   absence	   of	   a	   specific	  Mec1	   activator	   after	  phleomycin	   treatment.	   Western	   blot	   analysis	   of	   γH2A	   phosphorylation	   (upper	   panels,	  respectively)	  and	  PGK1	  as	  a	  control	   for	  protein	  concentrations	   (lower	  panels,	   respectively)	   in	  
WT	  cells	  or	  ddc1∆,	  dpb11∆C	  or	  dna2-­‐WYAA	  mutant	  cells,	  either	   in	  a	  WT	  background	  or	  a	  tel1∆	  background	  arrested	  in	  M	  phase.	  Samples	  were	  analysed	  at	  indicated	  time	  points.	  	  	  
Figure	  S5	  Regulators	  of	  the	  global	  checkpoint	  circuit	  (9-­‐1-­‐1	  axis)	  differentially	  localize	  to	  a	  DSB	  in	  G1	  and	  M	  phase-­‐arrested	  cells.	  	  
(A)	  Recruitment	  of	  9-­‐1-­‐1	   (Ddc1),	  Dpb11	  and	  Rad9	   is	   enhanced	   in	  M	  phase.	  ChIP-­‐qPCR	  of	  WT	  strains	  arrested	  in	  G1	  (left	  panels)	  or	  M	  phase	  (right	  panels)	  at	   indicated	  times.	  For	  detection,	  Ddc1,	   Dpb11	   and	   Rad9	   were	   tagged	   with	   a	   C-­‐terminal	   3FLAG	   tag,	   and	   ChIPs	   were	   directed	  against	  the	  FLAG	  tag.	  	  
(B)-­‐(D)Additional	  information	  to	  the	  microscopical	  Ddc1-­‐	  and	  RPA-­‐	  foci	  analysis	  in	  Fig.	  3D-­‐G.	  
(B)	   Representative	  microscopy	   images	   from	   the	   Rfa1-­‐	   and	   Ddc1-­‐foci	   analysis	   in	   G1-­‐arrested	  cells.	   A	  DSB	  was	   induced	   at	   the	  MAT	   locus	   in	   G1	   phase-­‐arrested	   cells	   using	  Gal-­‐HO	   and	   cells	  were	  microscopically	   analysed	   for	  Ddc1-­‐YFP	   foci	   (yellow,	   left	   panel)	   and	  Rfa1-­‐CFP	   foci	   (blue,	  second	   to	   the	   left	  panel)	   from	  4h	   timepoint.	  An	  overlay	  of	  both	   imaging	  channels	   is	   shown	   in	  panel	  three	  and	  a	  bright	  field	  image	  of	  the	  yeast	  cells	  in	  the	  right	  panel.	  	  
(C)	  FACS	  analysis	  of	  G1	  arrest.	  Cells	  were	  fixed	  for	  FACS	  analysis	  before	  addition	  of	  alpha-­‐factor	  at	  0,	  2	  and	  4	  hours	  of	  DSB	  induction.	  The	  graphs	  show	  the	  DNA	  content	  per	  cell.	  	  
(D)	  Normalization	  of	  Rfa1	   and	  Ddc1	   foci	   intensity	   against	  Rad52	   as	   a	   standard.	   YFP	   and	  CFP	  intensities	  were	  quantified	   throughout	   the	  nucleus	   and	   the	   total	   number	  of	   tagged	  molecules	  was	   calculated	   by	   comparing	   the	   values	   to	   the	   intensity	   of	   the	   respectively	   tagged	   Rad52	  molecules.	  	  	  
Figure	  S6	  The	  Rad9-­‐dpb11∆N	  fusion	  is	  partly	  dependent	  on	  Ddc1	  phosphorylation.	  	  
(A)	  ChIP-­‐qPCR	  analysis	  of	  DNA	  resection	  (upper	  panels)	  and	  Rad9	  recruitment	  (lower	  panels)	  in	  WT	   cells,	  Rad9-­‐dpb11∆N	  fusion	   cells	   and	  Rad9-­‐dpb11∆N	  fusion	  ddc1-­‐T602A	  cells.	  All	   strains	  
were	  arrested	  in	  M	  phase	  and	  samples	  were	  taken	  at	  indicated	  time	  points.	  For	  detection,	  Rad9	  and	   the	  Rad9	   fusion	  were	   tagged	  C-­‐terminally	  with	  a	  3FLAG	   tag	  and	   the	  ChIPs	  were	  directed	  against	  the	  3FLAG	  tag.	  The	  data	  in	  the	  left	  and	  middle	  panels	   is	   identical	  to	  the	  data	  shown	  in	  Fig.	  4C.	  	  
(B)	  The	  same	  strains	  as	  in	  (A)	  were	  analysed	  for	  checkpoint	  activation	  in	  a	  Rad53	  Western	  Blot,	   including	   a	   ddc1-­‐T602A	   mutant	   strain.	   The	   Western	   Blot	   samples	   are	   from	   the	   same	  experiment	  as	  shown	  in	  Fig.	  4D.	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A cell cycle-independent mode 
of the Rad9-Dpb11 interaction is 
induced by DNA damage
Giulia di Cicco, Susanne C. S. Bantele, Karl-Uwe Reusswig  & Boris Pfander  
Budding yeast Rad9, like its orthologs, controls two aspects of the cellular response to DNA double 
strand breaks (DSBs) – signalling of the DNA damage checkpoint and DNA end resection. Rad9 binds 
to damaged chromatin via modified nucleosomes independently of the cell cycle phase. Additionally, 
Rad9 engages in a cell cycle-regulated interaction with Dpb11 and the 9-1-1 clamp, generating a 
second pathway that recruits Rad9 to DNA damage sites. Binding to Dpb11 depends on specific S/TP 
phosphorylation sites of Rad9, which are modified by cyclin-dependent kinase (CDK). Here, we show 
that these sites additionally become phosphorylated upon DNA damage. We define the requirements 
for DNA damage-induced S/TP phosphorylation of Rad9 and show that it is independent of the cell 
cycle or CDK activity but requires prior recruitment of Rad9 to damaged chromatin, indicating that it is 
catalysed by a chromatin-bound kinase. The checkpoint kinases Mec1 and Tel1 are required for Rad 
9 S/TP phosphorylation, but their influence is likely indirect and involves phosphorylation of Rad9 at S/
TQ sites. Notably, DNA damage-induced S/TP phosphorylation triggers Dpb11 binding to Rad9, but 
the DNA damage-induced Rad9-Dpb11 interaction is dispensable for recruitment to DNA damage sites, 
indicating that the Rad9-Dpb11 interaction functions beyond Rad9 recruitment.
DNA damage (such as double strand breaks (DSBs)) elicits cellular signalling pathways, collectively known as the 
DNA damage response (reviewed in ref. 1). Among these, checkpoint mechanisms control cell cycle progression 
as well as transcriptional and post-translational regulation of DNA repair and replication. Furthermore, local 
signalling events are critical in directing DNA repair pathway choice. Budding yeast Rad9 was the first checkpoint 
protein to be discovered2. Since then, it has become evident that Rad9, as well as its orthologs such as fission yeast 
Crb23, 4 and human 53BP1 (reviewed in ref. 5), play a crucial role in the DNA damage response, having at least 
two functions: signal transduction in the DNA damage checkpoint (reviewed in ref. 1) and control of DNA end 
resection, a local process that critically determines DSB repair pathway choice (reviewed in ref. 6).
As checkpoint signalling mediator, Rad9 links the signal transduction from the apical kinase Mec1 to the 
effector kinase Rad537–12. As such, it is essential for activation of Rad53 and therefore for the activation of a 
global checkpoint response upon DNA damage. Moreover, Rad9 is also an inhibitor of DNA end resection13–16. 
Since DNA end resection generates the DNA substrate for recombination-based repair and interferes with 
ligation-based repair, Rad9 is a critical regulator of DSB repair pathway choice. To fulfil these two functions, Rad9 
engages in several protein-protein interactions that occur within damaged chromatin17–22.
Rad9 binds to modified histones via two distinct domains. The TUDOR domain of Rad9 interacts with histone 
H3 in its K79-methylated form19, 22, a widespread modification of chromatin that is introduced by the methyl-
transferase Dot123, 24. The tandem-BRCT domain of Rad9 interacts with histone H2A in its S129-phosphorylated 
form (γH2A21, 25), a DNA damage-specific chromatin mark introduced by the apical checkpoint kinases Mec1 
and Tel126. As such, Rad9 is a bivalent nucleosome binder, a feature that is conserved among Rad9 orthologs, even 
though different histone marks are being recognized27–31.
Rad9 also binds to the scaffold protein Dpb1117, 18. Dpb11 contains two pairs of BRCT domains, which provide 
two phospho-protein binding surfaces (reviewed in ref. 32). While Rad9 binds to BRCT1 + 2, Dpb11 also inter-
acts with the 9-1-1 complex via BRCT3 + 417, 33, 34. Physical and genetic interaction data suggest that these inter-
actions generate a second pathway that recruits Rad9 to DNA damage sites: DNA damage-loaded 9-1-1 can tether 
Dpb11, which in turn can recruit Rad917, 33. Notably, the interaction of Dpb11 with Rad9 depends on Rad9 phos-
phorylation at S462 and T474 residues17. Both sites match the minimal consensus (S/TP) for phosphorylation 
Max Planck Institute of Biochemistry, DNA Replication and Genome Integrity, Martinsried, Germany. 
Correspondence and requests for materials should be addressed to B.P. (email: bpfander@biochem.mpg.de)
Received: 20 July 2017
Accepted: 30 August 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIeNtIfIC RepoRts | 7: 11650  | DOI:10.1038/s41598-017-11937-z
by cyclin-dependent kinase (Cdc28, in the following referred to as CDK) and consistently a CDK-dependent 
interaction between Rad9 and Dpb11 can be observed in G2/M-arrested cells17.
Furthermore, Rad9 binds to the checkpoint effector kinase Rad537, 8, 10, 12. This interaction involves phospho-
rylation of Rad9 in the S/TQ cluster domain (SCD), which is specifically bound by the FHA domains of Rad53. 
Rad9 is phosphorylated in the SCD by the apical kinases Mec1 and Tel1 upon association with damaged chro-
matin7, 12. Current models suggest that Rad53 is transiently recruited to damaged chromatin by this mechanism 
(reviewed in ref. 1). Here, it becomes activated by Mec1/Tel1 phosphorylation, before it dissociates from the DNA 
damage site to set off the global DNA damage response.
Promoting Rad53 phosphorylation and activation offers a straightforward mechanism of how Rad9 mediates 
checkpoint signalling. In contrast, it is less clear by which mechanism Rad9 regulates DNA end resection13, 14, 
even though an antagonistic relationship between Rad9 and the resection-promoting nucleosome remodeller 
Fun30 has been demonstrated35, 36.
Rad9 recruitment to damaged chromatin occurs in all cell cycle phases19. However, individual Rad9 recruit-
ment mechanisms are apparently under cell cycle control17, 33. Previous data has therefore led to a model where 
in G1 only one Rad9 recruitment pathway (via interaction with modified nucleosomes, referred to as the ‘his-
tone pathway’19–22, 25) is active, while outside of G1 a second Rad9 recruitment pathway (via Dpb11 and 9-1-1, 
referred to as the ‘Dpb11 pathway’) is additionally available17, 33. However, the underlying reason for restricting 
the Rad9-Dpb11 interaction to specific cell cycle phases is not understood.
Here, we report new aspects in the regulation of Rad9 in the response to DSBs. We find that the Rad9 S/TP 
sites, which facilitate Dpb11-binding, are also phosphorylated upon DNA damage independently of the cell cycle 
phase. DNA damage-dependent phosphorylation of these sites can be detected even in G1 cells or upon inhi-
bition of CDK. Notably, these phosphorylation events depend on prior chromatin-recruitment of Rad9 via the 
‘histone pathway’ and on the integrity of the SCD domain of Rad9. Furthermore, the Rad9 phosphorylation facil-
itates the interaction between Rad9 and Dpb11, similarly to our previous results on the CDK-dependent mode of 
interaction. These findings suggest that Dpb11 and Rad9 can interact even in G1, where Dpb11 is not involved in 
recruiting Rad9 to damaged chromatin.
Results
DNA damage induces phosphorylation of Rad9 S/TP sites and binding of Rad9 to Dpb11. 
Orthologs of Rad9 and Dpb11 were found to interact in different organisms17, 18, 29, 37. In case of budding yeast, our 
previous work has shown that Rad9 specifically interacts with Dpb11 in cells arrested in M phase, but not in cells 
arrested in G117. The cell cycle-regulation of the interaction is achieved by CDK-dependent phosphorylation of 
two S/TP motifs on Rad9 (S462 and T474, referred to as Rad9 S/TP sites hereafter), which are recognized by the 
BRCT1 + 2 domain of Dpb1117.
We observed that Rad99myc from cell extracts of cells containing MMS-induced DNA damage showed 
increased interaction with GSTDpb11 in pulldown experiments (Fig. S1A). Strikingly, even when we used cells 
arrested in G1, we found that DNA damage treatment with the DSB-inducing agent phleomycin resulted in 
an increased interaction of Rad99myc with GSTDpb11 (Figs 1A and S1B). Phleomycin treatment causes Rad9 to 
undergo a phospho-shift (Fig. 1A)8, 10–12. Notably, we found Dpb11 to associate with this hyperphosphorylated 
form of Rad9 (Fig. 1A). In contrast, in M phase cell extracts Rad99myc was able to interact with GSTDpb11 even in 
the absence of DNA damage treatment (Fig. 1A), consistent with our previous result on the CDK regulation of 
Rad917.
The interaction between Rad9 and Dpb11 critically depends on phosphorylation of S462 and T474 on Rad917. 
We therefore tested, whether phosphorylation of these sites is also induced by DNA damage. To this end, we 
used our previously generated phosphorylation-specific antibodies directed against Rad9-epitopes contain-
ing either phosphorylated S462 or phosphorylated T474, respectively17 (note that anti-Rad9-T474p is highly 
specific for the phosphorylated form, while anti-Rad9-S462p retains some binding to the unmodified form). 
When we purified Rad9 via IP from M phase cells, we observed that these Rad9 S/TP sites were phosphoryl-
ated in the presence as well as in the absence of DNA damage, consistent with these sites being modified by 
CDK (Figs 1B and S1C)17. Notably, we observed that the S/TP sites were also phosphorylated specifically in 
phleomycin-treated G1 cells, but not in the absence of DNA damage (Fig. 1B, note the phleomycin-induced phos-
phorylation shift). The anti-Rad9-T474p antibody can also detect Rad9 S/TP phosphorylation from cell extracts. 
Figure 1C shows Rad9-T474 phosphorylation in undamaged M phase cells, as well as damaged G1 and M phase 
cells, but not in undamaged G1 cells, corroborating the result of the IP experiment. Moreover, cells expressing the 
rad9-ST462,474AA variant (referred to as rad9-AA hereafter) did not show any reactivity with the Rad9-T474p 
antibody, confirming specificity (Figs 1C and S1D). We therefore conclude that there are two different modes of 
Rad9 S/TP phosphorylation: mode 1, which is cell cycle-regulated and depends on CDK17, and mode 2, which is 
DNA damage-dependent.
In order to verify that the DNA damage-induced phosphorylation of Rad9 in G1 is CDK-independent, we 
used a cdc28-as1 mutant strain, in which CDK activity was effectively inhibited by addition of 1-NM-PP1, but this 
did not abrogate Rad9-T474 phosphorylation after DNA damage (Figs 1D and S1E). We furthermore used the 
same strategy of CDK-inhibition in M phase-arrested cells and found that CDK-dependent phosphorylation of 
Rad9-T474 in undamaged cells was effectively inhibited in line with previous results (Figs 1E and S1F)17. Notably, 
phleomycin treatment efficiently stimulated phosphorylation of Rad9-T474 in M phase-arrested cells after CDK 
inhibition (Fig. 1E). Taken together, these data show that the damage-induced phosphorylation of the Rad9 S/TP 
sites occurs independently of the cell cycle phase and CDK activity (Fig. 1E).
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DNA damage-induced phosphorylation of the Rad9 S/TP sites depends on the apical check-
point kinases Mec1 and Tel1 and the Rad9 SCD. Upon DNA damage, the apical checkpoint kinases 
Mec1 and Tel1 target several sites on Rad98, 11, 12. Therefore, we tested whether also the phosphorylation of 
Rad9 S/TP sites would be dependent on Mec1 and Tel1. Notably, T474 phosphorylation in G1-arrested, 
Figure 1. A CDK-independent, DNA damage-dependent mode of Rad9-S462 and -T474 phosphorylation 
and interaction with Dpb11. (A) DNA damage stimulates the Rad9-Dpb11 interaction in cell extracts. GST 
pulldown experiment with GSTDpb11-N (contains BRCT1 + 2, which is the Rad9 interaction site) and extracts 
from Rad99myc-expressing cells arrested in G1 (α-factor arrest) or M phase (nocodazole arrest) and treated 
with phleomycin or mock treated. FACS profiles in Fig. S1B. (B,C) Phosphorylation of Rad9-S462 and -T474 
is stimulated by DNA damage in G1. (B) Rad93FLAG was purified from cells treated as in (A) by FLAG-IP. 
Phosphorylation of Rad9 S/TP sites was determined using Rad9-S462p and Rad9-T474p phosphorylation-
specific antibodies. FACS profiles in Fig. S1C. (C) Cells treated as in (A) were used to prepare whole cell extract, 
which was probed with the Rad9-T474p phosphorylation-specific antibody. The rad9-AA strain (harbouring 
the S462A and T474A mutations) was used as specificity control. Pgk1 immunoblot serves as loading control. 
FACS profiles in Fig. S1D. (D,E) CDK inhibition does not affect damage-induced Rad9 S/TP phosphorylation. 
(D) 1-NM-PP1 was used to inhibit CDK in G1-arrested cdc28-as1 cells, but this did not affect Rad9-T474 
phosphorylation after DNA damage. FACS profiles in Fig. S1E. (E) As in (D), but with M phase-arrested cells. 
1-NM-PP1 treatment abolished T474 phosphorylation in undamaged cdc28-as1 cells, demonstrating that CDK 
is inhibited under these conditions. In contrast T474 is efficiently phosphorylated after phleomycin treatment, 
even after CDK inhibition. Pgk1 immunoblot serves as loading control. The asterisk denotes a crossreactive 
band. FACS profiles in Fig. S1F.
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phleomycin-treated cells was reduced in mec1Δ and tel1Δ mutant cells and completely abolished in a mec1Δ 
tel1Δ double mutant (Figs 2A and S2A). Therefore, phosphorylation of Rad9 S/TP sites shows a dependency on 
the apical checkpoint kinases, which is highly similar to overall damage-induced Rad9 phosphorylation (indi-
cated by the phosphoshift, Fig. 2A). In contrast, the deletion mutants of the checkpoint effector kinases RAD53 or 
CHK1, alone or in combination, did not affect T474 phosphorylation (Figs 2B and S2B).
It could thus be reasoned that Rad9 S/TP sites are themselves targeted by the apical checkpoint kinases Mec1 
and Tel1, similarly to Rad9 S/TQ sites8, 11, 12. However, we did not obtain evidence that purified Mec1 would show 
activity towards Rad9 S/TP sites in vitro (data not shown). Therefore, we considered the option that the apical 
checkpoint kinases could promote Rad9 S/TP site phosphorylation indirectly. Possible mechanisms include a 
priming role of Rad9 S/TQ phosphorylation or Mec1/Tel1 promoting chromatin recruitment of a factor involved 
in S/TP site phosphorylation, such as the kinase acting on Rad9 or Rad9 itself (via γH2A). Indeed, we found that 
a Rad9 mutant harbouring six S/T to A exchanges in the S/TQ cluster domain (SCD) (rad9-6AQ)12 abolished 
phleomycin-induced phosphorylation of Rad9 S/TP sites in G1 (Figs 2C and S2C). In contrast, CDK-dependent 
phosphorylation of these sites in M phase was unaffected by the rad9-6AQ mutant (Fig. S2D). Previous work has 
suggested that phosphorylation of the SCD would induce Rad9 dimerization38. However, we excluded dimeriza-
tion as underlying cause for the SCD-dependency, as the dimerization-defective Rad9-S1129A variant38 showed 
normal phosphorylation of Rad9-T474 both in G1 after DNA damage and in M phase (Figs 2C and S2D). Overall, 
we conclude that Mec1/Tel1-dependent phosphorylation of the SCD of Rad9 is required for phosphorylation 
of the Rad9 S/TP sites upon DNA damage, but additional direct and/or indirect roles of the apical checkpoint 
kinases are possible.
Figure 2. Mec1 and Tel1 are required for phosphorylation of Rad9 S/TP sites after DNA damage. (A) 
Rad9-T474 phosphorylation after DNA damage depends on the apical checkpoint kinases Mec1 and Tel1. 
G1-arrested cells with indicated genotypes were treated with phleomycin, Rad9-T474 phosphorylation was 
visualized by immunoblotting. Strains containing the mec1Δ mutation are in sml1Δ background. Pgk1 
immunoblot serves as loading control. An asterisk denotes a crossreactive band. FACS profiles in Fig. S2A. 
(B) Rad9-T474 phosphorylation after DNA damage is independent of checkpoint effector kinases Chk1 and 
Rad53. G1-arrested cells with indicated genotypes were treated with phleomycin and subjected to analysis with 
immunoblots as in (A). Strains containing the rad53Δ mutation are in sml1Δ background. FACS profiles in 
Fig. S2B. (C) Integrity of the Rad9 SCD domain is important for damage-induced Rad9 S/TP phosphorylation. 
Treatment and immunoblotting of WT, rad9-6AQ and rad9-S1129A strains as in (A). FACS profiles in Fig. S2C.
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Chromatin-recruitment of Rad9 is required for phosphorylation of the Rad9 S/TP sites. 
Previous studies suggest two possible pathways by which Rad9 is recruited to damaged chromatin (‘histone 
pathway’19–22, 25 and ‘Dpb11 pathway’17, 33). In G1 cells, however, the ‘histone pathway’ is apparently uniquely 
required17, 33. Given our findings, we re-investigated the possibility that the ‘Dpb11 pathway’ may be contributing 
to Rad9 recruitment and also tested the alternative model that the damage-induced Rad9-Dpb11 interaction in 
G1 may rely on the ‘histone pathway’.
A critical element of the ‘histone pathway’ is K79-methylation of H3, which is catalysed by the Dot1 methyl-
transferase23 and recognized by the TUDOR domain of Rad919, 22. We therefore tested Rad9 binding to damaged 
chromatin by ChIP in G1-arrested cells and used the GAL-HO system to induce a site-specific, non-repairable 
DSB at the MAT locus39. While Rad9 became enriched in the chromatin region surrounding the DSB in WT cells 
after DSB induction, Rad9 enrichment was strongly decreased in dot1Δ cells (Figs 3A and S3A). Consistent with 
a lack of Rad9 recruitment to damaged chromatin, we observed that damage-induced phosphorylation of Rad9 
S/TP sites was reduced in G1 cells lacking Dot1 (Figs 3B and S3D).
Intriguingly, deletion of DOT1 caused a strong reduction of Rad9-T474 phosphorylation in 
phleomycin-treated G1 cells (Fig. 3B). To ascertain that this effect originated from a defect in the interac-
tion of Rad9 with nucleosomes (i.e. a deficient ‘histone pathway’), we introduced the corresponding H3 
K79-binding-defective mutation in the Rad9 TUDOR domain (rad9-Y798Q19) and observed a highly similar 
Figure 3. Dot1 is required for phosphorylation of Rad9 S/TP sites and interaction with Dpb11. (A) Dot1 is 
required for Rad9 association with a double strand break (DSB). Induction of an non-repairable DSB at MAT 
locus using galactose-induced HO. ChIP against Rad93FLAG to regions from 1.1 kb to 8 kb distal of the DSB site 
and 1, 2 and 4 h after DSB induction. FACS profiles in Fig. S3A. (B–D) The ‘histone pathway’ is required for 
efficient damage-induced phosphorylation of Rad9-T474 and binding to Dpb11. (B) Phleomycin-induced T474 
phosphorylation is reduced in dot1Δ or rad9-Y789Q cells (deficient in TUDOR domain-dependent binding to 
K79-methylated H3). Experiment as in Fig. 2A, but with WT, dot1Δ and rad9-Y789Q cells. Pgk1 immunoblot 
serves as loading control. An asterisk denotes a crossreactive band. FACS profiles in Fig. S3D. (C) Dpb11 does 
not bind to Rad9 from extracts of G1-arrested, phleomycin-treated dot1Δ cells. GST-Dpb11-N pulldown as 
in Fig. 1A (D) DNA damage-induced Rad9-T474 phosphorylation in G1 as in (B), but with WT, ddc1-T602A, 
dot1Δ or dot1Δ ddc1-T602A strains. FACS profiles in Fig. S3E.
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reduction in Rad9-T474 phosphorylation in this background (Fig. 3B). This effect was again specific for the DNA 
damage-induced phosphorylation of Rad9 S/TP sites (mode 2), as neither a dot1Δ nor a rad9-Y798Q mutation 
diminished CDK-dependent phosphorylation of Rad9-T474 in M phase (Fig. S3B,C).
We expected that a lack of Rad9 S/TP phosphorylation would translate into an inability to bind to Dpb11. 
Indeed, we observed a reduced association of Rad9 in GSTDpb11 pulldowns in the absence of Dot1, when the 
Rad9-Dpb11 association was induced by phleomycin-treatment of G1-arrested cells (Fig. 3C).
We observed that dot1Δ as well as rad9-Y798Q cells showed minor residual Rad9-T474 phosphorylation in 
G1 (Fig. 3B), which responded dose-dependently to phleomycin (Fig. S3D). Since M phase cells could compen-
sate a defect in the ‘histone pathway’ by Dpb11-dependent Rad9 recruitment (‘Dpb11 pathway’17, 33), we tested 
if the ‘Dpb11 pathway’ would be responsible for the residual phosphorylation of Rad9. However, we did not 
observe any additional defect in Rad9-T474 phosphorylation, when we introduced the Dpb11-binding-deficient 
ddc1-T602A allele either alone or in combination with dot1Δ (Figs 3D and S3E). Therefore, we conclude that 
Rad9 S/TP site phosphorylation after DNA damage as well as the interaction of Dpb11 and Rad9 are dependent 
on the ‘histone pathway’.
Forced Rad9 recruitment to damaged chromatin allows efficient Rad9 S/TP site phosphoryla-
tion. The ‘histone pathway’ facilitates Rad9 recruitment to damaged chromatin. We reasoned that the depend-
ency of the damage-induced Rad9 S/TP-phosphorylation on the ‘histone pathway’ could be easily explained, if 
Rad9 needed to localize to damaged chromatin in order to become phosphorylated. We therefore aimed to create 
a cellular scenario, which forces Rad9 localization to damaged chromatin independently of the ‘histone pathway’.
We have previously shown that covalent protein-fusions containing the BRCT3 + 4 domain of Dpb11 
localized efficiently and cell cycle-independently to damaged chromatin36. In case of Rad9, this fusion protein 
(Rad9-Dpb11∆N, referred to as Rad9-Dpb11 fusion) hyperactivates DNA damage checkpoint signalling17. To 
ascertain that this fusion acts by forcing Rad9 localization to damaged chromatin, we measured inhibition of 
DNA end resection by Rad9 as a read-out of Rad9 function13, 14. Therefore, we tested the extent of resection at 
an HO-induced DSB using ChIP against the ssDNA-binding protein RPA. In the presence of the Rad9-Dpb11 
fusion, the spreading of resection was strongly reduced independently of the cell cycle phase and the functionality 
of the ‘histone pathway’ (Figs 4A and S3A,B). These data therefore suggest a model whereby the Rad9-Dpb11 
fusion forces enhanced Rad9 recruitment to damaged chromatin, where it causes hyperactivation of the DNA 
damage checkpoint, as well as inhibition to DNA end resection, consistent with previous results17, 40.
Next, we used the Rad9-Dpb11 fusion to test its effects on Rad9 S/TP site phosphorylation. We found that 
after DNA damage induction Rad9-T474 phosphorylation was enhanced in the context of the Rad9-Dpb11 
fusion and even present to low levels without induction of exogenous damage (Figs 4B and S4C,D). Importantly, 
in the context of the fusion Rad9-T474 phosphorylation was largely independent of Dot1 (Fig. 4B), while it still 
showed dependency on the apical kinases Mec1 and Tel1 (Figs 4C and S4E). Overall, these data suggest that the 
function of the ‘histone pathway’ in damage-induced Rad9 S/TP phosphorylation lies entirely in the recruitment 
of Rad9 to damaged chromatin.
Rad9 S/TP phosphorylation in G1 is dispensable for DNA end resection and the DNA damage 
checkpoint. Outside of G1, CDK-phosphorylation of Rad9 S/TP sites provides a pathway of Rad9 recruit-
ment to damaged chromatin17. However, in case of the damage-induced Rad9 phosphorylation mode, our data 
rather suggest a function downstream of recruitment (Figs 3 and 4). So far, Rad9 is known to have two functions 
– (A) inhibition of DNA end resection and (B) activation of the DNA damage checkpoint. Therefore, we tested if 
the rad9-AA variant would show a G1-specific defect in any of these functions.
To measure DNA end resection, we again used the GAL-HO system and ChIP against RPA. Consistent with 
previous studies13, 14, we observed enhanced spreading of the RPA-ChIP signal away from the site of the DSB in 
rad9Δ and dot1Δ strains, indicating enhanced DNA end resection in the absence of chromatin-bound Rad9 
(Figs 5A and S5A). However, we did not observe any significant change in DNA end resection in G1-arrested 
rad9-AA cells, even in the absence of Yku70, suggesting that the Rad9-Dpb11 interaction on its own is not 
required for regulation of DNA end resection in G1 (Figs 5A,B and S5B).
For checkpoint activation, we have previously shown that the rad9-AA mutant on its own does not induce any 
defects in the phosphorylation of the Rad53 effector kinase in G1 cells17 (see also Figs 5C and S5C). We therefore 
considered the possibility that a defect in damage-induced Rad9 S/TP phosphorylation may be compensated 
by other factors. Specifically, we tested compensation by the 9-1-1 complex, since both Rad9 and 9-1-1 could 
in principle serve to recruit Dpb11 to sites of DNA damage. Therefore, we combined the rad9-AA mutant with 
the ddc1-T602A mutant, which abolishes the 9-1-1-Dpb11 interaction. However, while the ddc1-T602A muta-
tion strongly reduced Dpb11 association with a site-specific DSB in G1-arrested cells, the rad9-AA mutant did 
not induce a measurable defect (Fig. S5D). Consistently, checkpoint activation was still largely functional in the 
rad9-AA mutant, even in the ddc1-T602A background (Fig. 5C).
Overall, the functional relevance of the damage-induced mode of Rad9 S/TP phosphorylation therefore 
remains unclear. Given the high degree of redundancy in the checkpoint signalling network, it is highly likely that 
a defect in the rad9-AA mutant is compensated, perhaps by phosphorylation of an additional factor or by other 
phosphorylation sites in Rad9.
Discussion
S/TP site phosphorylation has been shown to be an important cellular mechanism that facilitates cell cycle con-
trols (see ref. 41 for a review on control of the DNA damage response by S/TP phosphorylation). Our study 
provides experimental evidence for DNA damage-dependent, but cell cycle-independent phosphorylation of the 
budding yeast checkpoint protein Rad9 at S/TP sites. These sites have previously been shown to be phosphorylated 
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by CDK and to facilitate interaction with Dpb1117, 42. Notably, we found that also the DNA damage-induced, 
CDK-independent phosphorylation of Rad9 leads to an interaction with Dpb11. When testing the attributes 
of DNA damage-induced phosphorylation, we found that it requires the histone methyltransferase Dot1, indi-
cating a dependency on the ‘histone pathway’, which is known to target Rad9 to damaged chromatin19–22, 25. 
Moreover, the covalent Rad9-Dpb11 fusion, which is known to tether Rad9 to damaged chromatin17, 40, bypasses 
this dependency on the ‘histone pathway’.
We found that damage-induced Rad9 S/TP phosphorylation is abolished, when Rad9 cannot be recruited to 
damaged chromatin. In this regard, damage-induced Rad9 S/TP phosphorylation is highly similar to Rad9 S/TQ 
phosphorylation19–23, which can be measured as an overall Rad9 phosphorylation shift. Conversely, we observed 
that forced localization of Rad9 to chromatin, reinstates S/TP phosphorylation, suggesting that Rad9 has to be 
recruited to damaged chromatin in order to become phosphorylated for both damage-induced S/TP phosphoryl-
ation and S/TQ phosphorylation.
Our data therefore suggest that Rad9 S/TP sites are targeted by a chromatin-localized kinase. The apical check-
point kinases Mec1 and Tel1 would fulfil this requirement, as they are specifically active at damaged chroma-
tin43. Consistently, we found that damage-induced Rad9 S/TP phosphorylation is abolished in a mec1Δ tel1Δ 
double mutant. However, this influence could also be indirect, since Mec1 and Tel1 are necessary for efficient 
phosphorylation of the Rad9 SCD, which itself is required for damage-induced phosphorylation of Rad9 S/TP 
sites. Moreover, we could not find any in vitro evidence to support that Mec1 or Tel1 would directly target S/
TP motifs. Currently, the best candidates for this novel mode of Rad9 S/TP phosphorylation, are the transcrip-
tional kinases of the CDK family – Kin28, Srb10, Bur1 and Ctk1 – given their similarity to Cdc28 and their 
chromatin-localization. In the future, it will therefore be interesting to test the connection between transcrip-
tional CDKs and the DNA damage checkpoint.
Several studies have collectively suggested a model of cell cycle-regulated Rad9 recruitment and activation in 
budding yeast17, 33, 42 and fission yeast4. These models suggest that the ‘histone pathway’ is exclusively required 
for Rad9 recruitment to damaged chromatin in G1, while in M phase both ‘histone pathway’ and ‘Dpb11 path-
way’ are active. While our study suggests that Rad9 and Dpb11 can interact in G1 as well, this view of Rad9 
Figure 4. A Rad9-Dpb11 fusion forces Rad9 recruitment to DSBs and T474 phosphorylation independently 
of the ‘histone pathway’. (A) The Rad9-Dpb11 fusion blocks resection, also in the absence of Dot1. RPA-ChIP 
at the indicated positions from an HO-induced DSB (0, 2, 4 and 6 h after HO induction) in WT, dot1Δ, RAD9-
DPB11ΔN and RAD9-DPB11ΔN dot1Δ indicates the extent of DNA end resection. FACS profiles in Fig. S4A. 
(B,C) The Rad9-Dpb11 fusion bypasses the requirement for Dot1, but not for Mec1 and Tel1. Measurement of 
Rad9-T474 phosphorylation as in Fig. 2A, but in G1-arrested cells expressing the Rad9-Dpb11 fusion in (B) WT 
and dot1Δ background or (C) WT and mec1Δ tel1Δ background. Immunoblotting against Rad9 or Rad9-T474 
phosphorylation. A Pgk1 immunoblot serves as loading control. An asterisk denotes a crossreactive band. FACS 
profiles in Fig. S4C and E respectively. Strains containing the mec1Δ mutation are in sml1Δ background.
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recruitment pathways is not affected, since Rad9 recruitment via the ‘histone pathway’ is upstream of and 
required for damage-induced Rad9 S/TP site phosphorylation and the Rad9-Dpb11 interaction in G1. Dpb11, 
therefore, does apparently not function as Rad9 recruiter in G1. As such, it is currently unresolved what function 
the damage-induced phosphorylation of Rad9 S/TP sites and subsequent binding to Dpb11 could have. We have 
not found any phenotypes in the G1 checkpoint or in the control of DNA end resection in G1, when we used the 
rad9-AA mutant. So far, we have investigated possible redundancies in Dpb11 recruitment (using the ddc1-T602A 
allele, Fig. 5) and Rad9 recruitment (using the dot1Δ allele, ref. 17), but also this did not reveal a defect. Therefore, 
the damage-induced Rad9 phosphorylation at S/TP sites may either act redundantly with a currently unknown 
factor or mediate an entirely new function.
Eukaryotic orthologs of Rad9 have been shown to be recruited to damaged chromatin by related mecha-
nisms4, 27–31, 44–47. Specifically, both fission yeast Crb2 and human 53BP1 were found to interact with the respective 
Dpb11 orthologs29, 37. Notably, in human cells 53BP1 and TOPBP1 were found to interact specifically in G137. This 
interaction, therefore, does seemingly not require CDK-phosphorylation, but would rather be consistent with a 
DNA damage-induced mode of interaction as described here. The phosphorylation sites on 53BP1 that mediate 
Figure 5. Lack of damage-induced Rad9 S/TP phosphorylation does not directly affect checkpoint signalling 
or DNA end resection. (A,B) The rad9-AA mutant – in contrast to the rad9Δ mutant – does not induce hyper-
resection in G1-arrested cells. A site-specific DSB was induced at the MAT locus using galactose-induced HO 
in G1-arrested cells. DNA end resection is shown by ChIP against RPA at 0, 2, 4 and 6 h after HO induction 
within 0–80 kb distance to the DSB. (A) Resection was measured in WT, rad9Δ, yku70Δ and rad9Δ yku70Δ 
strains. FACS profiles in Fig. S5A. (B) as (A), but with WT, rad9-AA, yku70Δ and rad9-AA yku70Δ strains. 
FACS profiles in Fig. S5B. (C) The rad9-AA mutant does not induce apparent defects in checkpoint activation in 
G1 even in the background of the ddc1-T602A mutation. Hyperphosphorylation of Rad53 induced by different 
concentrations of phleomycin added to the growth medium is used as measure of checkpoint activation. FACS 
profiles in Fig. S5C.
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TOPBP1-binding are currently unknown and it remains to be established whether the DNA damage-induced 
mode of the Rad9-Dpb11 interaction is evolutionary conserved.
Given the abundance of target proteins that are modified at S/TP sites by CDK48, S/TP site phosphorylation 
is often interpreted as phosphorylation by CDK. Our results caution, however, that this may be an oversimplified 
view. It will be interesting to see if CDK-independent S/TP site phosphorylation is a general phenomenon that 
can be observed on other proteins as well. Phosphoproteomic experiments in human cells treated with etoposide 
or γ-irradiation have rather suggested an opposite trend, as S/TP phosphorylation was generally decreased49. 
However, this decrease is caused by the inhibition of Cdk1 and Cdk2 after DNA damage in human cells. In order 
to test whether a substantial number of S/TP phosphorylation substrates become modified specifically after DNA 
damage, a system would be required, where CDK is not generally downregulated after DNA damage. While bud-
ding yeast fulfils this requirement, previous phosphoproteomic studies of the DNA damage response in budding 
yeast have primarily focussed on damage-induced S/TQ phosphorylation and checkpoint kinase dependencies50, 51. 
A systematic investigation of DNA damage-induced S/TP phosphorylation, as well as the involved kinases, there-
fore appears worthwhile.
Methods
Materials. All yeast strains used in this study were derived from W303 MATa and were constructed using 
standard methods52. Cells were grown in YP glucose or YP raffinose media at 30 °C. All strains used in this study 
are listed in Supplementary Table 1, all antibodies in Supplementary Table 2.
Measurement of Rad9 and Rad53 phosphorylation. Cells were grown in YP glucose media at 30 °C 
or 24 °C. Cell cycle synchronization was performed using α-factor (5 μg/ml or 0.25 μg/ml for bar1Δ mutants) or 
nocodazole (5 μg/ml) for 2–3 hours. To inhibit CDK, a strain containing the cdc28-as1 allele53 was treated with 
1 µM 1-NM-PP1. To induce DNA damage, phleomycin (Invivogen) was added to the medium to a final concen-
tration of 50 µg/ml - or concentrations as indicated. Denaturing cell extracts were prepared by alkaline lysis fol-
lowed by trichloroacetic acid (TCA) precipitation and precipitated proteins were collected by centrifugation and 
resuspended in SDS-PAGE sample buffer containing 8 M urea for subsequent SDS-PAGE analysis.
To detect Rad9 phosphorylation on S462 and T474, previously described phospho-specific antibodies were 
used17. Rad53 phospho-shifts were resolved on 10% acrylamide gels.
Rad9 Immunoprecipitations. For Rad93FLAG IPs cell extracts were prepared from 200 OD yeast cells 
treated as above for cell cycle arrest and DNA damage. Cells were harvested, washed in ice-cold sorbitol buffer 
(1 M sorbitol, 25 mM Hepes pH 7.6), and resuspended in a 1:1 ratio with lysis buffer supplemented with protease 
and phosphatase inhibitors (100 mM Hepes, 200 mM KOAc, 0.1% NP-40, 10% glycerol, 2 mM β-mecaptoethanol, 
100 nM okadaic acid, 10 mM NaF, 20 mM β-glycerophosphate, 400 μM PMSF, 4 μM aprotinin, 4 mM benzamidin, 
400 μM leupeptin, 300 μM pepstatin A), snap-frozen to liquid nitrogen and lysed using a Spex Sample Prep cryo 
mill. The extracts were cleared by centrifugation and incubated with anti‐FLAG agarose resin (Sigma) for 1 hour 
(4 °C, rotation). After five washes with lysis buffer, Rad93FLAG was eluted twice with 0.5 mg/ml 3xFLAG peptide 
(Sigma). The elutions were pooled and proteins were precipitated with TCA prior to analysis on 4–12% NuPAGE 
gels (Invitrogen) and standard western blotting.
GST-Dpb11 pulldowns. The Dpb11-Rad9 interaction was tested as described17. GST, GST-Dpb11 FL or a 
GST-Dpb11 fragment containing BRCT1 + 2 were immobilized on glutathione sepharose 4B (GE Healthcare) 
and incubated with 600 ml ammonium sulphate-precipitated (57%) cell extracts (in 200 mM KOAc, 100 mM 
Hepes pH 7.6, 10% glycerol, 0.02% NP-40, 2 mM β-mercaptoethanol, 20 mM β-glycerophosphate, 10 mM NaF, 
100 mM okadaic acid, protease inhibitors) corresponding to 50 OD yeast cells. The pulldown was incubated 
1 hour (4 °C, rotation), washed and eluted by boiling in SDS-PAGE sample buffer.
Chromatin Immunoprecipitation (ChIP) to a DSB and qPCR analysis. For chromatin immuno-
precipitation of Rad9, RPA and Dpb11, cells were grown in YP raffinose to an OD of 0.5 and cell cycle arrest 
was induced with α-factor or nocodazole. A single double strand break at the MAT locus was introduced by 
inducing the HO endonuclease from the galactose promoter by addition of galactose to the cultures to a 2% final 
concentration. 100 ODs of cells were crosslinked with formaldehyde (final 1%) for 16 minutes at timepoints as 
indicated and the reaction was quenched with glycine. Cells were harvested by centrifugation, washed in ice-cold 
PBS and snap-frozen. Cell pellets were resuspended in 800 μl lysis buffer (50 mM HEPES KOH pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS) and lysed with zirconia beads using a 
bead beating device. The chromatin was sonified to shear the DNA to a size of 200–500 bp. The obtained extracts 
were cleared by centrifugation, 1% was taken as input sample and 40% were incubated with either anti-FLAG-M2 
magnetic beads (Sigma) for 2 hours (Rad93FLAG ChIPs) or with anti-RPA antibody (AS07-214, Agrisera) followed 
by 30 min with Dynabeads ProteinA (Invitrogen, for RPA ChIPs). The beads were washed 3x in lysis buffer, 2x 
in lysis buffer with 500 mM NaCl, 2x in wash buffer (10 mM Tris-Cl pH 8.0, 0.25 M LiCl, 1 mM EDTA, 0.5% 
NP-40, 0.5% Na-deoxycholate) and 2x in TE pH 8.0. DNA-protein complexes were eluted in 1% SDS, proteins 
were removed via proteinase K digestion (3 h, 42 °C) and crosslinks were reversed (8 h or overnight, 65 °C). The 
DNA was subsequently purified using phenol-chloroform extraction and ethanol precipitation and quantified by 
quantitative PCR (Roche LightCycler480 System, KAPA SYBR FAST 2x qPCR Master Mix, KAPA Biosystems) 
at indicated positions with respect to the DNA double strand break. As a control, 2-3 control regions on other 
chromosomes were quantified.
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Figure	  S1:	  
Damage-­‐induced	  interaction	  of	  Dpb11	  and	  Rad9.	  	  
(A)	  Pulldown	  with	  recombinant	  GST-­‐Dpb11	  and	  extracts	  of	  asynchronous	  cells	  after	  MMS	  treatment	  shows	  damage-­‐induced	  interaction	  of	  Rad9	  and	  Dpb11.	  	  
(B)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  1A.	  	  
(C)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  1B.	  	  
(D)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  1C.	  
(E)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  1D.	  	  
(F)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  1E.	  	  
Figure	  S2:	  	  
Involvement	  of	  checkpoint	  kinases	  in	  Rad9-­‐T474	  phosphorylation.	  	  
(A)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  2A.	  	  
(B)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  2B.	  	  
(C)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  2C.	  	  
(D)	   Cell	   extracts	   of	   G2/M-­‐arrested	   cells	   treated	   with	   phleomycin	   or	   mock-­‐treated	   were	   probed	   with	   indicated	   antibodies.	   The	   Rad9-­‐T474p	  phosphospecific	  antibody	  detects	  cell	  cycle-­‐specific	  Rad9	  phosphorylation	  in	  all	  mutant	  backgrounds.	  FACS-­‐based	  DNA	  content	  measurement	  below.	  
	  	  
Figure	  S3:	  	  
Involvement	   of	   Rad9-­‐recruitment	   pathways	   in	   Rad9-­‐T474	  
phosphorylation.	  	  
(A)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  3A.	  	  
(B)	   dot1Δ	   cells	   retain	   S/TP	   phosphorylation	   of	   Rad9	   in	   G2/M.	   Extracts	   from	  G2/M-­‐arrested	  and	  phleomycin-­‐treated	  cells	  of	  the	  indicated	  mutant	  background	  were	   probed	   with	   the	   indicated	   antibodies.	   FACS-­‐based	   DNA	   content	  measurement	  below.	  
(C)	   A	   defect	   in	   the	   Rad9	   TUDOR-­‐domain	   (rad9-­‐Y798Q)	   does	   not	   abolish	   Rad9	  T474	  phosphorylation	   S/TP	   phosphorylation	   in	   G2/M	   cells	   after	  DNA	  damage.	  	  Experiment	  as	  (B),	  FACS-­‐based	  DNA	  content	  measurement	  below.	  
(D)	   RAD9	  mutant	   backgrounds	   impairing	   its	   recruitment	   to	   chromatin	   (dot1Δ	  and	   rad9-­‐Y798Q)	   lead	   to	   defects	   in	   Rad9-­‐T474	   phosphorylation	   and	   Rad53	  phosphorylation,	  when	  arrested	  in	  G1.	  Rad53	  activation	  measured	  by	  detecting	  its	   phospho-­‐shift	   on	   10%	   SDS-­‐gels	   using	   anti-­‐rad53	   antibodies.	   Right:	   FACS-­‐based	  DNA	  content	  measurement.	  
(E)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  3D.	  	  
Figure	  S4:	  	  
Influence	  of	  a	  Rad9-­‐Dpb11	  fusion	  on	  Rad9	  function	  and	  phosphorylation.	  	  
(A)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  4A.	  
(B)	  RPA	  ChIPs	  demonstrate	  inhibition	  of	  resection	  in	  the	  presence	  of	  the	  RAD9-­‐
DPB11ΔN	  fusion.	  RPA	  recruitment	  was	  measured	  at	  positions	  spanning	  1.1	  to	  70	  kb	  from	  an	  HO-­‐induced	  DSB	  at	  the	  indicated	  time-­‐points	  in	  G2/M	  arrested	  cells.	  Lower	   panel:	   DNA	   loss	   visualized	   by	   ChIP-­‐DNA	   inputs	   (input	   DNA	   at	   each	  position	   relative	   to	   controls	   outside	   of	   the	   affected	   region).	   Right:	   FACS-­‐based	  DNA	  content	  measurement.	  
(C)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  4B.	  
(D)	  S/TP	  phosphorylation	  of	  Rad9	  occurs	  in	  G2/M	  arrested	  cells	  independently	  of	   RAD9-­‐DPB11ΔN.	   Extracts	   were	   probed	   with	   indicated	   phosphospecific	  antibodies.	  	  FACS-­‐based	  DNA	  content	  measurement	  below.	  
(E)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  4C.	  	  
Figure	  S5:	  	  
Phenotypic	  analysis	  of	  the	  rad9-­‐AA	  mutant,	  deficient	  in	  binding	  to	  Dpb11.	  	  
(A)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  5A.	  
(B)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  5B.	  
(C)	  FACS-­‐based	  DNA	  content	  measurement	  of	  experiment	  in	  Figure	  5C.	  
(D)	   Dpb11	   binding	   to	   DSBs	   in	   G1	   as	   visualized	   by	   Dpb11-­‐3FLAG	   ChIPs	   is	  abolished	  in	  ddc1-­‐T602	  cells,	  but	  not	  in	  the	  rad9-­‐AA	  cells.	  Dpb11	  enrichment	  and	  spreading	   was	   measured	   starting	   from	   1.1kb	   until	   75kb	   away	   from	   an	   HO-­‐induced	   DSB	   at	   the	   indicated	   time-­‐points.	   FACS-­‐based	   DNA	   content	  measurement	  below.	  	  
Figure	  S6:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  1A	  
(B)	  Original	  Western	  blots	  relating	  to	  Figure	  1B	  
(C)	  Original	  Western	  blots	  relating	  to	  Figure	  1C	  
(D)	  Original	  Western	  blots	  relating	  to	  Figure	  1D	  
(E)	  Original	  Western	  blots	  relating	  to	  Figure	  1E	  	  
Figure	  S7:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  S1A	  	  
Figure	  S8:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  2A	  
(B)	  Original	  Western	  blots	  relating	  to	  Figure	  2B	  
(C)	  Original	  Western	  blots	  relating	  to	  Figure	  2C	  	  
Figure	  S9:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  S2D	  	  
Figure	  S10:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  3B	  
(B)	  Original	  Western	  blots	  relating	  to	  Figure	  3C	  
(C)	  Original	  Western	  blots	  relating	  to	  Figure	  3D	  	  
Figure	  S11:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  S3B	  
(B)	  Original	  Western	  blots	  relating	  to	  Figure	  S3C	  
(C)	  Original	  Western	  blots	  relating	  to	  Figure	  S3D	  	  
Figure	  S12:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  4B	  
(B)	  Original	  Western	  blots	  relating	  to	  Figure	  4C	  	  
	  
Figure	  S13:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  S4D	  
	  
Figure	  S14:	  
(A)	  Original	  Western	  blots	  relating	  to	  Figure	  5C	  
	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  
	  
	  	  	  	  
Table	  1:	  	  	  
strain	   Relevant	  genotype	   reference	  W303	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  [phi+	  ]	   Thomas	  and	  Rothstein,	  1989	  JPY923	   MATa	  FLAG-­‐rad53::LEU2	  bar1	  Δ::hisG	  cdc13-­‐1	  cdc15-­‐2	   Usui	  et	  al.,	  2008	  JPY993	   MATa	  FLAG-­‐rad53::LEU2	  bar1Δ::hisG	  cdc13-­‐1	  cdc15-­‐2	  rad9S1129A::URA3	   Usui	  et	  al.,	  2008	  JPY3344	   MATa	  FLAG-­‐rad53::LEU2	  bar1Δ::hisG	  cdc13-­‐1	  cdc15-­‐2	  rad9-­‐6AQ	   Usui	  et	  al.,	  2008	  YBP61	   MATa	  RAD9-­‐9myc::hphNT1	   Pfander	  &	  Diffley,	  2011	  YBP109	   MATa	  dot1Δ::kanMx4	   Pfander	  &	  Diffley,	  2011	  YBP269	   MATa	  ddc1-­‐T602A::his3Mx6	   Pfander	  &	  Diffley,	  2011	  YBP270	   MATa	  ddc1-­‐T602A::his3Mx6	  dot1Δ::kanMx4	   Pfander	  &	  Diffley,	  2011	  YBP366	   MATa	  rad9Δ::natNT2	  TRP1::RAD9-­‐3FLAG::HISMx6	  pep4::hphNT1	   Pfander	  &	  Diffley,	  2011	  YBP388	   MATa	  pep4Δ::LEU2	   Pfander	  &	  Diffley,	  2011	  YBP390	   MATa	  bar1Δ::TRP1	   Pfander	  &	  Diffley,	  2011	  YBP403	   MATa	  rad9Δ::natNT2	  TRP1::rad9-­‐3FLAG::HIS3Mx6	  pep4Δ::LEU2	  dot1	  Δ::kanMx4	   Pfander	  &	  Diffley,	  2011	  YBP406	   MATa	  rad9Δ::NATNT2	  	  TRP1::rad9AA-­‐3FLAG::HIS3Mx6	  pep4Δ::LEU2	   Pfander	  &	  Diffley,	  2011	  YGD030	   MATa	  rad9Δ::NATNT2	  bar1Δ::HISMX6	  trp1::RAD9-­‐DPB11ΔN::TRP1	   This	  study	  YGD031	   MATa	  RAD9-­‐3FLAG::hphNT1	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  	  pGal-­‐HO::ADE3	   This	  study	  YGD032	   rad9Δ::hphNT1	  hml::pRS	  hmr::pRS	  bar1	  Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD034	   MATa	  rad9Δ::hphNT1	  LEU2::RAD9AA-­‐3FLAG	  hml::pRS	  hmr::pRS	  bar1::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD035	   MATa	  RAD9-­‐3FLAG::hph	  dot1	  Δ::kanMX4	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD036	   MATa	  rad9Δ::NATNT2	  trp1-­‐1::RAD9-­‐DPB11ΔN::TRP1	  mec1Δ::LEU2	  tel1Δ::hphNT1	  bar1Δ::HISMX6	  sml1Δ::URA3	   This	  study	  YGD037	   MATa	  trp1-­‐1::RAD9-­‐DPB11::TRP1	  mec1Δ::LEU2	  bar1Δ::HISMX6	  rad9Δ::NATNT2	  sml1Δ::URA3	   This	  study	  YGD038	   MATa	  mec1Δ::LEU2	  tel1Δ::NATNT2	  bar1Δ::TRP1	  sml1Δ::URA3	   This	  study	  YGD039	   MATa	  rad53Δ::kanMX4	  chk1Δ::NATNT2	  bar1Δ::TRP1	   This	  study	  YGD040	   MATa	  yku70::NAT	  rad9Δ::hphNT1	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  
YGD041	   MATa	  yku70::NATNT2	  dot1Δ::kanMX4	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD042	   MATa	  RAD9-­‐DPB11ΔN-­‐3FLAG::hphNT1	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD043	   MATa	  RAD9-­‐DPB11ΔN-­‐3FLAG::hphNT1	  dot1Δ::kanMX4	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD044	   MATa	  rad9Δ::hphNT1	  	  leu2-­‐3::Rad9AA-­‐3FLAG::LEU2	  yku70Δ::NATNT2	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   This	  study	  YGD045	   MATa	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  	  pGal-­‐HO::ade3	  dpb11-­‐3FLAG::kanMX4	  rad9-­‐AA::NATNT2	   This	  study	  YGD046	   MATa	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  	  pGal-­‐HO::ADE3	  ddc1-­‐T602A::hphNT1	  DPB11-­‐3FLAG::kanMX4	  rad9-­‐AA::NATNT2	   This	  study	  YKR112	   MATa	  cdc28-­‐F88G	   Reusswig	  et	  al.,	  2016	  YSB95	   MATa	  mec1Δ::LEU2	  bar1Δ::TRP1	  sml1Δ::URA3	   This	  study	  YSB96	   MATa	  rad53Δ::hphNT1	  bar1Δ::TRP1	  sml1Δ::URA3	   This	  study	  YSB97	   MATa	  tel1Δ::NATNT2	  bar1Δ::TRP1	   This	  study	  YSB98	   MATa	  chk1Δ::NATNT2	  bar1Δ::TRP1	   This	  study	  YSB189	   MATa	  rad9Δ::NATNT2	  pep4Δ::kanMX4	  leu2-­‐3::rad9-­‐Y798Q-­‐3FLAG::LEU2	   This	  study	  YSB517	   MATa	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	   Bantele	  et	  al.	  2017	  YSB812	   MATa	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	  dpb11-­‐3FLAG::kanMX4	   This	  study	  YSB816	   MATa	  hml::pRS	  hmr::pRS	  bar1Δ::TRP1	  pGal-­‐HO::ADE3	  ddc1-­‐T602A::hphNT1	   This	  study	  
	  
	   	  
Table	  2:	  
	  
	  
Antibody	   Antigen	   Source	  Mouse	  anti-­‐Pgk1	   Pgk1	   Invitrogen	  Rabbit	  anti-­‐Rad9	   Rad9	   F.	  Lowndes	  EMBO	  J.	  1998	  Rabbit	  anti-­‐Rad9-­‐S462P	   Rad9	  S462P	  peptide	   Pfander,	  B.	  &	  J.	  Diffley	  EMBO	  J.	  2010	  Rabbit	  anti-­‐Rad9-­‐T474P	   Rad9	  T474P	  peptide	   Pfander,	  B.	  &	  J.	  Diffley	  EMBO	  J.	  2010	  Rabbit	  anti-­‐Rad53	   Rad53	   Abcam	  Rabbit	  anti-­‐RPA	   Rfa1,	  Rfa2,	  Rfa3	   Agrisera	  Rabbit	  anti-­‐FLAG	   Synthetic	  FLAG	  sequence	  containing	  peptide	  DYKDDDDK-­‐GC	   Sigma	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A cell cycle-regulated Slx4–Dpb11
complex promotes the resolution of DNA
repair intermediates linked to stalled
replication
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A key function of the cellular DNA damage response is to facilitate the bypass of replication fork-stalling DNA
lesions. Template switch reactions allow such a bypass and involve the formation of DNA joint molecules (JMs)
between sister chromatids. These JMs need to be resolved before cell division; however, the regulation of this process
is only poorly understood. Here, we identify a regulatory mechanism in yeast that critically controls JM resolution by
the Mus81–Mms4 endonuclease. Central to this regulation is a conserved complex comprising the scaffold proteins
Dpb11 and Slx4 that is under stringent control. Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the
Dpb11–Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the
additional association of Mus81–Mms4 with the complex, thereby promoting JM resolution. Finally, the DNA
damage checkpoint counteracts Mus81–Mms4 binding to the Dpb11–Slx4 complex. Thus, Dpb11–Slx4 integrates
several cellular inputs and participates in the temporal program for activation of the JM-resolving nuclease Mus81.
[Keywords: DNA damage response; cell cycle; post-replicative repair; homologous recombination; joint molecule
resolution]
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Intrinsically and extrinsically induced DNA lesions can
compromise the integrity of the genetic information and
threaten cell viability. DNA lesions are particularly dan-
gerous during S phase, when faithful DNA replication
relies on two intact DNA strands. DNA lesions hamper
the progression of replication forks and thereby the com-
plete duplication of chromosomes. Moreover, replication
forks that are stalled at DNA lesion sites can collapse and
cause chromosome breaks and genome instability (Branzei
and Foiani 2010).
Eukaryotes possess two fundamentally different mecha-
nisms to bypass DNA lesions that affect one of the parental
DNA strands: translesion synthesis (TLS) and template
switching. TLS employs specialized polymerases (trans-
lesion polymerases) that inmany cases are able to replicate
the damaged strand but with a reduced fidelity (Prakash
et al. 2005). On the other hand, during template switching,
the genetic information is copied from the newly synthe-
sized, undamaged sister chromatid. This mechanism is
therefore error-free in principle, yet its precise mechanism
remains poorly understood. Template switching is a com-
plex process that can be initiated by different recombina-
tion-based mechanisms (homologous recombination [HR]
and error-free post-replicative repair [PRR]) (Branzei et al.
2008). The choice between the different bypass mecha-
nisms is regulated by ubiquitin and SUMO modifications
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of the replication protein PCNA at sites of stalled replica-
tion forks (Pfander et al. 2005).
Template switch mechanisms involve the formation of
DNA joint molecules (JMs; also referred to as sister
chromatid junctions [SCJs] or X molecules) as repair in-
termediates (Branzei et al. 2008). In order to allow com-
pletion of DNA replication and faithful chromosome
segregation, these X-shaped DNA structures need to be
disentangled before sister chromatids are separated during
mitosis. To date, three enzymatic activities—the topoisom-
erase-containing Sgs1–Top3–Rmi1 complex (STR) as well
as the Mus81–Mms4 and Yen1 structure-specific endonu-
cleases—were shown to process JMs in budding yeast
(Liberi et al. 2005; Blanco et al. 2010; Mankouri et al.
2011; Szakal and Branzei 2013). These three activities
can be distinguished by their mechanism (termed disso-
lution for STR and resolution forMus81–Mms4 and Yen1)
(Gaillard et al. 2003; Ip et al. 2008; Cejka et al. 2010) but
show a partial functional overlap. Moreover, they are
differentially regulated during the cell cycle: Whereas the
STR activity appears to be cell cycle-independent, the
activity of Mus81–Mms4 is stimulated by CDK-mediated
and Cdc5 (budding yeast Polo-like kinase)-mediated phos-
phorylation and peaks in mitosis (Matos et al. 2011, 2013;
Gallo-Ferna´ndez et al. 2012; Szakal and Branzei 2013).
Accordingly, the Mus81 regulation is assumed to create
a hierarchy, with STR acting as a primary resolution
pathway and Mus81–Mms4 acting as a salvage pathway.
How Mus81–Mms4 phosphorylation by cell cycle kinases
facilitates this temporal regulation of JM resolution path-
ways remains hardly understood.
The bypass of DNA lesions during replication is addi-
tionally regulated by the DNA damage checkpoint, the
main cellular signaling pathway in response to DNA
damage (Harrison andHaber 2006). As the primary purpose
of the checkpoint is the stabilization of stalled replication
forks (Branzei and Foiani 2010), its activation is a funda-
mental requirement for all fork repair and reactivation
reactions. Notably, the checkpoint has been suggested to
be involved in the choice of the JM resolution pathway,
since precocious activation of the Mus81–Mms4 endonu-
clease is observed in checkpoint-deficient mutants (Szakal
and Branzei 2013). However, it remains to be clarified how
this second layer of regulation of JM resolution is achieved
on a molecular level and how it is linked to cell cycle
regulation.
Here, we identify an evolutionarily conserved protein
complex comprising two scaffold proteins, Slx4 andDpb11/
TopBP1, as an important regulator of JM resolution by
Mus81–Mms4. We show that the formation of the Slx4–
Dpb11 complex is regulated by the cell cycle stage. An slx4
mutant, compromised specifically in Dpb11 binding, ex-
hibits hypersensitivity to the replication fork-stalling drug
MMS, a delay in the resolution of X-shaped DNA JMs, and
a reduced propensity to form crossovers (COs). The func-
tion of the Slx4–Dpb11 scaffold in JM resolution correlates
with the finding that Dpb11 binds to the Mus81–Mms4
endonuclease. This association is restricted to mitosis,
since it is dependent on themitotic kinase Cdc5.Moreover,
the checkpoint acts antagonistically to the regulation of JM
resolution by Slx4 and Dpb11, as we found that partial
inactivation of the DNA damage checkpoint can compen-
sate for defects in formation of the Slx4–Dpb11 scaffold
complex.
Results
An evolutionarily conserved and phosphorylation-
dependent interaction between Slx4 and Dpb11/
TopBP1
Dpb11 and its human homolog, TopBP1, are critical re-
gulators of the cellular DNA damage response and interact
with several DNA replication, repair, and checkpoint
proteins (Garcia et al. 2005; Germann et al. 2011). In these
protein complexes, Dpb11/TopBP1 specifically binds to
phosphorylated proteins via its tandemBRCTdomains (Yu
2003; Garcia et al. 2005). A key role of Dpb11/TopBP1 is to
function as a scaffold, bringing together specific sets of
proteins via several interaction surfaces. In budding yeast,
two Dpb11 complexes have been described in detail,
which regulate replication initiation (with Sld3 and Sld2)
(Tanaka et al. 2007; Zegerman and Diffley 2007) and the
DNA damage checkpoint (with Rad9, the 9-1-1 complex,
and Mec1–Ddc2) (Mordes et al. 2008; Navadgi-Patil and
Burgers 2008; Puddu et al. 2008; Pfander and Diffley 2011),
respectively (Fig. 1A). Recently, a third Dpb11 complex
with Slx4 and Rtt107 was identified (Ohouo et al. 2010,
2012). In this latter complex, Slx4 appears to inhibit the
formation of theDpb11DNA damage checkpoint complex
(Ohouo et al. 2012).
In the course of our studies of Dpb11 function, we
identified an interaction between a Dpb11 fragment that
includes the tandem BRCT repeats 3 and 4 (BRCT3+4) and
Slx4 using a two-hybrid screen. To confirm this finding, we
tested the binding of different Dpb11 constructs to Slx4
and known Dpb11 binders. As observed before (Puddu
et al. 2008; Pfander and Diffley 2011), we found that Rad9
binds to BRCT1+2 of Dpb11, whereas Ddc1 binds to
BRCT3+4 (Fig. 1B). For Slx4, we found an interaction with
full-lengthDpb11 and the BRCT3+4 fragment but not with
the BRCT1+2 domain (Fig. 1B). When we tested binding of
Slx4 from cell extracts to recombinant, purified fragments
of Dpb11, Slx4 also bound to BRCT3+4, albeit weaker than
to the full-length protein (Supplemental Fig. S1A). More-
over, ablation of Dpb11 Thr451, which is predicted to be
part of the BRCT3+4 phospho-protein-binding surface
(Rappas et al. 2011), partially inhibited the Slx4–Dpb11
interaction (Supplemental Fig. S1B). A recent report sug-
gested that the Dpb11 BRCT1+2 domain is involved in
Slx4 binding (Ohouo et al. 2012). However, although our
data do not rule out a contribution of BRCT1+2 in overall
binding, our two independent lines of evidence clearly
demonstrate that BRCT3+4 of Dpb11 significantly con-
tributes to Slx4 binding.
Next,wemapped theDpb11-binding site on Slx4 starting
from a fragment (amino acids 461–738) that was common
to all Slx4 clones identified in our initial Dpb11 two-hybrid
screen. Truncated variants that begin at amino acid 490
failed to interact with Dpb11 (Supplemental Fig. S1C),
Slx4 and Dpb11 regulate joint molecule resolution
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indicating that the region between amino acid 461 and
amino acid 490 is important for Dpb11 interaction. As
several examples indicate that Dpb11 binds phosphorylated
S/TP motifs, we tested all S/TP motifs within the C-
terminal part of Slx4 for their ability to mediate Dpb11
binding. Indeed, we found that alteration of Ser486 in Slx4
into a nonphosphorylatable alanine residue (slx4-S486A
mutant) reduced Dpb11 binding in a two-hybrid system
(Supplemental Fig. S1D). Moreover, whereas immunopre-
cipitation of wild-type Slx4 efficiently copurified endoge-
nousDpb11 from cell extracts, in particular followingMMS
treatment, the Slx4–Dpb11 interaction was strongly de-
creased in extracts from cells expressing the slx4-S486A
mutant, even after induction of DNA damage (Fig. 1C; see
also Ohouo et al. 2012). Furthermore, the phospho-S486-
containing peptide was specifically enriched (17-fold), when
Dpb11 immunoprecipitations were analyzed by quantita-
tive mass spectrometry (MS) (Supplemental Fig. S4A). We
therefore conclude that the Slx4–Dpb11 interaction in-
volves the BRCT3+4 region of Dpb11 and a region of Slx4
harboring the phosphorylated residue S486.
We further tested whether also the human homologs
TopBP1 and Slx4 are binding partners. Indeed, we detected
a specific interaction of TopBP1 and Slx4 or an N-termi-
nally truncated version of Slx4 after transient transfection
in human embryonic kidney (HEK) 293T cells (Fig. 1D). In
contrast to the yeast proteins, we did not observe a stimu-
lation of TopBP1 binding to Slx4 by DNA damage (Supple-
mental Fig. S1E). Human Slx4 is substantially larger than
yeast Slx4, with an overall sequence conservation of only
17.9%. Nonetheless, we identified a conserved short linear
motif present in Slx4 proteins from different eukaryotes
that comprises Ser486 in budding yeast and Thr1260 in
humans (Supplemental Fig. S2). Mutation of Thr1260 to
a nonphosphorylatable alanine (T1260A) in human Slx4
reduced the interaction with TopBP1 (Fig. 1D), suggesting
that this residue may function analogously to Ser486 in
budding yeast. These data suggest the presence of a novel,
evolutionarily conserved motif in Slx4 that functions in
Dpb11/TopBP1 binding.
Cdk1-dependent phosphorylation of Slx4 regulates
binding to Dpb11
In order to unravel the regulation of the Slx4–Dpb11-
binding surface, we quantified the relative amount of
Ser486 phosphorylation under different cellular conditions
using SILAC-based quantitativeMS.We observed a specific
increase of Ser486 phosphorylation in G2/M-arrested cells
compared with G1-arrested cells, indicating that the ana-
lyzed Slx4 phosphorylation is cell cycle-regulated (Fig. 2A).
In agreement with Ser486 matching the consensus target
sequence for phosphorylation by cyclin-dependent kinase
Cdk1 (S/TPxK) (Holt et al. 2009), we observed a marked
reduction of Ser486 phosphorylation in G2/M-arrested
cells when Cdk1 activity was abrogated using the cdc28-
as1 allele (Bishop et al. 2000) in combination with 1NM-
PP1 inhibitor treatment (Fig. 2B). Notably, we also detected
Figure 1. An evolutionarily conserved, phos-
phorylation-dependent interaction between Slx4
and Dpb11/TopBP1. (A) Schematic diagram of
Dpb11 domain structure depicted with its in-
teraction partners in replication initiation and
DNA damage checkpoint. (B) Slx4 binds to the
BRCT3+4 domain of Dpb11. Two-hybrid analy-
sis of GAL4-BD fused to full-length Dpb11 or to
BRCT1+2 and BRCT3+4 fragments and of
GAL4-AD fusions with Slx4, Rad9, and Ddc1.
(C) The Slx4–Dpb11 interaction is reduced by
mutation of Slx4 Ser486 and is regulated by
DNA damage. Coimmunoprecipitation of en-
dogenous Dpb11 with Slx43Flag or phosphoryla-
tion-deficient Slx4-S486A3Flag from undamaged
cells or cells treated for 30 min with 0.033%
MMS. (D) Human TopBP1 and Slx4 interact
dependent on Thr1260 of Slx4. Coimmunopre-
cipitation of human mycTopBP1 with GFPSlx4 or
N-terminally truncated GFPSlx4DN after tran-
sient overexpression in HEK293T cells. Slx4 or
Slx4DN was expressed either as wild type (WT)
or a T1260A phosphorylation-deficient variant.
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Figure 2. The Slx4–Dpb11/TopBP1-binding interface is cell cycle-regulated by Cdk1 phosphorylation of Slx4. (A) Ser486 phosphorylation is
cell cycle-regulated. Relative abundance of the Slx4 480–489 phospho-peptide and six unmodified Slx4 peptides was measured by SILAC-based
quantitative MS using 15N2
13C6 lysine (Lys8) and compared between Slx4 isolated from G1- and G2/M-arrested cells. H/L ratios for individual
peptides were normalized to total Slx4 ratios. Error bars represent standard deviations from two independent experiments, including label
switch. (B) S486 phosphorylation depends on Cdk1. Analysis as inA but comparing Slx4 from G2/M-arrested cells with normal Cdk1 activity
with cells in which Cdk1 has been inactivated using the cdc28-as1 allele and 500 nM 1NM-PP1. (C) The Slx4–Dpb11 interaction is regulated
by CDK. Coimmunoprecipitation of Dpb11 and Slx43Flag fromG2/M-arrested cells or G2/M-arrested cells in which Cdk1 has been inactivated
as in B. (D) The Slx4–Dpb11 interaction is regulated by cell cycle phase andDNA damage. Experiment as inC but with G1- andG2/M-arrested
cells, which were either damaged by 50 mg/mL phleomycin or left untreated. (E) Binding of human Slx4 and TopBP1 is regulated by CDK
phosphorylation. Coimmunoprecipitation of mycTopBP1 with GFPSlx4 and GFPSlx4DN after transient overexpression in HEK293T cells. Cells
were left untreated or treated with 10 mg/mL roscovitine for the indicated times to inhibit CDK activity.
GENES & DEVELOPMENT 1607
 Cold Spring Harbor Laboratory Press on June 8, 2018 - Published by genesdev.cshlp.orgDownloaded from 
reduced Slx4 binding to Dpb11 when Cdk1 was inhibited
(Fig. 2C).
In addition to cell cycle-dependent regulation, we also
observed a stimulation of Slx4–Dpb11 binding by DNA
damage (Figs. 1C, 2D, Supplemental Fig. S1F). When Slx4
binding to recombinant GST-Dpb11 was tested, the DNA
damage-dependent stimulation was less pronounced (Sup-
plemental Fig. S1A), substantiating the notion that the
Slx4–Dpb11 interactionmay be additionally regulated by a
damage-induced post-translational modification of Dpb11.
On the other hand, Slx4 harbors several sites that can be
targeted by kinases of the DNA damage checkpoint path-
way. Mutation of seven sites in Slx4 partially inhibits its
binding to Dpb11 (Ohouo et al. 2010), and the correspond-
ing mutant shows phenotypes similar to those of slx4-
S486A (Supplemental Fig. S3). As we cannot fully exclude
pleiotropic defects for thismutant, we focused our analysis
on slx4-S486A.
Taken together, our findings suggest that the Slx4–
Dpb11 complex integrates at least two cellular signals: (1)
cell cycle state through Cdk1 phosphorylation of Slx4 at
Ser486 and (2) the presence of DNA damage through
checkpoint kinase phosphorylation of several sites on
Slx4 and perhaps on Dpb11.
Interestingly, the CDK regulation of this interaction is
conserved between yeast and humans, since addition of
the CDK inhibitor roscovitine reduced binding of Slx4
and TopBP1 (Fig. 2E).
The Slx4–Dpb11 complex is required for the response
to replication fork stalling
Budding yeast Slx4 is known to bind to several DNA repair
proteins (Slx1, Rtt107, and Rad1–Rad10) (Mullen et al.
2001; Roberts et al. 2006; Flott et al. 2007; Ohouo et al.
2010). However, whether these interaction partners are part
of only one or several distinct complexes is unknown.
While Slx4 has several independent DNA repair functions
in budding yeast (Flott et al. 2007), until now, a detailed
phenotypic characterization has only been conducted for
slx4D deletion mutants. To test the specificity of the
Dpb11-binding-deficient slx4-S486A phosphorylation site
mutant, we compared its binding partners with those of
wild-type Slx4 using quantitative proteomics. Indeed, we
found that the mutant protein (Slx4-S486A3Flag) displayed
eightfold reduced binding to Dpb11 (Fig. 3A). This variant
still bound Slx1 and Rtt107 as efficiently as wild-type Slx4,
indicating that Ser486 phosphorylation is specifically rele-
vant for the Dpb11 interaction (Fig. 3A; see Supplemental
Fig. S4A for specific Slx4 interactors). We thus took
advantage of the slx4-S486A separation-of-functionmutant
to reveal a specific role of the Slx4–Dpb11 complex.
Using different DNA-damaging agents, we observed that
the slx4-S486A mutant is particularly sensitive to MMS
and, to a lesser extent, 4-NQO (Fig. 3B; Supplemental Fig.
S4B), two reagents that create toxicity through replication
fork stalling. Notably, the mutant was not sensitive to
reagents that generate DNA strand breaks or interstrand
cross-links, consistent with a recombination rate that was
similar towild type (Supplemental Fig. S4B,C). Remarkably,
expression of a fusion protein of the phospho-site mutant
variant of Slx4 with Dpb11 (Dpb11–Slx4-S486A) rescued
the MMS hypersensitivity phenotype almost to wild-type
levels (Fig. 3B), suggesting that binding of Slx4 to Dpb11 is
crucial for tolerance of replication fork-stalling lesions.
Next, we tested whether the response to stalled repli-
cation forks is aberrant in the slx4-S486Amutant. To this
end, we treated synchronized cells with a pulse of MMS
in early S phase. Under these conditions, the slx4-S486A
mutant completed DNA replication with slightly slower
kinetics compared with wild-type cells (Fig. 3C, 1-h time
point). Also, the appearance of fully replicated and re-
paired chromosomes, as visualized by pulsed-field gel
electrophoresis, was delayed (Fig. 3D, 1-h time point).
This finding indicates that stalled replication fork struc-
tures or repair intermediates persist longer in the absence
of the Slx4–Dpb11 complex. Additionally, the DNA
damage checkpoint activation was prolonged in slx4-
S486A cells (Fig. 3E), as determined by the phosphoryla-
tion status of the checkpoint kinase Rad53. This effect
was specific for MMS treatment and could not be ob-
served in cells in which double-strand breaks were in-
duced by zeocin or phleomycin inside or outside of S
phase (Supplemental Fig. S4D).
Defects in a checkpoint-antagonistic pathway (check-
point ‘‘dampening’’) (Ohouo et al. 2012) in slx4 mutants
could, in principle, lead to prolonged checkpoint activa-
tion and could thereby indirectly lead to slow S-phase
kinetics and DNA damage hypersensitivity. Alternatively,
persistence of unrepaired DNA lesions or DNA repair
intermediates could lead to very similar phenotypes. In
order to discriminate between the two possibilities, we
examined the DNA damage levels during recovery from an
MMS pulse in wild-type and slx4-S486A cells. To this end,
we investigated the appearance and disappearance of
nuclear foci formed by the ssDNA-binding protein RPA
after MMS treatment in S phase. Indeed, slx4-S486A cells
contained more RPA foci, which persisted longer than in
wild-type cells (Fig. 3F). Therefore, we conclude that
unrepaired DNA lesions or DNA repair intermediates that
contain ssDNA persist in slx4-S486A mutants. This find-
ing does not necessarily exclude a role of Slx4 as a regulator
of the DNA damage checkpoint yet strongly suggests an
additional direct function of the Slx4–Dpb11 complex in
the repair of replication fork structures.
The Slx4–Dpb11 complex promotes Mus81–Mms4-
dependent JM resolution
As our findings pointed to a function of the Slx4–Dpb11
complex in the response and repair of MMS-induced
lesions, we next investigated whether the complex is
involved in the DNA damage bypass. Therefore, we
tested possible functions in HR and error-prone or error-
free PRR. From several lines of genetic evidence, we
conclude that the Slx4–Dpb11 complex is not exclusively
involved in either PRR or HR (Supplemental Fig. S5).
First, the slx4-S486A mutation enhanced the MMS hy-
persensitivity of mutants defective in error-free PRR
(double mutant with either mms2D, rad5-KT538,539AA,
Gritenaite et al.
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Figure 3. Mutation of slx4-S486A results in a specific defect in binding to Dpb11 and the response to stalled replication forks. (A) The slx4-
S486A mutant leads to a specific defect in binding to Dpb11. Relative enrichment of Slx4 interactors (see Supplemental Fig. S4A) found in
purifications of wild-type (WT) Slx43Flag versus Slx4-S486A3Flag as determined by SILAC-based quantitative MS. Values >1 indicate a reduced
binding to the Slx4-S486A relative to wild-type Slx4. (B) The slx4-S486Amutant, but not aDpb11–slx4-S486A-fusion, is hypersensitive toMMS.
Wild type or strains expressing slx4-S486A or the Dpb11–slx4-S486A-fusion from the SLX4 promoter as only a copy of SLX4 were spotted in
fivefold serial dilutions on MMS-containing medium and assayed for growth after 2 d. (C,D) Replication fork stalling is prolonged in the slx4-
S486A mutant. Cells were treated with a pulse of MMS during S phase, and recovery was analyzed by FACS (C; to measure cellular DNA
content) and pulsed-field gel electrophoresis (D; tomeasure intact, fully replicated chromosomes). (D) For quantification, the fluorescence signal of
chromosomes that migrated into the gel was divided by the total signal, including the pocket, and all signals were normalized to the G1 sample
from each strain. (E) The DNA damage checkpoint is inactivated with reduced kinetics in the slx4-S486Amutant. Cells were treated as inC, and
checkpoint activity was determined by anti-Rad53 Western blot. (F) The slx4-S486A mutant shows increased DNA damage foci and delayed
recovery after transientMMS treatment in S phase. DNA damage sites were visualized by the ssDNA-binding RFA13mCherry after transientMMS
treatment during S phase. Cells were sorted into three categories: multiple, dispersed RFA1 foci; one RFA1 focus; and no RFA1 foci. Values are
from two independent experiments, counting 100–150 cells per strain and time point. Error bars represent standard deviations.
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or rad5-C914S), error-prone PRR (double mutant with
either rev1D, rev3D, or rad30D), or HR (double mutant
with rad51D) (Supplemental Fig. S5A). Second, spontane-
ous mutagenesis, a hallmark of error-prone PRR, was not
significantly altered in slx4-S486Amutants (Supplemental
Fig. S5B). Third, recombination rates, as determined by
a direct repeat recombination assay, were similar between
wild-type and slx4-S486A strains (Supplemental Fig. S4C).
Fourth, siz1D or srs2DC mutations, which cause an up-
regulation of HR at stalled replication forks (Pfander et al.
2005), did not alleviate the MMS hypersensitivity of slx4-
S486A mutants (Supplemental Fig. S5C).
The nonepistatic relationship of the slx4-S486Amutant
to PRR or HR pathways could be explained if Slx4 and
Dpb11 participated in a step common to both error-free
PRR and HR because, in such a scenario, both pathways
would be affected by the slx4-S486A mutation. Both HR
and error-free PRR operate via template switching in order
to bypass the replication fork-stalling lesion by copying
the undamaged information from the sister chromatid. A
critical step in template switching is the final removal of
X-shaped DNA intermediates (JMs) that link the two sister
chromatids (Mankouri et al. 2013). JM removal pathways
act, in principle, independently of the pathway by which
JMs have been created (Branzei et al. 2008; for mus81D
phenotypes, see Interthal and Heyer 2000; Li and Brill
2005). To test whether the Slx4–Dpb11 complex is in-
volved in this late step, we visualized these DNA in-
termediates in an sgs1D mutant (deficient in JM dissolu-
tion) by two-dimensional (2D) gel electrophoresis (Liberi
et al. 2005; Mankouri et al. 2011). In this mutant, MMS
treatment in S phase leads to enhanced levels of JMs,
which subsequently disappear during late S, G2, and M
phase (Szakal and Branzei 2013). The additional mutation
of slx4-S486A in the sgs1D background does not alter the
formation of JMs, indicating that the Slx4–Dpb11 complex
is not required at early steps (Supplemental Fig. S6A).
Interestingly, however, during the recovery from theMMS
treatment, JMs are more slowly resolved in the sgs1D slx4-
S486A double mutant compared with the sgs1D single
mutant (Fig. 4A). A similar effect can be observed using an
slx4D mutant and conditionally inactivated SGS1 in the
same experimental setup (Supplemental Fig. S6B). Consis-
tently, we observed an enhanced MMS sensitivity for the
sgs1D slx4-S486A double mutant compared with the re-
spective single mutants (Fig. 4B). From these experiments,
we conclude that the Slx4–Dpb11 complex is involved in
the resolution of JMs that are supposedly intermediates
arising from a template switch reaction and that this
complex functions in a pathway parallel to dissolution
by the STR complex.
To elucidate a potential role of the Slx4–Dpb11 complex
in a resolution mechanism, we investigated the genetic
interaction with Mus81–Mms4. Indeed, the MMS sensitiv-
ities of slx4-S486A mms4D or slx4-S486A mus81D double
mutants were identical to those of mms4D or mus81D
singlemutants (Fig. 4C). This suggests that the Slx4–Dpb11
complex acts in the Mus81–Mms4 pathway. The same
epistatic relationship was seen between mms4D and slx4-
S486A when we investigated JM resolution by 2D gel
electrophoresis when the STR complex was inactivated
using the Tc-sgs1 allele (Supplemental Fig. S6C). We note
that the MMS hypersensitivity and the JM resolution
defect of the slx4-S486A mutant are less pronounced
compared with the deletion mutants that fully abolish
Mus81 function (Fig. 4C; Supplemental Fig. S6C), suggest-
ing that not all functions of the Mus81–Mms4 endonucle-
ase depend on the Slx4–Dpb11 complex.
We also tested the involvement of other structure-
specific endonucleases (Slx1, Rad1–Rad10, and Yen1)
(Tomkinson et al. 1993; Fricke and Brill 2003; Coulon
2006; Ip et al. 2008), specifically of Slx1, as it associates
with the Slx4–Dpb11 complex (Supplemental Fig. S4A).
We found that rad1D showed an additive phenotype with
slx4-S486A, while slx1D and yen1D mutants were not
hypersensitive to MMS (Supplemental Fig. S6D; Fricke
and Brill 2003; Coulon 2006; Blanco et al. 2010). We
therefore conclude that these factors either are not in-
volved in the resolution of template switch intermediates
by Mus81 and the Slx4–Dpb11 complex or (in case of Slx1
and Yen1) have a function that can be taken over by
a redundant pathway in the respective deletion mutant.
Interestingly, the yen1D mutation caused an increase of
MMS sensitivity specifically of the sgs1D slx4-S486A
double mutant (Supplemental Fig. S6E), suggesting that
Yen1 function becomes specifically important if the STR
complex is inactive and function of the Slx4–Dpb11
complex is reduced.
The balance between STR-dependent JM dissolution
and Mus81-dependent JM resolution is reflected in the
ratio of CO to non-CO (NCO) products (Ira et al. 2003; Ho
et al. 2010; Mankouri et al. 2013), since STR-mediated
dissolution will not yield COs, while Mus81-mediated
resolution can generate CO products. We therefore ana-
lyzed the rates of CO formation in the slx4-S486Amutant
with a recombination assay using interchromosomal arg4
heteroalleles (Robert et al. 2006; Szakal and Branzei 2013).
Despite a slight increase in overall recombination rates,
we measured a reduction in CO rates in the slx4-S486A
mutant compared with wild-type cells (Fig. 4D). We
therefore conclude that the Slx4–Dpb11 complex is an
important regulator of JM removal pathways and that it
acts by stimulating JM resolution, inhibiting JM dissolu-
tion, or both.
Persistent JMs interfere with the separation of sister
chromatids in mitosis. Under circumstances in which JMs
are not resolved before anaphase, these repair intermedi-
ates are thought to give rise to anaphase bridges between
the dividing DNA masses (Chan et al. 2007; Mankouri
et al. 2013). Consistent with a role in the resolution of JMs,
Dpb11 localizes to DNA bridges between the separated
chromosome masses in anaphase (Germann et al. 2014).
Dpb11-containing anaphase bridges can be observed with
a low frequency in undamaged cells (<5%) and are induced
upon MMS treatment, suggesting that they arise from
replication fork stalling (Germann et al. 2014). Interest-
ingly, the occurrence of Dpb11 bridges is increased in
sgs1D cells (Germann et al. 2014), indicating that the
localization of Dpb11 to chromatin bridges reflects its
action in a resolution mechanism. We observed a pro-
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Figure 4. The Dpb11 binding-deficient slx4-S486A mutant causes defects in the Mus81–Mms4-dependent JM resolution. (A) JM
structures are resolved slower in sgs1D slx4-S486A cells. X-shaped JMs were visualized as spike signal in 2D gels in sgs1D and sgs1D
slx4-S486A cells that have been treated with a pulse of MMS in S phase. (B) MMS sensitivity is enhanced in the sgs1D slx4-S486A
double mutant compared with each single mutant. Analysis of the MMS hypersensitivity phenotype as in Figure 3B. (C) The MMS
hypersensitivity ofmms4D andmus81Dmutants is not further enhanced by an additional slx4-S486Amutation. Experiment as in B. (D)
The slx4-S486Amutation leads to a reduced CO formation. COs and NCOs from an interchromosomal recombination assay using arg4
heteroalleles on chromosome V and VIII (Robert et al. 2006) were determined using a PCR-based strategy. (Top panel) Recombination
and CO rates were determined by fluctuation analysis using a maximum likelihood approach. (Bottom panel) CO ratio is quotient of
CO rate and overall recombination rate. Error bars represent standard deviations of two to 11 independent experiments. (E) Dpb11
anaphase bridge structures occur more frequently when JM dissolution and the Dpb11–Slx4 interaction are defective. (Right panel)
Quantification of Dpb11 ultrafine bridges (UFBs) or chromatin bridges in wild-type (WT), sgs1D, slx4D, slx4-S486A, and slx4-S486A
sgs1D strains. Cells express Dpb11-YFP, NLS-RFP as a marker of the nucleoplasm and Spc110-CFP as a marker of the spindle pole body.
DNA is stained with Hoechst. (Left panel) Images of representative anaphase cells are shown. Bar, 3 mm. Error bars indicate 95%
confidence intervals. Significance is as follows: (*) P < 0.01 (compared with wild type); (#) P < 0.01 (compared with the single mutants);
(ns) not significantly different from wild type.
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nounced increase of cells containing Dpb11 bridges when
the sgs1D and slx4-S486A mutants were combined (Fig.
4E). The genetic requirements for Dpb11 bridges are
therefore highly similar to those for persistent JMs (Fig.
4A), supporting a role for Dpb11 and Slx4 in JM resolution.
In line with this model, we observed frequent colocaliza-
tion of either Slx4YFP orMus81YFP with Dpb11CFP-positive
bridges that is further enhanced in sgs1D cells (Supple-
mental Fig. S7A). We also noticed a colocalization of Slx4,
Mus81, and Dpb11 in DNA damage foci yet to a lesser
extent (Supplemental Fig. S7B). Overall, the data in Figure
4 provide strong support for an involvement of the Slx4–
Dpb11 complex in JM resolution by Mus81–Mms4.
Mus81–Mms4 interacts with the Slx4–Dpb11 complex
during mitosis in a Cdc5-dependent fashion
To elucidate how the Slx4–Dpb11 complex regulates
Mus81 function, we investigated a possible physical in-
teraction. In previous studies using asynchronously grow-
ing yeast cells, no binding of Slx4 to Mus81–Mms4 was
detectable (Schwartz et al. 2012). However, we detected
Mms4 as a cell cycle-specific interactor if Slx43Flag immuno-
precipitations were investigated by SILAC MS (such as in
Fig. 2A). Moreover, when we arrested cells in G2/M by
nocodazole treatment, immunopurification of Mms43Flag
copurified Dpb11 and Slx4 (Fig. 5A). Notably, this interac-
tion is highly cell cycle-specific, as it could not be observed
in G1- or S-phase cells (Fig. 5A). We determined, using an
unbiased SILACMS approach, that Dpb11, Slx4, andRtt107
are among the best interactors of Mus81–Mms4 in G2/M-
arrested cells (Supplemental Fig. S8A).
Next, we testedwhetherDpb11, Slx4, andMus81–Mms4
form a single protein complex. Indeed, the three proteins
comigrated at a size of ;33 S (Supplemental Fig. S8B,
fractions 18–20, apparent molecular weight 1.1–1.2 MDa)
when the eluate of an Mms43Flag purification from G2/M
cells was subjected to a glycerol gradient centrifugation.
When we analyzed the complex architecture by a two-
hybrid approach, we detected a direct interaction of Dpb11
and Mms4 that is independent of Slx4 (Supplemental Fig.
S8C). Moreover, when we immunoprecipitated Mms43Flag
in the slx4-S486A background, we observed a reduction of
Slx4, but not Dpb11, binding to Mms43Flag (Fig. 5B). These
findings thus suggest that Dpb11, Slx4, and Mus81–Mms4
are part of a multiprotein complex in which Dpb11 acts as
a bridge between Slx4 and Mus81–Mms4.
We observed that Dpb11 and Slx4 could be partially
eluted from Mms4-containing beads using l-phosphatase
treatment (Supplemental Fig. S8D), suggesting that the
binding is at least in part dependent on protein phosphor-
ylation. Previous work has established that Mus81 activ-
ity is decisively up-regulated in mitosis in response to
a sequential phosphorylation of Mms4 by CDK and the
Polo-like kinase Cdc5 (Matos et al. 2011; Gallo-Ferna´ndez
et al. 2012; Saugar et al. 2013; Szakal and Branzei 2013).
We therefore used two systems to interfere with Cdc5
activity: the cdc5-as1 analog-sensitive allele, which we
inhibited using chloromethylketone (CMK) (Snead et al.
2007), and transcriptional shutoff of pGAL-CDC5 using
glucose repression. Both types of Cdc5 inactivation re-
sulted in a loss of the slower-migrating species of Mms4
in gels and at the same time diminished the binding of
Dpb11 and Slx4 to Mms43Flag (Fig. 5C; Supplemental Fig.
S9A). In order to rule out indirect effects, we tested
whether Cdk1 activity was uninfluenced under condi-
tions of Cdc5 inhibition/shutoff and saw that neither the
interaction between Slx4 and Dpb11 nor phosphorylation
of a CDK target site on Rad9 (T474) (Pfander and Diffley
2011) was influenced by Cdc5 inactivation (Supplemental
Fig. S9B,C). Together with our results on the architecture
of the Slx4–Dpb11–Mms4–Mus81 complex, these exper-
iments suggest that binding of Mms4 to Dpb11 is regu-
lated by Cdc5 phosphorylation.
We also tested whether the formation of the Slx4–
Dpb11–Mms4–Mus81 was regulated upon DNA damage.
We found thatMms43Flag bound similar amounts of Dpb11
and Slx4 after phleomycin or mock treatment of G2/M-
arrested cells (Supplemental Fig. S9D).Moreover, we could
also observe formation of the Slx4–Dpb11–Mms4–Mus81
complex during recovery from MMS pulse treatment
during S phase (Fig. 5D). However, this binding occurred
only once Cdc5 became active, as visualized by the slower-
migrating form of Mms4, indicating that even after DNA
damage, the Dpb11–Mms4 interaction is dependent on
Cdc5 (Fig. 5D).
Given that the cell cycle regulation of Mus81 activity
and the cell cycle regulation of the Slx4–Dpb11–Mms4–
Mus81 complex formation have the same requirements,
we tested whether the up-regulation of Mus81 nuclease
activity requires Slx4 and Dpb11. We analyzed in vitro
resolution of nicked Holliday junctions, Holliday junc-
tions, and model replication fork structures on immuno-
purified Mus81–Mms4 and found that the enhanced
activity of mitotic Mus81 is similar, independently of
whether Mus81 was purified from wild-type or slx4-
S486A cells (Fig. 5E; Supplemental Fig. S9E). Therefore,
we conclude that cell cycle kinases regulate Mus81 by at
least two mechanisms: direct up-regulation of the cata-
lytic activity, which can be reconstituted in vitro, and an
up-regulation through formation of an Slx4–Dpb11–
Mms4–Mus81 complex, which could be seen in vivo.
The DNA damage checkpoint regulates the Slx4–
Dpb11-dependent Mus81 function
The DNA damage checkpoint prevents collapse of stalled
replication forks and thereby is fundamentally required for
all aspects of the response to stalled replication forks
(Branzei and Foiani 2010). Moreover, the checkpoint was
also suggested to counteract Cdc5-dependent Mus81 acti-
vation, since premature Mms4 phosphorylation by Cdc5
was observed after MMS treatment of checkpoint-defi-
cient cells (Szakal and Branzei 2013). Possible explanations
for this phenomenon are a faster S-phase progression in the
checkpoint mutants or a direct inhibition of Cdc5 activity
by the checkpoint (Zhang et al. 2009).
To address these possibilities, we investigated the in-
fluence of the DNA damage checkpoint on Slx4–Dpb11–
Mms4–Mus81 complex function. Interestingly, we found
Gritenaite et al.
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that a partial defect in DNA damage checkpoint signaling
alleviated the phenotypes of the slx4-S486A mutant (Fig.
6A,B; Supplemental Fig. S10A,B; see also Ohouo et al.
2012). In these experiments, we used three distinct mu-
tants, which were partially impaired in checkpoint signal-
ing: ddc1-T602A (defective in Dpb11-dependent Rad9
recruitment (Puddu et al. 2008), dot1D (defective in
chromatin-dependent Rad9 recruitment) (Giannattasio
et al. 2005), and rad53-3HA (a hypomorphic Rad53 allele)
(Cordon-Preciado et al. 2006). All three mutants partially
suppressed the hypersensitivity of slx4-S486A to chronic
exposure of MMS (Fig. 6A; Supplemental Fig. S10A).
Furthermore, the recovery fromMMS treatment as judged
by the reappearance of fully replicated chromosomes in
PFGE and reappearance of unphosphorylated Rad53 was
enhanced in slx4-S486A ddc1-T602A cells compared with
slx4-S486A cells (Fig. 6B; Supplemental Fig. S10B).
A plausible interpretation of these results is that a partial
inactivation of the checkpoint may compensate for a re-
duced or delayed formation of the Slx4–Dpb11–Mms4–
Figure 5. Slx4, Dpb11, and Mus81–Mms4 form a Cdc5-dependent complex at the G2/M cell cycle stage. (A) Mms4 binds to Dpb11 and
Slx4 specifically in G2/M. Coimmunoprecipitation samples of Mms43Flag from G1, S, or G2/M cells were tested for binding to Dpb11 and
Slx4. (B) Slx4-S486A is partially lost from the Slx4–Dpb11–Mms4–Mus81 complex, suggesting that Dpb11 bridges the interaction between
Mms4 and Slx4. Mms43Flag coimmunoprecipitation were carried out as in A but from G2/M-arrested wild-type (WT) or slx4-S486A
mutant cells. (C) The Dpb11–Mms4 interaction is dependent on the Polo-like kinase Cdc5. cdc5-as1 was inhibited by 2, 5, and 20 mM
CMK in G2/M-arrested cells. Mms43Flag coimmunoprecipitation was performed as in A. (D) Cdc5 hyperphosphorylated Mus81–Mms4
binds to Slx4 and Dpb11 during recovery from MMS damage. Cells were treated with a 30-min pulse of 0.03% MMS. Mms43Flag
coimmunoprecipitations were performed from samples after 0, 30, 60, 90, and 120 min of recovery in nocodazole-containing medium. (E)
Cell cycle regulation of Mus81–Mms4 nuclease activity remains intact in the slx4-S486A mutant. Mms43Flag and control immunopre-
cipitations (see the bottom panel for immunoprecipitation samples) from cells arrested in their cell cycle by a factor, HU, or nocodazole
were incubated with a fluorescence-labeled nicked Holliday junction substrate.
Slx4 and Dpb11 regulate joint molecule resolution
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Mus81 complex. Such compensation may occur by either
a direct up-regulation of the Slx4–Dpb11–Mms4–Mus81
complex or hyperactivation of a Mus81-independent sal-
vage pathway. We therefore tested whether the observed
rescue would depend on Mms4. Consistent with a direct
influence of the checkpoint on the Slx4–Dpb11–Mms4–
Mus81 complex, a partial inactivation of the checkpoint
did not rescue the MMS hypersensitivity of themms4D or
mms4D slx4-S486A mutants (Fig. 6C). In contrast, the
sgs1D slx4-S486A or yen1D slx4-S486A double mutants
could be rescued by additional mutation of ddc1-T602A
(Supplemental Fig. S10C), suggesting that neither STR nor
Yen1 activity is required for the rescue. Furthermore,
mms4D ddc1-T602A mutants show a slow checkpoint
recovery after a pulse of MMS in S phase that is similar to
mms4D cells (Fig. 6D). These results suggest that the
rescue of slx4-S486A mutants upon partial checkpoint
inactivation is due to the action of Mms4–Mus81.
Furthermore, when we transiently exposed cells toMMS
during S phase and released them into a G2/M arrest, we
observed that the Cdc5-dependent phosphorylation shift of
Mms4, which in this experiment serves as a marker for the
interaction with Slx4–Dpb11, was slightly delayed in slx4-
S486A cells compared with wild-type cells (Fig. 6E), prob-
ably because of a slower S-phase progression (see Fig. 3C).
Importantly, the additional partial inactivation of the
checkpoint (slx4-S486A ddc1-T602A) (Fig. 6E,F) allowed
Cdc5-dependent Mms4 phosphorylation to occur earlier.
Concomitantly, the binding of Mms4 to Dpb11 and Slx4
was rescued by partial checkpoint inactivation when
immunoprecipitations were performed during the recovery
phase (Fig. 6F). The occurrence of Mms4 phosphorylation
Figure 6. Partial inactivation of the DNA
damage checkpoint rescues slx4-S486A pheno-
types in an MMS4-dependent manner. (A) The
DNA damage repsonse defect of slx4-S486A is
suppressed by partial inactivation of the DNA
damage checkpoint. Wild type (WT), slx4-
S486A, the partial checkpoint mutant ddc1-
T602A, and the slx4-S486A ddc1-T602A dou-
ble mutant were spotted in fivefold serial
dilutions on MMS-containing plates. (B) The
prolonged replication fork stalling of the slx4-
S486A mutant is rescued by the ddc1-T602A
mutation. Cells were cell cycle-synchronized
and treated with a 30-min pulse of 0.033%
MMS in S phase. Recovery of fully replicated
chromosomes was analyzed by pulsed-field gel
electrophoresis. Quantification as in Figure
3D. (C) A complete defect in Mus81 activity
(mms4D) cannot be rescued by checkpoint
inactivation. The MMS hypersensitivity phe-
notypes of slx4-S486A, mms4D, and ddc1-
T602A mutants and double and triple mutant
combinations were analyzed as in A. (D) The
checkpoint recovery defect ofmms4Dmutants
is not rescued by a partial checkpoint mutant.
Cells were treated as in B, and checkpoint
activity was measured by Rad53 phosphoryla-
tion. (E,F) Cdc5-dependent hyperphosphoryla-
tion of Mms4 and concomitant binding to
Dpb11 and Slx4 occur earlier during recovery
from replication fork stalling in slx4-S486A
ddc1-T602A double mutants compared with
slx4-S486A mutants. (E) Cells were treated
with a 40-min pulse of 0.033% MMS in S
phase. The Cdc5-dependent Mms43Flag phos-
phorylation shift was measured by anti-Flag
Western blot, checkpoint activity was mea-
sured by Rad53 phosphorylation, and cell cycle
progression was followed by anti-Clb2 and
anti-Cdc5 Westerns. (F) Wild-type, slx4-
S486A, and slx4-S486A ddc1-T602A cells that
contain MMS43Flag were harvested during the
recovery phase (2.5 h after MMS removal) and
subjected to anti-Flag immunoprecipitation.
Coimmunoprecipitation samples were tested
for binding to Dpb11 and Slx4.
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1614 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on June 8, 2018 - Published by genesdev.cshlp.orgDownloaded from 
in the twomutants inversely correlated with DNA damage
checkpoint activation (Rad53 phosphorylation) (Fig. 6E). It
needs to be emphasized that Slx4–Dpb11 interaction is
reduced, but not abolished, in the slx4-S486Amutant (Figs.
1B, 3A). The results in Figure 6, E and F, therefore suggest
that the Slx4–Dpb11–Mms4–Mus81 complex can form
earlier and potentially to a larger extent in the slx4-S486A
ddc1-T602Amutant compared with the slx4-S486A single
mutant. This offers a straightforward explanation for the
rescue of the slx4-S486A mutant phenotypes by partial
inactivation of the DNA damage checkpoint.
Taken together, we therefore identified an intricate
regulatory mechanism of the Mus81 endonuclease, which
critically depends on the formation of an Slx4–Dpb11–
Mms4–Mus81 complex. The formation of this complex is
activated by cell cycle stage-specific signaling and antago-
nized by the DNA damage checkpoint. Remarkably, com-
plex formation and the direct control of Mus81 catalytic
activity occur with similar timing, at the G2/M transition
(Fig. 7).
Discussion
In this study, we describe a new facet of JM resolution
following the bypass of DNA damage via template switch
recombination. We describe a multiprotein complex con-
taining Slx4, Dpb11, and Mus81–Mms4. This complex is
cell cycle-controlled by at least two mechanisms: Cdk1-
dependent phosphorylation of Slx4 and Cdc5-dependent
phosphorylation of Mms4, and Dpb11 acts as a reader of
both modifications. The conservation of the Slx4–Dpb11/
TopBP1 interaction and its cell cycle regulation suggests
that a similar complexmay be involved in JM resolution in
human cells. Importantly, the inhibition of Slx4 binding to
Dpb11 causes phenotypes that are indicative of JM reso-
lution defects, and we therefore infer that the association
with Slx4 and Dpb11 promotes Mus81 function.
Slx4–Dpb11 multiprotein complex formation
correlates with DNA JM resolution
The starting point of our analysis was a multiprotein
complex containing Slx4, Dpb11, Slx1, and Rtt107 (Ohouo
et al. 2010, 2012). In order to characterize a putative
function of this complex inDNA repair, we testedwhether
the Slx4–Dpb11 complex would transiently interact with
DNA repair enzymes and found an interaction with the
Mus81–Mms4 structure-specific endonuclease specifically
in mitotic cells. Based on the findings that the slx4-S486A
mutant impairs complex formation and results in JM
resolution defects, we propose that the Slx4–Dpb11 com-
plex regulates Mus81–Mms4 activity. Our binding studies
furthermore indicate a direct Dpb11–Mms4 interaction.
Given the nature of Dpb11 as a scaffold protein, it appears
likely that Dpb11 operates by tethering Mus81 to other
activities that collaborate in the resolution reaction or
targeting Mus81 to JM structures.
An intricate feature of the Slx4–Dpb11 complex is its
complexity, as it involves four scaffold proteins: Dpb11,
Slx4, Rtt107, and Mms4. An obvious advantage of such
a multiscaffold complex is that its formation depends on
several interaction surfaces, which offer numerous possi-
bilities for regulation. The assembly of the complex
therefore allows the integration of different cellular signals
(for example, cell cycle and DNA damage), or one specific
signal may control complex assembly by several mecha-
nisms. Such a setup includes features of multisite phos-
phorylation systems, which have the ability to create
switch-like transitions (Nash et al. 2001).Moreover, amulti-
scaffold complex may allow the assembly and coordina-
tion of different enzymatic activities (see below).
Our work has identified Mus81 as one catalytically
active component of the Slx4–Dpb11 complex; a second
one could potentially be Slx1. Recently, the Mus81 and
Slx1 endonucleases from humans and mice have been
shown to cooperate in the resolution of Holliday junctions
in an Slx4-dependent manner (Wyatt et al. 2013). While
our results suggest that also in budding yeast, Mus81 and
Slx1 may be part of the same complex, we did not observe
any specific defects in the response to MMS-induced
replication fork stalling for slx1D cells (Supplemental Fig.
S6D). Therefore, we conclude that either Slx1 is not
involved in Mus81-dependent JM resolution in budding
yeast or a functionally redundant nuclease compensates
for the defects of the slx1D mutant.
Cell cycle regulation of the response to replication fork
stalling and JM resolution
The cellular response to replication fork-stalling DNA
lesions is intimately linked to the progression of the cell
cycle. First, the primary problem, fork stalling, arises
specifically in S phase. Moreover, the cells are required to
finish the repair/bypass process at the latest in mitosis,
when sister chromatids need to be accurately separated,
and any remaining links between the chromatids have to
be resolved.
In this study, we characterized two Dpb11 interactors:
Slx4 and Mms4. Both proteins are phosphorylation tar-
Figure 7. Model of the temporal response to replication fork
stalling and its regulation by Slx4–Dpb11 complexes.
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gets of CDKs; however, Mms4 is additionally phosphor-
ylated by the Polo-like kinase Cdc5 (Matos et al. 2011;
Gallo-Ferna´ndez et al. 2012; Szakal and Branzei 2013).
Interestingly, the Slx4–Dpb11 and Mms4–Dpb11 interac-
tions display distinct cell cycle specificities: We observed
a strong Slx4–Dpb11 interaction in asynchronous cul-
tures as well as in S-phase andmitotic cells (Figs. 1C, 2C),
while the Mms4–Dpb11 interaction was highly specific
for mitosis (Fig. 5A). Accordingly, we found that the
Mms4–Dpb11 interaction requires Cdc5, suggesting that
Dpb11 can act as a reader of phosphorylation events that
are initiated by different cell cycle kinases.
The cell cycle regulation of the Mus81–Mms4 associ-
ation with the Slx4–Dpb11 complex correlates exactly
with the known activity profile of Mus81 (Matos et al.
2011). Notably, the multiprotein complex is not the only
mechanism of cell cycle regulation: Our in vitro resolu-
tion assays suggest that Cdc5 phosphorylation of Mus81–
Mms4 directly stimulates Mus81 independently of com-
plex formation. Therefore, we conclude that at least two
parallel pathways of cell cycle regulation exist that pro-
mote appropriate Mus81 function in mitosis.
To date, it remains uncertain why cells restrict the
activity of Mus81 until mitosis. The temporal regulation
of Mus81 channels a large proportion of JMs into the Sgs1–
Top3–Rmi1 dissolution pathway (Matos et al. 2011; Szakal
and Branzei 2013). It has therefore been speculated that
Sgs1-dependent dissolution, which leads to a NCO out-
come (Ira et al. 2003), may be beneficial for cells dividing by
a mitotic cell cycle. A second reason for restricting Mus81
activity may be the necessity to achieve temporal separa-
tion of the lesion bypass reaction and the JM resolution
reaction (Saugar et al. 2013). Mus81 could impede the
bypass reaction, given its relatively broad substrate spec-
ificity to a range of DNA structures (e.g., replication forks,
D-loop structures, and Holliday junctions).
Intriguingly, the differences in the temporal regulation
of the Slx4–Dpb11 and Mms4–Dpb11 interactions suggest
that the composition of the Slx4–Dpb11 complex changes
from the replication-associated template switch to the
resolution reaction. Supporting the idea of several distinct
Slx4–Dpb11 complexes is the fact that not all features of
the Slx4–Dpb11 interaction (for example, enhanced bind-
ing after DNA damage) are seen in the Slx4–Dpb11–
Mms4–Mus81 complex. It therefore appears plausible that
Slx4–Dpb11 may associate with stalled replication forks
already in S phase, while Mus81–Mms4 joins the complex
in mitosis. It is tempting to speculate that the Slx4–Dpb11
complex may chaperone the DNA lesion site/repair in-
termediates until resolution (Fig. 7).
Regulation of JM resolution by the DNA damage
checkpoint
The DNA damage checkpoint antagonizes JM resolution
byMus81 (Fig. 6; Szakal and Branzei 2013), and it has been
suggested that Slx4 may act as negative regulator (‘‘damp-
ener’’) of the checkpoint by competing with binding of the
checkpoint mediator Rad9 to Dpb11 (Ohouo et al. 2012).
The JM resolution phenotypes of the slx4-S486A mutant
could therefore, in principle, be explained by an indirect
effect arising from checkpoint hyperactivation. Given the
extensive ties between checkpoint and DNA repair path-
ways, the presented in vivo experiments cannot rule out
a contribution of checkpoint misregulation to the ob-
served JM resolution phenotypes.
We favor, however, a more direct role of Slx4 and Dpb11
in JM resolution for two reasons. First, the formation of the
Slx4–Dpb11–Mms4–Mus81 complex and its regulation
correlate with the temporal activation of Mus81. Second,
the ‘‘dampener’’ model cannot account for all observed
phenotypes. For example, the rescue of the MMS hyper-
sensitivity of the slx4-S486A mutant by a covalent fusion
with Dpb11 cannot be explained by competition, since in
the fusion mutant, cells express two copies of full-length
Dpb11 (one endogenous, one fused to Slx4), and therefore
evenmore Dpb11molecules (not less) are able to engage in
checkpoint signaling complexes. Moreover, our analysis of
RPA foci suggests that DNA lesions or repair intermedi-
ates persist and accumulate in the absence of a functional
Slx4–Dpb11 complex, indicative of a role for Slx4 and
Dpb11 in DNA repair.
Importantly, we found that the checkpoint regulates the
formation of the Slx4–Dpb11–Mms4–Mus81 complex: Par-
tial inhibition of the checkpoint enables Cdc5-dependent
hyperphosphorylation of Mms4, which allows Dpb11 bind-
ing to occur earlier during the recovery from anMMS pulse
and thereby reverses the effect of the slx4 mutant. These
findings suggest that at least in the slx4-S486A mutant
background, the DNA damage checkpoint antagonizes the
Slx4–Dpb11–Mms4–Mus81 complex. Partial inactivation
of the checkpoint may therefore extend the temporal
window during which Mus81 is active, which we propose
to be beneficial in mutants with reduced JM resolution
activity such as slx4-S486A.Whether this inhibitorymech-
anism takes place on the level of Cdc5 regulation in general
(Zhang et al. 2009; Matos et al. 2013) or by specifically
regulating Mms4 phosphorylation by Cdc5 remains to be
determined. The important implication of this finding is
that the activation ofMus81 is temporally restricted by two
pathways: activation by cell cycle kinases and inhibition by
the DNA damage checkpoint.
The Slx4–Dpb11 complex is conserved among
eukaryotes
In addition to the mechanistic studies of the budding yeast
Slx4–Dpb11 complex,we also provide the first evidence that
at least parts of this complex may be found in human cells
as well, since Slx4 and TopBP1 interact in a manner that
depends on CDK phosphorylation of Slx4. It is worth noting
that not all aspects of the protein network that controls
resolution of JMs are conserved through evolution: While in
human cells, Slx4 binds directly to Mus81–Eme1, this
interaction appears to be absent in budding yeast (Fekairi
et al. 2009; Mun˜oz et al. 2009; Svendsen et al. 2009;
Schwartz et al. 2012). Given that both Slx4 and Mms4 bind
to Dpb11, our data suggest that Dpb11may serve as a bridge
between the two proteins. Although a direct interaction
between Slx4 and Mus81–Mms4 cannot be definitively
Gritenaite et al.
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excluded, it appears as if the bridging interaction with
Dpb11 in yeast may replace the direct interaction of Slx4
and Mus81 in human cells. Importantly, similar to our
results in yeast, a stimulation of Slx4 binding to Mus81–
Eme1 after phosphorylation by CDK and Polo-like kinase
was observed in mitotic human cells as well (Wyatt et al.
2013). At this point, it seems therefore very likely that in
both systems, JM resolution is promoted by a cell cycle-
regulated complex containing several scaffold proteins.
Materials and methods
Yeast strains
All yeast strains are based on W303. Genotypes are listed in
Supplemental Material.
Interaction assays
Coimmunoprecipitations of yeast extracts were performed using
anti-Flag agarose resin (Sigma). Bound proteins were eluted with
33 Flag-peptide (Sigma).
For GST pull-downs, GST-Dpb11 or GST-tagged protein frag-
ments were recombinantly expressed and purified as described
(Pfander and Diffley 2011). Pull-downs were performed with am-
monium sulphate-precipitated (57%) yeast extracts on glutathione
sepharose 4B (GE Healthcare).
For coimmunoprecipitations from HEK293T, GFP-tagged pro-
teins were transiently overexpressed and precipitated using GFP-
Trap magnetic beads (Chromotek).
Nuclease activity assays
Nuclease assays on Mms43Flag immunoprecipitations were done
as described (Matos et al. 2011).
DNA gel electrophoresis
PFGE and 2D gel analysis of DNA intermediates were performed
as previously described (Karras and Jentsch 2010; Szakal and
Branzei 2013).
Mutation and recombination assays
Mutation rates were determined using a CAN1 forward mutation
assay. Interchromosomal recombination rates were determined
using a direct repeat system using leu2 heteroalleles (Aguilera and
Klein 1988). CO rates were determined using a system harboring
two arg4 alleles on chromosome V and VIII (Robert et al. 2006;
Szakal and Branzei 2013). In all, rates were determined by fluc-
tuation analysis using a maximum likelihood approximation
(Pfander et al. 2005).
Microscopy and immunofluorescence
Microscopy experiments were carried out as described (Germann
et al. 2014).
A detailed methods description is provided in the Supplemen-
tal Material.
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Supplemental Figure Legends 
Figure S1.  
The binding surface of the evolutionary conserved Slx4 and Dpb11 
complex contains BRCT3+4 of Dpb11 and S486 of Slx4 in S. cerevisiae. 
A Slx4 binds to Dpb11 fragments containing BRCT3+4. Pulldown of Slx4 from 
undamaged or phleomycin-treated G1 or G2/M cell extracts using GST-Dpb11 
fragments (N: aa 1-275, M: aa 276-600, C: aa 556-764, ΔC: aa 1-600). B 
Mutation of the Dpb11 BRCT3+4 phospho-protein binding surface reduces 
Slx4 binding to Dpb11. Two-hybrid analysis of GAL4-BD fused to WT Dpb11 
or to Dpb11-T451A, and GAL4-AD fusions with Slx4. C A region in Slx4 
sequence between aa 461 and aa 490 is important for Dpb11 interaction. 
Two-hybrid analysis of GAL4-BD (left panel) fused to WT Dpb11 or to the 
BRCT3+4 fragment, and GAL4-AD fusions with Slx4 C-terminal fragments. 
Expression of the constructs was verified by western blot analysis (right 
panel). D Mutation of S486 in Slx4 to a non-phosphorylatable alanine residue 
reduces Dpb11 binding. Two-hybrid analysis of GAL4-BD (left panel) fused to 
WT Dpb11 or to the BRCT3+4 fragment, and GAL4-AD fusions with WT Slx4 
or with Slx4-S486A. Expression of the constructs was verified by western blot 
analysis (right panel). E The presence of DNA damage does not stimulate 
TopBP1 binding to Slx4 in human cells. Co-immunoprecipitation of mycTopBP1 
with GFPSlx4 and GFPSlx4ΔN after transient overexpression in HEK 293T cells. 
Cells were left untreated or treated with 0.001% or 0.003% (++) MMS or 
100 µg/ml zeocin for 30 min to induce DNA damage. F The Slx4-Dpb11 
interaction is regulated by cell cycle phase and DNA damage. Co-
immunoprecipitation of Slx4 and Dpb113FLAG from G1 or G2/M arrested cells, 
which were either damaged by 50 µg/ml phleomycin or left untreated. 
 
Figure S2.  
A phosphorylation-dependent Dpb11/TopBP1 binding motif in 
eukaryotic Slx4 proteins. 
Slx4 proteins from different eukaryotes comprise a conserved, short linear 
motif, which harbours serine 486 in budding yeast and threonine 1260 in 
humans. Multiple sequence alignment of the Dpb11/TopBP1 interaction motif. 
Conserved residues in more than one class are highlighted in yellow. 
Phosphorylation sites in Saccharomyces cerevisiae and Homo sapiens, as 
well as predicted sites as inferred from homology are indicated in red, 
alternative sites with unclear homology in light green. Species abbreviations, 
as well as accession numbers are listed in Supplementary Table 2.  
 
Figure S3. 
Mutation of seven SQ/TQ motifs in the C-terminus of Slx4 leads to 
similar phenotypes as the slx4-S486A mutation. 
A The slx4-S486A and slx4-7A mutants are hyper-sensitive to MMS. WT or 
strains expressing slx4-S486A or the slx4-7A as only copy of Slx4 from the 
SLX4 promoter were spotted in 5-fold serial dilutions on MMS-containing 
media and assayed for growth after two days. B Replication fork stalling is 
prolonged in the slx4-S486A and slx4-7A mutant. Cells were treated with a 
pulse of MMS during S-phase and recovery was analysed by pulsed-field gel 
electrophoresis to measure intact, fully replicated chromosomes. For 
quantification, the fluorescence signal of chromosomes that migrated into the 
gel was divided by the total signal including the pocket and all signals 
normalized to the G1 sample from each strain. C The Slx4-7A and Slx4-
S486A mutant proteins show reduced binding to Mms4 and Dpb11. Co-
immunoprecipitation of endogenous Dpb11 and Slx4 with Mms43FLAG in 
combination with phosphorylation-deficient mutants of Slx4, S486A or 7A, or 
Slx4 deletion from G2/M arrested cells. 
 
Figure S4. 
Analysis of composition and function of the Slx4-Dpb11 complex.  
A Slx4 and Dpb11 are part of a multi-protein complex containing Rtt107 and 
Slx1. Co-immunoprecipitations of Dpb113FLAG (left panel) and Slx43FLAG (right 
panel) were compared to purifications from untagged control strains using a 
SILAC setup. Cells were treated with 0.033% MMS, whereby strains 
containing Dpb113FLAG/Slx43FLAG were grown in heavy (15N2 13C6 lysine (Lys8) 
and 15N4 13C6 arginine (Arg10)) medium, untagged control strains in light 
medium. Proteins shown in red are enriched in both purifications (Dpb11, 
Slx4, Rtt107, Slx1). The best scoring MS-MS spectra of the Slx4 peptide 
containing phosphorylated S486A from the Dpb113FLAG CoIP is shown. This 
peptide showed an H/L ratio of 17 in the Dpb113FLAG pulldown. B The slx4-
S486A mutant is slightly sensitive to 4-NQO (in addition to MMS (Fig. 3B)), 
but not to other DNA damaging drugs. WT cells or the slx4-S486A mutant 
were spotted in 5-fold serial dilutions on media containing phleomycin, HU, 
CPT, cisplatin and 4-NQO and assayed for growth after two days. C The slx4-
S486A mutant has a similar recombination rate compared to WT. 
Recombination rates were measured using an intrachromosomal direct-repeat 
system (leu2-112::URA3::leu2-k, Aguilera and Klein 1988). Fluctuation 
analysis was performed using 10 independent cultures and recombinants 
were determined by plating on plates lacking leucine or leucine and uracil. 
Single colonies were counted and recombination rates were calculated using 
a maximum-likelihood method. The shown values represent means of three 
independent experiments. Error bars represent standard deviations. D The 
checkpoint response after treatment with DSB-inducing agents is similar in 
WT and slx4-S486A cells. Cells were treated with a 30 min pulse of 50 µg/ml 
phleomycin or zeocin during G2/M- or S-phase (see samples +Phl/+Zeo) and 
recovery was analysed by checkpoint activity as determined by anti-Rad53 
western blot (upper panel) and by cellular DNA content as determined by 
FACS (lower panel). 
 
Figure S5. 
The Slx4-Dpb11 complex is not exclusively involved in either post-
replicative repair (PRR) or homologous recombination (HR). 
A A defect in the Dpb11-Slx4 complex further enhances the hyper-sensitivity 
of PRR and HR mutants. Strains expressing slx4-S486A as endogenous copy 
of Slx4 alone or in combination with mutants defective in error-free PRR 
(mms2Δ, rad5-KT538,539AA and rad5-C914S), error-prone PRR (rev1Δ, 
rev3Δ and rad30Δ) or HR (rad51Δ) were spotted in 5-fold serial dilutions on 
MMS-containing media and assayed for growth after two days. B The 
spontaneous mutagenesis rate of the slx4-S486A mutant is similar to WT. A 
forward mutagenesis assay was performed using a CAN1 tester strain and 
resistance to canavanine. Fluctuation analysis was carried out with 10 
independent cultures. Colonies on canavanine-containing plates were 
counted and mutation rates were determined using a maximum-likelihood 
approach. The mean from 2 independent experiments is shown. Error bars 
represent standard deviations. C Up-regulation of HR at replication forks does 
not rescue the MMS hyper-sensitivity of slx4-S486A mutants. Strains 
expressing WT Slx4 or slx4-S486A in combination with siz1Δ or srs2ΔC were 
spotted as in A.  
 
 
Figure S6. 
The Slx4-Dpb11 complex is involved in JM resolution by Mus81-Mms4 
and functions separately from Sgs1, Yen1 and Rad1-Rad10.  
A DNA joint molecules form to a similar extent in sgs1Δ and sgs1Δ slx4-
S486A. Cells were treated with 0.033% MMS in S-phase and after 90’, 150’ 
and 210’ X-shaped JMs were visualized as spike signals in 2D gels. B JM 
structures are resolved slower in slx4Δ tc-sgs1 cells. A conditional sgs1 (tc-
sgs1) allele was used because of sgs1Δ slx4Δ lethality (Mullen et al. 2001). In 
the tc-sgs1 allele, Sgs1 translation is prevented upon addition of tetracycline 
(Gonzalez-Huici et al. 2014). Cells were treated with a pulse of MMS in S-
phase and the profile of recombination intermediates was examined 0 h, 2 h, 
3 h, 4 h and 6 h after release from MMS. X-shaped JMs were visualized as 
spike signal in 2D gels in tc-sgs1 and slx4Δ tc-sgs1 mutants. C The JM 
resolution defect in slx4-S486A mutants is weaker than in mms4Δ and both 
mutants show epistasis. Tc-sgs1 inactivation and experiment as in B, but 
samples were examined 0 h, 2 h, 3 h, 4 h and 5 h after release from MMS.  D 
The Slx4-Dpb11 complex function in response to MMS is not related to the 
structure-specific endonucleases Rad1-Rad10, Slx1 or Yen1. Strains 
expressing slx4-S486A as endogenous copy of Slx4 alone or in combination 
with rad1Δ, slx1Δ and yen1Δ were spotted in 5-fold serial dilutions on MMS-
containing media and assayed for growth after two days. E The yen1Δ 
increases MMS sensitivity of the sgs1Δ slx4-S486A double mutant, but not of 
either single mutant. yen1Δ, sgs1Δ, slx4-S486A mutants alone and double 
and triple mutant combinations were spotted as in D. 
 
Figure S7. 
Slx4 and Mus81 structures co-localize with Dpb11 anaphase bridge. A 
Quantification of Slx4 and Mus81 foci and bridges at Dpb11 anaphase 
bridges. WT or sgs1∆ cells expressing Dpb11CFP and Slx4YFP, Slx4-S486AYFP 
or Mus81YFP were subjected to live cell fluorescence microscopy. 
Representative examples of Slx4 and Mus81 foci and bridges co-localizing 
with Dpb11 anaphase bridges are shown. Scale bar, 3 µm. Yellow arrowhead 
marks foci. Error bars correspond to 95% confidence intervals. B Slx4YFP and 
Mus81YFP show a partial co-localization with Dpb11CFP in spontaneous and 
DNA damage induced foci. Cells were treated with 0.03% MMS or 200 µg/ml 
zeocin for 1 h and co-localization (green arrow) of Dpb11CFP with Slx4YFP (top 
panel) and Mus81YFP (lower panel) in foci was scored manually. Error bars 
correspond to 95% confidence intervals. Arrowheads mark foci. 
 
Figure S8.  
Mus81-Mms4 forms a complex with Dpb11 and Slx4. 
A Mus81-Mms4 from mitotic cells binds specifically to Dpb11, Slx4 and 
Rtt107. A SILAC MS experiment comparing an Mms43FLAG IP to a control IP 
from an untagged strain using 15N2 13C6 lysine (Lys8) and Lys-C digestion is 
shown. All cells were arrested in mitosis by nocodazole. H/L ratios from two 
label-switch experiments without ratio count cut-off are plotted. #, as the only 
protein of the analysis Dpb11 displayed exclusively peptides, which were 
derived from the Mms43FLAG IP samples, but not the control samples, making 
Dpb11 a highly specific interactor of Mus81-Mms4. B Slx4, Dpb11 and 
Mus81-Mms4 are part of one multi-protein complex. Mms43FLAG 
immunoprecipitates (as in A) from G2/M arrested cells were subjected to 
glycerol gradient (10%-30%) centrifugation. Slx4, Dpb11 and Mms4 co-
migrate in fractions 18-20 (marked by box), corresponding to a multi-protein 
complex with an apparent molecular weight of 1-1.5 MDa. Arrowheads 
indicate elution peaks of single proteins. C The Dpb11-Mms4 interaction is 
independent of Slx4. Two-hybrid analysis in WT and slx4Δ cells with Gal4-BD-
Dpb11 and Gal4-AD-Mms4. D Dpb11 and Slx4 binding to Mms4 is partially 
phosphatase-sensitive. Mms43FLAG immunoprecipitates (as in A) from G2/M 
arrested cells were either mock treated or treated with 24,000 U/ml λ-
phosphatase for 20 min at 4°C. Shown is the phosphatase eluate and a 
3xFLAG peptide-eluate of the remaining bound material.  
 
 
 
Figure S9.  
Mus81-Mms4 show a Cdc5-dependent association with Slx4-Dpb11 in 
mitosis. A Mms4 interaction with the Slx4-Dpb11 complex is dependent on 
Polo-like kinase Cdc5 activity. CDC5 was expressed from a pGAL1-10 
promoter. Cells were grown in raffinose-containing medium, arrested in G1, 
then expression was either induced in G1 by switching cells to galactose-
containing medium prior to G2/M arrest (lane 2) or shut-off in G1 by switching 
cells to glucose-containing medium (lane 3). Co-immunoprecipitations of 
Mms43FLAG were performed from the corresponding cell extracts and tested 
for binding to Dpb11 and Slx4. B CDK activity is not influenced by interfering 
with Cdc5 activity. TCA samples of experiments shown in Fig. 5C and 
Fig. S9A were tested for CDK-mediated phosphorylation of Rad9-T474 by 
using a phospho-specific antibody in western blot analysis. The asterisk 
denotes a cross-reactive band. C The Slx4-Dpb11 interaction is not 
dependent on the Polo-like kinase Cdc5. Co-immunoprecipitation of Dpb11 
and Slx43FLAG from G2/M arrested cells or G2/M arrested cells, in which Cdc5 
has been inactivated by using the cdc5-as1 allele and 10 µM CMK. D The 
formation of the Slx4-Dpb11-Mms4-Mus81 complex is not influenced by the 
presence of DNA damage. Co-immunoprecipitation samples of Mms43FLAG 
cell extracts from G2/M arrested cells, which were either damaged by 
50 µg/ml phleomycin or left untreated, were tested for binding to Dpb11 and 
Slx4. E Cell cycle regulation of Mus81-Mms4 nuclease activity remains intact 
in the slx4-S486A mutant. Mms43FLAG and control IPs from cells arrested at 
G2/M with nocodazole (see lower panel for the inputs) were incubated with 
fluorescence-labelled Holliday junction, replication fork and nicked Holliday 
junction substrates. 
 
Figure S10. 
Partial inactivation of the DNA damage checkpoint rescues the defects 
of the slx4-S486A mutant in response to MMS. 
A A partial defect in DNA damage checkpoint signalling suppresses the slx4-
S486A mutant hyper-sensitivity to MMS. Strains expressing slx4-S486A in 
combination with mutants defective in DNA damage checkpoint signalling 
(dot1Δ, ddc1-T602A and rad53-3HA) were spotted in 5-fold serial dilutions on 
MMS-containing media and assayed for growth after two days. B The slx4-
S486A mutant recovers faster after a partial inactivation of the DNA damage 
checkpoint. WT, slx4-S486A and slx4-S486A ddc1-T602A mutant cells were 
treated with a pulse of 0.033% MMS during S-phase, and recovery was 
analysed by cellular DNA content as determined by FACS (upper panel) and 
by checkpoint activity as determined by anti-Rad53 western blot (lower panel). 
C Yen1 and Sgs1 are not required for the rescue of the slx4-S486A MMS 
hyper-sensitivity by partial checkpoint inactivation. MMS hyper-sensitivity 
phenotypes of slx4-S486A, sgs1Δ, yen1Δ, ddc1-T602A mutants and double or 
triple mutant combinations were spotted in 5-fold serial dilutions on MMS-
containing media and assayed for growth after two (lower panel) or three 
(upper panel) days. 
 
Supplemental Methods 
 
Yeast strains  
All yeast strains are based on W303 (Thomas and Rothstein 1989). 
Genotypes are listed below. All biochemical experiments were performed in a 
W303-1A pep4Δ background. The genetic studies in Fig. 3B-E, 4, 6A-E and 
Fig. S3A-B, S4B-D, S5, S6, S10 were performed in a W303 RAD5+ 
background to exclude any effect from a partial defect of the rad5-535 allele, 
but similar results were obtained using W303-1A. Two-hybrid analyses were 
performed in the strain PJ69-7A (James et al. 1996). 
S. cerevisiae strains were prepared by genetic crosses and transformation 
techniques. Deletion of particular genes and endogenous protein tagging 
were performed as described (Knop et al. 1999). Correct integrations were 
checked by genotyping PCR. Denaturing cell extracts were prepared by 
alkaline lysis and TCA precipitation (Knop et al. 1999). The slx4-S486A allele 
was generated using site-directed mutagenesis and integrated as a linear 
plasmid at the TRP1 locus.  
 
List of strains used in this study.  
Strain Full genotype Relevant genotype Source 
1093-5A MATa ADE2+ RAD5+ CAN1+ 
ura3-1 his3-11,15 trp1-1 leu2-
3,112 
CAN1+ Klein lab  
FY1060 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 trp1-1 leu2-3,112 
can1-100 GAL PSI+ sgs1::HIS3 
sgs1 Branzei 
lab  
HY4021 MATa RAD5+ ade2-1 trp1-1 leu2-
3,112 his3-11,15 ura3-1 can1-100 
sgs1::pADH1-tc3-3xHA-Sgs1 
Tc-SGS1 Branzei 
lab  
(NATMX) 
HY4072 MATa RAD5+ ade2-1 trp1-1 leu2-
3,112 his3-11,15 ura3-1 can1-100 
slx4::HIS3 sgs1::pADH1-tc3-
3xHA-Sgs1 (HPHMX4) 
slx4 Tc-SGS1 Branzei 
lab  
ML664-
10A 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-YFP::KanMX NLS-
yEmRFPrv::URA3 SPC110-
CFP::KAN 
DPB11-YFP 
SPC110-CFP 
Lisby lab 
ML678-
12B 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-YFP::KanMX NLS-
yEmRFPrv::URA3 SPC110-
CFP::KanMX sgs1::HIS3 
DPB11-YFP 
SPC110-CFP sgs1 
Lisby lab 
ML779-4A MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-YFP::KanMX NLS-
yEmRFPrv::URA3 SPC110-
CFP::KanMX slx4::KanMX 
DPB11-YFP 
SPC110-CFP slx4 
Lisby lab 
ML781-
8D 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-YFP::KanMX NLS-
yEmRFPrv::URA3 SPC110-
CFP::KanMX slx4::KanMX trp1-
1::slx4-S486A::TRP1 
DPB11-YFP 
SPC110-CFP slx4 
slx4-S486A 
Lisby lab 
ML798-
4C 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-YFP::KanMX NLS-
yEmRFPrv::URA3 SPC110-
CFP::KanMX slx4::KanMX trp1-
1::slx4-S486A::TRP1 sgs1::HIS3 
DPB11-YFP 
SPC110-CFP slx4 
slx4-S486A sgs1 
Lisby lab 
ML789-
7D 
MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
tTA(tetR-VP16)-tetO2-DPB11-
4ala-CFP::KanMX SLX4-4ala-
YFP 
DPB11-CFP 
SLX4-YFP 
Lisby lab  
ML799-
2C 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-CFP::KanMX SLX4-
YFP sgs1::HIS3 
DPB11-CFP 
SLX4-YFP sgs1 
Lisby lab 
ML806-
3C 
MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-CFP::KanMX slx4-
S486A-YFP 
DPB11-CFP slx4-
S486A-YFP 
Lisby lab 
ML806-3A MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-CFP::KanMX slx4-
S486A-YFP sgs1::HIS3 
DPB11-CFP slx4-
S486A-YFP sgs1 
Lisby lab 
ML792-
2D 
MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
DPB11-CFP 
MUS81-YFP 
Lisby lab  
tTA(tetR-VP16)-tetO2-DPB11-
4ala-CFP::KanMX MUS81-4ala-
YFP 
ML800-9A MATa tTA(tetR-VP16)-tetO2-
DPB11-4ala-CFP::KanMX 
MUS81-YFP sgs1::HIS3 
DPB11-CFP 
MUS81-YFP sgs1 
Lisby lab 
Y2050 MATα ade2-1 trp1-1 his3-11 his3-
15 can1-100 leu2-
112::URA3::leu2-k 
leu2-
112::URA3::leu2-k 
Jentsch 
lab  
YBP388 MATa ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 leu2-
3,112::pep4::LEU2 
pep4 This 
study 
YBP392 MATa ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 trp1-
1::bar1::TRP1 leu2-
3,112::pep4::LEU2 
bar1 pep4 This 
study 
YBP418-1 MATa ade2-1 ura3-1 his3-11,15 
can1-100 lys1::NAT-NT2 
arg4::hph-NT1 trp1-1::bar1::TRP1 
leu2-3,112::pep4::LEU2 SLX4-
3FLAG::KanMx4 
lys1 SLX4-3FLAG This 
study 
YBP420 MATa ade2-1 ura3-1 his3-11,15 
can1-100 arg4::hph-NT2 
lys1::NAT-NT1 leu2-
3,112::pep4::LEU2 trp1-
1::bar1::TRP1 
lys1 arg4  This 
study 
YBP422 MATa ade2-1 ura3-1 his3-11,15 
can1-100 arg4::hph-NT2 
lys1::NAT-NT1 leu2-
3,112::pep4::LEU2 trp1-
1::bar1::TRP1 DPB11-
3FLAG::KanMx 
lys1 arg4 DPB11-
3FLAG 
This 
study 
YDG40 MATα ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 
slx4-S486A This 
study 
YDG66 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
rad51::natNT2 
rad51 This 
study 
YDG96 MATα ade2-1 trp1-1 his3-11 his3-
15 can1-100 leu2-
112::URA3::leu2-k slx4::kanMx 
slx4-S486A::TRP1 
leu2-
112::URA3::leu2-k 
slx4-S486A 
This 
study 
YDG126 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
rad1::hphNTI 
rad1 This 
study 
YDG134 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
slx1::hphNTI 
slx1 This 
study 
YDG135 MATa ade2-1 ura3-1 his3-11,15  
leu2-3,112 can1-100 slx4::KanMx 
trp1-1::slx4-S486A::TRP1 
slx1::hphNTI 
slx4-S486A slx1 This 
study 
YDG150 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
mms2::hphNTI 
mms2 This 
study 
YDG151 MATα ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1 
mms2::hphNTI 
slx4-S486A mms2 This 
study 
YDG175 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
rad5::hphNTI 
rad5 This 
study 
YDG182 MATa ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1 
rad51::hphNT1 
slx4-S486A rad51 This 
study 
YDG183 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
rev1::hphNT1 
rev1 This 
study 
YDG184 MATa ade2-1 ura3-1 his3-11,15  
leu2-3,112 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1 
rev1::hphNT1 
slx4-S486A rev1 This 
study 
YDG185 MATa ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 
rev3::hphNT1   
rev3 This 
study 
YDG186 MATa ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1 
rev3::hphNT1 
slx4-S486A rev3 This 
study 
YDG187 MATa ade2-1 ura3-1 his3-11,15  
trp1-1 leu2-3,112 can1-100 
rad30::hphNT1 
rad30 This 
study 
YDG188 MATa ade2-1 ura3-1 his3-11,15 
leu2-3,112 can1-100 slx4::kanMx 
slx4-S486A rad30 This 
study 
trp1-1::slx4-S486A::TRP1 
rad30Δ::hphNT1 
YDG189 MATa RAD5+ ade2-1 ura3-1 
leu2-3,112 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1  his3-
11,15::sgs1::HIS3 
slx4-S486A sgs1 This 
study 
YDG190 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 can1-100 
slx4::kanMx trp1-1::slx4-
S486A::TRP1 
slx4-S486A This 
study 
YDG206 MATα RAD5+ CAN1+ ADE2+ 
ura3-1 his3-11,15 leu2-3,112 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 
CAN1+ slx4-
S486A 
This 
study 
YDG207 MATa CAN1+ ADE2+ ura3-1 
his3-11,15 trp1-1 leu2-3,112 
rad5::hphNT1 
CAN1+ rad5 This 
study 
YDG209 MATa ade2-1 his3-11,15 trp1-1 
leu2-3,112 can1-100 
rad5::hphNT1 ura3-
1::RAD5+::URA3 
rad5 RAD5+ This 
study 
YDG211 MATa ade2-1 his3-11,15 trp1-1 
leu2-3,112 can1-100 
rad5::hphNT1 ura3-1::rad5+-
C914S::URA3 
rad5+-C914S This 
study 
YDG212 MATa ade2-1 his3-11,15  leu2-
3,112 can1-100 slx4::kanMx4 
trp1-1::slx4-S486A::TRP1 
rad5::hphNT1 ura3-
1::RAD5+::URA3 
slx4-S486A rad5Δ 
RAD5+ 
This 
study 
YDG214 MATa ade2-1 his3-11,15  leu2-
3,112 can1-100 slx4::kanMx4 
trp1-1::slx4-S486A::TRP1 
rad5::hphNT1 ura3-1::rad5+-
C914S::URA3 
slx4-S486A rad5+-
C914S 
This 
study 
YDG217 MATa RAD5+ ade2-1 his3-11,15  
trp1-1 ura3-1 leu2-3,112 can1-
100 srs2ΔC::hphNT1 
srs2ΔC This 
study 
YDG218 MATa RAD5+ ade2-1 his3-11,15 
ura3-1 leu2-3,112 can1-100  
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 srs2ΔC::hphNT1 
slx4-S486A 
srs2ΔC 
This 
study 
YDG219 MATa RAD5+ ade2-1 his3-11,15  siz1 This 
trp1-1 ura3-1 leu2-3,112 can1-
100 siz1::hphNT1 
study 
YDG220 MATa Rad5+ ade2-1 his3-11,15 
ura3-1 leu2-3,112 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 siz1::hphNT1 
slx4-S486A siz1 This 
study 
YDG240 MATa ade2-1 his3-11,15 trp1-1 
leu2-3,112 can1-100 
rad5::hphNT1 ura3-1::rad5+-
KT538,539AA::URA3 
rad5+-
KT538,539AA 
This 
study 
YDG241 MATa ade2-1 his3-11,15 leu2-
3,112 can1-100 rad5::hphNT1 
ura3-1:rad5+-
KT538,539AA::URA3 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 
slx4-S486A rad5+-
KT538,539AA 
This 
study 
YDG251 MATa RAD5+ ade2-1 leu2-3,112 
ura3-1 trp1-1 can1-100 his3-
11,15::rad53-3HA::HIS3 
rad53-3HA This 
study 
YDG252 MATa RAD5+ ade2-1 leu2-3,112 
ura3-1 can1-100 slx4Δ::kanMx4 
trp1-1::slx4-S486A::TRP1 his3-
11,15::rad53-3HA::HIS3 
slx4-S486A rad53-
3HA 
This 
study 
YDG287 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 dot1::natNT2 
slx4-S486A dot1 This 
study 
YDG288 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 ddc1-
T602A::natNT2 
slx4-S486A ddc1-
T602A 
This 
study 
YDG289 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 mms4::hphNT1 
mms4 This 
study 
YDG290 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 mms4::hphNT1 
slx4-S486A mms4 This 
study 
YDG291 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 yen1::hphNT1 
yen1 This 
study 
YDG292 MATa RAD5+ ade2-1 his3-11,15 slx4-S486A yen1 This 
leu2-3,112 ura3-1 can1-100  
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 yen1::hphNT1 
study 
YDG293 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100  
slx4::kanMx trp1-1::DPB11-slx4-
S486A::TRP1 
DPB11-slx4-
S486A 
This 
study 
YDG295 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 ddc1-
T602A::natNT2 yen1::hphNT1 
slx4-S486A ddc1-
T602A yen1 
This 
study 
YDG296 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 ddc1-T602A::natNT2 
yen1::hphNT1 
ddc1-T602A yen1 This 
study 
YDG329 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 trp1-1 leu2-3,112 
can1-100 sgs1::hphNT1 
sgs1 This 
study 
YDG303 MATa Rad5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 ddc1-T602A::natNT2 
ddc1-T602A This 
study 
YDG304 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 dot1::natNT2 
dot1 This 
study 
YDG309 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 ddc1-
T602A::natNT2 mms4::hphNT1 
slx4-S486A ddc1-
T602A mms4 
This 
study 
YDG310 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 ddc1-T602A::natNT2 
mms4::hphNT1 
ddc1-T602A mms4 This 
study 
YDG313 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 ddc1-
T602A::natNT2 sgs1::hphNT1 
slx4-S486A ddc1-
T602A sgs1 
This 
study 
YDG314 MATa RAD5+ ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-
100 ddc1-T602A::natNT2 
sgs1::hphNT1 
ddc1-T602A sgs1 This 
study 
YDG335 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 trp1-1 
can1-100 mus81Δ::hphNT1 
mus81 This 
study 
YDG336 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 can1-100 
slx4::kanMx4 trp1-1::slx4-
S486A::TRP1 mus81::hphNT1 
slx4-S486A mus81 This 
study 
YDG339 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 trp1-1 leu2-3,112 
can1-100 MMS4-3FLAG::hphNTI 
MMS4-3FLAG This 
study 
YDG340 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 can1-100 
slx4::kanMx trp1-1::slx4-
S486A::TRP1 MMS4-
3FLAG::hphNTI 
slx4-S486A 
MMS4-3FLAG 
This 
study 
 
 
 
 
YDG355 MATa RAD5+ ade2-1 his3-11, 15 
trp1-1 ura3-1 can1-100 
mms4::hphNTI leu2-
3,112::mms4SS184,201AA::LEU2 
mms4-
SS184,201AA 
This 
study 
YDG356 
MATa RAD5+ ade2-1 trp1-1 ura3-
1 can1-100 mms4::hphNTI leu2-
3,112::mms4SS184,201AA::LEU2 
his3-11,15::sgs1::HIS3 
mms4-
SS184,201AA 
sgs1 
This 
study 
YDG366 MATa RAD5+ ade2-1 his3-1,15 
leu2-3,112 ura3-1 can1-100 
slx4::kanMx trp1-1::slx4-
S486A::TRP1 ddc1-
T602A::natNT2 MMS4-
3FLAG::hphNTI 
slx4-S486A ddc1-
T602A MMS4-
3FLAG 
This 
study 
YDG375 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 can1-100 
slx4::NAT trp1-1::slx4-7A::TRP1 
slx4-T457A, 
T474A, S499A, 
T597A, S627A, 
S659A, S725A 
This 
study 
YDG376 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 trp1-1 leu2-3,112 
can1-100 yen1::hphNT1 
sgs1::natNT2 
yen1 sgs1 This 
study 
YDG377 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 can1-100 
slx4::kanMx trp1-1::slx4-
S486A::TRP1 yen1Δ::hphNT1 
sgs1::natNT2 
slx4-S486A yen1 
sgs1 
This 
study 
YKR44 MATa ade2-1 ura3-1 his3-11 
his3-15 can1-100 trp1-
1::bar1::TRP1 leu2-
3,112::pep4::LEU2 DPB11-9myc:: 
KanMX4 
DPB11-9myc This 
study 
YLP15 MATa ade2-1 ura3-1 his3-11 
his3-15 can1-100 trp1-
1::bar1::TRP1 leu2-
3,112::pep4::LEU2 lys1::nat-NT2 
lys1 This 
study 
YLP18 MATa ade2-1 ura3-1 can1-100 
trp1-1::bar1::TRP1 leu2-
3,112::pep4::LEU2 lys1::nat-NT2 
his3-11,15::SLX4-3FLAG::HisMx 
lys1 SLX4-3FLAG This 
study 
YLP30 MATa ade2-1 ura3-1 trp1-1 leu2-
3,112 can1-100 pep4::NAT 
slx4::KanMx his3-11,15::slx4-
S486A-3FLAG::HISMx 
slx4-S486A-
3FLAG 
This 
study 
YLP41 MATa ade2-1 ura3-1 trp1-1 leu2-
3,112 can1-100 his3-11,15::slx4-
S486A-3FLAG::HisMx pep4::NAT 
lys1::hph 
lys1 slx4-S486A-
3FLAG  
This 
study 
YLP42 MATa ade2-1 his3-11 his3-15 
can1-100 trp1-1::bar1::TRP1 
leu2-3,112::pep4::LEU2 SLX4-
3FLAG::KanMx4 ura3-
1::cdc28as-1 F88G::URA3 
SLX4-3FLAG 
cdc28-as1 
This 
study 
YLP43 MATa ade2-1 his3-11,15 can1-
100 lys1::hph trp1-1::bar1::TRP1 
leu2-3,112::pep4::LEU2 SLX4-
3FLAG::KanMx4 ura3-
1::cdc28as-1 F88G::URA 
lys1 SLX4-3FLAG 
cdc28-as1 
This 
study 
YLP47 MATa ade2-1 ura3-1 can1-100 
trp1-1::bar1::TRP1 leu2-
3,112::pep4::LEU2 his3-
11,15::DPB11-3Flag::HIS3 
DPB11-3FLAG This 
study 
YLP57 MATa RAD5+ ade2-1 ura3-1 trp1-
1 leu2-3,112 can1-100 MMS4-
3Flag::hphNTI his3-
11,15::pep4::HIS3 
MMS4-3FLAG This 
study 
YLP59 MATa ade2-1 ura3-1 trp1-1 leu2-
3,112 can1-100 MMS4-
3Flag::hph-NT1 his3-
11,15::pep4::HIS3Mx4 pGAL1-
MMS4-3FLAG 
pGal1-Cdc5 
This 
study 
CDC5::KanMx 
YLP62 MATa ade2-1 ura3-1 leu2-3,112 
can1-100 MMS4-3Flag::hph-NT1 
his3-11,15::pep4::HIS3Mx4 
slx4::KanMx trp1-1::slx4-
S486A::TRP1 
MMS4-3FLAG 
slx4-S486A 
This 
study 
YLP63 MATa RAD5+ ade2-1 ura3-1 trp1-
1 leu2-3,112 can1-100 cdc5-as1 
MMS4-3Flag::hph-NT1 his3-
11,15::pep4::HIS3Mx4 
MMS4-3FLAG 
cdc5-as1 
This 
study 
YLP64 MATa RAD5+ ade2-1 leu2-3,112 
ura3-1 can1-100 slx4::kanMx 
trp1-1::slx4-S486A::TRP1 
ddc1T602A:: natNT2 MMS4-
3Flag::hphNTI his3-
11,15::pep4::HIS3Mx4 
MMS4-3FLAG 
slx4-S486A ddc1-
T602A 
This 
study 
YLP78 MATa ade2-1 leu2-3,112 trp1-1 
ura3-1 can1-100 MMS4-
3Flag::hph-NT1 his3-
11,15::pep4::HIS3Mx4 
slx4::KanMx 
MMS4-3FLAG slx4 This 
study 
YLP80 MATa RAD5+ ade2-1 leu2-3,112 
ura3-1 can1-100 MMS4-
3Flag::hph-NT1 his3-
11,15::pep4::HIS3Mx4 
slx4::KanMx trp1-1::Slx4 T457A, 
T474A, S499A, T597A, S627A, 
S659A, S725A::TRP1 
MMS4-3FLAG 
slx4-T457A, 
T474A, S499A, 
T597A, S627A, 
S659A, S725A 
This 
study 
YLP83 MATa RAD5+ ade2-1 his3-1,15 
trp1-1 ura3-1 can1-100 leu2-
3,112::pep4::LEU2 SLX4-
3Flag::KanMx4 cdc5-as1 
SLX4-3FLAG 
cdc5-as1 
This 
study 
YLP87 MATa RAD5+ ade2-1 leu2-3,112 
trp1-1 ura3-1 can1-100 his3-
11,15::pep4::HIS 
pep4 This 
study 
YLP88 MATa RAD5+ ade2-1 leu2-3,112 
ura3-1 can1-100 slx4Δ::kanMx 
trp1-1::slx4-S486A::TRP1 MMS4-
3Flag::hphNTI his3-
11,15::pep4::HIS 
MMS4-3FLAG 
slx4-S486A 
This 
study 
YSB79 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 trp1-1 
can1-100 RFA1-
RFA1-3xmCherry This 
study 
3xmCherry::hphNT1 
YSB86 MATa RAD5+ ade2-1 ura3-1 
his3-11,15 leu2-3,112 trp1-1 
can1-100 RFA1-
3xmCherry::hphNT1 slx4::kanMx4 
trp1-1:Slx4-S486A::TRP1 
RFA1-3xmCherry  
slx4-S486A 
This 
study 
YSS3 MATa ade2-1 ura3-1 trp1-1 leu2-
3,112 can1-100 MMS4-
3Flag::hph-NT1 his3-
11,15::pep4::HIS3Mx4 
MMS4-3FLAG This 
study 
YSS5 MATa ade2-1 ura3-1 his3-11,15 
can1-100 trp1-1::bar1::TRP1 
leu2-3,112::pep4::LEU2 SLX4-
3Flag::KanMx4 
SLX4-3FLAG This 
study 
 
 
Synchronization by α-factor and nocodazole 
Logarithmic growing cells were synchronized in G2/M-phase by nocodazole 
(5 µg/ml), or in G1-phase by α-factor (5-10 µg/ml, or 167 ng/ml for bar1 cells). 
The release from synchronization was performed by washing once in YPD, 
and suspending cells in YPD with 0.033% or 0.04% MMS. For recovery 
experiments, cells were washed after 30’ (45’ in Fig. 6E, S3B) of damage 
treatment, and suspended in drug free YPD media with (Fig. 5D, 6E-F) or 
without nocodazole. 
 
Drug treatment 
DNA damage in liquid cultures was induced by MMS (final concentration 
0.033%, or 0.04% (Fig. 3C-E, 6D)) or phleomycin/zeocin (final concentration 
50 µg/ml). 
For solid media, concentrations of methyl methanesulfonate (MMS), 
hydroxyurea (HU), phleomycin, cisplatin, camptothecin (CPT) or 4-
nitroquinoline 1-oxide (4-NQO) were as indicated in the figures. 
 
FACS analysis 
1x107 - 2x107 cells were harvested by centrifugation and resuspended in 70% 
ethanol + 50 mM Tris pH 7.8. After centrifugation cells were washed with 1 ml 
50 mM Tris pH 7.8 (Tris buffer) followed by resuspending in 520 µl RNase 
solution (500 µl 50 mM Tris pH 7.8 + 20 µl RNase A (10 mg/ml in 10 mM Tris 
pH 7.5, 10 mM MgCl2) and incubation for 4 h at 37 °C. Next, cells were 
treated with proteinase K (200 µl Tris buffer + 20 µl proteinase K (10 mg/ml in 
50% glycerol, 10 mM Tris pH 7.5, 25 mM CaCl2) and incubated for 30' at 
50 °C. After centrifugation cells were resuspended in 500 µl Tris buffer. 
Before measuring the DNA content, samples were sonified (5''; 50% CYCLE) 
and stained by SYTOX solution (999 µl Tris buffer + 1 µl SYTOX). 
Measurement was performed using FL1 channel 520 for SYTOX-DNA on a 
BD FACSCalibur system. 
 
Interaction assays  
After cell growth under the indicated conditions, yeast extracts were obtained 
by freezer mill lysis in lysis buffer (100 mM Hepes, 200 mM KOAc, 0.1 % NP-
40, 10 % glycerol, 2 mM b-ME, protease inhibitors, 100 mM ocadaic acid, 10 
mM NaF, 20 mM b-glycerophosphate). Co-IP was performed for 2 hours by 
head-over-tail rotation at 4 °C using anti-FLAG agarose resin (Sigma). Non-
specific background was removed by six washes and bound proteins were 
eluted by incubation with 0.5 mg/ml 3X FLAG-peptide (Sigma). The TCA 
precipitated eluates were resolved on 4-12% NuPAGE gradient gels 
(Invitrogen), and analyzed by standard Western blotting techniques. 
For GST pulldowns (Fig. S1A), GST-Dpb11 or GST-tagged protein fragments 
were recombinantly expressed and purified as described (Pfander and Diffley 
2011). Proteins were immobilizied on glutathione sepharose 4B (GE 
Healthcare) and incubated with ammonium sulphate-precipitated (57%) yeast 
extracts (lysis buffer as described above). Non-specific background was 
removed by five washes and bound proteins were eluted by Laemmli buffer. 
For Co-IP from HEK 293T cells were lysed in lysis buffer (see yeast lysates) 
for 30’ on ice. Protein concentrations were determined by Bradford. GFP-
tagged proteins were precipitated using GFP-Trap magnetic beads 
(Chromotek) and incubated for 1.5 h with head-over-tail rotation. Non-
specifically bound proteins were removed by 6 washes with lysis buffer using 
a magnetic rack, and specifically bound proteins were eluted by Laemmli 
buffer.   
 
Analysis of interacting proteins by SILAC 
For Co-IP experiments followed by mass spectrometry analysis, cells deficient 
in lysine biosynthesis were grown in synthetic complete (SC) medium 
supplemented with normal lysine (“light” medium) or heavy-isotope-labeled 
lysine (Lys8; “heavy” medium) from Cambridge Isotope Laboratories.  
For SILAC Co-IP experiments shown in Fig. S4A, cells deficient in lysine and 
arginine biosynthesis were grown in synthetic complete (SC) medium 
supplemented with normal lysine and arginine (“light” medium) or heavy-
isotope-labeled lysine and arginine (Lys8, Arg10; “heavy” medium) from 
Cambridge Isotope Laboratories. All other SILAC experiments were done 
using lysine-only labeling. 
Lysates were prepared by harvesting cells in equal amounts after growth 
under the indicated conditions. After co-IP, eluted proteins from light and 
heavy cultures were pooled, TCA precipitated and separated on 4-12% 
NuPAGE Bis-Tris gel (Invitrogen). The gel was stained with GelCode Blue 
(Thermo Scientific). The gel lane was excided into ten slices and peptides 
were analyzed by LC-MS/MS after in-gel Lys-C or trypsin digestion. Samples 
were measured on an LTQ-Orbitrap and analyzed using MaxQuant (Cox and 
Mann 2008). 
 
Antibodies 
Proteins were detected using specific antibodies: rabbit-anti-Rad53 (JD147, J. 
Diffley), rabbit-anti-Dpb11 (BPF19; Pfander and Diffley 2011), rabbit-anti-
Rad9-T474-P (BPF25, Pfander and Diffley 2011), rabbit-anti-Slx4 (2057, 
Pfander lab), goat-anti-Cdc5 (sc-6733, Santa Cruz), rabbit-anti-Clb2 (sc-9071, 
Santa Cruz), rabbit-anti-FLAG (Sigma), rabbit-HRP-coupled-anti-GST (Z-5; 
sc-459, Santa Cruz), mouse-anti-myc (clone 4A6; Millipore), mouse-anti-GFP 
(B2; Santa Cruz), mouse-anti-Gal4-AD (TA-C10; Santa Cruz), mouse-anti-
Gal4-BD (RK5C1; Santa Cruz). 
 
Pulsed-field gel electrophoresis 
In the recovery experiments (Fig. 3D, 6B, S3B) 8x107 of cells were taken for 
every time point and centrifuged at 5,000 x g 10 min at 4 °C. Cells were 
resuspended in 1 ml cold 0.1% sodium azide and centrifuged at 3,000 rpm for 
3 min. Remaining pellets were resuspended in 50 µl zymolyase buffer (50 mM 
EDTA, 10 mM Tris pH 8.0, 20 mM NaCl, 1 mg/ml zymolyase (T100)) and 
mixed with equal amount of 2% agarose. The samples were transferred to the 
plug mold. The plugs were incubated in zymolyase buffer at 37 °C for 1 h, 
followed by treatment with proteinase K (0.5 M EDTA pH 8.0, 1 mg/ml 
proteinase K, 10 mg/ml sodium lauryl sarcosine) at 50 °C for 24-48 h. Next, 
the plugs were washed 3 times with 50 mM EDTA and loaded. 
Electrophoresis was performed using the CHEF-DRIII pulsed-field 
electrophoresis system (Bio-Rad) according to the manufacturer’s 
instructions. The gel was stained with 1 µg/ml ethidium bromide and scanned 
under UV light. Quantification of PFGE signals was performed using ImageJ. 
For every time point the signal from the bands that have entered the gel was 
normalized to the total signal in the lane including that from the well, and the 
values from every time point were normalized relative to the G1 signal. 
 
2D gel analysis and quantification of replication/recombination 
intermediates 
The experiments were conducted as described previously (Szakal and 
Branzei, 2013). The DNA samples were digested with HindIII and EcoRV and 
analysed with probes for ARS305. In all, 200 ml cultures (2-4x109 cells) were 
arrested by addition of sodium azide (final concentration 0.1%) and cooled 
down in ice. Cells were harvested by centrifugation, washed in cold water, 
and incubated in spheroplasting buffer (1 M sorbitol, 100 mM EDTA pH 8.0, 
0.1% b-ME, and 50 U zymolase/ml) for 1.5 h at 30 °C. In all, 2 ml water, 200 
µl RNase A (10 mg/ml), and 2.5 ml Solution I (2% w/v cetyl-trimethyl-
ammonium-bromide (CTAB), 1.4 M NaCl, 100 mM Tris-HCl pH 7.6, and 25 
mM EDTA pH 8.0) were sequentially added to the spheroplast pellets and 
samples were incubated for 30 min at 50 °C. In all, 200 µl proteinase K (20 
mg/ml) was then added and the incubation was prolonged at 50 °C for 1 h 30 
min, and at 30 °C overnight. The sample was then centrifuged at 4,000 rpm 
for 10 min: the cellular debris pellet was kept for further extraction, while the 
supernatant was extracted with 2.5 ml chloroform/isoamylalcohol (24/1) and 
the DNA in the upper phase was precipitated by addition of 2 volumes 
Solution II (1% w/v CTAB, 50 mM Tris-HCl pH 7.6, and 10 mM EDTA) and 
centrifugation at 8,500 rpm for 10 min. The pellet was resuspended in 2 ml 
Solution III (1.4 M NaCl, 10 mM Tris-HCl pH 7.6, and 1 mM EDTA). Residual 
DNA in the cellular debris pellet was also extracted by resuspension in 2 ml 
Solution III and incubation at 50 °C for 30 min, followed by extraction in 1 ml 
chloroform/isoamylalcohol (24/1). The upper phase was pooled together with 
the main DNA preparation. Total DNA was then precipitated with 1 volume 
isopropanol, washed with 70% ethanol, air dried, and finally resuspended in 
TE 1X. Quantification of X-shaped intermediate signals was performed using 
the Image Quant software as previously described (Liberi et al. 2005; Branzei 
et al. 2008; Vanoli et al. 2010). For each time point, areas corresponding to 
the monomer spot (M), the X-spike signal and a region without any replication 
intermediates as background reference were selected and the signal 
intensities (SIs) in percentage of each signal were obtained. The values for 
the X and monomer were corrected by subtracting from the SI value the 
background value after the latter was multiplied for the ratio between the 
dimension of the area for the intermediate of interest and for background. 
Thus, the values for X and M were calculated in the following way: 
Value for X=SI (Xs)-(SI (background) (area (Xs)/area (background)); 
Value for M=SI (M)-(SI (background) (area (M)/area (background)). 
The relative SI for the X was then determined by dividing the value for X with 
the sum of the total signals (the sum of the X and monomer values). The 
resulting values for X signals were then normalized. For instance, for recovery 
experiments the relative value of X obtained after MMS treatment was 
considered as 100% and the other X values were normalized to it. 
 
Mutation and recombination assays 
Mutation rates were determined using a CAN1 forward mutation assay (Klein 
2001). Interchromosomal recombination rates were determined using a direct-
repeat system using leu2 heteroalleles (Aquilera and Klein 1988) and 
crossover rates were determined using a system harbouring two arg4 alleles 
on chromosome V and VIII (Robert et al. 2006, Szakal and Branzei 2013). In 
all cases mutation/recombination rates were determined using fluctuation 
analysis and a maximum-likelihood approach. Therefore, for each strain ten 
independent cultures originated from the single cell were analyzed. To get 
single colonies 100 cells were plated or streaked out for single colonies on 
YPD media plates and incubated for 2 days at 30 °C. The frequency of 
mutants/recombinants in all cultures was determined by plating on selective 
media. The total cell number was determined by plating an appropriate 
dilution on non-selective media. For determination of CO rates, for each 
culture ten ARG+ colonies were picked, analyzed by PCR for CO or NCO 
events (Szakal and Branzei 2013) and the overall number of crossover 
recombinants was extrapolated. From the number of 
mutants/recombinants/crossover recombinants the number of 
mutational/recombinational/crossover events was determined using a 
maximum-likelihood approach and rates were determined by dividing by the 
number of cell divisions (Pfander et al. 2005). For each strain 2-10 
independent experiments were performed to determine mean and standard 
deviation.   
 
Microscopy and immunofluorescence 
Yeast cells were grown in synthetic complete (SC) medium supplemented 
with 100 µg/ml adenine (SC+Ade) and processed for fluorescence microscopy 
as described (Eckert-Boulet et al. 2011). For staining of DNA in live yeast 
cells, 5 µg/ml of Hoechst 33258 (B2883, Sigma-Aldrich) were added to the 
culture 10-15 min prior to microscopy and washed out with fresh medium 
immediately prior to microscopy and imaged at 25 °C. Fluorophores used in 
yeast were cyan fluorescent protein (CFP, clone W7) (Heim and Tsien 1996) 
and yellow fluorescent protein (YFP, clone 10C) (Ormo et al. 1996). 
Microscopy was performed using an AxioImager Z1 (Carl Zeiss MicroImaging, 
Inc) equipped with a 100x objective lens (Zeiss PLAN-APO, NA 1.4), a cooled 
Orca-ER CCD camera (Hamamatsu, Japan), differential interference contrast 
(DIC), and a Zeiss HXP120C illumination source, or on a Deltavision Elite 
microscope (Applied Precision, Inc) equipped with a 100x objective lens 
(Olympus U-PLAN S-APO, NA 1.4), a cooled Evolve 512 EMCCD camera 
(Photometrics, Japan), and a Insight solid state illumination source (Applied 
Precision, Inc). Images were acquired using Volocity (PerkinElmer) or 
softWoRx (Applied Precision, Inc) software. Images were acquired and 
processed using Volocity (PerkinElmer) software. Images were 
pseudocoloured according to the approximate emission wavelength of the 
fluorophores. 
For analysis of RPA foci (Fig. 3F) cells were grown in SC media, arrested with 
α-factor and treated in S-phase with 0.033% MMS for 120 min, then released 
into the fresh SC media for recovery. For microscopy cells were fixed in FA for 
30 min and quenched in 2.5 M glycine for 30 min. Cells were washed twice 
and resuspended in 50 mM Tris, pH 7.5. Images of cells were obtained using 
a fully automated Zeiss inverted microscope (AxioObserver Z1) equipped with 
a MS-2000 stage (Applied Scientific Instrumentation, USA), a CSU-X1 
spinning disk confocal head (Yokogawa, Herrsching), LaserStack Launch with 
selectable laser lines (Intelligent Imaging Innovations, USA) and an X-CITE 
Fluorescent Illumination System. Images were captured using a CoolSnap HQ 
camera (Roper Scientific, Canada) under the control of the Slidebook 
software (Intelligent Imaging Innovations, USA). All fluorescence signals were 
imaged with a 63x oil objective.   
 
Cell culture and transfection techniques 
HEK 293T cells were cultured at 37 °C at 7.5% CO2 in DMEM (GIBCO-BRL) 
supplemented with 10% FCS. Transient transfections were performed in 6-
well plates (HeLa) using the calcium phosphate method. In general 5x105 
293T cells per well were seeded and transfected the next day using 20 µg 
total DNA. After 4-6 h incubation the TF medium was replaced with fresh 
growth medium, and cells were cultured for another 18-20 h.  
 
Nuclease assays  
5’-end-Cy3-labeled oligonucletides were used to prepare synthetic DNA 
substrates as described (Rass & West 2006). Nuclease assays were carried 
out with immobilized Mms4-FLAG. The Anti-FLAG immunoprecipitates were 
extensively washed and mixed with 10 µl reaction buffer (50 mM Tris-HCl pH 
7.5, 3 mM MgCl2) containing ~2.5 nM 5’-Cy3-end-labeled substrate (Matos et 
al 2011). Reactions were incubated for 15-45 min with gentle rotation at 30 °C 
and stopped by addition of 4 µl 10 mg/ml proteinase K and 2% SDS, and 
further incubation at 37 ºC for 1 h. Loading buffer was added and radiolabeled 
products were separated by 10% PAGE, and analyzed using a Typhoon 
scanner. 
 
Sequence analysis 
Close orthologues of budding yeast and human Slx4 were found by NCBI-
BLAST (Altschul et al. 1997) and verified by reciprocal BLAST searches. 
Individual multiple sequence alignments of fungal and mammalian Slx4 were 
done using ClustalX (Chenna et al. 2003). The Profile Alignment feature was 
used in ClustalX to align the two profiles from mammalian and fungal Slx4 
proteins. This identified the potential Dpb11/TopBP1 interaction motif in 
human Slx4. Slx4 proteins from further classes were identified by BLAST and 
first aligned with members of their individual class using ClustalX. Resulting 
multiple sequence alignments were manually analyzed for the occurrence of 
the Dpb11/TopBP1 motif and subsequently manually aligned to the yeast and 
mammalian motif. 
 
Species abbreviations and accession numbers for Figure S2. 
Sp Schizosaccharomyces pombe NP_594064 
Sc Saccharomyces cerevisiae NP_013236 
Kl Kluyveromyces lactis XP_453790 
Ec Eremothecium cymbalariae XP_003646141 
Nc Naumovozyma castellii XP_003928518 
Ka Kazachstania naganashii CCK71307 (emb) 
Td Toluraspora delbrueckii XP_003682477 
Zr Zygosaccharomyces rouxii XP_002497655 
Vp Vanderwaltozyma polyspora XP_001647185 
Lt Lachancea thermotolerans  XP_002555561 
Hs Homo sapiens NP_115820 
Sb Samiri b. boliviensis  XP_003928518 
Mm Mus musculus NP_803423 
Rn Rattus norvegicus XP_001079342 
Sh Sacrophilus harrisii XP_003761955 
Tm Trichechus manatus latirostris XP_004373478 
Oo Orcinus orca XP_004270504 
Xt Xenopus tropicalis XP_002932505 
Dr Danio rerio XP_003201146 
Dm Drosophila melanogaster NP_648104 
Dg Drosophila grimshawi XP_001983575 
Dw Drosophila willistoni XP_002062409 
Cc Ceratitis capitata XP_004526156 
Ag Anopheles gambiae XP_001687887 
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